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Summary 
Inequalities in cancer survival outcomes can partly be explained by prolonged cancer 
symptom presentation among socioeconomically deprived groups. This PhD aimed to (1) 
understand the barriers to cancer symptom presentation among low socioeconomic groups 
and (2) develop a targeted cancer awareness intervention to promote timely symptom 
presentation.  
The COM-B (Capability, Opportunity, Motivation-Behaviour) model was selected to guide 
understanding of the influences on cancer symptom presentation behaviour. Systematic 
review and qualitative methods (30 in-depth interviews and six focus groups) were 
employed to identify the factors influencing symptom presentation. Findings from these 
studies and a scoping review of cancer awareness interventions were used to inform 
intervention development, guided by the Behaviour Change Wheel. The intervention was 
tested for acceptability with two groups of potential users.  
The combination of poor cancer symptom knowledge, fearful and fatalistic beliefs about 
cancer, and barriers such as problems associated with obtaining and accessing a primary 
care appointment prolonged cancer symptom presentation among low socioeconomic 
groups. In addition, the wider social and environmental opportunities available to people 
from low socioeconomic groups including economic hardship and negative experiences of 
cancer were identified as key influences on behaviour.  
An intensive community group based educational session was developed targeted at current 
or former smokers and family members of smokers, aged 40 years or over from 
socioeconomically deprived communities. Content was developed to increase cancer 
symptom knowledge, modify beliefs and enable timely symptom presentation by utilising 
strong social networks in the community. Findings from user testing confirmed that group 
education was an acceptable mode of intervention delivery.  
Understanding the complex interaction between individual psychological characteristics and 
the wider environment in which people from low socioeconomic groups live in is essential 
for modifying cancer symptom presentation behaviour. Community education could be used 
as a strategy to engage low socioeconomic groups in early cancer detection and warrants 
further feasibility and pilot testing.  
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Chapter 1 
Introduction 
This PhD aims to achieve an in-depth understanding of the barriers to cancer symptom 
presentation among low socioeconomic groups using qualitative research methods and 
review methodology. The results will be used to develop a pilot cancer awareness 
intervention targeted at socioeconomically deprived communities to encourage timely 
presentation with potential cancer symptoms. The current chapter aims to provide an 
overview of the context and problem of cancer survival among low socioeconomic groups, 
and how the need to reduce socioeconomic inequalities in cancer outcomes is reflected in 
policy and initiatives. Encouraging earlier cancer symptom presentation through 
interventions will be discussed as a strategy for improving cancer outcomes. The rationale 
for a shift in focus for the current intervention content from generic cancer to lung cancer 
will be discussed in relation to changes in public policy. Finally, the aims and objectives of 
the PhD will be presented.  
1.1 Cancer survival in the UK 
 
Overall survival rates for cancer are improving.  In the UK, 10 year survival has doubled over 
the past 40 years and around half of those living in the UK diagnosed with cancer can expect 
to survive for 10 years or more (Cancer Research UK, 2015a). However, there is large 
variation across tumour sites, where 10 year survival ranges from 3% in pancreatic cancer to 
98% in testicular cancer (Cancer Research UK, 2015a). In addition, when compared with 
similar countries within Europe, survival rates for cancer have been consistently lower in the 
UK (Sant et al, 2001; Berrino, 2009; Sant et al, 2009; Verdecchia et al, 2009; Coleman et al, 
2011; Foot and Harrison, 2011) and may be linked to socioeconomic inequalities in cancer 
outcomes (Machenbach et al, 2003; Sant et al, 2003; Rachet et al, 2010; Ellis et al, 2012; 
McPhail et al, 2015). It has been estimated that around 5000 deaths from cancer annually 
would be avoided if survival in England was comparable to the European average (Abdel-
Rahman et al, 2009; Richards, 2009a).  
 
Through earlier diagnosis of cancer, survival outcomes can be improved (McPhail et al, 
2015). Early detection of cancer can be achieved through screening programmes and prompt 
symptomatic presentation. Socioeconomic inequalities in cancer screening uptake and the 
timeliness of presenting with symptoms to a primary care doctor partly explain poorer 
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cancer survival outcomes among low socioeconomic groups in the UK, with people from 
socioeconomically deprived groups less likely to engage in screening and/or more likely to 
prolong symptom presentation (Macleod et al, 2009; McPhail et al, 2015). 
1.2 Socioeconomic inequalities in cancer incidence, survival and mortality 
 
People from low socioeconomic groups are more likely to receive a diagnosis of cancer, are 
less likely to survive cancer and are more likely to die from cancer compared to those from 
high socioeconomic groups (National Cancer Intelligence Network, 2014; Welsh Cancer 
Intelligence and Surveillance Unit, 2014; McPhail et al, 2015; Cancer Research UK Statistics, 
2015b). Whilst overall survival rates for cancer have improved, the rate of improvement is 
much faster amongst high socioeconomic groups, and as a consequence cancer survival 
inequalities are widened (Coleman et al, 2004; Lyratzopoulos et al, 2010). One, three and 
five year cancer survival is lowest and mortality is highest in the UK among low 
socioeconomic groups (Coleman et al, 2001; Rachet et al, 2010; Moller et al, 2012; Cancer 
Research UK Statistics, 2015b).  
 
The relationship between cancer outcomes and socioeconomic group is likely to reflect more 
advanced stage disease at diagnosis, where access to curative treatment is limited (Macleod 
et al, 2000; Shack et al, 2008a; Lyratzopoulos et al, 2013; McPhail et al, 2015). This can partly 
be explained by prolonged cancer symptom presentation (Macleod et al, 2009) and a high 
incidence of smoking-related cancers such as lung or head and neck cancers among low 
socioeconomic groups (Shack et al, 2008b; McDonald et al, 2014; Cancer Research UK 
Statistics, 2015c) which are harder to diagnose in the early stages (Birt et al, 2014; Neal et al, 
2014; Cancer Research UK Statistics, 2015c). These types of cancer have poor survival 
outcomes, with minimal improvement in survival rates in comparison to other cancer sites 
such as breast or prostate (Cancer Research UK Statistics, 2015a). Poor outcomes could 
reflect difficulties in detecting these types of cancer promptly due to vague and non-specific 
symptoms in the early stages, where individuals may perceive symptoms as not serious and 
therefore prolong symptom presentation (Birt et al, 2014; Neal et al, 2014).  
 
If inequalities in cancer outcomes were reduced, overall cancer survival could be improved. 
By eradicating socioeconomic inequalities at stage of diagnosis, it has been estimated that 
5600 patients in the UK annually could be diagnosed with earlier stage disease 
(Lyratzopoulos et al, 2013). Studies suggest that 11% of deaths from common cancer in the 
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UK could be avoided if 3 year survival in low socioeconomic groups matched that in high 
socioeconomic groups, accounting for approximately 7122 lives annually (Ellis et al, 2012).  
 
1.3 Characteristics of a low socioeconomic group  
 
1.3.1 Low socioeconomic group: a definition  
 
A low socioeconomic group can be defined as referring to individuals within a group or a 
collective group of individuals, who are socially and economically disadvantaged in relation 
to others (Kawachi et al, 2002). It is common for researchers to use the terms socioeconomic 
gradient, socioeconomic status or socioeconomic position. Such terms could be perceived as 
value-laden, therefore throughout this thesis, the terms socioeconomic group or 
socioeconomically deprived community will be used.  
 
Socioeconomic group can be measured using individual level indicators such as income, 
educational attainment and occupation, where lower annual income, lower educational 
attainment and manual or unskilled occupations are defined as representing low 
socioeconomic groups. Group level indicators such as postcode data can be used to indicate 
area level deprivation and are frequently used to measure socioeconomic group. There are 
strengths and limitations associated with the use of group and individual level indicators. 
Individual level indicators attempt to capture the assets of the individual and are relatively 
simple to measure (Galobardes et al, 2006a). However, some individual level indicators such 
as occupation or educational attainment are age relevant, where educational attainment 
level varies with different birth cohorts and an older study population is more likely to be 
retired, making socioeconomic group classification difficult. In addition, individual level 
indicators, particularly when measured in isolation, may not accurately represent an 
individual’s current social circumstances (Galobardes et al, 2006a). Therefore, it is important 
to measure multiple individual level indicators to overcome these limitations.  
 
Socioeconomic group level indicators are calculated using aggregated measures such as 
employment and crime rates in a pre-defined area for a collective group of individuals. 
These are usually calculated based on the most recent census or similar data available 
(Galobardes et al, 2006b). This can be problematic as the deprivation score assigned to an 
individual within the area may not fully represent the individual’s social circumstances: they 
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might live in a deprived area as defined by the area level indicator but are not experiencing 
social or economic hardship, or vice versa. In addition, when the pre-defined area is large, 
there is potential for misclassification of the particular area (Galobardes et al, 2006b). A 
combination of both individual and group level indicators is likely to overcome some of 
these issues and ensure a more complete indication of socioeconomic group.  
 
In Wales, postcode data can be used to generate a Welsh Index of Multiple Deprivation 
(WIMD) score, which is an area level socioeconomic group indicator. Wales has been 
organised into 1896 Lower Layer Super Output Areas (LSOAs) with approximately 1500 
people in each area. Each LSOA was ranked from 1 (the most deprived) to 1896 (the least 
deprived) (WIMD, 2011). Their WIMD score reflects this, for example a WIMD score of 1 
represents the most deprived LSOA in Wales. Scores are calculated based on employment, 
income, educational attainment, health, crime rates, geographical access to services, 
housing standards and quality of physical environment within the LSOA (WIMD, 2011).  
 
In an attempt to tackle poverty in Wales, the Welsh Government initiative ‘Communities 
First’ was set up. There are 52 Communities First clusters in Wales supporting the most 
deprived areas in Wales based on WIMD score. This PhD aims to target individuals within a 
low socioeconomic group defined as an individual living in the most deprived quartile (those 
with a WIMD score between 1 and 474) and/or those living in a ‘Communities First’ area. 
Due to the graded effect of deprivation and its association with cancer survival outcomes, 
those within a low rather than lower socioeconomic groups were targeted for this PhD in 
order to ensure that those in the most deprived areas were targeted. A low socioeconomic 
group is defined as the most deprived quartile, whereas a lower socioeconomic group could 
be defined as the lowest two quartiles.  
 
1.3.2 The social gradient in health  
 
Health inequalities can be defined as ‘uneven distributions of health benefits and disease 
burdens that are unjust, unfair and avoidable’ (Mabhala, 2014). The social gradient in health 
and health outcomes refers to disparities in health in relation to socioeconomic group, 
where health decreases with increasing deprivation (Marmot, 2015). Life expectancy is 
lower, and there is a higher prevalence of obesity and chronic illnesses such as heart disease 
and diabetes among low socioeconomic groups (Department of Health, 2009; Buck and 
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Maguire, 2015; Office for National Statistics, 2015). In addition, there is a gradient for 
perceptions of health, where those from low socioeconomic groups are more likely to self-
report poor health (Welsh Health Survey, 2015). Socioeconomic inequalities in cancer 
outcomes are one example of the social gradient in health.  
 
1.3.3 The social determinants of health  
 
The relationship between socioeconomic group and health is complex, and is likely to reflect 
a complex interaction between the environment and the individual. There are various 
factors which can directly and indirectly affect health, which have been termed the social 
determinants of health.  
 
Lifestyle factors such as smoking, alcohol consumption, poor diet and non-active lifestyles 
can directly affect health and are more prevalent in low socioeconomic groups (Fone et al, 
2012; Hiscock et al, 2012; Farrell et al, 2013; Welsh Health Survey, 2015). People from a low 
socioeconomic group are more than twice as likely to smoke, are less likely to eat the 
recommended five pieces of fruit and vegetables per day, and report the highest number of 
zero active days compared to high socioeconomic groups (Farrell et al, 2013; Welsh Health 
Survey, 2015). One explanation for the high prevalence of smoking and alcohol consumption 
in low socioeconomic groups is to buffer individuals against the psychosocial stresses of their 
circumstances created by the environment (Wilkinson, 1997). Feelings of disempowerment 
as a consequence of a perceived lack of control over daily life are likely to impact health and 
present as reluctance to engage in healthy behaviours, or increase the likelihood of 
participating in unhealthy behaviours (Pampel et al, 2010). Therefore, it could be argued 
that health inequalities and the social gradient in health are a consequence of the 
environment and social conditions in which people live (Marmot, 2010). Whist lifestyle 
factors can directly affect health, these are generally a product of the environment and any 
opportunities afforded to the individual are not always choices made by the individual; 
instead, in some cases they reflect a lack of availability of resources and opportunities.  
 
According to The Health Map (Barton and Grant 2006; Figure 1.1), a major determinant of 
health is the wider physical, social and economic environment in which an individual lives. 
The Health Map takes into account the influence of the immediate environment such as 
lifestyle and the broader cultural, political and economic factors as determinants of health. 
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Unemployment, poor housing conditions, lower levels of educational attainment and higher 
levels of crime are all associated with socioeconomically deprived communities and are 
likely to influence risk of illness and health outcomes (Acheson, 1997). For example, 
unemployment or low income restricts the financial resources available to the individual, 
which can act as a barrier to maintaining a healthy lifestyle due to cost and lack of 
availability of ‘healthier’ foods (James et al, 1997; Mabhala, 2014). Whilst these factors are 
important in determining health and cancer outcomes, it is not within the scope of this PhD 
to explore these, or attempt to change the social determinants of health at these levels. The 
focus of this PhD will be to understand the influences on cancer symptom presentation 
behaviour among low socioeconomic groups and to design an intervention to encourage 
timely cancer symptom presentation at the individual level, whilst being mindful of the 
broader social determinants.  
 
 
Figure 1.1 The Health Map (Barton and Grant, 2006) 
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1.4 The National Awareness and Early Diagnosis Initiative (NAEDI) and the Model of Pathways 
to Treatment (MPT) 
 
1.4.1 The National Awareness and Early Diagnosis Initiative (NAEDI) 
 
NAEDI was launched in 2008 as part of the Cancer Reform Strategy (Department of Health, 
2007), led by Cancer Research UK, the Department of Health, NHS England and Public Health 
England. NAEDI aims to improve cancer survival outcomes through research and activities 
which promote earlier diagnosis of cancer. It outlined seven work streams, including regular 
assessment of public cancer symptom awareness and the development of interventions to 
promote early symptom presentation.  
 
1.4.2 The NAEDI pathway 
 
The NAEDI pathway was developed in 2009 (Richards, 2009b) and updated in 2015 as a 
framework for testing hypotheses related to potentially avoidable deaths from cancer 
(Hiom, 2015) (Figure 1.2). According to the NAEDI hypothesis, advanced stage disease 
reflects late presentation to secondary care as a consequence of low uptake of cancer 
screening or late presentation to a primary care doctor. Low public awareness of cancer, 
negative beliefs about cancer, barriers to help seeking and difficulty accessing primary care 
are considered likely to contribute to late presentation to a general practitioner (GP) and/or 
low uptake of cancer screening. The terms awareness of cancer and cancer knowledge are 
often conceptualised as a broad understanding of cancer including knowledge of the 
aetiology, prevention and symptoms of cancer; however, throughout this PhD thesis, the 
term ‘cancer knowledge’ refers specifically to cancer symptom awareness. In the updated 
version of the NAEDI hypothesis, demographic background factors including socioeconomic 
group were included as influences on prolonged presentation (Hiom, 2015).   
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Figure 1.2 The original and updated NAEDI pathway (Richards, 2009; Hiom, 2015) 
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1.4.3 Empirical evidence underlying the NAEDI pathway  
Empirical evidence supports the earlier stages of the NAEDI pathway where cancer 
awareness, beliefs about cancer and barriers to help-seeking appear to influence the 
decision to present to a primary care doctor with symptoms, or affect cancer screening 
uptake. Low cancer symptom knowledge has been associated with reduced likelihood to 
engage in cancer screening (Wardle et al, 2000). Poor cancer symptom knowledge 
contributes to misattribution of symptoms and attenuates the decision to present to the 
doctor with  symptoms, because individuals are more likely to perceive symptoms  as not 
serious and therefore not requiring medical help (Mitchell et al, 2008; Macleod et al, 2009; 
Simon et al, 2010; Noonan, 2014; Walter et al, 2012; Whitaker et al, 2014). Poorer 
knowledge of the symptoms for cancer and lower suspicion that a current symptom could 
indicate cancer has been associated with low socioeconomic groups (Robb et al, 2009; Brain 
et al, 2014; Whitaker et al, 2015a) and could contribute to prolonged cancer symptom 
presentation among these groups.  
 
Negative fearful and fatalistic beliefs about cancer have been associated with non-uptake of 
cancer screening due to fear of undergoing the screening test and fear of test results 
(Wardle et al, 2000; Austin et al, 2002; Waller et al, 2009; Miles et al, 2011). Fearful beliefs 
about cancer such as fear of receiving a diagnosis of cancer or fear of the treatments for 
cancer have also been associated with prolonged cancer symptom presentation (Sheikh and 
Ogden, 1998; Bish et al, 2005; Smith et al, 2005; Mitchell et al, 2008; Macleod et al, 2009). 
Fatalistic beliefs about cancer such as ‘cancer is a death sentence’ or ‘there is no cure for 
cancer’ have been associated with more advanced stage disease at diagnosis (Lyratzopoulos 
et al, 2015a), which could reflect the influence of such beliefs on the decision to seek 
medical help, where symptom presentation is prolonged.  
 
Fearful and fatalistic beliefs about cancer are more common among low socioeconomic 
groups (Niederdeppe and Levy, 2007; Beeken et al, 2011; Miles et al, 2011; Lyratzopoulos et 
al, 2015a; Quaife et al, 2015a). Those from a low socioeconomic group have reported lower 
perceived value of early detection and higher fear associated with disclosing cancer 
symptoms to a primary care doctor (Beeken et al, 2011). Emotions such as fear of cancer are 
likely to influence interpretation of symptoms (Whitaker et al, 2015b) and the decision to 
seek medical help, where negative fearful and fatalistic beliefs are likely to prolong symptom 
presentation (Balasooriya-Smeekens et al, 2015; Sheikh and Ogden, 1998; Bish et al, 2005; 
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Smith et al, 2005; Mitchell et al, 2008; Macleod et al, 2009) particularly among low 
socioeconomic groups. 
 
Barriers such as difficulty making or getting to an appointment for cancer screening have 
been associated with a lower likelihood of cancer screening attendance (Maheswaran et al, 
2006; Waller et al, 2009). More reported barriers to cancer symptom presentation have 
been associated with the longest anticipated times to cancer symptom presentation (Robb 
et al, 2009; Simon et al, 2010). The types of barriers reported have been found to vary with 
socioeconomic group: emotional barriers such as embarrassment and worry what the doctor 
might find were more prevalent among low socioeconomic groups, whereas high 
socioeconomic groups were more likely to endorse practical barriers such as ‘being too busy’ 
(Robb et al, 2009).  
 
Whilst the influences on cancer screening attendance and prompt cancer symptom 
presentation to primary care appear to be similar, the prompts preceding screening and 
symptom presentation behaviours are different. Those who attend screening are often 
asymptomatic, and in most cases receive a letter or screening kit through the post inviting 
them to take part in screening. This bypasses the stages of noticing and appraising a 
symptom, and deciding whether or not to seek medical help (Walter et al, 2012). 
Symptomatic individuals do not receive a prompt or reminder letter to encourage them to 
seek help for a symptom and are therefore required to consciously assess their symptom 
and decide whether to seek medical help. It is beyond the scope of this PhD to explore both 
screening and symptom presentation behaviour, therefore the barriers to cancer symptom 
presentation will be the focus of this thesis.  
 
Studies of cancer symptom presentation support the NAEDI hypothesis that poor 
knowledge, negative beliefs and barriers to help-seeking contribute to prolonged cancer 
symptom presentation. In addition, studies provide an indication of which of these factors 
are more prominent in low socioeconomic groups. However, a more detailed understanding 
is required regarding the ways in which socioeconomic group influences the relationship 
between each of the factors highlighted in the NAEDI hypothesis and symptom presentation 
is required. Therefore, the primary focus of this PhD is to explore the barriers to cancer 
symptom presentation among low socioeconomic groups.  
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1.4.4 The Model of Pathways to Treatment (MPT) 
 
The MPT (Walter et al, 2012; Figure 1.3) was developed from the Anderson Model of Total 
Patient Delay (Andersen and Cacioppo, 1995), to conceptualise time between detection of a 
bodily symptom and the start of cancer treatment. The MPT outlines four time intervals, the 
processes involved during each interval, and suggests patient factors that are likely to 
influence each of the time intervals. The first two intervals, representing appraisal and help 
seeking, can be conceptualised as the ‘patient interval’, where symptoms are appraised and 
the individual decides whether to seek medical help for the detected bodily change (Walter 
et al, 2012). This time period is often referred to as patient delay; however this term carries 
connotations of blame (Dobson et al, 2014; Weller et al, 2012), therefore the term 
‘prolonged’ cancer symptom presentation will be used throughout this PhD thesis.  
 
The factors involved in the NAEDI pathway can facilitate understanding of the processes 
involved at each stage which influence the decision to seek medical help for symptoms. The 
‘appraisal interval’ refers to the process of appraising a bodily change once detected (Walter 
et al, 2012). This requires conscious cognitive processing and an awareness of cancer 
symptoms to facilitate appraisal (Scott et al, 2012; Walter et al, 2012). Knowledge of the 
symptoms of cancer is considered to be most influential at this stage and emotions such as 
fear are likely to influence interpretation of symptoms (Walter et al, 2012). Once the 
symptom is appraised, the individual must decide whether to consult a health care 
professional (HCP) and arrange an appointment during the ‘help-seeking interval’. The 
remaining factors from the NAEDI pathway- beliefs about cancer, barriers to symptom 
presentation- are likely to lengthen or shorten the help-seeking interval. Throughout this 
PhD thesis, the term ‘cancer symptom’ will be used to refer to bodily changes that are 
perceived by the symptomatic individual as unusual, troubling or of potential oncological 
significance.  
 
The patient interval has been found to account for the greatest proportion of time in the 
pathway from symptom discovery to the start of cancer treatment (Allgar and Neal, 2005; 
Ristvedt and Trinkaus, 2005; Lyratzopoulos et al, 2015b), and has been found to lengthen 
with increasing socioeconomic deprivation (Macleod et al, 2009). Both the MPT and NAEDI 
pathway suggest that patient factors influence the decision to seek medical help; however, 
due to their descriptive nature, neither model provides an explanation for how 
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socioeconomic factors mediate symptom presentation. A more detailed understanding of 
how knowledge, beliefs, barriers and other factors relating to low socioeconomic groups 
might influence symptom presentation is required. Through identification of the factors 
influencing the appraisal of symptoms and the decision to seek medical help for a cancer 
symptom, interventions may be developed to encourage prompt symptom presentation in 
low socioeconomic groups in order to reduce inequalities in cancer outcomes. 
 
1.5 Diagnosing cancer in primary care 
 
Primary care doctors face pressure from patients and policy makers to diagnose cancer 
earlier and refer to secondary care more promptly, but also pressure from secondary care to 
reduce the number of referrals. Each year, a GP will see on average 8 new cases of cancer 
per year (Roope, 2015) which is relatively small considering a GP will engage in five to ten 
thousand interactions with patients each year. The symptoms that patients present with are 
often vague and can be symptoms of many other benign conditions, thus GPs are challenged 
with the difficult task of knowing when a referral to secondary care is appropriate (Baughan 
et al, 2011; Andersen and Vedsted, 2015; Neal et al, 2015). Patients are often required to 
visit the GP multiple times before a referral to secondary care is made which can be 
problematic if the patient also prolongs a return visit. For example it takes an average thee 
consultations with the GP before a chest x-ray is ordered (Lyratzolplous et al, 2012; Neal et 
al, 2015). Although it is beyond the scope of this PhD thesis to explore doctor/patient 
interactions within the primary care consultation or the referral behaviour of GPs, the 
difficulties of diagnosing cancer in primary care are acknowledged.  
 
 
13 
 
 
Figure 1.3 The Model of Pathways to Treatment (MPT) (Walter et al, 2012)
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1.6 UK Policy  
 
The need to reduce inequalities in cancer outcomes is consistently reflected in UK policy. In 
2000, the National Health Service (NHS) Cancer Plan prioritised the need to improve cancer 
outcomes in the NHS (Department of Health, 2000). Its aims were to improve cancer survival 
rates in the UK so that they were comparable with the best in Europe by 2010, improve 
cancer services and tackle socioeconomic inequalities in cancer survival. A strategy was 
outlined to facilitate delivery of these aims.  
 
To build on the progress in relation to cancer survival since the NHS Cancer Plan 
(Department of Health, 2000), the Cancer Reform Strategy (Department of Health, 2007) 
was developed. It outlined the direction for cancer services in the UK for the next five years, 
acknowledging that there were further advances to be made. Its main aims were to save 
more lives and reduce inequalities in cancer outcomes. The document outlined various areas 
of action to improve cancer outcomes including earlier cancer diagnosis through screening 
programmes, improving public awareness of the signs and symptoms of cancer, and 
reducing cancer inequalities in incidence, access to services and outcomes according to 
various demographic risk factors for poorer cancer survival, including deprivation. 
 
In Wales, the Cancer Delivery Plan (2012) outlined a five year strategic plan to reduce cancer 
incidence, improve survival rates and decrease cancer mortality. In the annual updates, 
there was an overall increase in cancer survival; however, each report acknowledged areas 
for improvement (Welsh Government, 2013). In the 2014 update, it was reported that 
survival rates for stomach, lung and kidney cancer were still lower than the European 
average, and that socioeconomic inequalities in incidence, mortality and survival remained 
(Welsh Government, 2014). In the 2015 update, there was a particular focus on the need to 
improve lung cancer outcomes in Wales in response to the National Lung Cancer Audit, 
where 5 year lung cancer survival was 6.5%. It was reported that lung cancer accounted for 
the highest proportion of cancer related deaths in Wales and almost half of all lung cancer 
cases were diagnosed in the advanced stages (Welsh Government, 2015; National Lung 
Cancer Audit, 2015; Welsh Cancer Intelligence and Surveillance Unit, 2015). Consequently, 
lung cancer and the need to improve lung cancer outcomes were considered a national 
priority in Wales in 2015/16 and 2016/17 as part of the Welsh Lung Cancer Initiative (Welsh 
Government, 2015).  
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In response to these policy developments, the decision to focus the intervention on lung 
cancer was made during the course of the PhD. Whilst the primary aim of the thesis is to 
understand the barriers to cancer symptom presentation in low socioeconomic groups, the 
secondary aim is to develop a lung cancer intervention targeted at low socioeconomic 
groups. This change in focus will be reflected in the narrative of subsequent chapters.  
 
1.7 Lung cancer as a priority  
 
1.7.1 Lung cancer statistics  
 
Lung cancer survival is particularly poor. In the UK, 32% of people survive for one year or 
more after a diagnosis of lung cancer, 10% survive for 5 years or more and 5% of people 
diagnosed with lung cancer survive for 10 years or more (Cancer Research UK Statistics, 
2015d). Whilst survival rates for many other cancers have improved, lung cancer survival has 
remained stable over the past 40 years (Cancer Research UK Statistics, 2015d). It is the third 
most commonly diagnosed cancer in the UK, with around 40,000 new cases each year 
(National Lung Cancer Audit, 2015) and is the leading cause of cancer related death in the UK 
(Kmietowicz, 2015). In 2012, lung cancer became the second biggest cause of death in men 
and the fifth biggest cause of death in women in the UK, where over 35,000 people died 
from lung cancer (National Lung Cancer Audit, 2015; Kmietowicz, 2015). In Wales, there are 
more deaths from lung cancer each year than deaths from breast and bowel cancer 
combined, and it has been estimated that if lung cancer survival in Wales matched that of 
the best in Europe in 2012, 113 more women and 77 more men each year might survive at 
least five years (Welsh Cancer Intelligence and Surveillance Unit, 2015).  
 
1.7.2 Lung cancer and socioeconomic group  
 
Lung cancer is reported to represent the strongest association with deprivation of all the 
common cancers across the UK context (Welsh Cancer and Surveillance Unit, 2015). Lung 
cancer incidence and mortality is higher amongst low socioeconomic groups compared to 
high socioeconomic groups (Welsh Cancer Intelligence and Surveillance Unit, 2015). Age-
standardised incidence rates for Scotland are 61.3/100,000 for high socioeconomic groups 
versus 183.7/100,000 for low socioeconomic groups (Information Service Division Scotland, 
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2015b). Similar disparities are observed in Wales where lung cancer is two and a half times 
more common among low socioeconomic groups compared with high socioeconomic groups 
(Welsh Cancer Intelligence and Surveillance Unit, 2015). This represents an absolute 
difference of 79 more new cases of lung cancer per 100,000 of the population per year 
between low and high socioeconomic groups, and this incidence-deprivation gap has 
widened over the past ten years by 27% (Welsh Cancer Intelligence and Surveillance Unit, 
2015). The high incidence of lung cancer among low socioeconomic groups reflects the high 
prevalence of smoking, which accounts for 80% of new lung cancer cases each year (Welsh 
Cancer Intelligence and Surveillance Unit, 2015; Parkin, 2011) and industrial employment 
such as mining among low socioeconomic groups which contributes to increased risk for 
lung cancer (Welsh Cancer Intelligence and Surveillance Unit, 2015).  
 
The inequalities in lung cancer mortality follow a similar pattern to the inequalities observed 
for cancer incidence. In Scotland, age-standardised mortality rates are 48.3/100.000 for high 
socioeconomic groups compared to 148.2/100,000 for low socioeconomic groups 
(Information Service Division Scotland, 2015). In Wales, the difference between high and low 
socioeconomic groups represents an absolute difference of 61 deaths per 100,000 
population (Welsh Cancer Intelligence and Surveillance Unit, 2015). Survival differences by 
socioeconomic group in the UK are 1.4% between high and low socioeconomic groups, 
which has been estimated to account for around 1300 deaths from lung cancer as a result of 
socioeconomic inequalities in cancer outcomes (Coleman, 2004; Cancer Research UK 
Statistics, 2015d).  
 
1.7.3 Lung cancer early detection strategies 
 
Low dose computed tomography (LDCT) can be used to screen for lung cancer and is 
currently being evaluated in trials across Europe and the US involving high risk individuals 
(Aberle et al, 2011; Aggestrup et al, 2012; Rasmussen et al, 2015; van den Bergh et al, 2011; 
Brain et al, 2016). Although the results of lung cancer screening trials are promising in terms 
of lung cancer mortality (Aberle et al, 2011), the number of false positive results has been 
reported to range from 20%-50% (Aberle et al, 2011; O’Connor and Hatabu, 2012) and could 
contribute to distress and anxiety among those who take part in screening. LDCT is currently 
not available routinely through the NHS to screen for lung cancer. Therefore, lung cancer is 
diagnosed on the basis of individuals presenting with symptoms in primary care, or in 
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secondary care as an emergency case. It has been reported that around half of lung cancer 
cases present through emergency services (Ellis-Brookes et al, 2012).  
 
Due to the vague nature of symptoms of lung cancer (NICE 
https://www.nice.org.uk/Guidance/CG121 [accessed 30.09.2016]), particularly in the early 
stages, and rapid progression of lung cancer from the early to late stages, patients are faced 
with the difficulty of knowing when to present to the doctor with symptoms (Lyratzolplous 
et al, 2012; Mitchell et al, 2013). Early symptoms such as a persistent cough or 
breathlessness can be symptoms of minor ailments such as a cold or other co-morbid 
conditions such as COPD, or attributed to smoking habit. These types of symptoms are often 
ignored or dismissed as normal, prolonging cancer symptom presentation (Birt et al, 2014; 
Corner et al, 2006; Chatwin and Sanders, 2013). Furthermore, 80% of lung cancer cases are 
smoking related (Welsh Cancer Intelligence and Surveillance Unit, 2015) and those who 
smoke or are ex-smokers are at the highest risk for developing lung cancer. Smokers are less 
likely than non-smokers to go to the doctor with symptoms suggestive of lung cancer 
(Friedemann-Smith et al, 2016). This could reflect worry about being told by their primary 
care doctor to stop smoking, or feelings of shame if they associate their smoking habit to be 
the cause of their symptoms adding to the perception of lung cancer as a self-inflicted 
disease (Corner et al, 2006). Lung cancer is highly stigmatised in comparison to other cancers 
such as breast cancer (Marlow et al, 2015), due to the association of lung cancer with 
smoking (Chatwin and Sanders, 2013; Chapple et al, 2004a) and low public awareness of 
other risk factors other than smoking (Simon et al, 2012). Consequently, individuals with 
symptoms of lung cancer are likely to experience feelings of blame and guilt, and not feel 
worthy of seeking help or treatment for symptoms (Quaife et al, 2016a). In addition, it has 
been reported that smokers are more likely than non-smokers to hold fearful and fatalistic 
beliefs about cancer (Quaife et al, 2015b; Quaife et al, 2016a) and more pessimistic beliefs 
about early detection (Silvestri et al, 2007; Quaife et al, 2016b). Such beliefs have been 
associated with advanced stage disease at diagnosis (Lyratzopoulos et al, 2015a). These and 
other factors which potentially prolong symptom presentation will be discussed throughout 
the thesis, followed by an outline for an intervention designed to overcome these issues.  
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1.8 The Medical Research Council (MRC) Framework  
 
The MRC framework is a guide for the development and evaluation of complex interventions 
(Craig et al, 2008), and will be used to guide intervention development for this PhD. The 
MRC framework outlines four phases of development and evaluation (Figure 1.4). During the 
first development phase, researchers should identify the evidence base, relevant theory and 
model processes and outcomes for intervention development. Studies relating to 
intervention development using primary and secondary data will be reported in Chapters 3 
to 5. The second MRC feasibility and piloting phase involves preliminary testing of 
intervention acceptability and feasibility of recruitment procedures before a full-scale 
evaluation is carried out. Intervention acceptability testing will be described in Chapter 8. 
The evaluation phase can be used to assess effectiveness and cost-effectiveness of 
intervention and to understand change process (Craig et al, 2008). The final MRC phase 
refers to implementation if the intervention is feasible and shows evidence of effectiveness, 
and requires intervention surveillance and monitoring through long term follow-up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 The key elements of the MRC intervention development and evaluation process 
(Craig et al, 2008)  
 
 
Feasibility and piloting 
Testing procedures  
Estimating recruitment and retention 
Determining sample size 
Development 
Identifying the evidence base 
Identifying or developing theory 
Modelling process and outcomes  
Evaluation 
Assessing effectiveness  
Understanding change process 
Assessing cost effectiveness  
Implementation  
Dissemination 
Surveillance and monitoring 
Long term follow-up 
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1.9 The Behaviour Change Wheel  
 
Intervention development will be guided by the Behaviour Change Wheel (Michie et al, 
2011). The Behaviour Change Wheel was developed in response to the need for a 
comprehensive, theory based framework for intervention development that can be applied 
to a wide range of behaviour change contexts. The MRC framework highlights the 
importance of theory in intervention development; however, there is a lack of guidance 
regarding how to select or use theory when developing behaviour change interventions 
(Michie et al, 2005). In an attempt to reduce researcher bias in the selection of theory and 
provide a systematic framework for the development of behaviour change interventions, the 
Behaviour Change Wheel was developed by Michie and colleagues for use in conjunction 
with the MRC framework (Michie et al, 2011; Michie et al, 2014). The Behaviour Change 
Wheel is underpinned by the Theoretical Domains Framework (TDF) and the COM-B model 
(Capability, Opportunity, Motivation-Behaviour) (Michie et al, 2011). The TDF and COM-B 
model provide a potentially useful framework for understanding cancer symptom 
presentation behaviour and will be discussed in more detail in the forthcoming chapters. 
 
The COM-B model and TDF are used in the first stage of the Behaviour Change Wheel 
process to perform a ‘behavioural analysis’ of the target behaviour. The behavioural analysis 
is performed to understand the barriers and facilitators to the target behaviour, which in 
this context is cancer symptom presentation behaviour among low socioeconomic groups. 
Based on the sources of behaviour identified by mapping barriers and facilitators to the 
COM-B model constructs, findings at this stage determine which intervention functions (the 
type of intervention) and behaviour change techniques (intervention content) could be used 
to bring about change (Michie et al, 2011). Finally, suggested policy categories and mode of 
intervention delivery are considered to guide the researcher on how the intervention could 
be implemented to bring about behaviour change (Michie et al, 2011). For this PhD, the 
Behaviour Change Wheel was used to guide intervention development due to its systematic 
nature and theoretical underpinning. All steps involved in the intervention development 
process using the Behaviour Change Wheel are described in Chapter 7.  
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1.10 Aims and objectives of this PhD thesis 
 
The primary aim of this PhD thesis is to understand the barriers to cancer symptom 
presentation among low socioeconomic groups. The contributions of cancer symptom 
knowledge, beliefs about cancer and barriers to symptom presentation will be explored 
using primary qualitative data (interviews and focus groups) and secondary systematic 
review data. This will involve exploration of the wider socio-environmental influences on 
cancer symptom presentation behaviour, in order to gain an understanding of how 
socioeconomic factors influence knowledge, beliefs and symptom presentation.  
 
Secondary aims are to develop a theory-driven cancer awareness intervention targeted at 
low socioeconomic groups, and to pilot test the draft intervention for acceptability with a 
group of potential users. This will be guided by the MRC framework for intervention 
development and relevant theory to ensure that the mechanisms underlying the behaviour 
(cancer symptom presentation) can be understood in terms of a theoretical framework, and 
are addressed in the content of the intervention. This is important because theory can be 
used to guide intervention content and facilitate the selection of suitable evaluation 
measures. The decision to shift the intervention focus away from generic cancer and focus 
exclusively on lung cancer awareness was made in response to recent cancer intelligence 
data that highlighted particular socioeconomic disparities in lung cancer incidence and 
survival, and the subsequent policy drive to reduce inequalities and improve lung cancer 
outcomes. 
 
Objective for this PhD are: (1) to identify relevant theory for cancer awareness, beliefs about 
cancer and symptom presentation behaviour; (2) to identify studies of cancer symptom 
knowledge, beliefs about cancer, barriers to cancer symptom presentation and actual or 
anticipated cancer symptom presentation behaviour using systematic review methods;  (3) 
to identify the factors influencing cancer symptom presentation among low socioeconomic 
group using qualitative methods; (4) to identify and review interventions designed to 
encourage earlier cancer symptom presentation among low socioeconomic groups; (5) to 
develop an intervention to encourage earlier lung cancer symptom presentation among low 
socioeconomic groups and examine its acceptability with a sample of potential users.  
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1.11 Thesis structure  
 
Chapter 2 
 
Chapter two presents the theoretical underpinning of this thesis. Heath behaviour theories 
relevant to cancer symptom presentation behaviour will be described and critically 
evaluated. The TDF and COM-B model will be discussed as most relevant in this context.  
Chapter 3 
This chapter describes a systematic review of the literature up to July 2015 relating to cancer 
symptom knowledge, beliefs about cancer, barriers/facilitators to symptom presentation 
and time to symptom presentation. It reports the variation of cancer symptom knowledge, 
beliefs about cancer and barriers/facilitators to symptom presentation according to 
socioeconomic group to consider how these might influence cancer symptom presentation 
behaviour.   
Chapter 4 
The findings from a qualitative interview study with men and women over the age of 50 
from a low socioeconomic group are reported in Chapter 4. Individual factors such as cancer 
knowledge and the wider socio-environmental factors are explored and discussed in terms 
of their influences on cancer symptom presentation behaviour.  
Chapter 5 
Chapter 5 reports the results of a focus group study with members of public living in 
deprived communities and local stakeholders (healthcare professionals and community 
partners) who work in deprived communities. It reports findings from a cancer symptom 
attribution task and discusses the influence of the wider social environment on 
interpretation of symptoms and timely cancer symptom presentation behaviour.  
Chapter 6 
This chapter describes a scoping review using database and online searches to identify 
cancer awareness interventions targeted at low socioeconomic groups.  It describes the 
type, content and effectiveness (if data available) of cancer awareness interventions and 
implications for intervention development in this PhD.  
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Chapter 7  
Chapter 7 presents the development of an intensive lung cancer awareness group based 
educational intervention targeted at individuals living in deprived communities. The 
Behaviour Change Wheel was used in combination with findings from studies described in 
Chapters 3-6 to facilitate intervention development. The intervention is designed to increase 
lung cancer symptom knowledge, break down negative beliefs about cancer and mobilise 
social networks to encourage more timely lung cancer symptom presentation for individuals 
living in a deprived community.  
Chapter 8  
This chapter presents findings from an intervention acceptability testing study with a group 
of potential users: people over the age of 40 from socioeconomically deprived communities 
who were current smokers, former smokers or family members of smokers.  
Chapter 9 
The concluding chapter summarises the key findings of the thesis and locates the findings 
within the wider context of cancer inequalities. Methodological limitations and implications 
of findings are discussed.  Suggestions for further evaluation and potential for 
implementation are provided.   
1.12 The Awareness and Beliefs about Cancer (ABACus) study 
 
The focus group study reported in Chapter 6 was conducted as part of an aligned project 
‘’Development of the Tenovus health check: a targeted cancer awareness intervention for 
people from deprived communities’’ funded Cancer Research UK (the ABACus study, Smits 
et al, 2016). Focus groups were conducted to understand the influences on cancer symptom 
presentation in deprived communities and to offer feedback on the Tenovus health check, 
followed by intervention development using the Behaviour Change Wheel. All focus group 
data reported in this PhD thesis were analysed by the PhD researcher independently of the 
ABACus study. In addition, intervention development for this PhD thesis using the Behaviour 
Change Wheel was conducted independently of the ABACus study. The role of the PhD 
researcher in the development and conduct of focus groups will be described in more detail 
in Chapter 6.
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Chapter 2 
Critical evaluation of behavioural and sociological theories relevant to cancer 
symptom awareness, beliefs and presentation in low socioeconomic groups 
 
2.1 Chapter overview 
 
The theoretical underpinning of the PhD will be presented in this chapter. Theories and 
models of symptom attribution, attitude and belief formation, and the wider social and 
environmental influences on behaviour will be described and critically evaluated. A range of 
behavioural and sociological theories and models will be used to discuss the influences on 
cancer symptom presentation behaviour in the context of socioeconomic deprivation. The 
Theoretical Domains Framework (TDF) and COM-B model (Capability, Opportunity, 
Motivation-Behaviour) will be discussed as most relevant in the context of cancer symptom 
presentation behaviour (Michie et al, 2011). Finally, the role of theory in this PhD thesis and 
the development of a cancer awareness intervention using the Behaviour Change Wheel, 
which is underpinned by the TDF and COM-B model, will be discussed.  
 
2.2 Introduction  
 
As discussed in Chapter 1, the present PhD is concerned with understanding the barriers to 
cancer symptom presentation among people in low socioeconomic groups, to ultimately 
develop an intervention targeted at low socioeconomic groups to encourage timely cancer 
symptom presentation. The updated National Awareness and Early Diagnosis Initiative 
(NAEDI) pathway (Hiom, 2015) outlined in Chapter 1 suggests that low public awareness of 
cancer, negative beliefs about cancer, barriers to symptom presentation and socioeconomic 
factors are likely to prolong cancer symptom presentation.  Whilst the NAEDI pathway 
provides a framework for testing hypotheses, it does not attempt to provide detailed 
explanations for the influences of awareness, beliefs and barriers on symptom presentation 
behaviour. Examining theories that are relevant to the “patient interval” component of the 
NAEDI pathway, is likely to facilitate a deeper understanding of which factors are most likely 
to affect cancer symptom presentation behaviour, and why these might influence behaviour. 
Relevant theories can then be used to guide intervention design and evaluation.  
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As outlined in Chapter 1, the Medical Research Council (MRC) framework for developing and 
evaluating complex behaviour change interventions highlights the importance of identifying 
relevant theory in order to guide the researcher to certain aspects of behaviour, and to gain 
an understanding of the barriers and facilitators to behaviour (Campbell et al, 2007; Craig et 
al, 2008). This is to allow insight into the likely processes underlying the behaviour before 
pilot testing, so that intervention content is designed to specifically address these processes, 
and suitable evaluation measures can be selected to test for intervention efficacy (Campbell 
et al, 2007; Craig et al, 2008).  
 
Theories and models from health psychology textbooks, studies of cancer symptom 
presentation behaviour and all theories and models underpinning the Behaviour Change 
Wheel were reviewed. A selection of behavioural and sociological theories and models that 
were considered to be most relevant to cancer symptom presentation behaviour among low 
socioeconomic groups were selected and will be presented in this chapter. The most 
relevant theory or model to cancer symptom presentation behaviour will be selected for this 
PhD.  
 
It is helpful to understand the distinction between the terms theories and models, since 
these terms are often used inter changeably. Theories are explanatory and predictive, 
helping to guide selection of appropriate methods for conducting research, and predicting 
behaviour to guide intervention development (Gabrenya, 2003). Models are generally 
descriptive, showing simplified cause and effect of the key aspects of behaviour, often as 
simplified versions of theories (Gabrenya, 2003).  
 
2.3 Relevant theories and models of the influences on cancer symptom presentation 
behaviour  
 
2.3.1 The Common Sense Model of Illness Self-Regulation of Health and Illness 
 
The Common Sense Model of Illness Self-Regulation (CSM) (Leventhal et al, 1984) is a model 
of illness cognitions, attempting to explain how illness is inferred, understood and acted 
upon. The CSM provides a useful framework for understanding how a symptom may or may 
not be attributed to cancer and an explanation of which factors influence the decision to 
seek medical help. There are three key constructs of the CSM: (1) representation of illness; 
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(2) the coping response to the health threat; (3) appraisal of coping efforts after coping 
response (Figure 2.1). The model assumes that the individual is an active problem solver, 
responding to a health threat through two parallel processes: cognitive processing 
(understanding, identifying and responding to the health threat) and emotional processing 
(the individual’s feelings towards the health threat, and what steps can be taken cope with 
their emotions) (Leventhal et al, 1997).  
 
According to the CSM, when forming representations of illness, an individual makes 
common sense interpretations about their bodily signs or symptoms to infer illness. 
Interpretations are based on mental representations of illness, formed from previous illness 
experiences. The model  describes five domains on the cognitive processing pathway which 
affect interpretation of symptoms and the decision to act on symptoms: identity (the label 
given to the illness or health threat), causes (whether the illness is perceived to be caused by 
internal or external factors), timeline (perceptions of how long the illness will last), 
consequences (possible physical and emotional consequences of illness), and 
curability/controllability (perceptions of whether the illness could be treated or cured), 
(Leventhal et al, 2003; Figure 2.1).  
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Figure 2.1. Common Sense Model of Illness Self-Regulation (adapted from a figure from Leventhal et al, 2003, p50)  
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According to the CSM, when a bodily change is detected, an automatic initial (unconscious) 
assessment is made. Bodily changes which do not exceed the unconscious threshold for 
inferring illness will be dismissed as normal and attributed to part of the body’s normal 
function. Bodily changes which exceed the threshold for inferring illness are perceived as a 
symptom, which the individual may interpret as abnormal, depending on the outcome of a 
conscious assessment of the symptom. During the conscious assessment of the symptom, 
previous illness episodes and schema are used as reference points to explain the current 
illness episode. For example, the individual might notice blood in their stools. According to 
the CSM, the individual will consciously assess the symptom against previous symptom 
episodes, such as bleeding from haemorrhoids and reference points such as ‘blood in poo’ 
cancer awareness campaigns. In addition, the timeline of the symptom (how long they have 
had the symptom or expect the symptom to last) may be used to decide if the symptom is 
part of their normal functioning i.e. a symptom of their haemorrhoids, or something 
abnormal i.e. bowel cancer.   
 
If bodily changes or symptoms are dismissed as ‘normal’ during the conscious or 
unconscious assessments of symptoms, this provides a potential opportunity for prolonged 
symptom presentation. If an individual attributes their symptom to normal bodily 
functioning such as haemorrhoids, they may decide no medical help is required.  If the 
individual interprets the symptom as abnormal and thus requiring medical intervention, the 
final three domains of consequences, internal and external causes and control are used to 
guide action planning and coping responses. The individual uses past experiences and 
schema to guide response to the symptom, such as beliefs about cancer treatments causing 
unpleasant side effects, beliefs about curative treatment for cancer, or beliefs about the 
benefits of early diagnosis of cancer. For example, if the individual with blood in stools 
decides the symptom is abnormal, their knowledge of the screening tests for bowel cancer, 
any family history of bowel cancer and beliefs about the treatments for bowel cancer would 
influence their coping response of whether to seek medical help or not.  
 
In addition to cognitive representations of illness, the CSM posits that an individual makes 
emotional representations of their illness. The cognitive and emotional processes are 
thought to occur simultaneously. Emotional reactions such as fear or worry guide illness 
representations and action, and coping strategies are used to deal with emotions. Finally, all 
coping strategies on the cognitive and emotional dimension are appraised. The individual 
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evaluates the impact of their coping strategy on illness outcome and their emotional 
reaction (Figure 2.1).  
 
Many of the symptoms of cancer are vague, particularly in the early stages, and often go 
unnoticed during the unconscious assessment stage, or are misattributed to benign causes 
during the conscious processing stage and dismissed as normal (Carter-Harris, 2015; Emery 
et al, 2013; Scott et al, 2007). There is evidence of people who received a diagnosis of cancer 
where symptoms of cancer were retrospectively recalled, but often misattributed to 
symptoms of other health problems such as haemorrhoids or other factors such as ageing 
(Andersen et al, 2010; Brandner et al, 2014; Whitaker et al, 2014), which supports the CSM. 
In addition, there is evidence of the role of emotions in the decision to seek medical help 
once a symptom is perceived as abnormal (Balasooriya-Smeekens et al, 2015), where beliefs 
such as cancer fatalism can prolong cancer symptom presentation on the emotional 
processing pathway (Bergamo et al, 2013; Chonjnacka-Szwalowska, 2013; Shahid et al, 2009; 
Lyratzopoulos et al, 2015a).  
 
The CSM is a useful model for understanding how individuals might notice, interpret and 
decide to seek medical help for symptoms of cancer, and is clearly applicable in the current 
context. A strength of the model is the inclusion of emotional factors such as fear, worry and 
anxiety which are missing from many other behavioural models and theories. However, 
certain emotional factors such as embarrassment are currently not represented in the CSM 
but have been found to influence cancer symptom presentation (Marlow et al, 2014). In 
addition, the CSM does not include the influence of family and friends on illness 
representation and the coping response. Finally, testing the predictive validity of the CSM is 
challenging due to its complexity (Llwelln et al, 2007) and studies have reported low 
predictive power in the context of cancer symptom presentation (Grunfield et al, 2003; 
Hunter et al, 2003).  
 
2.3.2 The Health Belief Model   
 
The Health Belief Model (HBM; Rosenstock et al, 1988) was initially developed to explain 
risk-related health behaviour.  More recently, the HBM has been used to predict other 
health related behaviours, in particular screening behaviour for cancer (Austin et al, 2002; 
Wardle et al, 2000; Murray & McMillan, 1993) and studies of ovarian cancer symptom 
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awareness (Brain et al, 2014; Smits, PhD thesis). According to the HBM, behaviour is 
determined by perceptions of the disease and the strategies available to guide health 
behaviour (Rosenstock et al, 1988). The model assumes that when faced with a health 
threat, an individual will take into account their perceptions of: susceptibility to illness, the 
severity of illness, perceived barriers and benefits of behavioural performance (Stretcher 
and Rosenstock, 1997). The HBM suggests that these four constructs are influenced by 
demographic variables such as age, gender and socioeconomic group, as well as structural 
variables such as knowledge of the disease and self-efficacy. In addition, cues to action are 
included in the HBM as influences on behaviour. Cues to action include social cues such as 
advice from a family member prompting an individual to seek medical help, or system-
related cues such as cancer awareness campaigns in the media (see Figure 2.2).   
 
Perceived susceptibility refers to an individuals’ perception of their risk associated with 
acquiring the disease. Greater perceived susceptibility is assumed to motive the individual to 
engage in behaviour to minimise the risk. In the context of cancer symptom presentation, 
perceptions of risk might influence symptom attributions. For example, if an individual has a 
family history of bowel cancer, they might assume they are more susceptible to receiving a 
diagnosis of bowel cancer in future. Someone who perceives themselves to be at high risk 
for bowel cancer might be more likely to attribute a symptom such as change in bowel habit 
to cancer, rather than something benign such as irritable bowel syndrome.  
 
Perceptions of severity of illness are often based on an individual’s medical knowledge and 
the beliefs an individual has formed about the disease. Beliefs about the disease severity 
include perceptions of what impact a diagnosis of disease could have on their daily life, and 
are usually formed from other members of the community or media sources. For example, 
an individual may know someone with breast cancer whose treatment was limited to 
surgery, where their recovery was good with little disruption to daily life. Conversely, they 
may know someone with breast cancer who underwent multiple treatments such as surgery, 
chemotherapy and radiotherapy, with a long recovery time and extensive disruption to daily 
life during and after treatment. Based on these experiences, an individual would perceive 
breast cancer as a more serious disease in the latter example when compared to the first 
example. The perceived impact that a diagnosis of cancer would have on daily life is taken 
into account when deciding how serious a symptom of cancer is. For example, if an 
individual perceives a diagnosis of cancer as disruptive, requiring extensive time off work for 
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treatment and recovery, any potential financial difficulties which might arise from 
unemployment during this time would guide the individual to perceive cancer as more 
serious.  
 
According to the HBM, when the perceived benefits of behavioural performance outweigh 
the perceived barriers, the likelihood of action is greater. In the context of cancer symptom 
presentation, an individual may understand the benefits of early cancer detection of cancer, 
prompting them to seek medical help quickly for a symptom of cancer. However, they might 
perceive barriers to symptom presentation such as lack of time to get to a GP appointment. 
The HBM suggests that an individual would present with symptoms if the perceived benefits 
(their beliefs about the need to diagnose cancer early) outweighed any perceived barriers 
(their perceptions of lack of time to get to an appointment). In support of the model, an 
ovarian symptom presentation study reported that emotional and practical barriers were 
predictors of anticipated delay (Brain et al, 2014).  
 
While aspects of the HBM are potentially useful for understanding how symptoms might be 
perceived as a health threat and certain factors which are taken into account when deciding 
to seek medical help, there are limitations. Unlike the CSM, the HBM does not include 
emotions such as fear and worry which are particularly salient in this context and have been 
reported to influence cancer symptom presentation behaviour (Balasooriya-Smeekens et al, 
2015). In addition, although demographic variables such as age and gender are taken into 
account, environmental or contextual factors are not included in the HBM and are likely to 
be important in the context of socioeconomic deprivation. Furthermore, there is evidence to 
suggest that the HBM is most useful when applied to higher risk individuals, rather than the 
general population (Smits, PhD thesis chapter 4).  
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Figure 2.2 The Health Belief Model adapted from Strecher & Rosenstock (1997) in Glanz et al 
(2008), p.34.  
 
2.3.3 The Extended Parallel Processing Model  
 
The Extended Parallel Processing Model (EPPM; Witte, 1992) was developed from Protection 
Motivation Theory (Rogers, 1975). The EPPM has previously been applied to assess the 
impact of health risk information on behaviour. The EPPM is relevant to understanding 
behavioural responses to health threats such as a potential cancer symptom, or fear 
inducing messages used in cancer awareness campaigns. Similarly to the HBM, the EPPM 
posits that a threat is appraised by the individual based on perceived susceptibility (how 
likely they are to be affected by the threat) and severity of the threat (how serious they 
perceive the threat to be), Figure 2.3. If the threat is perceived to be moderate or high, fear 
may be elicited and the individual may re-appraise the threat based on perceptions of self-
efficacy (their ability to respond to the threat) and response efficacy (the likelihood that 
their response will be effective). The EPPM assumes that if perceived threat and perceived 
efficacy are high, the fear-inducing message is likely to be accepted and the individual is 
motivated to change behaviour to avoid the threat, termed ‘adaptive changes’. However, if 
perceived threat is high and perceived efficacy is low, the individual may devise fear-
reducing strategies such as denial, as a way of coping with fear, termed ‘maladaptive 
changes’ (Witte, 1992). 
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In the context of cancer symptom presentation, a fearful response to a cancer symptom is 
likely to result is an adaptive response (seeking medical help) if the individual perceives 
themselves to have the ability to effectively seek medical help (high self-efficacy). In 
addition, beliefs about the benefits of early diagnosis and effectiveness of treatments for 
cancer (response efficacy) are likely to promote an adaptive response. For an individual who 
responds to a symptom of cancer with fear, but does not perceive themselves able to cope 
with the threat (low self-efficacy), or believes the treatments for cancer are ineffective 
(response efficacy), symptom presentation may be prolonged or completely inhibited. For 
individuals from a low socioeconomic group where fearful and fatalistic beliefs about cancer 
are more common (Quaife et al, 2015a), perceptions of self- and response efficacy are likely 
to be important when deciding whether to seek medical help for a cancer symptom, and 
could potentially explain prolonged symptom presentation.  
 
There is evidence to support the EPPM from a meta-analysis of interventions using fear-
inducing messages in public health campaigns for various target groups, including smoking 
cessation messaging and skin cancer messaging (Witte & Allen, 2000). The review found that 
public health campaigns were most effective when high fear-inducing messages were 
combined with high self-efficacy messages (Witte & Allen, 2000). However, the authors 
recommend using fear-inducing messaging with caution, and suggest that certain 
demographic characteristics such as age or gender influence how fear appeals are perceived 
(Witte & Allen, 2000). Considering fear of cancer is prevalent among low socioeconomic 
groups, the use of fear-inducing messages in a cancer awareness intervention should be 
avoided. Whilst the inclusion of individual differences is a strength of the EPPM, the model 
assumes that fear is the only response to a health threat and that fear is required to initiate 
a behavioural response. Other emotional responses such as embarrassment may be relevant 
in this context and influence the decision to present with symptoms (Marlow et al, 2014), 
but are currently not represented in the model. In addition, there is no representation in the 
EPPM for symptom attributions to decide whether the symptom is a health threat or not.   
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Figure 2.3 The Extended Parallel Processing Model (adapted from Witte, 1992) 
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2.3.4 The Theory of Planned Behaviour  
 
The Theory of Planned Behaviour (TPB; Ajzen, 1991) was developed as an extension of the 
Theory of Reasoned Action (Fishbein and Ajzen, 1975). A key assumption of the TPB is that 
behavioural, normative and control beliefs influence intentions to perform a given health 
behaviour, which in turn influence performance or non-performance of behaviour (Ajzen, 
1991; figure 2.4). Behavioural beliefs are defined as beliefs about the likely outcomes of 
behaviour, which produce a favourable or unfavourable attitude towards the behaviour. 
Normative beliefs result in perceived social pressure and subjective norms, which are 
formed as a result of normative expectations of others and the individual’s motivation to 
comply with these. Finally, control beliefs result in perceived behavioural control, which 
refers to the perceived ease or difficulty of performing a given behaviour. According to the 
TPB, performance of a health behaviour is governed by the strength of intention to perform 
behaviour. Strong intentions are formed from favourable beliefs about the behaviour and 
high perceived behavioural control, which are more likely to translate into behavioural 
performance.  
 
According to the TPB, if an individual discovers a symptom of cancer, the strength of 
intention to seek medical help is influenced by behavioural beliefs about the consequences 
of seeking medical help and undergoing diagnostic testing, normative beliefs such as social 
pressure from friends and family to seek medical help, and control beliefs such as 
perceptions about how easy or difficult seeking medical help would be. For example, if an 
individual believes the diagnostic tests for cancer to be non-invasive (behavioural beliefs), 
the individual is faced with social pressure from family members to present to the doctor 
with symptoms (normative beliefs), and they predict ease of performing the behaviour 
(control beliefs), their intention to visit the doctor would be high, and more likely to result in 
symptom presentation.  
 
The TPB has been applied to testicular self-examination (Brubaker and Wickersham, 1990), 
cancer screening attendance (Rutter, 2000) and a range of non-health and health behaviours 
including self-examination (Armitage and Conner, 2001). The TPB constructs subjective 
norms and perceived behavioural control were found to be most influential for self-
examination behaviour (Brubaker and Wickersham, 1990). Subjective norms were more 
influential for screening behaviour (Rutter, 2000), and only weakly related to intentions in 
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the review of health and non-health behaviour (Armitage & Conner, 2001). However, there 
is evidence for an intention-behaviour gap, in that the TPB has been observed to predict 
intentions to perform a behaviour (Hunter et al, 2003), but not actual behaviour (Sheeran, 
2002). In addition, the role of emotions is not represented in the TPB (Perugini and Bagozzi, 
2001), but as previously discussed are important in the context of cancer symptom 
presentation behaviour (Balasooriya-Smeekens et al, 2015). Furthermore, the TPB does not 
attempt to explain how an individual decides or interprets whether a symptom requires 
medical help or not.   
 
 
Figure 2.4 Theory of Planned Behaviour (Armitage and Conner, 2001) 
 
2.3.5 Ecological Model of Health Behaviour  
 
Ecological models take into account the environmental causes of behaviour, assuming that 
there are multiple, interacting levels of influence on behaviour (Sallis et al, 2003). 
Descriptions and definitions of the levels of influence vary between ecological models, but 
generally start with levels of influence closest to the individual such as family members and 
friends, and ending with wider societal influences on behaviour, such as policies or cultural 
values.  
 
The Ecological Model of Health Behaviour (McLeory et al, 1988) was developed as a 
variation of Bronfenbrenner’s ecological model of child development (Bronfenbrenner, 
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1977), with a specific focus on health behaviour. The model proposes that there are five 
levels of influence on health behaviour (Figure 2.5). The first level, ‘intrapersonal factors’, is 
defined as characteristics of the individual such as knowledge, attitudes and self-efficacy. 
The second level, ‘interpersonal factors’, is defined as formal and informal relationships 
within social networks such as family members friends and work groups. The model suggests 
that social relationships at this level are essential aspects of social identity, where social 
relationships can provide social support and influence behaviour through social norms. The 
third level, ‘institutional factors’, refers to social and organisational institutions that can 
influence behaviour such as the work place, neighbourhood organisations and the church. 
Organisations at this level provide economic and social resources for the individual, and can 
have both positive and negative effects on behaviour. For example, workplaces might 
support healthy behaviours by providing health promotion activities or incentives for 
smoking cessation. The fourth level of influence, ‘community factors’, is defined as 
relationships among organisations and informal networks and relationships within defined 
demographic and geographic boundaries. The fifth, and final level of influence described by 
the model is ‘public policy’, defined as laws and public policy that influence and restrict 
behaviour, for example a ban on smoking in public places.  
 
Although the Ecological Model of Health Behaviour has not been applied specifically to 
cancer symptom presentation, it is likely that each level of influence can affect symptom 
presentation behaviour. For example, at the interpersonal level, friends and family may have 
previously discussed negative experiences in a healthcare setting. These experiences might 
influence behaviour at the individual level, where the individual recalls these instances and 
decides not to seek medical help based on these negative experiences. In addition, revisions 
of policy at the public policy, level such as the need to focus on lung cancer in Wales as a 
national priority, are likely to bring about change at the community and institutional levels 
through local initiatives and changes in lung cancer services. Initiatives or campaigns at 
community and institutional levels have the potential to influence the intrapersonal and 
interpersonal levels, for example, awareness campaigns might improve lung cancer 
knowledge for people in the community.  
 
The Ecological Model of Health Behaviour has been applied to various health behaviours, 
and has been used to create multi-level interventions to successfully reduce socioeconomic 
inequalities for various aspects of health (Trickett and Beehler, 2013). In addition, ecological 
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models have been used to understand sources of smoking behaviour to aid development of 
successful interventions reducing smoking behaviour using a multi-level approach (Fisher, 
2004). Using multi-level interventions based around ecological models is considered most 
important for low socioeconomic groups, taking into account wider environmental 
influences on behaviour and modifying factors at these levels (Trickett and Beehler, 2013; 
Hill et al 2005). Most interventions focus on an intervention at a single level, usually at the 
individual level, and it has been suggested that interventions designed to target behaviour at 
a single level are likely to increase health inequalities between affluent and deprived groups 
(Hill et al, 2005) and have short-term effects on behaviour change (Schensul, 2005). 
Ecological models are useful to facilitate detailed analysis of the target behaviour across the 
various levels of influence and in a specific context, in order to understand the wider 
contextual influences on behaviour. However, they do not attempt to offer insight into how 
cancer knowledge, beliefs or barriers could influence the decision to seek medical help for a 
potential cancer symptom.  
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Figure 2.5 Ecological Model of Health Behaviour (McLeory et al, 1988) 
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2.3.6 Diffusion of Innovations Theory  
 
Diffusion of Innovations Theory (Rogers, 1983) attempts to explain how an ‘innovation’ (a 
new or novel behaviour to the community) is diffused throughout the community, and 
adopted or rejected by an individual or social group (Figure 2.6). The theory assumes that 
social networks can disseminate information and adoption of the innovation through a 
process called diffusion. Diffusion refers to the different ways in which information about 
the innovation is communicated over time. According to Diffusion of Innovations theory, 
there are two types of communication channels: mass media communication channels 
(transmission of a message to a large audience) and interpersonal communication channels 
(face-to-face communication). The theory suggests that communication through 
interpersonal channels is more effective in adoption of the innovation, especially when the 
message is communicated by a peer. The speed with which the innovation is adopted is 
termed the rate of adoption.  According to the theory, the rate of adoption can be 
influenced by the social system, where adoption or dismissal of an innovation may be 
dependent on the adoption or rejection of the innovation by an opinion leader (an individual 
who is socially accessible, conforms to social norms and has technical ability).  
 
Although Diffusion of Innovations Theory has not been applied to cancer symptom 
presentation behaviour, it is likely to be useful for understanding how intervention messages 
can be diffused through the community to encourage cancer symptom presentation. 
Diffusion of Innovations Theory has been used in peer-led educational sexual health and 
school based smoking interventions (Campbell et al, 2008; Hart & Elford, 2003). In these 
interventions, well regarded and popular members of a particular social network were 
selected and trained as peer educators, to disseminate information about the risks of 
unprotected sex or smoking within their social network. Both interventions found a positive 
effect on condom use among gay men and smoking behaviour in schools, respectively, and 
were effective methods of using social networks to disseminate messages about health 
protective behaviour. The school based smoking intervention (ASSIST) was most effective in 
clearly defined and close-knit communities, such as the Welsh Valleys (Campbell et al, 2008). 
This was assumed to reflect the well-defined and stable relationships between peer 
supporters who have regular interpersonal contact (Campbell et al, 2008). This has 
implications in the current context as the Welsh Valleys are areas of deprivation, and such a 
strategy could be used to guide intervention message communication. 
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Although sexual health and smoking interventions provide evidence of the predictive value 
of the Diffusion of Innovations Theory, there are limitations. The theory assumes that 
adoption of an innovation is a linear process, from the individual who decided to diffuse the 
information, to early innovation adopters and finally late innovation adopters. However, in 
reality it is unlikely that adoption of an innovation is completely linear. In addition, although 
media channels are included in the theory as a type of innovation communication, the 
Diffusion of Innovations Theory has been criticised for downplaying the role of media 
(Afolayan et al, 2012). Media is considered to create innovation awareness and stimulate 
discussion, and is thought to play a bigger role in adoption than that stated by the model 
(Afolayan et al, 2012). Finally, Diffusion of Innovations Theory does not attempt to explain 
how beliefs or barriers might influence adoption of an innovation and the decision to seek 
medical help for a symptom.  
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Figure 2.6 The five stages in the Innovation-Decision Process (adapted from Rogers, 1983)
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2.3.7 The COM-B model and Theoretical Domains Framework 
 
The Theoretical Domains Framework (TDF) was developed by a consensus group of experts 
in response to the overlapping nature of behaviour change theories, to create one unifying 
theory of behaviour change (Cane et al, 2012). In addition, the TDF was intended to 
overcome some of the problems associated with selecting theory for intervention 
development, providing a framework which could be applied to any behaviour change 
context. Eighty three behaviour change theories comprising a total of 122 constructs were 
identified, and refined into 14 theoretical domains (Cane et al, 2012), as shown in Table 2.1.  
 
Table 2.1 TDF domain definitions and corresponding COM-B model construct (adapted from 
Cane et al 2012 and Michie et al, 2014 p88-91). 
TDF domain Definition of TDF domain Corresponding 
COM-B model 
construct 
Knowledge An awareness of the existence of an entity or concept e.g. knowledge of 
a health condition 
Capability 
 
Skills 
 
An ability or proficiency acquired though practice e.g. interpersonal 
skills 
Memory attention and 
decision processes  
The ability to retain information, focus selectively on aspects of the 
environment and choose between two or more alternatives e.g. 
decision making 
Behavioural regulation  Anything aimed at managing or changing objectively observed or 
measured actions e.g. self-monitoring 
Social/professional role 
and identity 
A set of behaviours and displayed personal qualities of an individual in a 
social or work setting e.g. social or professional identity 
Motivation 
Beliefs about capabilities Acceptance of the truth, reality or validity about an ability, talent or 
facility that a person can put to constructive use e.g. self-efficacy 
Optimism 
 
The confidence that things will happen for the best or that desired goals 
will be attained e.g. unrealistic optimism 
Beliefs about 
consequences  
Acceptance of the truth, reality or validity about outcomes of a 
behaviour in a given situation e.g. outcome expectancies  
Intentions  
 
 
A conscious decision to perform a behaviour or resolve to act in a 
certain way e.g. stability of interventions 
Goals  Mental representations of outcomes or end states that an individual 
wants to achieve e.g. action planning 
Reinforcement Increasing the probability of a response by arranging a dependent 
relationship, or contingency, between the response and a given stimulus 
e.g. incentives 
Emotions   A complex reaction pattern, involving experiential, behaviour and 
psychological elements, by which the individuals attempts to deal with a 
personally significant matter or event e.g. fear 
Environmental context 
and resources  
Any circumstance of a person’s situation or environment that 
discourages or encourages the development of skills and abilities, 
independence, social competence, and adaptive behaviour e.g. 
resources/material resources 
Opportunity  
 
Social influences  
 
 
Interpersonal processes that can cause individuals to change their 
thoughts, feelings and behaviours e.g. social norms 
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The COM-B (Capability, Opportunity, Motivation-Behaviour) model was developed from the 
TDF, where each of the TDF constructs fit under each of the COM-B constructs (see Table 
2.1). According to the COM-B model, behaviour is influenced through the constructs 
‘Capability’, ‘Opportunity’ and ‘Motivation’ (Michie et al, 2011) (Figure 2.7). The COM-B 
model suggests that in order for behaviour to occur, an individual must have the ‘Capability’ 
(physical or psychological capacity of a person to perform behaviour) as well as the 
‘Opportunity’ (physical opportunities created by the physical environment or social 
opportunities created by the cultural environment) (Michie et al, 2011). In addition, 
‘Motivation’ to engage in the target behaviour must outweigh motivation to engage in 
competing behaviours. ‘Motivation’ may be automatic (automatic process e.g. habitual or 
emotional responses) or reflective (slower, deliberative processes e.g. conscious decision 
making) (Michie et al, 2011). The TDF can be used in combination with the COM-B model to 
provide a more granular level of understanding for each of the COM-B model constructs. 
 
The arrows within the COM-B model represent how each construct could influence another 
within the system (Figure 2.7). The model assumes that both ‘Capability’ and ‘Opportunity’ 
can influence ‘Motivation’. The bidirectional nature of the arrows with relation to each of 
the constructs and behaviour suggest that ‘Capability’, ‘Opportunity’ and ‘Motivation’ all 
influence behaviour, but also that behaviour influences them. The interaction between 
‘Opportunity’ and ‘Capability’ is currently not represented in the model, and will be explored 
in this PhD. Each COM-B model construct will be described in further detail.  
 
 
Figure 2.7 The COM-B Model (Michie et al, 2011) 
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Capability  
The COM-B model construct ‘Capability’ is defined as the individual possessing the 
relevant skills or knowledge and capacity to engage in the necessary thought processes 
to perform the behaviour (Michie et al, 2011). As shown in, the TDF constructs 
‘knowledge’, ‘cognitive and interpersonal skills’, ‘memory, attention and decision 
processes’, ‘behavioural regulation’, and ‘physical skills’ are represented under the 
Capability construct in the COM-B model. In the context of cancer symptom 
presentation, knowledge of cancer symptoms and perceptions of interpersonal skills in 
relation to presenting to the doctor with symptoms are required. Once a symptom is 
appraised using their knowledge of the symptoms of cancer, the individual decides 
whether to seek medical help or not (Walter et al, 2012). At this point, perceptions of 
whether they hold the interpersonal skills to present to the doctor with symptoms are 
likely to influence their decision to present to the GP. If an individual perceives 
themselves to not hold the necessary interpersonal skills to discuss symptom concerns 
with the doctor, they might prolong cancer symptom presentation.  
 
Motivation 
The construct ‘Motivation’ refers to psychological processes that energise and direct 
behaviour, conceptualised as automatic and reflective processes. Automatic motivation 
is defined as fast, unconscious processes such as emotions, involving automatic impulses 
as a result of associative learning. Reflective motivation involves slower, more 
deliberative processes, using conscious reflective decision making and goal directed 
behaviour involving evaluations and plans. The TDF constructs ‘reinforcement’, 
‘emotions’, ‘social/professional role and identity’, ‘beliefs about capabilities’, ‘beliefs 
about consequences’, ‘goals’ and ‘intentions’ are represented under the Motivation 
construct in the COM-B model (see Table 2.1).  
 
Beliefs about cancer can be used to understand the processes underlying automatic and 
reflective motivation. As previously discussed, beliefs about cancer are important in the 
context of cancer symptom presentation behaviour among people from a low 
socioeconomic group. Studies of beliefs about cancer report that participants often hold 
contradictory beliefs about cancer, in which fear of cancer co-exists with positive beliefs 
about treatments and cures for cancer (Robb et al, 2014; Quaife et al, 2015a). A study by 
Robb et al, (2014) of public perceptions of cancer found that most negative responses 
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towards cancer were fast and emotional, representing automatic motivation. However, 
for those who expressed positive beliefs about cancer, such as improved survival rates 
for cancer, such responses tended to be slower and much less emotional, representing 
reflective motivation (Robb et al, 2014). There is evidence to suggest that people from a 
low socioeconomic group hold more pessimistic beliefs about cancer and are less likely 
endorse statements reflecting positive beliefs about cancer (Quaife et al, 2015). It is 
likely that negative beliefs about cancer are represented on both the automatic and 
reflective motivation systems to prolong cancer symptom presentation.  
 
Opportunity  
Opportunity is defined as ‘all the factors that lie outside of the individual that make the 
behaviour possible’ (Michie et al, 2011). The COM-B model distinguishes between two 
types of opportunity: those created by the physical environment, such as financial 
resources or cues, and those created by the social environment, such as social networks 
and the cultural environment. The TDF constructs ‘social influences’, ‘environmental 
context and resources’ are represented under the Opportunity construct in the COM-B 
model. Whilst many psychological theories neglect to consider the wider physical and 
socio- environmental influences on behaviour (Glanz and Bishop 2010), the construct of 
Opportunity takes these influences into account. In socioeconomically deprived 
communities, where many people are living with economic hardship, poor housing and 
limited access to services, opportunity afforded by the environment is likely to impact 
on health and medical help seeking behaviour (Steptoe and Feldman, 2001; Ellen et al, 
2001). Exploring the wider influences on symptom presentation behaviour is important 
in the context of this PhD, due to the focus on symptom awareness, beliefs and 
presentation in deprived communities of South Wales.  
 
Although the TDF and COM-B model have not been applied in the current context, they offer 
a potentially useful insight into how both individual and socio-environmental factors might 
lengthen time to cancer symptom presentation in low socioeconomic groups. As previously 
discussed, both individual and environmental factors appear important in the context of 
cancer symptom presentation among low socioeconomic groups. Since the COM-B model 
and TDF take both individual and environmental factors into account, but other models and 
theories focus solely on either individual influences on behaviour or the environmental 
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influences on behaviour, the COM-B model and TDF were considered most comprehensive 
and relevant in this context.  
 
Furthermore, four of the six theories and models described in this chapter underpin the TDF 
and COM-B model, with the exception of the CSM and the Ecological Model of Health 
Behaviour. Although the Ecological Model of Health Behaviour (McLeory et al, 1988) does 
not formally underpin the TDF and COM-B model, other ecological models applied to a 
specific health context such as diabetes (Burnet et al, 2002) were included in the 
development of the TDF and COM-B model. Therefore the theoretical constructs from 
ecological models are represented under the Opportunity construct of the COM-B model 
and associated TDF constructs of ‘social influences’ and ‘environmental context and 
resources’. A general ecological model of health (the Ecological Model of Health Behaviour) 
was selected and described in this chapter because this was considered most useful in this 
context, rather than describing an ecological model adapted to a specific health context. The 
CSM attempts to explain how illness is inferred; however, the COM-B model and TDF are not 
formally underpinned by this model or a similar model. Therefore, symptom interpretations 
are not explicitly represented by the TDF or COM-B model. However, the domains of 
‘knowledge’ and ‘memory, attention and decision processes’ are implicitly similar to the 
CSM construct of symptom identity and timeline. In addition, the CSM construct of 
consequences could be linked to the TDF domain beliefs about consequences. Therefore, 
although the CSM does not formally underpin the COM-B model or TDF, there is overlap 
between the models.  
 
Since the COM-B model and TDF appear most relevant and comprehensive in the context of 
cancer symptom presentation among low socioeconomic groups, they will be used 
throughout this PhD thesis. The role of theory will be discussed in further detail later in this 
chapter.  
 
2.4 Discussion  
 
This chapter presented the theoretical underpinning of this PhD, which is concerned with 
understanding the influences on cancer symptom presentation behaviour in the context of 
socioeconomic deprivation. Eight theories and models of symptom attribution, attitude and 
belief formation, and the wider social and environmental influences on behaviour were 
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described and critically evaluated. A range of psychological and sociological theories 
including the Health Belief Model, Theory of Planned Behaviour, the Extended Parallel 
Processing Model, Diffusion of Innovations Theory, the Common Sense Model of Illness Self-
Regulation, the Ecological Model of Health Behaviour, the Theoretical Domains Framework, 
and the COM-B model were identified as relevant in the current context. The TDF and COM-
B model were considered most useful in the context of cancer symptom presentation 
behaviour among low socioeconomic groups, combining both individual and environmental 
factors to understand behaviour.  
 
Although the six theories and models presented before the TDF and COM-B model could be 
applied to the context of cancer symptom presentation, they were considered to be 
potentially limiting if used in isolation. The main limitations were a lack of inclusion of 
emotional factors and the wider social and environmental influences on behaviour. For 
example, the HBM was useful for understanding how perceptions of severity, susceptibility, 
barriers and facilitators, and cues to action could guide behaviour. However, the HBM does 
not include emotions or environmental factors, which were discussed as important in this 
context (Balasooriya-Smeekens et al, 2015). In addition, the Ecological Model of Health 
Behaviour focused entirely on the environmental factors with no detail to guide 
understanding of how cancer knowledge and beliefs, or barriers to cancer symptom 
presentation could influence behaviour.  
 
The TDF and COM-B model were identified as the most comprehensive of all the theories or 
models described in this chapter, and was selected as most relevant to the context and aims 
of this PhD. The breadth of the COM-B model and TDF including individual and 
environmental factors was considered key a strength. Therefore, the COM-B model and TDF 
could offer a potential solution to the limitations of each individual theory or model 
discussed, by including individual factors such as cancer symptom knowledge, motivational 
factors such as beliefs about cancer, and wider social and environmental factors such as 
contextual factors in the community.  
 
However, there are potential limitations associated with reducing 83 behaviour change 
theories to a single framework. The main criticism of the TDF and COM-B model is that they 
are overly broad and reductionist. There are limitations associated with the wide range of 
theories which underpin the COM-B model and TDF, where certain theories are unrelated to 
 
 
48 
 
the context of cancer symptom presentation behaviour. For example, some of the 83 
included theories are theories of non-health behaviour, including offending behaviour (e.g. 
General Theory of Deviant Behaviour; Kaplan, 1972), and are therefore redundant in the 
context of cancer symptom presentation behaviour.  Finally, as previously discussed 
symptom interpretations are currently not explicitly represented under the COM-B model or 
TDF which could potentially limit in depth exploration of how symptoms might be 
interpreted. However, using the Common Sense Model of Illness Self-Regulation for this PhD 
thesis would be potentially limiting due to lack of inclusion of certain emotional factors and 
environmental influences on behaviour. Although there are limitations of the COM-B model 
and TDF, they implicitly or explicitly include all of the factors discussed, and are likely to be 
useful for understanding the factors influencing cancer symptom presentation behaviour 
among low socioeconomic groups. 
 
2.5 The role of theory in this PhD 
 
The primary aim of this PhD is to explore the barriers to cancer symptom presentation 
among low socioeconomic groups, using qualitative interviews and focus group studies. The 
qualitative studies will be supported by semi-structured topic guides, and will be developed 
in accordance with relevant theory identified in this chapter. Qualitative data analysis will 
involve framework analysis based around each of the COM-B constructs, to facilitate 
understanding of the influences on cancer symptom presentation behaviour among low 
socioeconomic groups. Themes generated from the data will be grouped under each of the 
COM-B model constructs, with the TDF used to facilitate grouping of themes.  
 
The Behaviour Change Wheel will be used to facilitate intervention development for the 
secondary aim of this PhD. The Behaviour Change Wheel is theoretically underpinned by the 
TDF and the COM-B model, which are used to guide intervention development in the first 
stage of the intervention mapping process. This first stage involves mapping the barriers and 
facilitators of behaviour to the TDF and COM-B model, in order to understand the potential 
influences on cancer symptom presentation behaviour among low socioeconomic groups. It 
is important to fully understand the theoretical frameworks of the COM-B model and TDF, 
since these form the basis of the Behaviour Change Wheel. Basing qualitative data analysis 
around the TDF and COM-B model will be an advantage when using the Behaviour Change 
Wheel for intervention development, facilitating accurate mapping through an in depth 
 
 
49 
 
understanding of these barriers and facilitators to behaviour. All steps involved in the 
intervention development process using the Behaviour Change Wheel are described in 
Chapter 7. 
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Chapter 3 
Systematic review of cancer symptom knowledge, beliefs about cancer, 
barriers/facilitators to symptom presentation and time to symptom presentation 
 
3.1 Chapter overview 
 
This chapter presents a systematic review of literature relating to cancer symptom 
knowledge, beliefs about cancer, barriers/facilitators to symptom presentation and time to 
symptom presentation (McCutchan et al, 2015; Appendix 1). The influences of knowledge, 
beliefs, and barriers/facilitators to symptom presentation on actual or anticipated cancer 
symptom presentation behaviour are explored. Further analysis of studies which include 
measures of socioeconomic group and lung specific studies were undertaken to allow insight 
into barriers to symptom presentation specific to certain socioeconomic groups or lung 
cancer, respectively. Finally, the evidence was critically appraised to explore the strength of 
evidence in relation to the research question for this systematic review.  
 
3.2 Introduction 
 
As outlined in Chapter 1, the Model of Pathways to Treatment (Walter et al, 2012) 
conceptualises the period of time between noticing a symptom and the start of cancer 
treatment into various intervals. The National Awareness and Early Diagnosis Initiative 
(NAEDI) framework provides a potentially useful insight into the factors influencing cancer 
symptom presentation behaviour, and suggests poor knowledge, negative beliefs and 
barriers can prolong the decision to seek medical help.  
 
Knowledge of cancer symptoms is likely to be important during the appraisal stage, with 
potential misattribution of symptoms attenuating the decision to present (Low et al, 2015; 
Whitaker et al, 2015b). Beliefs about cancer are considered to be important in both the 
appraisal and help-seeking stages, where emotions such as fear might influence 
interpretation of symptoms (Whitaker et al, 2015b) and the decision to seek medical help 
(Bish et al, 2005; Macleod et al, 2009; Mitchell et al, 2008; Sheikh & Ogden, 1998; Smith et 
al, 2005). Barriers such as competing life events and ease of getting a medical appointment 
are thought to prolong symptom presentation during the help-seeking interval (Walter, 
2012). However, a more detailed understanding of the psychosocial influences on cancer 
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symptom presentation is needed, in particular its relation to socioeconomic deprivation. 
Such insight is essential for developing behavioural interventions designed to promote 
timely symptom presentation and reduce socioeconomic inequalities in cancer outcomes. 
Previous reviews have focused on tumour site-specific delay factors (Bish et al, 2005; 
Mitchell et al, 2008; Ramirez et al, 1999) or common cancers only (Macleod et al, 2009), or 
have been restricted to qualitative studies (Smith et al, 2005) and patients with cancer 
(Macleod et al, 2009; Mitchell et al, 2008; Smith et al, 2005). The current review is the first 
to systematically examine the relationship between cancer symptom knowledge, beliefs 
about cancer, barriers/facilitators to symptom presentation and actual or anticipated cancer 
symptom presentation across all tumour sites, with a particular focus on socioeconomic 
deprivation.  
 
3.2.1 Aims of present review  
 
The present systematic review was conducted to:  
 Identify literature relating to the domains of interest (cancer symptom knowledge, 
beliefs about cancer, barriers/facilitators to cancer symptom presentation, and time 
to symptom presentation). 
 Provide insight into the relationship between cancer symptom presentation 
behaviour and cancer symptom knowledge, beliefs about cancer, and 
barriers/facilitators to symptom presentation.  
 Gain insight into relationship between the domains of interest and socioeconomic 
group. 
 Identify gaps in the literature and assess the quality of studies. 
 Identify lung specific studies to explore how the domains of interest outlined above 
might influence lung cancer symptom presentation.  
 
3.2.2 Systematic review methods 
 
A systematic review involves using a clearly defined, prospectively developed research 
question, and explicit methods at each stage of the search, study selection, critical appraisal 
of studies and data analysis (Khan et al, 2003). All stages of the systematic review method 
are double checked by an independent coder to reduce any potential bias during study 
selection, critical appraisal and data analysis (Khan et al, 2003). Consequently, systematic 
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reviews are regarded as the highest level of evidence, due to measures taken to reduce bias 
and explicit, transparent methods utilised (Khan et al, 2003). 
 
A systematic review differs from other types of review methods such as scoping review 
mainly due to the types of literature searches performed and the stages involved for the 
methodology (Davis et al, 2009). For example, a scoping review does not formally require 
the researcher to perform quality assessments of studies, or involve an independent coder 
to double check each stage of the methodology. In addition, the research question can be 
adapted throughout a scoping review, whereas for a systematic review, the research 
question remains fixed and should be formally registered prospectively on a systematic 
review protocol register. Finally, systematic reviews typically involve searches of multiple 
academic databases, where grey literature searches are optional. Whereas for a scoping 
review, a mixture of sources such as academic databases and grey literature (e.g. Google and 
key organisation websites) are searched for potential studies for inclusion in the review 
(Cacchione, 2016). Grey literature searches are performed to identify studies which have not 
formally undergone peer-review, and to allow the inclusion of smaller scale local studies. A 
systematic review method was considered most appropriate for the present review due to 
the high number of studies on the topic of cancer symptom presentation behaviour 
published in academic journals. Using systematic review method was considered to limit any 
potential bias at all stages of the review, and provide high strength of evidence.  
 
3.3 Method 
 
This systematic review followed the PRISMA guidelines for conduct of systematic reviews 
(Moher et al, 2009). The protocol was registered on PROSPERO which is an international 
prospective register for systematic review protocols (CRD42014013220; McCutchan et al, 
2014) and is available on the NIHR HTA programme website (www.hta.ac.uk). At all stages of 
the search, data extraction and quality appraisal, 10% of studies were double checked for 
consistency by another PhD student. All discrepancies were resolved through discussion.  
 
3.3.1 Search Strategy 
 
The literature was searched up to July 2015 on the electronic databases of MEDLINE, 
PsycINFO, EMBASE and CINAHL. The de-duplicate function was used on Ovid and CINAHL 
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before reviewing abstracts. Manual searches of reference lists of included studies were 
performed. No grey literature was searched due to the high number of peer reviewed 
articles available for the topic of barriers to cancer symptom presentation. Smaller scale 
studies, potentially of lower quality, were therefore considered irrelevant for this review.  
A SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) search 
strategy tool was used for retrieval of studies (Appendix 2; Cooke et al, 2012). Other search 
tools such as PICO (Population, Intervention, Comparison, Outcomes) were considered; 
however, the ‘Intervention’ element in other search tools such as PICO was redundant 
because the present review was not concerned with outcomes of an intervention. 
Therefore, SPIDER was selected as most relevant in this context. Databases were searched 
using terms relating to symptom presentation, cancer symptom knowledge, beliefs about 
cancer, perceived barriers and facilitators to symptom presentation (Appendix 2).  
 
3.3.2 Inclusion criteria  
 
Included publications reported data from two or more of the following domains: symptom 
presentation, knowledge, beliefs and perceived barriers/facilitators. Definitions for each 
domain were:  
 ‘Symptom presentation’: studies which measured actual symptom presentation 
(retrospectively recalled) or anticipated symptom presentation (hypothetically 
estimated) measured as continuous (time to presentation) or binary (did/did not 
present) variables. Studies of actual symptom presentation examined time to 
symptom presentation using a timeline for participants awaiting a diagnosis for 
suspected cancer symptoms or those who had previously received a diagnosis of 
cancer. Studies which examined anticipated time to symptom presentation asked 
participants to predict the length of time it might take for them to present to their 
doctor with a symptom.  Studies which did not report duration of time to symptom 
presentation reported whether symptomatic participants did/did not present or 
asked asymptomatic participants to anticipate if they would/would not present with 
symptoms.  
 ‘Knowledge’: studies which assessed knowledge for the symptoms of cancer through 
recall e.g. ‘What symptoms of cancer can you list?’ or recognition methods e.g. 
‘Which of these are symptoms of cancer?’, or through retrospective recall of 
symptom interpretation and attributions at the time of symptom discovery.  
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 ‘Beliefs’: studies which explored any positive (e.g. beliefs about the benefits of early 
diagnosis and curability) or negative (e.g. fear and fatalism) beliefs surrounding 
cancer.  
 ‘Perceived barriers/facilitators’: studies which assessed any actual or anticipated 
barriers or facilitators to symptom presentation.  
 
There were no restrictions on date of publication or study methodology. Only English 
language studies from high income countries as classified by Organisation for Economic Co-
operation and Development (OECD) membership (OECD, 2014) were included.  
 
3.3.3 Socioeconomic group  
 
Further analysis was undertaken for studies which measured socioeconomic group. 
Measures for socioeconomic group included individual or group level indicators such as 
education, income, postcode data, occupation, employment, or area level indicators such as 
postcode. Where measured and reported, the association between the domains of interest 
and socioeconomic indicator was described and the relevant statistics were extracted.  
 
3.3.4 Lung cancer 
 
Additional analysis was undertaken for studies examining lung cancer due to the change in 
focus of the proposed intervention (described in Chapter 1). Studies relating to lung cancer 
were further analysed to explore the influences of the domains of interest on lung cancer 
symptom presentation.  
 
3.3.5 Exclusion criteria 
 
Studies not relating to cancer and those that did not measure two or more of the domains of 
interest were excluded. Studies of self-examination behaviour, efficacy of interventions, 
genetic risk, healthcare professionals’ perspective, cancer prevention, treatments for cancer 
or living with cancer, and studies involving children were excluded. Studies not written in 
English, review papers or conference abstracts were excluded. Studies of screening 
behaviour and studies using participants with screen detected cancer were excluded as the 
barriers to presenting to the doctor with self-detected symptoms are likely to be different to 
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the barriers experienced in a potentially asymptomatic sample, prompted with a letter 
reminding them to engage in screening. Studies from low/middle income countries were 
excluded as the barriers to presentation are likely to be different in low income countries 
where healthcare provision is poor (Figure 3.1).  
 
3.3.6 Data extraction and synthesis 
 
Data were extracted onto a template using the following headings: method, sample 
characteristics, tumour site, symptom presentation, knowledge, beliefs, perceived 
barriers/facilitators, socioeconomic group measure, statistical association between variables 
of interest and socioeconomic measure. Headings were selected based around the NAEDI 
framework outlined in Chapter 1. Typically, systematic reviews involve a meta-analysis; 
however, due to the heterogeneity of included studies a meta-analysis was precluded, and a 
narrative synthesis was performed using guidance outlined by Popay et al (2006).  
 
Data from the narrative of qualitative and quantitative articles were extracted and entered 
onto an Excel spreadsheet under each heading outlined above. Where reported, statistical 
associations between the variables of interest were entered onto the spreadsheet. The 
spreadsheet was subsequently used to explore relationships within and between studies to 
identify similar and disparate themes (Popay et al, 2006).  
 
3.3.7 Critical Appraisal 
 
The methodological quality of all included studies was examined using a Critical Appraisal 
Skills Programme tool (CASP, 2014) appropriate for the study design. Quality was assessed 
according to each domain on the CASP checklists: rationale of study, methodology, design, 
recruitment, data collection, data analysis, ethical issues, reporting of findings and 
contribution to research. The CASP tool was adapted to assess contribution of research to 
the specific research question to include quality assessments on timeliness of study post 
diagnosis, use of theory, socioeconomic variation within sample etc. (see Appendix 3 for 
adapted CASP tool). For example, if lung cancer patients were interviewed 12 months post 
diagnosis, the sample would be biased due to poor lung cancer survival rates. Overall quality 
was categorised as good, medium or poor.  
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Figure 3.1 PRISMA flow chart  
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3.4 Results 
 
The search returned a total of 1536 studies after 810 duplicates had been removed. A total 
of 1309 studies were excluded based on title and abstract, leaving 227 studies to be read in 
full. A total of 106 studies met the inclusion criteria (Figure 3.1). Twenty-two of these studies 
were found through hand searching reference lists.  
 
Included studies employed qualitative methods (n=36), quantitative methods (n=61) and 
mixed methods (n=9). Quality of studies was good (n=21), medium (n=72) and poor (n=13). 
Limitations of lower quality studies included measuring but not reporting socioeconomic 
group differences for all outcome measures, leaving a long period of time between cancer 
diagnosis and participation in the study, and recruitment of samples biased towards higher 
socioeconomic groups. The overall combined percentage agreement between raters (GM 
and RR) for inclusion/exclusion of studies, critical appraisal and data extraction was 87%.  
A total of 70 studies examined time to symptom presentation, 14 studies reported 
presentation behaviour (if participants did/did not present or anticipate presenting to their 
doctor with reported symptoms), 66 studies retrospectively measured actual time to 
symptom presentation, 17 studied anticipated time to symptom presentation, 82 studies 
assessed knowledge for cancer symptoms, 54 studies explored beliefs about cancer and 83 
studies examined perceived barriers/facilitators to symptom presentation. Studies by 
tumour site included: breast (n=30), any cancer/multiple tumour sites (n=29), colorectal 
(n=12), skin (n=10), oral and pharyngeal (n=7), lung (n=5), ovarian (n=4), prostate (n=3) 
gynaecological (n=2), testicular (n=2), lymphoma (n=1) and endometrial (n=1) (Table 3.1). 
Results are presented according to domain headings. 
 
3.4.1 Symptom presentation 
 
Studies examining anticipated symptom presentation reported shorter time to symptom 
presentation compared with studies that examined actual time to symptom presentation. In 
the former, most participants anticipated seeking medical help within one week (Brain et al, 
2014; Forbes et al, 2011; Hunter, 2003) or within one month (Cooper et al, 2013; Low et al, 
2013; Quaife et al, 2014; Robb et al, 2009), in contrast to real-world studies where it was 
more common for patients to have waited over two months before seeking medical help 
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(Blum et al, 1999; Cassileth et al, 1988; Chonjnacka-Szwalowska, 2013; Corner et al, 2005; 
Crosland & Jones, 1995; Emery et al, 2013; Freidman, 2006; Gascoigne et al, 1999; Gould, 
2010; Henderson, 1965; Kakagia et al, 2013; Lund-Nielsen et al, 2011; Oliveria, 1999; 
Ristvedt, 2014; Roncoroni et al, 1999; Schmid-Wendtner et al, 2002; Scott et al, 2009; Scott 
et al, 2008; Siminoff et al, 2014; Trivers et al, 2011; Walter et al, 2014). The most prompt 
actual and anticipated symptom presentation was reported for lumps (Burgess et al, 2001; 
Burgess et al, 2006; Burgess et al, 1998; Caplan, 1995; Chapple et al, 2004b; Coates et al, 
1992; de Nooijer et al, 2001; Emery et al, 2013; Freidman, 2006; Grunfeld et al, 2003; Lauver 
et al, 1995; Meechan, 2003; O'Mahony & Hegarty, 2009; Quaife et al, 2014; Sheikh & Ogden, 
1998) or bleeding (Birt et al, 2014; Cooper et al, 2013; Corner et al, 2005; de Nooijer et al, 
2001; Hale et al, 2007; McCaffery et al, 2003; Quaife et al, 2014; Robb et al, 2009; Sheikh & 
Ogden, 1998; Simon et al, 2010; Smith & Anderson 1985; Trivers et al, 2011; van Osch et al, 
2007; Waller et al, 2009). Studies examining participants who reported experiencing a 
potential symptom of cancer in the past three months found that between 41% and 75% of 
participants had consulted a doctor about their symptom (Cameron & Hinton, 1968; 
Cockburn, 2003; Courtney et al, 2012; Simon et al, 2010; Whitaker et al, 2014).  
 
Disparity between actual and anticipated symptom presentation relating to socioeconomic 
group was observed. In five studies, shorter anticipated time to symptom presentation was 
observed in lower compared to higher socioeconomic groups (Brain et al, 2014; Low et al, 
2013; Quaife et al, 2014; Robb et al, 2009; van Osch et al, 2007). Conversely, in two studies, 
longer anticipated time to symptom presentation was reported in those from lower 
socioeconomic groups compared with higher socioeconomic groups (Facione et al, 2002; 
Fitzpatrick et al, 1998).   
 
Studies which measured actual time to symptom presentation reported the longest times to 
symptom presentation among individuals with lower educational attainment (Cameron & 
Hinton, 1968; Coates et al, 1992; Cockburn, 2003; Facione, 2006; Goldsen et al, 1957; 
Kakagia et al, 2013; Ristvedt, 2014; Tomlinson et al, 2012), lower annual income (Goldsen et 
al, 1957; Samet et al, 1988), lower occupation and employment (Burgess et al, 2001; 
Goldsen et al, 1957; Lam, 2003) and those from deprived areas (Forbes et al, 2014; Scott et 
al, 2008). This effect was also observed in studies of actual symptom presentation where 
multiple socioeconomic indices were reported (Caplan, 1995; Coates et al, 1992; Goldsen et 
al, 1957; Kakagia et al, 2013; Li et al, 2012; Rauscher et al, 2010). In addition, later stage 
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cancer was associated with lower annual income (Lannin et al, 1998) and higher tumour 
thickness was associated with lower educational attainment (Baumert et al, 2007). Twenty-
three studies found no group differences for socioeconomic group indicators and time to 
symptom presentation (Brouha et al, 2005; Burgess et al, 1998; Burgess et al, 2000; Carter-
Harris, 2015; Chonjnacka-Szwalowska, 2013; Esteva et al, 2013; Greer, 1974; Hunter, 2003; 
Loehrer et al, 1991; Magery et al, 1977; McCaffery et al, 2003; Meechan, 2003; Mor, 1990; 
Oliveria, 1999; Richard et al, 2000; Ristvedt, 2014; Rozniatowski et al, 2005; Siminoff et al, 
2014; Simon et al, 2010; Temoshok, 1983; Tomlinson et al, 2012; Trivers et al, 2011).  
 
3.4.2 Knowledge  
 
Knowledge of symptoms based on recall methods was generally lower than in studies that 
used recognition methods. Lump symptoms were the most recalled and well-recognised 
potential cancer symptom (de Nooijer et al, 2001; Facione et al, 2002; Forbes et al, 2014; 
Grunfeld et al, 2002; Hvidberg et al, 2014; Marlow et al, 2014; McCaffery et al, 2003; Niksic 
et al, 2015; Phillips & Taylor, 1961; Quaife et al, 2014; Robb et al, 2009; Sheikh & Ogden, 
1998; van Osch et al, 2007; Waller et al, 2009). This was supported by retrospective studies 
where patients presenting with a lump were most likely to have attributed their lump 
symptom to cancer (Burgess et al, 2001; Burgess et al, 1998; Gould, 2010; Mor, 1990; 
O'Mahony et al, 2011). 
 
Knowledge was generally poor for non-specific symptoms of cancer. Symptoms such as 
fatigue or unexplained weight loss were poorly recalled or recognised as potential symptoms 
of cancer (Brain et al, 2014; de Nooijer et al, 2001; Forbes et al, 2011; Hvidberg et al, 2014; 
Low et al, 2013; Marlow et al, 2014; Tod & Joanne, 2010; Waller et al, 2009). In retrospective 
studies, patients experiencing non-specific symptoms recalled attributing them to other 
benign causes or life stresses  (Andersen et al, 2010; Brandner et al, 2014; Brouha et al, 
2005; Carter-Harris, 2015; Cochran et al, 1986; Gascoigne et al, 1999; Li et al, 2012; Siminoff 
et al, 2014; Smith & Anderson 1985; Tod et al, 2008; Tod & Joanne, 2010; Whitaker et al, 
2015c; Whitaker et al, 2014) or not recognising the seriousness of their symptoms (Andersen 
et al, 2010; Brouha et al, 2005; Burgess et al, 2001; Burgess et al, 2006; Burgess et al, 1998; 
Cameron & Hinton, 1968; Coates et al, 1992; Cockburn, 2003; Facione & Giancarlo, 1998; 
Fitzpatrick et al, 1998; Grant et al, 2010; Greer, 1974; Henderson, 1965; Howell et al, 2008; 
Larkey et al, 2001; Li et al, 2012; O'Mahony & Hegarty, 2009; Oliveria, 1999; Richard et al, 
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2000; Ristvedt, 2014; Ristvedt & Trinkaus, 2005; Roncoroni et al, 1999; Schmid-Wendtner et 
al, 2002; Siminoff et al, 2014; Smith & Anderson 1985;Tomlinson et al, 2012; Whitaker et al, 
2015c; Whitaker et al, 2014) resulting in patients prolonging symptom presentation 
(Brandner et al, 2014; Brouha et al, 2005; Gould, 2010; Henderson, 1965; Howell et al, 2008; 
Roncoroni et al, 1999; Siminoff et al, 2014; Smith & Anderson 1985) or experiencing later 
stage at diagnosis (Carter-Harris, 2015). 
 
There was a tendency to normalise symptoms, attributing symptoms to ageing (Brandner et 
al, 2014; Burgess et al, 2006; Corner et al, 2005; Emery et al, 2013; Howell et al, 2008) or 
other benign causes such as haemorrhoids (Brandner et al, 2014; Chapple et al, 2004b; 
Cooper et al, 2013; Courtney et al, 2012; Emery et al, 2013; Ramos et al, 2009; Roncoroni et 
al, 1999) before interpreting symptoms as potentially serious (Cassileth et al, 1988; Cooper 
et al, 2013; Courtney et al, 2012; Scott et al, 2009; Scott et al, 2008). Two studies found that 
symptom interpretations were influenced by perceptions of cancer risk. Individuals who 
perceived themselves as low risk for cancer, were less likely to attribute symptoms as 
potentially indicative of cancer and consequently prolonged symptom presentation 
(Andersen et al, 2010; Emery et al, 2013).  
 
Four studies examined the relationship between knowledge and symptom presentation. 
Good cancer symptom knowledge was associated with appropriately timed intentions to 
seek medical help (de Nooijer et al, 2003; Grunfeld et al, 2003; Ruiter et al, 2008; Sheikh & 
Ogden, 1998). 
 
Poorer cancer symptom knowledge was associated with low socioeconomic group when 
measured by educational attainment (Brain et al, 2014; Cockburn, 2003; Facione et al, 2002; 
McCaffery et al, 2003; Quaife et al, 2014; Schmid-Wendtner et al, 2002), occupation 
(Grunfeld et al, 2002; Waller et al, 2009) and multiple indicators (Brain et al, 2014; Hvidberg 
et al, 2014; Lannin et al, 1998; Niksic et al, 2015; Rauscher et al, 2010; Robb et al, 2009; 
Scanlon et al, 2006). These findings were consistent across site-specific and non site-specific 
studies, suggesting poor general cancer symptom knowledge in low socioeconomic groups 
regardless of cancer type.  One study found that people from low socioeconomic groups 
attributed poor cancer knowledge to reluctance to talk about cancer in the community 
(Scanlon et al, 2006). 
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3.4.3 Beliefs about cancer 
 
In most studies, beliefs were formed from participants’ past experiences of cancer, usually 
witnessing friends or family with the disease (Burgess et al, 2001; Chonjnacka-Szwalowska, 
2013; Facione, 2006; Henderson, 1965; Marlow et al, 2014; O'Mahony & Hegarty, 2009; 
O'Mahony et al, 2011; Shahid et al, 2009). Positive beliefs were identified in nine studies 
(Blum et al, 1999; Burgess et al, 2001; Cameron & Hinton, 1968; Chonjnacka-Szwalowska, 
2013; Cockburn, 2003; Hunter, 2003; Marlow et al, 2014; O'Mahony et al, 2011; van Osch et 
al, 2007) and tended to focus on the effectiveness of modern cancer treatments, where 
participants expressed trust in doctors and the medical system and endorsed the benefits of 
early diagnosis (Blum et al, 1999; Cameron & Hinton, 1968; Facione, 2006; Grunfeld et al, 
2003; Hunter, 2003; Marlow et al, 2014; Scanlon et al, 2006) or acknowledged that cancer 
can be cured (Marlow et al, 2014; Scanlon et al, 2006). Such beliefs tended to encourage 
timely symptom presentation to a primary care physician (Cameron & Hinton, 1968; Facione, 
2006; Grunfeld et al, 2003; Hunter, 2003; Lauver et al, 1995; Marlow et al, 2014; O'Mahony 
et al, 2011; Scott et al, 2009). Two studies found that those with low educational attainment 
were less likely to endorse positive beliefs about the benefits of early detection (Cockburn, 
2003; Quaife et al, 2015a). 
 
Negative beliefs tended to manifest in fear or fatalism regarding cancer. Fear was frequently 
reported across all studies examining beliefs. This included fear of diagnosis (Cameron & 
Hinton, 1968; Chapple et al, 2004b; Facione, 1995; Gould, 2010; Hale et al, 2007; Henderson, 
1965; Kakagia et al, 2013; Lam, 2003; Larkey et al, 2001; Lauver et al, 1995; Lyubomirsky et 
al, 2006; Mor, 1990; Tod et al, 2008; Tod & Joanne, 2010; Whitaker et al, 2015c), fear of 
treatment (Burgess et al, 2001; Cameron & Hinton, 1968; Chapple et al, 2004b; Facione, 
1995; Facione, 2006; Fitzpatrick et al, 1998; Greer, 1974; Grunfeld et al, 2003; Hunter, 2003; 
Lyubomirsky et al, 2006; Marlow et al, 2014), and fear of dying (Facione, 1995; Facione, 
2006; Marlow et al, 2014; Sheikh & Ogden, 1998). Fatalistic beliefs were a common theme 
throughout studies, but were expressed only by a minority of participants per study 
(Chapple et al, 2004b; Chonjnacka-Szwalowska, 2013; Coates et al, 1992; Facione et al, 2002; 
Facione, 1997; Facione, 2006; Goldsen et al, 1957; Kakagia et al, 2013; Marlow et al, 2014; 
O'Mahony et al, 2011; Price, 1993; Sheikh & Ogden, 1998). Fearful and fatalistic beliefs 
about cancer were more likely to be expressed by individuals from low socioeconomic 
groups based on educational attainment (Chonjnacka-Szwalowska, 2013; McCaffery et al, 
 
 
62 
 
2003; Quaife et al, 2015a), or multiple indices (Coates et al, 1992; Loehrer et al, 1991; 
Scanlon et al, 2006). People from low socioeconomic groups were more likely to hold 
negative beliefs around cancer survival (Grunfeld et al, 2002) or wrongly estimate five-year 
cancer survival (Hvidberg et al, 2014) based on occupation and multiple indices respectively.  
 
When considering time to symptom presentation, fearful beliefs about cancer appeared to 
operate at the two extremes of immediate or prolonged symptom presentation (de Nooijer 
et al, 2001). For participants whose fearful beliefs encouraged immediate (actual or 
hypothetical) presentation to doctors (Burgess et al, 2001; Burgess et al, 1998; Cameron & 
Hinton, 1968; de Nooijer et al, 2001; Facione, 1997; Facione, 2006; Goldsen et al, 1957; 
Marlow et al, 2014; Mor, 1990; O'Mahony et al, 2011; Ramos et al, 2009), a visit to the 
doctors was used to alleviate anxiety associated with the symptom (Burgess et al, 2001; 
Cameron & Hinton, 1968; de Nooijer et al, 2001; Facione, 2006; Goldsen et al, 1957; Lund-
Nielsen et al, 2011; Marlow et al, 2014; O'Mahony & Hegarty, 2009; Richard et al, 2000; 
Rogers et al, 2011; Scott et al, 2009). This was usually coupled with the participant 
expressing trust in the medical profession and positive beliefs surrounding early diagnosis 
(Burgess et al, 2001; Facione, 2006; Scott et al, 2009).  
 
For individuals whose fearful beliefs led to prolonged symptom presentation (sometimes 
years) (Burgess et al, 2001; Burgess et al, 2006; de Nooijer et al, 2001; Freidman, 2006; 
Goldsen et al, 1957; Gould, 2010; Greer, 1974; Grunfeld et al, 2003; Hale et al, 2007; Hunter, 
2003; Kakagia et al, 2013; Lannin et al, 1998; Lauver et al, 1995; Marlow et al, 2014; Mor, 
1990; O'Mahony & Hegarty, 2009; O'Mahony et al, 2011; Ramos et al, 2009; Scanlon et al, 
2006; Smith & Anderson 1985; Tod & Joanne, 2010), denial of or ignoring symptoms initially 
alleviated anxiety associated with the symptom (Brouha et al, 2005; Chapple et al, 2004b; de 
Nooijer et al, 2001; Facione, 2006; Freidman, 2006; Gould, 2010; Greer, 1974; Hale et al, 
2007; Henderson, 1965; Lauver et al, 1995; Magarey et al, 1977; Marlow et al, 2014; 
O'Mahony & Hegarty, 2009; O'Mahony et al, 2011; Shahid et al, 2009; Sheikh & Ogden, 
1998). Such beliefs were usually combined with fatalistic beliefs such as ‘cancer cannot be 
cured’ (Facione, 2006; Goldsen et al, 1957; Lannin et al, 1998; O'Mahony et al, 2011; Scanlon 
et al, 2006; Tod & Joanne, 2010), and were associated with the longest times to symptom 
presentation or were expressed by those with advanced stage disease (Bergamo et al, 2013; 
Chonjnacka-Szwalowska, 2013; Facione et al, 2002; Facione, 1997; Facione, 2006; Shahid et 
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al, 2009). This is likely to reflect a lack of perceived benefit in presenting to doctors due to 
the belief that ‘nothing can be done’ (Facione, 2006; Marlow et al, 2014).  
 
3.4.4 Barriers to symptom presentation 
 
Some participants reported service barriers relating to concerns about wasting doctors’ time 
(Burgess et al, 2001; Forbes et al, 2011; Hale et al, 2007; Kakagia et al, 2013; Low et al, 2013; 
Robb et al, 2009; Scott et al, 2009; Tod et al, 2008; Tod & Joanne, 2010; Walter et al, 2014; 
Whitaker et al, 2015c; Whitaker et al, 2014), lack of continuity with their primary care doctor 
(Coates et al, 1992; Emery et al, 2013; Whitaker et al, 2015c) or difficulties with accessing 
and making an appointment (Burgess et al, 2006; Facione et al, 2002; Forbes et al, 2011; 
Freidman, 2006; Hale et al, 2007; Kakagia et al, 2013; Li et al, 2012; Marlow et al, 2014; 
Quaife et al, 2014; Scanlon et al, 2006; Tod & Joanne, 2010; Waller et al, 2009; Whitaker et 
al, 2015c; Whitaker et al, 2014). Low general health service utilisation for acute or long term 
conditions lengthened time to cancer symptom presentation (Burgess et al, 2001; Cameron 
& Hinton, 1968; Coates et al, 1992; Cooper et al, 2013; Corner et al, 2005; Facione, 1997; 
Fitzpatrick et al, 1998; Goldsen et al, 1957; Greer, 1974; Kakagia et al, 2013; Lannin et al, 
1998; Larkey et al, 2001; Marlow et al, 2014; Rauscher et al, 2010; Richard et al, 2000; 
Ristvedt & Trinkaus, 2005; Rozniatowski et al, 2005; Tod et al, 2008). In addition, a poor 
relationship with the doctor (Bergamo et al, 2013; Henderson, 1965; Larkey et al, 2001) or 
the belief that the doctor could not do anything to treat their symptoms prolonged 
symptom presentation (de Nooijer et al, 2001; Shahid et al, 2009).  
 
Practical barriers such as being ‘too busy to make an appointment’ prolonged symptom 
presentation (Burgess et al, 2001; Gould, 2010; Low et al, 2013; Marlow et al, 2014; Mor, 
1990; Richard et al, 2000; Schmid-Wendtner et al, 2002; Simon et al, 2010) and such barriers 
were more frequently reported in high socioeconomic groups (Robb et al, 2009).  Other 
practical barriers reported included work and family commitments (Andersen et al, 2010; 
Chapple et al, 2004b; de Nooijer et al, 2001; Emery et al, 2013; Lauver et al, 1995; Scott et 
al, 2009) or ill health of another family member (Brandner et al, 2014; Lund-Nielsen et al, 
2011), prolonging symptom presentation due to time constraints. Those from a low 
socioeconomic group based on multiple indices were more likely to report problems with 
transportation to get to an appointment (Niksic et al, 2015; Scott et al, 2009).   
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Emotional barriers included embarrassment or fear associated with undergoing intimate 
diagnostic tests (Emery et al, 2013; Fitzpatrick et al, 1998; Forbes et al, 2011; Hale et al, 
2007; Henderson, 1965; Kakagia et al, 2013; Larkey et al, 2001; Low et al, 2013; Marlow et 
al, 2014; Price, 1993; Robb et al, 2009; Shahid et al, 2009; Siminoff et al, 2014; Simon et al, 
2010; Tod & Joanne, 2010; Whitaker et al, 2015c) or embarrassment associated with 
disclosing symptoms to the doctor (Cameron & Hinton, 1968; Chapple et al, 2004b; de 
Nooijer et al, 2001; Gascoigne et al, 1999; Hale et al, 2007; Henderson, 1965; Shahid et al, 
2009; Sheikh & Ogden, 1998). Worry about being perceived as a hypochondriac (Chapple et 
al, 2004b) and worry about what the symptoms might be were also reported as barriers to 
symptom presentation  (Crosland & Jones, 1995; Tod & Joanne, 2010). Stoicism in men 
prolonged symptom presentation, where seeking medical help was perceived as a sign of 
weakness (Chapple et al, 2004b; Emery et al, 2013; Hale et al, 2007; Scanlon et al, 2006). 
People from low socioeconomic groups based on multiple indices were more likely to report 
embarrassment, being too scared, or worry what the doctor might find as barriers to 
symptom presentation (Niksic et al, 2015). One study found that those with low education 
attainment were more likely to report not wanting to know if they had cancer (Quaife et al, 
2015a). 
 
One study reported that confidence in the ability to communicate symptoms was a barrier 
to symptom presentation in low socioeconomic groups based on multiple indices (Niksic et 
al, 2015). In countries where patients pay for their healthcare, those with lower annual 
income were more likely to report the cost of consultation as a barrier to symptom 
presentation (Cooper et al, 2013; Freidman, 2006; Lam, 2003; Lannin et al, 1998).  
 
3.4.5 Facilitators of symptom presentation 
 
The most common facilitator of symptom presentation was disclosure of symptoms to a 
family member or friend (Andersen et al, 2010; Brandner et al, 2014; Brouha et al, 2005; 
Burgess et al, 2001; Burgess et al, 2006; Burgess et al, 1998; Crosland & Jones, 1995; de 
Nooijer et al, 2001; Emery et al, 2013; Esteva et al, 2013; Facione & Giancarlo, 1998; 
Facione, 1997; Goldsen et al, 1957; Gould, 2010; Hale et al, 2007; Howell et al, 2008; Kakagia 
et al, 2013; Li et al, 2012; Marlow et al, 2014; O'Mahony & Hegarty, 2009; O'Mahony et al, 
2011; Pedersen et al, 2011; Ramos et al, 2009; Richard et al, 2000; Rogers et al, 2011; 
Rozniatowski et al, 2005; Scott et al, 2009; Tod & Joanne, 2010; Trivers et al, 2011; Walter et 
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al, 2014; Whitaker et al, 2015c; Whitaker et al, 2014). For some participants, symptom 
disclosure acted as a facilitator when symptoms were re-evaluated as potentially serious 
(Andersen et al, 2010), or acted as a cue to action (de Nooijer et al, 2001) when participants 
were encouraged to seek help by family members and friends (Andersen et al, 2010; Burgess 
et al, 2006; Gascoigne et al, 1999; Trivers et al, 2011). In some cases, disclosure of symptoms 
reduced time to symptom presentation by half (Chonjnacka-Szwalowska, 2013) or by six 
times (Burgess et al, 1998). However, one study found that symptom presentation was 
sometimes prolonged following disclosure of symptoms, as friends and family confirmed 
beliefs about the benign nature of symptoms or reinforced fears of diagnostic tests (Emery 
et al, 2013). One study found that individuals from a low socioeconomic group who 
disclosed their symptom to a family member or friend took longer to seek medical help 
compared to those from a high socioeconomic group (Li et al, 2012).  
 
The appearance of a new symptom (Brouha et al, 2005; Burgess et al, 2001; Carter-Harris, 
2015; Cooper et al, 2013; de Nooijer et al, 2001; Facione, 1995) or persistence of the current 
symptom(s) (Brouha et al, 2005; Burgess et al, 1998; Carter-Harris, 2015; Cooper et al, 2013; 
Courtney et al, 2012; Facione, 1997; Gascoigne et al, 1999; Ramos et al, 2009; Scott et al, 
2009; Whitaker et al, 2015c) facilitated decisions to seek medical help. When symptoms 
interfered with daily life (Brandner et al, 2014; Emery et al, 2013), were painful (Cameron & 
Hinton, 1968; Scott et al, 2009) or opposed the ideal body image held by patients, this often 
triggered symptom presentation (Brandner et al, 2014). In eight studies, participants waited 
until they developed another health complaint or tagged their cancer symptom on to the 
end of a consultation which provided an opportunity to disclose the cancer symptom during 
the consultation (Burgess et al, 1998; Cameron & Hinton, 1968; Coates et al, 1992; Courtney 
et al, 2012; Grant et al, 2010; Greer, 1974; Howell et al, 2008; Whitaker et al, 2015c). 
 
3.4.6 Lung cancer specific studies 
 
Nine studies reported data relating to lung cancer symptom presentation. One study found 
that those with lung cancer were more likely to be diagnosed with advanced stage cancer 
when compared to participants with breast or colorectal cancers (Mor, 1990). Six studies 
retrospectively examined lung cancer symptom attributions. Many participants reported 
experiencing vague and non-specific symptoms such as a cough or fatigue prior to diagnosis 
(Andersen et al, 2010; Carter-Harris, 2015; Emery et al, 2013; Mor, 1990; Tod et al, 2008; 
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Tod & Joanne, 2010). Participants often prolonged presenting with such symptoms, 
dismissing them as not serious (Andersen et al, 2010; Emery et al, 2013; Mor, 1990), or 
attributing them to acute conditions such as a cold, symptoms of other chronic conditions 
such as COPD (Andersen et al, 2010; Carter-Harris, 2015; Emery et al, 2013; Tod et al, 2008; 
Tod & Joanne, 2010) or smoking habit (Carter-Harris, 2015). Participants reported a 
reluctance to seek help for vague and non-specific symptoms due to worries about wasting 
the doctor’s time (Tod et al, 2008; Tod & Joanne, 2010). Such barriers were reinforced by 
cultural messages encouraging patients to reduce consultation behaviour (Tod et al, 2008). 
Three studies found that participants who perceived themselves as low risk for developing 
lung cancer were more likely to provide benign explanations for symptoms, further 
prolonging symptom presentation (Andersen et al, 2010; Emery et al, 2013; Tod et al, 2008). 
This was particularly salient in never and ex-smokers who perceived their risk for developing 
lung cancer as nil or low (Tod et al, 2008).  
 
Four studies reported that fearful and fatalistic beliefs about lung cancer were related to 
prolonged medical help seeking (Mor, 1990; Tod et al, 2008; Tod & Joanne, 2010) or later 
stage lung cancer (Bergamo et al, 2013). Two studies found that negative beliefs were 
formed by media campaigns associating lung cancer with death (Tod et al, 2008; Tod & 
Joanne, 2010). The stigma surrounding lung cancer and its association with smoking 
attenuated the decision to present with symptoms (Corner et al, 2005; Tod et al, 2008; Tod 
& Joanne, 2010), even in those who had never smoked (Tod et al, 2008).   
 
Haemoptysis prompted the fastest symptom presentation (Corner et al, 2005; Tod & Joanne, 
2010). When symptoms persisted, worsened or new symptoms developed, medical help was 
sought (Carter-Harris, 2015). Family members facilitated symptom presentation, legitimising 
the need to seek medical attention for symptoms (Tod et al, 2008; Tod & Joanne, 2010). In 
addition, family members helped with making an appointment with the doctor and 
accompanying participants to an appointment (Tod et al, 2008; Tod & Joanne, 2010), 
overcoming previously reported barriers.  
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Table 3.1 Table of included studies 
Study  Method  Sample  
 
Country  Tumour 
site 
Socio-
economic 
measure 
Measures: Knowledge (K), Beliefs (B), Perceived 
barriers (PB), Perceived facilitators (PF), 
Symptomatic Presentation (SP) 
Measure of association between 
and socioeconomic indicator 
Quality 
Appraisal  
Andersen et 
al (2010)  
Retrospective, 
Qualitative  
30 men (n=16) and 
women (n=14) 
Netherl-
ands  
Lung, 
Malignant 
Melanoma, 
Colon  
  K: Symptom interpretation 
PB: Competing life priorities, holiday booked 
PF: Symptom disclosure, worsening of symptoms, 
symptoms interfering with daily life 
N/A Medium  
Arnold-
Reed et al 
(2008)  
Hypothetical, 
Quantitative 
503 men. Mean age: 
62 years 
Australia  Prostate Education K: Recognition (best for difficulty urinating, impotence, 
chronic groin pain) 
B: ‘Prostate cancer will cause rapid death’ (58%) 
K: NR 
B: NR 
Poor 
Baumert et 
al (2007)  
Retrospective, 
Quantitative 
217 men (n=101) 
and women 
(n=116). Mean age: 
54.7 years 
Germany Melanoma  Education K: Knowledge pre-diagnosis (no, n=17.5%; yes, n=82.5%) 
SP: Sought medical help within 1 month (16.1%); tumour 
thickness  
K: NR 
SP: Lower education associated with 
thicker tumours (MR 1.53, 95% CI: 1.11-
2.11, p<0.05) 
Poor 
Bergamo et 
al (2013)  
Retrospective, 
Quantitative 
357 men (n=252) 
and women (n=105) 
from minority 
groups (n=142, 
mean age: 64.5 
years) or non-
minority groups 
(n=215, mean age: 
66 years)  
US Lung Education, 
employment, 
health 
insurance, 
annual 
income 
K: Recognition  
B: Fatalism 
PB: Medical mistrust 
 
K: NR 
B: NR 
PB: NR 
Medium  
Blum et al 
(1999) 
Retrospective, 
Quantitative 
429 men (n=184) 
and women 
(n=245). Median 
age: 52 years  
Germany Melanoma    B: 82% understood the benefits of early diagnosis 
PB: Misdiagnosis from physician on first visit  
PF: Symptoms noticed by another person  
SP: Mean time to symptom presentation (61 days) 
N/A Medium  
Brain et al 
(2014)  
Hypothetical, 
Quantitative  
1043 women. Aged 
50 years and over  
Wales Ovarian  Postcode, 
education 
K: Recognition (mean, 6.85) 
B: Cancer worry  
PB: Emotional and practical barriers 
SP: Sought medical help in under 3 weeks (n=898) 
K: Lower education associated with 
lower knowledge (F(2, 1005)=8.23, 
p<0.001); higher deprivation (postcode) 
associated with lower knowledge 
(F(3,886)=2.82, p<0.05) 
B: NR 
PB: NR 
SP: Higher education associated with 
longer time to SP, (OR=2.64, p≤0.001); 
NS difference between deprivation by 
postcode and anticipated delay (X2(3)= 
6.73, p>0.05) NS 
Good 
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Brandner et 
al (2014) 
Retrospective, 
Qualitative 
42 women. Mean 
age: 57 years 
Germany  Ovarian   K: Symptom interpretations (symptoms normalised) 
PB: Competing life priorities, symptom disclosure 
PF: Symptom interfering with daily life, symptom opposed 
specific body image, social responsibilities 
N/A Medium  
Brouha et 
al (2005)  
Retrospective, 
Quantitative 
189 men and 
women. Mean age: 
59 years 
Holland  Oral and 
Pharyngeal 
Education, 
income 
K: Symptom interpretation (‘cancer’, n=2)  
PB: Symptom did interfere with daily life  
PF: Persistence of symptom, development of new symptom 
SP: Mean time to symptom presentation (pharyngeal, 45 
days; oral, 28 days) 
K: NR 
PB: NR 
PF: NR 
SP: Education and income not 
associated with time to SP (statistics 
NR) 
Medium  
Burgess et 
al (1998)  
Retrospective, 
Qualitative 
185 women. Mean 
age: 54 years 
UK Breast  Occupation K: Symptom interpretation (46% thought their symptom 
indicated cancer) 
B: Fear 
PF: Symptom disclosure, appearance of new symptoms, 
appointment booked with GP for another reason 
SP: Waited over 3 months to seek medical help (19%) 
N/A Medium  
Burgess et 
al (2000) 
Retrospective, 
Qualitative 
158 women. Mean 
age: 53 years 
UK Breast  Occupation PB: Life events 
SP: Waited over 3 months to seek medical help (18%) 
N/A Medium  
Burgess et 
al (2001)  
Retrospective, 
Qualitative 
46 women  UK Breast  Occupation K: Symptom interpretation (‘lump’ most attributed to 
cancer)  
B: Consequences of treatment 
PB: Not wanting to bother the doctor, poor health service 
utilisation, competing life priorities 
PF: Symptom disclosure, change in symptom  
SP: Waited over 3 months to seek medical help (n=31) 
N/A Medium  
Burgess et 
al (2006)  
Retrospective, 
Mixed 
69 women. Aged 65 
years and over  
UK Breast    K: symptom interpretation (‘cancer’, n=27) 
B: Fear  
PB: Competing life priorities, reservations about seeing GP 
PF: symptom disclosure 
SP: Waited over 3 months to seek medical help (n=29) 
 
N/A Medium  
Cameron 
and Hinton 
(1968)  
Retrospective, 
Quantitative 
83 women  UK Breast  Education, 
occupation  
K: Symptom interpretation 
B: Fear, worry  
SP: sought medical help within 1 month (61%) 
K: NR 
B: NR 
SP: Higher education associated with 
shortest time to SP for lump 
symptoms(𝑥2=6.6, p<0.05); Higher 
social group (husband’s occupation) 
associated with shortest time to SP 
(𝑥2=3.02, p<0.01) 
 
Poor 
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Caplan 
(1995)  
Retrospective, 
Quantitative 
162 women  US Breast  Income, 
education, 
employment 
PB: Fluctuating symptoms, relationship with GP  
SP: Waited over 2 months to seek medical help (n=27) 
PB: NR 
SP: Lower socioeconomic group 
(various indices) associated with longer 
time to SP, but NS: High vs low income 
(OR 2.56, 95% CI: 0.68-8.64*); High vs 
low education (OR 1.07, 95% CI: 0.41-
2.77*); Working vs non-working (OR 
0.72, 95% CI: 0.27-1.99*) 
Poor 
Carter-
Harris et al 
(2015)  
Retrospective 
Qualitative  
11 men (n=4) and 
women (n=7). Age 
range: 40-76 years 
US Lung Education, 
employment 
K: Symptom interpretations (one participant was alarmed 
at symptoms) 
PB: Vague and intermittent nature of symptoms 
PF: Worsening of symptoms, good relationship with GP 
SP: Immediate (n=1) 
N/A Medium  
Cassileth et 
al (1988)  
Retrospective, 
Mixed 
275 men (n=148) 
and women 
(n=127). Median 
age: 45 years 
US Melanoma Occupation, 
health 
insurance 
K: Symptom interpretation (interpreted as ‘cancer’, 13%) 
SP: Mean time to symptom presentation (8.6 months) 
K: NR 
SP: NR 
Poor  
Chapple et 
al (2004b)  
Retrospective, 
Qualitative 
45 men. Age range 
21 to 55 years  
UK Testicular Employment K: Symptom interpretation  
B: Fear, fatalism 
PB: Machoism, embarrassment, competing life priorities  
PF: Symptom disclosure 
SP: Waited over 3 months to seek medical help (n=11) 
N/A Good  
Chonjnacka
-
Szawlowska 
et al, (2013)  
Retrospective, 
Quantitative 
301 men (n=186) 
and women 
(n=115). Mean age: 
42.3 years 
Poland  All  Education  K: Recall, mean: 1.51  
B: Fatalism and cancer curability  
SP: Mean time: 6 months and 10 days 
K: NR 
B: NR 
SP: NS correlation between education 
and stage of cancer (statistics NR) 
Medium  
Coates et al 
(1992)  
Retrospective, 
Quantitative 
735 women (410 
black and 325 
white). Aged range: 
20 to 79  
US Breast  Education, 
occupation, 
income 
K: Symptom interpretation  
B: Fatalism 
PB: Symptom disclosure, other comorbid conditions, 
appointment with doctor booked for another reason  
SP: Median time to symptom presentation (black women, 
16 days; white women, 14 days) 
K: NR 
B: NR 
PB: NR 
SP: Higher education associated with 
shorter time to SP (Mantel-cox 1.43, 
95% CI: 1.11-1.86, p<0.05); Low 
deprivation (poverty index) associated 
with shorter time to SP (Mantel-Cox 
1.24, 95% CI: 1-1.54, p<0.05) 
Good 
Cochran et 
al (1986)  
Retrospective, 
Qualitative  
37 women. Median 
age: 64 years   
US Endomet-
rial  
Employment, 
education 
K: Symptom interpretation (interpreted as ‘cancer’, n=3)  
PB: Perceived lack of emotional support, low social support 
SP: Median time to symptom presentation (28 days) 
 
N/A Poor 
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Cockburn et 
al (2003)  
Retrospective, 
Quantitative 
1332 men (40%) and 
women (60%). Aged 
40 years and over  
Australia Colorectal 
(Bowel) 
Education  K: Recall (25% could not recall any symptom), symptom 
interpretation 
B: Benefits of early diagnosis 
SP: 306 had experienced a symptom, 31.9% did not seek 
medical help 
K: Higher education associated with 
higher K of symptoms (PR 0.93, 95% CI: 
0.89-0.96*) 
B: Higher education more likely to hold 
positive beliefs about the benefits of 
early diagnosis (statistics NR) 
SP: NR 
Medium  
Cooper et 
al (2013)  
Hypothetical, 
Qualitative  
15 focus groups 
with 132 women. 
Age range: 40 to 60 
years  
US Gynaecolog
ical  
Education, 
employment, 
income, 
health 
insurance  
K: Which symptoms would cause most concern (bleeding= 
most concern) 
PB: Lesion not visible, tendency to ignore health, cost 
SP: Range in time to symptom presentation (immediate to 
years). Changes in the skin on vulva= most timely and 
consistent response. 
N/A Medium  
Courtney et 
al (2012)  
Retrospective, 
Quantitative  
1085 men (n=508) 
and women 
(n=577). Age range: 
56 to 88 years  
Australia  Colorectal  Education K: Symptom interpretation 
PB: Watchful waiting 
PF: Persistence of symptom, appointment booked for 
another reason  
SP: 41% had experienced a symptom, 18% of those with 
rectal bleeding and 37% of those with a change in bowel 
habit (37%) waited over1 month to seek medical help   
K: NR 
PB: NR 
PF: NR 
SP: NR 
Medium  
Corner et al 
(2005)  
Retrospective, 
Qualitative 
22 men (n=12) and 
women (n=10). 
Median age: 68 
years 
England  Lung Occupation K: Symptom interpretations  
PB: Self-medication, stigma 
PF: symptoms interfering with daily life  
SP: Median time to symptom presentation (12months) 
N/A Good 
Crosland 
and Jones 
(1995)  
Retrospective, 
Mixed methods 
Postal survey: 1200 
men and women. Of 
these, 150 men and 
137 women 
experienced ‘blood 
in stools’. Of these, 
24 men and 36 
women were 
interviewed  
UK Colorectal   K: Symptom interpretation (‘cancer’, n=42) 
PF: Symptom disclosure, pain, embarrassment, 
appointment booked for another reason, worry symptom 
might be something serious 
PB: Worry symptom might be serious 
SP: 41% had sought medical advice for symptom, median 
time to symptom presentation (2 months) 
 
N/A Good 
de Noojer 
et al (2001)  
Retrospective, 
Qualitative  
23 men (n=10) and 
women (n=13). Age 
range: 32-75 years  
Netherla
nds  
Breast, 
colon, 
Melanoma, 
Testicular  
  K: Recall (1 or more symptoms, n=17) and symptom 
interpretation 
B: Fear  
PB: Embarrassment, perception doctor could not do 
anything 
PF: Symptom disclosure, worsening of symptoms, 
appearance of new symptoms  
SP: Immediate to several years. 
N/A Medium  
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de Noojer 
et al (2003)  
Hypothetical 
Quantitative 
588 men (n=135) 
and women 
(n=453). Mean age: 
47 years 
Netherla
nds  
All Education K: Recognition (good, mean 8.4) 
PB: Anticipated regret, social norms, self-efficacy 
K: NR 
PB: NR 
Medium  
Emery et al 
(2013)  
Retrospective, 
Mixed methods 
66 men (n=28) and 
women (n=38). 
Mean age: 60.5 
years  
Australia Breast, 
Colorectal, 
prostate, 
lung 
  B: Fear 
PB: Intermittent and mild symptoms, machoism in men, 
holiday booked, symptom disclosure, distance to get to 
surgery, competing life priorities  
PF: symptom disclosure  
SP: Mean time to symptom presentation: breast (33 days), 
colorectal (135 days), lung (37 days), prostate (320 days) 
K: NR 
PB: NR 
PF: NR 
SP: NR 
Medium  
Esteva et al 
(2013)  
Retrospective, 
Quantitative  
795 men and 
women  
Spain  Colorectal  Social class, 
education  
K: Symptom interpretation (interpreted as ‘not serious’, 
65.6%)  
PF: Symptom disclosure, good relationship with GP (trust)  
SP: Median time to symptom presentation (19 days) 
K: NR 
SP: NS association between social class 
and time to SP (statistics NR), NS 
association between education and 
time to SP (statistics NR)  
Medium 
Facione and 
Facione 
(2006)  
Retrospective, 
Qualitative 
28 women. Mean 
age: 42.34 years 
US Breast  Income, 
education, 
health 
insurance 
K: Symptom interpretation 
B: Fear, fatalism, benefits of early diagnosis  
PB: Worry about losing relationship with partner if 
diagnosed with cancer  
PF: Symptom disclosure  
SP: Waited over 3 months to seek medical help (n=15) 
N/A Medium  
Facione and 
Giancarlo 
(1998) 
Retrospective, 
Qualitative 
80 women into 16 
focus groups. Aged 
20 years and over 
US Breast  Income, 
employment, 
education 
K: Symptom interpretation (best for lump symptoms) 
B: ‘Cancer is a bad word’, fatalism  
PB: Stoicism, not wanting to bother the doctor, use of 
alternative therapies, embarrassment, influence of male 
partner, cost 
PF: Symptom disclosure, good relationship with doctor 
N/A Medium  
Facione et 
al (2002)  
Hypothetical, 
Quantitative  
669 women. Mean 
age: 46.95 years  
US Breast  Income, 
education, 
health care 
insurance 
K: Recognition (10% recognised all or all but one 
symptoms)  
B: Fatalism  
PB: Difficulties with access, prejudice in health care, 
concerns about deportation, use of alternative therapies   
SP: Likely to delay (23.7%). 
K: Higher education associated with 
higher symptom recognition 
(F3,690=32.32, p<0.001) 
B: NR 
PB: NR 
SP: Lack of insurance associated with 
longer time to SP (Cramer’s V = 0.187, 
p<0.001); Lower education associated 
with longer time to SP (Cramer’s V = 
0.288, p<0.001); Lower income 
associated with longer time to SP 
(Cramer’s V = 0.291, p<0.001) 
Good  
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Facione et 
al (1997)  
Hypothetical, 
Quantitative  
352 African 
American or Black 
women. Mean age: 
38.6 years 
US Breast  Income, 
Education, 
Employment 
B: Fear, fatalism 
PB: Poor health service utilization 
SP: 11.6%= strong disposition to SP. 
B: NR 
PB: NR 
SP: Stronger disposition to SP 
associated with lower education 
(r=0.19, p<0.01) and lower income 
(r=0.32, p<0.001)  
Medium  
Facione and 
Dodd 
(1995)  
Retrospective, 
Qualitative 
39 women. Mean 
age: 49.6 years 
US Breast  Income, 
education 
K: Symptom interpretation 
B: Fear 
PB: Competing life priorities 
PF: Appearance of new symptom, worsening of symptoms, 
symptom disclosure 
SP: 59% sought medical help within 1 week 
N/A Medium  
Fitzpatrick 
et al (1998)   
Hypothetical, 
Quantitative 
280 men. Mean age: 
53.7 years 
Ireland Prostate Health 
insurance, 
occupation 
B: Fear  
PB: Poor health service utilisation, dislike of doctors, 
embarrassment 
SP: 81% would seek medical help if developed urinary 
symptoms 
B: NR 
PB: NR 
SP: Non-manual social class associated 
with higher willingness to attend GP 
with symptoms (OR 1.8, p<0.05**) 
Good  
Forbes et al 
(2011)  
Hypothetical, 
Quantitative  
1515 women from 
various ethnic 
groups (White, 
South Asian, Black). 
Aged 30 years and 
over  
UK Breast  Postcode K: Recognition (18% recognised 5 or more non-lump 
symptoms)  
PB: self-efficacy, worry what the doctor might find, 
embarrassment, worry about wasting doctors time, 
difficulty getting an appointment  
SP: would seek help within 1 week (73%) 
K: Differences between ethnic groups 
for cancer awareness not due to IMD 
score or lower level of education 
(statistics NR) 
PB: Differences between ethnic groups 
for PB not due to IMD score (statistics 
NR) 
SP: NR 
Good  
Forbes et al 
(2014)   
Retrospective, 
Quantitative  
1999 men (n=1077) 
and women 
(n=922). Aged 50 or 
over 
UK All Postcode  K: Symptom interpretation  
PB: 48% of patients reported at least one barrier 
SP: Delay over 3 months (n=21%) 
B: NR 
PB: NR 
SP: Lowest socioeconomic group 
associated with longest time to SP 
(1.51, 95% CI: 1.18-1.88*) 
Good  
Freidman et 
al (2006) 
Retrospective, 
Quantitative 
124 women. Mean 
age: 44.3 years  
US Breast  Employment, 
education 
B: Fear 
PB: Worry what the symptom might be, difficulty getting an 
appointment, cost, denial  
SP: Mean time to symptom presentation (9 months) 
B: NR 
PB: NR 
SP: Lower education associated with 
longest time to SP (Fishers Exact test, 
p<0.01**) 
Medium  
Gascoigne 
and 
Whitear 
(1999)  
Retrospective, 
Qualitative 
16 men  Wales  Testicular    K: Symptom interpretation (‘cancer’, n=1) 
B: Fear 
PB: Previous misdiagnosis, symptoms manageable, 
embarrassment 
PF: symptom disclosure (wife), worsening of symptoms 
SP: Range in time to symptom presentation (6-52 weeks) 
N/A Medium 
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Goldsen et 
al (1957)   
Retrospective, 
Quantitative  
727 men and 
women  
US All Income, 
education 
and 
occupation  
K: Symptom interpretation (20% thought symptoms 
indicated cancer) 
B: Cancer worry, fatalism  
PB: Poor health service utilization, poor noticeability of 
symptom 
PF: Symptom disclosure   
SP: 51.3% sought medical help under 30 days 
K: NR 
B: NR 
PB: NR 
PF: NR 
SP: Lower income, education and 
occupation associated with longest time 
to SP (statistics NR) 
Medium  
Gould et al 
(2010)  
Retrospective, 
Qualitative 
14 women. Aged 
range: 30 to 69 
years  
Canada Breast  Education, 
employment, 
income  
K: Symptom interpretation (poor for non-lump symptoms) 
B: Fear  
PB: Previous benign disease, watchful waiting, competing 
life priorities  
PF: Symptom disclosure, already have another 
appointment booked.  
SP: All women waited 8+ weeks 
N/A Medium  
Grant et al 
(2010)  
Retrospective, 
Qualitative 
15 men (n=7) and 
women (n=8). Aged 
45 years and under 
Scotland Oral  Postcode  K: Symptom interpretation 
PB: Self medication  
PF: Already had an appointment booked 
SP: Sought medical help within 8 weeks (n=8) 
N/A Medium  
Greer 
(1974)  
Retrospective, 
Quantitative   
160 women with 
stage I or stage II 
cancer. Aged 70 
years and under 
UK Breast  Social Class  K: Symptom interpretation 
B: Fear, fatalism 
PB: Embarrassment 
SP: 64% sought medical help within 1 month 
K: NR 
B: NR 
PB: NR 
SP: NS difference between time to SP 
and social class (statistics NR) 
Poor  
Grunfield et 
al (2002)  
Hypothetical, 
Quantitative 
996 women. Mean 
age: 47 years 
UK Breast  Occupation K: Recognition (mean, 5.3 symtpoms) 
B: Beliefs about treatment, cancer survival outcomes 
K: ‘Unskilled workers’ or ‘never worked’ 
associated with poorer recognition 
(F(4,109)=10.43, p<0.001) 
B: ‘Professional’ and ‘intermediate’ 
skilled workers more likely to hold 
positive beliefs about cancer survival 
(𝑥2=25.30, d.f.=4, p<0.01) 
Medium  
Grunfield et 
al (2003)  
Hypothetical, 
Quantitative 
546 women. Mean 
age: 47 years 
UK Breast  Occupation PF: Easy to speak to doctor 
SP: Most likely to seek prompt medical help for lump 
symptoms 
PB: NR 
SP: NR 
Medium  
Hale et al 
(2007)  
Retrospective, 
Qualitative  
20 men. Age range: 
51 to 75 years  
UK Prostate Social class, 
education 
K: Symptom interpretations (poor) 
B: Fear  
PB: Embarrassment, machoism, medical mistrust  
PF: Symptom disclosure (wife), symptoms interfering with 
daily life 
N/A Medium 
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Henderson 
(1966)  
Retrospective, 
Quantitative 
50 men (n=2) and 
women (n=48). Age 
range: 26-67 years 
Scotland Breast, 
Cervix, 
Bowel. 
  K: Symptom interpretation (39.4% thought Symptom not 
serious)  
B: Fear 
PB: Embarrassment, financial constraints 
SP: Wait over 3 months to seek medical help, n=38 
N/A Medium  
Hvidberg et 
al (2014)  
Hypothetical, 
Quantitative  
3000 men (n=1341) 
and women 
(n=1659) over the 
age of 30.  
Netherla
nds  
Bowel, 
breast, 
ovarian, 
lung 
Education, 
occupation, 
income  
K: Recognition (median 9/11). Most recognised were 
change in mole (97.2%) and lump (94.3%). Least recognised 
were night sweats (15.6%) and sore that does not heal 
(67.8%) 
B: Beliefs about cancer survival. Correctly estimated 5-year 
survival (% participants): Bowel (42%), breast (49%), 
ovarian (9%), lung (19%). Survival overestimated for 
ovarian (86% participants) and lung (78% participants).  
K: Fewer symptoms recognised for 
those with lower education (PR 1.57, 
95%  CI: 1.39-1.78, p<0.01), those 
outside the labour force (PR 1.27, 95%  
CI: 1.11-1.46, p<0.01) and lower income 
(PR 1.33, 95% CI: 1.15-1.54, p<0.01) 
B: Participants outside the labour force 
were more likely to wrongly estimate 
survival for breast cancer (PR 1.15, 95%  
CI: 1.01-0.31), p<0.01); Lower income 
was associated with wrongly estimated 
survival for bowel cancer (PR 1.18, 95% 
CI: 1.05-1.33, p<0.01) 
Medium  
Howel et al 
(2008)  
Retrospective, 
Qualitative 
32 men (n=12) and 
women (n=20). 
Aged 65 years and 
over   
England  Lymphoma    K: Symptom interpretation (non-lump symptoms poorly 
attributed to cancer)  
PB: Intermittent nature of symptoms, competing life 
priorities, poor general health service utilisation 
PF: Worsening of symptoms, symptom disclosure 
N/A Medium 
Hunter et al 
(2003)  
Hypothetical, 
Quantitative 
546 women. Mean 
age: 47 years 
UK Breast  Occupation K: Recognition (good, mean 6.65)  
B: Beliefs about treatment 
SP: 58.6% would seek immediate medical help. 
K: NR 
NR: NR 
SP: Socioeconomic group not associated 
with time to SP (F(1,518) = 0.29, p>0.05) 
Medium  
Kakagia et 
al (2013)  
Retrospective, 
Quantitative 
513 men (n=56.5%) 
and women 
(n=43.5%). Mean 
age: 67.5 years 
Greece  Skin  Education, 
ethnicity, 
area of 
residence 
K: Symptom interpretation 
B: Fear, fatalism 
PB: Other serious comorbidities, poor health service 
utilisation, dislike of doctors and hospitals, transport issues, 
worry about wasting docs time, embarrassment, competing 
life demands  
PF: Symptom disclosure, active encouragement to seek 
medical help 
SP: Mean time to symptom presentation (3.9 months) 
K: NR 
B: NR 
PB: NR 
PF: NR 
SP: Longer time to SP associated with 
lower socioeconomic group (OR 1.89, 
95% CI: 0.9-3.8. p<0.001*****) and 
lower education (OR 3.01, 95% CI: 1.6-
5.6, p<0.001) 
 
 
 
Poor 
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Lam et al 
(2009)  
Retrospective, 
Qualitative 
37 women. Age 
range 20-81 years  
Hong 
Kong 
Breast  Employment, 
education 
K: Symptom interpretation  
B: fear, fatalism  
PB: Watchful waiting, poor general health service 
utilisation, cost, competing life priorities, embarrassment   
PF: Persistence of symptoms, appearance of new symptom, 
symptom disclosure, symptom interfering with daily life, 
appointment booked for another reason  
SP: Waited over 3 months to seek medical help (n=14) 
N/A Medium  
Lannin et al 
(1998)  
Retrospective, 
Quantitative 
540 women from 
ethnic minority 
groups (30%) or 
majority groups 
(70%) 
US Breast  Education, 
income, 
health 
insurance 
B: Fear, fatalism, folk beliefs, beliefs about treatment 
PB: Cost, poor general health service utilisation 
SP: Advanced stage cancer (17.4%) 
K: Higher knowledge associated with 
higher income and higher education 
(statistics NR) 
PB: NR 
SP: NS association with higher 
education and earlier stage cancer 
(OR1.6, 95% CI: 0.9-2.7,  NS). Higher 
income associated with earlier stage 
disease (OR 3.7, 95% CI:2.1-6.5)**- p 
value NR 
Medium 
Larkey et al 
(2001) 
Hypothetical 
(focus group) 
and 
retrospective 
(questionnaire) 
Mixed  
11 Focus groups: 90 
men (n=56) and 
women (n=34). 
Mean age: 39 
Questionnaire: 132 
men and women. 
Mean age:44.7years  
US All  Occupation, 
income 
K: Symptom interpretation 
PB: Practical barriers, cost, emotional barriers, previous 
negative experiences with health services 
PF: Trust in medical system, symptom disclosure  
 
K: NR 
PB: NR 
PF: NR 
Medium 
Lauver et al 
(1995)  
Retrospective, 
Qualitative 
138 women. Mean 
age: 37.5 years  
US Breast  Education, 
occupation, 
annual family 
income, 
health 
insurance  
B: Fear 
PB: Competing life priorities, cost, transport 
PF: 50% reported no barriers  
SP: Waited over 3 months to seek medical help (23%), 38% 
sought medical help within 1 week 
N/A Medium 
Li et al 
(2012)  
Retrospective, 
Quantitative 
425 women. Mean 
age: 51.97 years 
Hong 
Kong  
Breast  Employment, 
education 
B: Fear   
PB: cost, gender of doctor, unsure where to seek medical 
help, competing life priorities, no history of breast 
problems 
PF: Symptom disclosure  
SP: Median time to symptom presentation (14 days) 
B: NR 
PB: Symptom disclosure for women 
with lower education less likely to 
translate into immediate SP (𝑥2=6.4, 
d.f.=2, p<0.05) 
PF: NR 
SP: Longer time to SP associated with 
higher education (OR 3.35, 95% CI:1.19-
9.42, p<0.05) and full time employment 
(OR 2.52, 95% CI: 1.18-5.36, p<0.05) 
Good 
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Loehrer et 
al (1991)  
Retrospective, 
Qualitative  
128 men (n=33) and 
women (n=95). 
Mean age: 63 years  
US All  Employment, 
income, 
education 
B: Curability of cancer, cancer is contagious, surgery causes 
cancer to spread 
SP: Poor for non-specific symptoms 
N/A Medium  
Low et al 
(2013)  
Hypothetical, 
Quantitative 
1000 women. Mean 
age: 47 years 
UK Ovarian Education, 
car 
ownership, 
home 
ownership 
K: Recall (poor, mean 0.6) and recognition (good, mean 6.3) 
PB: Mean number of barriers endorsed (2.2), emotional, 
practical and service barriers 
SP: Varied by symptom, most would seek help under 2 
weeks 
K: NR 
PB: NR 
SP: Higher socioeconomic group 
associated with longer time to SP 
(beta=0.12, SE 0.05, p<0.001**) 
Good  
Lund-
Nielson et 
al (2011)  
Retrospective, 
Qualitative 
17 women. Median 
age: 69 years 
Denmark Breast  Education  B: Fear, beliefs about treatment 
PB: Competing life priorities, lack of resources 
SP: Median time to symptom presentation (24 months) 
N/A Medium  
Lyubomirsk
y et al 
(2006)  
Hypothetical 
and 
Retrospective, 
Quantitative 
Study 1 
(hypothetical): 147 
women. Age range: 
18 to 61 years 
Study 2 
(retrospective): 139 
women. Age range 
32-86 years  
US Breast  Occupation, 
education 
Study 1 
K: Recognition of lump symptoms  
B: Fear 
PB: Cost, personality type (ruminators vs non ruminators) 
Study 2 
PB: Personality type (ruminators vs non ruminators)  
SP: Median time to symptom presentation (Ruminators, 
52.5 days; non-ruminators, 13.9 days) 
K: NR 
B: NR 
PB: NR 
SP: NR 
Poor 
Magarey et 
al (1977)  
Retrospective, 
Qualitative 
64 women  Australia Breast  Education PB: Denial, anxiety 
SP: Sought medical help within 2 weeks (n=35) 
PB: NR 
SP: Education not associated with time 
to SP (statistics NR) 
Poor 
Marlow et 
al (2014)  
Hypothetical, 
Qualitative  
54 women from 
ethnic minority 
groups living with a 
comparison of white 
women. Age range: 
25-64 years 
UK Breast and 
Ovarian 
Employment, 
education, 
living 
arrangement 
K: Recall (good for lump/ bleeding, poor for other 
symptoms) 
B: Fear, fatalism, benefits of early diagnosis 
PB: Poor relationship with GP, emotional barriers, practical 
barriers, competing life priorities 
N/A Medium  
McCaffery 
et al (2003)  
Hypothetical, 
Quantitative 
1637 men (n=763) 
and women 
(n=874). Age range: 
16-74 years 
UK Colorectal  Education K: Recall (poor) 
B: Fear  
SP: 92.8% would anticipate seeking medical help if noticed 
blood in stool for more than 2 weeks. 
K: Higher education associated with 
higher symptom recall (𝑥2[4]=73.98, 
p<0.001) 
B: Lower education associated with 
most negative beliefs (𝑥2[4]=74.96, 
p<0.001) 
SP: NS association with education and 
SP intentions (statistics NR) 
Good  
Meechan et 
al (2003)  
Retrospective,  
Mixed  
85 women. Mean 
age: 38.9 years 
New 
Zealand 
Breast    PB: Having a family member with cancer, low emotional 
response to symptom 
PF: High emotional response to symptom 
SP: Median time to symptom presentation (14 days) 
PB: NR 
PF: NR 
SP: NS association between education 
and time to SP (t(83)= -1.26, p>0.05)  
Medium 
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Mor (1990)  Retrospective, 
Qualitative 
700 patients. Age 
range: 45 to 90 
years 
US Lung, 
Breast and 
Colorectal 
Education, 
housing, 
income, 
education  
K: Symptom interpretation (best knowledge breast cancer 
patients)  
B: Fear (16.8% of delayers) 
PB: ‘’thought it would go away’’ (60.5% of delayers), too 
busy (8.4% of delayers)  
SP: Waited over 3 months to seek medical help: lung 
(54.9%), breast (56.2%), colorectal (87.6%) 
 
 
K: NR 
B: NR 
PB: NR 
SP: NS relationship between 
socioeconomic group and time to SP 
(statistics NR)  
Medium  
Niksic et al 
(2015) 
Hypothetical,  
Quantitative  
49270 men (55%) 
and women (45%). 
Aged 54 and under 
(62%) and 55 and 
over (33%), missing 
(5%) 
UK All Education, 
employment, 
postcode 
(area income 
deprivation) 
K: Recognition (mean: 7.2/9). Most recognised was lump 
(94%); least recognised was cough/hoarseness (68%) and 
sore that does not heal (68%) 
B: Mean barriers endorsed= 1.8. Most highly endorsed 
barrier was ‘worry what the doctor might find (30%), least 
endorsed barrier was difficulty arranging transport (6%)  
 
K: Lowest knowledge associated with 
lowest education, highest area income 
deprivation and unemployment for all 
symptoms (OR, p<0.001)*** 
B: Strongest association for emotional 
barriers group (lower socioeconomic 
groups endorsed more emotional 
barriers): ‘Too embarrassed’ associated 
with most deprived quartile (postcode, 
OR 1.22, 99% CI: 1.08-1.39, p<0.001), 
lower education (OR 1.20, 99% CI: 1.09-
1.33, p<0.001) and unemployment (OR 
1.23, 99% CI: 1.11-1.35, p<0.001); ‘too 
scared’ associated with lower education 
(OR 1.24, 99% CI: 1.13-1.35, p<0.001) 
and unemployment (OR 1.15, 99% CI: 
1.06-1.26, p<0.001); ‘not confident to 
talk’ associated with lower education 
(OR 1.39, 99% CI: 1.22-1.58, p<0.001) 
and unemployment (OR 1.30, 99% CI: 
1.16-1.46, p<0.001); ‘worry what the GP 
might find’ associated with most 
deprived quartile (postcode, OR 1.12, 
99% CI: 1.02-1.27, p<0.001), lower 
education (OR 1.16, 99% CI: 1.05-1.27, 
p<0.001) and unemployment (OR 1.13, 
99% CI: 1.04-1.22, p<0.001)**** NR     
           
Good  
Oliveria et 
al (1999) 
Retrospective, 
Quantitative 
255 men and 
women. Aged 18 
years and over   
US Melanoma  Education, 
insurance 
K: Recognition (poor) 
SP: Mean time to symptom presentation (2 months) 
K: NR 
SP: Education not associated with time 
to SP (statistics NR) 
 
Medium  
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O’Mahony 
and 
Hegarty 
(2009)  
Retrospective, 
Quantitative 
99 women. Mean 
age: 40 years 
Ireland Breast Employment, 
education 
K: Symptom interpretation  
PB: Competing life priorities, emotional reactions to 
symptom (afraid, scared, unsure)  
PF: Symptom disclosure, anxiety 
SP: Waited over 1 month to seek medical help (n=26) 
K: NR 
PB: NR 
PF: NR 
SP: Higher education associated with 
longer time to SP (statistics NR) 
Medium  
O’Mahony 
et al (2011)  
Retrospective, 
Qualitative 
10 women. Mean 
age: 40 years 
Ireland Breast  Education, 
Employment 
K: Most aware that a lump was a symptom 
B: Fatalism, curability of cancer, fear 
PB: Denial, competing life priorities 
PF: Symptom disclosure, good perceived access to GP, good 
relationship with GP 
SP: Sought medical help within 1 month (n=6) 
N/A Medium  
Pedersen et 
al (2011)  
Retrospective, 
Quantitative 
901 men (n=423) 
and women 
(n=487). Mean age: 
61.8 years   
Denmark All Education PF: Symptom disclosure, good partner support  
SP: Median interval: 12 days 
PF: NR 
SP: NS association between education 
and time to SP: Lower secondary 
education and long SP (>55 days) (RRR 
0.79, 95% CI: 0.36-1.74, p>0.05); 
tertiary education and long SP (>55 
days) (RRR 1.30, 95% CI: 0.55-3.08, 
p>0.05)  
Medium  
Phillips and 
Taylor 
(1961)  
Hypothetical, 
Quantitative 
2000 women. Aged 
20 and over   
Canada All Occupation K: Recall and recognition (best for ‘lump’)   
B:‘Cancer is the country’s biggest killer’(44%);‘cancer  is the 
most serious disease’(30%);‘cancer cannot be cured’(27%) 
K: NR 
B: NR 
Poor 
Price (1993)  Hypothetical, 
Quantitative 
500 men (n=250) 
and women (n=250) 
from disadvantaged 
backgrounds. Mean 
age: 59.9 years 
US Colorectal  Income, car 
ownership, 
type of 
dwelling, 
education 
K: Recognition (poor, n=310; good, n=190) 
B: Curability of cancer (‘incurable’, 90%), perceived severity 
of cancer 
PB: Practical barriers 
K: NS association between education 
and knowledge (p>0.05**) 
B: Lower education associated with 
perceiving cancer as more serious 
(p<0.05**) 
PB: NR 
Medium  
Quaife et al 
(2014)  
Hypothetical, 
Quantitative 
6965 men (n=4330) 
and women 
(n=2635). Aged 50 
and over 
UK All Education K: Recognition (best for ‘lump’) 
PB: Poor access health services  
SP: Would wait 2+ weeks: (cough, n= 48.1%; breast change, 
n= 8.2%; rectal bleeding, n= 7.4%) 
K: Lower education associated with 
lower recognition for all 3 symptoms 
(𝑥2, p<0.05**) 
PB: NR 
SP: Lower education associated with 
shorter time to SP for cough (OR 0.61, 
95% CI: 0.54-0.68, p<0.001) and breast 
changes (OR 0.68, 95% CI: 0.52-0.89, 
p<0.001). NS association with education 
and time to SP for rectal bleeding (OR 
0.83, 95% CI: 0.67-1.03, p>0.05) 
Higher education associated with longer 
time to SP 
Good  
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Quaife et al 
(2015a)  
Hypothetical,  
Quantitative 
6965 men (n=2635) 
and women 
(n=4330). Aged 50 
and over, mean age: 
63 years  
UK All Education  B: Beliefs about curability of cancer, treatment side effects, 
early diagnosis 
PB: 12% ‘I would not want to know if I have cancer’  
B: Participants with lower education 
less likely to endorse ‘with cancer can 
expect to continue with normal 
activities’ (OR 0.67, 95% CI: 0.45-0.98, 
p<0.05), ‘going to the doctors quickly 
increases the chances of surviving 
cancer’ (OR 0.31, 95% CI: 0.11-0.82, 
p<0.05). NS association with education 
and ‘cancer can often be cured’ (OR 
0.78, 95% CI: 0.52-1.16, NS). Lower 
education more likely to endorse 
‘cancer is a death sentence’ (OR 1.94, 
95% CI: 1.43-2.63, p<0.001) and ‘cancer 
treatment is worse than the cancer’ (OR 
2.64, 95% CI: 2.04-3.43, p<0.001) 
PB: Those with lower education more 
likely to endorse ‘I would not want to 
know if I had cancer’ (OR 2.66, 95% CI: 
1.69-4.18, p<0.001) 
Medium  
Ramos et al 
(2010)  
Retrospective, 
Qualitative  
12 men (n=7) and 
women (n=5). Age 
range 45 to 82 years  
Spain  Colorectal  Education, 
Occupation  
K: Symptom interpretation 
PB: Fear 
PF: Changes to symptoms, persistence of symptoms, 
symptom disclosure, development of another health 
complaint (men only) 
N/A Medium  
Rauscher et 
al (2010)  
Retrospective, 
Quantitative 
438 women. Age 
range: 30 to 79 
years 
US Breast  Education, 
household 
income, 
health 
insurance 
status 
PB: Poor general health service utilisation 
SP: Waited over 3 months to seek medical help (16%) 
K: Lower income and education 
associated with more breast lump 
misconceptions (𝑥2, p<0.001**) 
PB: NR 
SP: Longer time to SP associated with 
lower education (𝑥2, p<0.05**) and 
lower income (𝑥2, p<0.05**) 
Medium  
Richard et 
al, (2000)  
Retrospective, 
Quantitative  
590 men (n=250) 
and women 
(n=340). Mean age: 
51.2 years 
France Melanoma  Residence, 
social level, 
education 
K: Symptom interpretation (‘not serious’, 34.8%) 
B: Fear  
PB: No symptoms, competing life priorities (work and 
family commitments)  
PF: Active encouragement from family  
SP: Sought medical help within 2 months (51.9%) 
K: NS 
B: NS 
PB: Those with higher education more 
likely to self-detect melanoma (𝑥2, 
p<0.01**) 
PF: NR 
SP: NS association with and time to SP 
and socioeconomic group (statistics NR) 
 
 
 
Medium  
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Rozniatows
ki et al 
(2005) 
Retrospective, 
Quantitative  
100 men (n=84) and 
women (n=16). 
Mean age: 57 years   
France  Head and 
Neck 
Education, 
occupation 
PB: Low anxiety, poor general health service utilisation 
PF: Symptom disclosure, active encouragement from 
partner to seek help 
SP: The majority of patients waited over 1 week to seek 
medical help 
K: NR 
PB: NR 
SP: NS association between 
socioeconomic group and time to SP 
(statistics NR) 
Medium  
Ristvedt et 
al (2014)  
Retrospective, 
Quantitative 
112 men (n=55) and 
women (n=57). 
Mean age: 59.3 
years   
US Colorectal Income, area 
of residence, 
education, 
health 
insurance 
coverage 
K: Symptom interpretation (70.5% thought symptom 
serious within 13 weeks post onset) 
SP: Median time to symptom presentation (10 weeks) 
K: NR 
SP: NS association between 
socioeconomic group (education and 
household income) and time to SP 
(statistics NR)   
Medium  
Ristvedt 
and 
Trinkhaus 
(2005)  
Retrospective, 
Quantitative  
69 men (n=42) and 
women (n=27). 
Mean age: 61.3 
years 
US Colorectal  Education K: Symptom interpretation (‘not cancer’, 71%) 
PB: Personality (low trait anxiety), poor health service 
utilisation 
SP: Mean time to symptom presentation (25 weeks) 
K: NR 
PB: NR 
SP: Lower education associated with 
longer time to SP (Kaplan-Meier: 
median 15 weeks, 95% CI: 9.0-26.0*); 
higher education associated with 
shorter time to SP (Kaplan-Meier: 
median 8 weeks, 95% CI: 4.0-15.0*)  
Medium  
Robb et al 
(2009)  
Hypothetical, 
Quantitative 
2216 men (n=968) 
and women 
(n=1240) 
UK All Education, 
occupation 
K: Recall (poor, mean=2.2) and recognition (good, 
mean=7.2)  
PB: Emotional and service barriers most endorsed  
SP: Most would seek medical help within 2 weeks 
K: Higher socioeconomic group 
(occupation) associated with highest 
knowledge (F(2,2015)=20.31, p<0.001) 
PB: Lower socioeconomic group 
(occupation) associated with more 
emotional barriers endorsed: ‘worry 
what the doctor might find’ 
(𝑥2(1,1989)=17.08, p<0.001), ‘too 
embarrassed’ (𝑥2(1,1993)=20.74, 
p<0.001), ‘not confident to talk about 
symptom’ (𝑥2(1,1992)=4.77, p<0.05), 
NS association with ‘too scared’ 
(𝑥2(1,1977)=1.82, p>0.05); Higher 
socioeconomic group (occupation) 
associated with more practical barriers 
endorsed: ‘too busy’ (𝑥2(1,2005)=59.0, 
p<0.001), ‘other things to worry about’ 
(𝑥2(1,1996)=15.34, p<0.001), ‘difficult 
to arrange transport’ 
(𝑥2(1,2010)=11.13, p<0.001);NS 
association between socioeconomic 
group (occupation) and service barriers: 
Good 
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‘difficult to make appointment’ 
(𝑥2(1,1983)=0.41, p>0.05), ‘worried 
about wasting the doctors time’ 
(𝑥2(1,1995)=1.44, p>0.05), ‘difficult to 
arrange transport’ (𝑥2(1,1938)=1.15, 
p>0.05) 
SP: Lower socioeconomic group 
(occupation) associated with shorter 
time to SP for unexplained bleeding 
(𝑥2(1,1991)=5.82, p<0.01), difficulty 
swallowing (𝑥2(1,1987)=28.41, 
p<0.001), lump (𝑥2(1,1988)=21.26, 
p<0.001), change in mole 
(𝑥2(1,1967)=24.24, p<0.001), 
unexplained pain (𝑥2(1,1965)=20.24, 
p<0.001), sore that does not heal 
(𝑥2(1,1977)=35.84, p<0.001), change in 
bowel/bladder habits 
(𝑥2(1,1982)=56.87, p<0.001), cough 
(𝑥2(1,1984)=48.32, p<0.001), 
unexplained weight loss 
(𝑥2(1,1963)=77.73, p<0.001) 
Rogers et al 
(2011) 
Retrospective, 
Mixed 
44 men (n= 26) and 
women (n=18)  
UK Oral and 
Pharyngeal 
  K: Symptom interpretation (‘serious’, 13%)  
B: Fear 
PB: More than 1 barrier endorsed (46%), difficulty with 
access, difficulty getting an appointment, cost 
PF: anxiety, worry, the need to resolve uncertainty, active 
encouragement by someone else  
SP: Sought medical help within 1 month (n=29) 
 
N/A Medium  
Roncoroni 
et al (1999)  
Retrospective, 
Quantitative  
100 men (n=48) and 
women (n=52). 
Mean age: 65 years 
Italy Colorectal    K: Symptom interpretation (‘cancer’, n=12) 
PF: Symptom disclosure 
SP: Mean time to symptom presentation (10.8 weeks) 
 
N/A Medium  
Rutier et al 
(2008)  
Hypothetical, 
Quantitative 
193 men (n=87 and 
women (n=106). 
Mean age: 49.2 
years  
 
 
Netherl-
ands  
All Education  K: Recognition 
SP: Well-known symptoms lead to best adaptive coping 
K: NR 
SP: NR 
Poor 
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Samet et al 
(1988) 
Retrospective, 
Quantitative  
800 men (n=396) 
and women 
(n=404). Mean age: 
72.2 years  
US All  Education, 
income  
PB: Poor general health service utilisation, poor access  
SP: Most sought medical help within 2 months 
PB: NR 
SP: Longer time to SP associated with 
lower income for breast and colorectal 
cancer (𝑥2, p<0.05**) and lower 
education for all tumour sites (𝑥2, 
p<0.05**) 
Medium  
Scanlon et 
al (2006)  
Hypothetical, 
Qualitative 
115 Irish (n=58) and 
white British (n=57) 
men (n=47) and 
women (n=70) in 25 
focus groups 
UK All  Employment, 
housing 
tenure, 
occupation 
K: Recall (poor)  
B: Positive (early detection) and negative (silent cancers), 
fear, fatalism, shame, stigma, cancer should be hidden.  
PB: Machoism, denial, never talk about health concerns, 
poor access to health services, long waiting times, rushed 
appointments, worry about being perceived as a 
hypochondriac, cost 
N/A Medium  
Schmid-
Wendter 
(2002)  
Retrospective, 
Quantitative  
233 men (n=109) 
and women 
(n=124). Mean age: 
54.5 years 
Germany Melanoma Education  B: Fear  
PB: Lesion not visible, too busy 
SP: Sought medical help within 1 month (15.5%) 
K: Higher education more likely to have 
knowledge about melanoma (𝑥2, 
p<0.001**) 
B: NR 
PB: NR 
SP: NR 
Medium  
Scott et al 
(2007)  
Retrospective, 
Qualitative 
57 men (n=11) and 
women (n=46). 
Mean age: 54 years 
UK Oral  Education K: Symptom interpretation (‘cancer’, 30%) 
PF: Persistence of symptoms, development of new 
symptom 
N/A Medium  
Scott et al 
(2008)  
Retrospective, 
Quantitative 
80 men (30%) and 
women (70%). 
Mean age: 53 years 
UK Oral  Postcode  
Education 
K: Symptom interpretation 
PB: Competing life priorities, poor access to health care  
SP: Mean time to symptom presentation, 71.2 days 
K: NR 
PB: NR 
SP: NS association between education 
and time to SP (OR=0.55, 95% CI=0.23-
1.36, p>0.05) longer time to SP for 
those living in deprived areas (OR=1.05, 
95% CI=1.01-1.09, p<0.05) 
Medium  
Scott et al 
(2009)  
Retrospective, 
Qualitative 
57 men (n=11) and 
women (n=46). 
Mean age: 54 years 
UK Oral Education K: Symptom interpretation 
B: Benefits of early diagnosis 
PB: Not wanting to bother the doctor, watchful waiting, 
previous bad experiences with health care system, 
competing life priorities 
SP: Mean time to symptom presentation (71.5 days) 
N/A Medium  
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Shahid et al 
(2009)  
Retrospective 
and 
Hypothetical, 
Qualitative 
37 Aboriginal men 
(n=8) and women 
(n=29). Aged 30 
years and over. 
Cancer diagnosis, 
(n=14), family 
members of people 
with cancer (n=16) 
and health service 
providers (n=7) 
Australia All  Area of 
residence 
K: Symptom interpretation (poor)  
B: Cancer is a curse, fatalism, shame, fear, cancer is 
contagious, stigma 
PB: Mistrust in the medical system, use of traditional 
medicines 
N/A Medium 
Sheikh and 
Ogden 
(1998)  
Hypothetical, 
Mixed methods 
Questionnaire: 400 
men and women 
(Quantitative) 
Interviews: 20 men 
(n=6) and women 
(n=14). Age range: 
17-70 years 
UK All  Education  K: Recognition (fair, lumps most recognised) 
B: Fear and fatalism  
PB: Embarrassment  
SP: Most timely for lumps/ thickening 
K: NR 
B: NR 
SP: NR 
Medium 
Siminoff et 
al (2014)  
Retrospective 
Mixed methods  
252 men (n=132) 
and women 
(n=120). Mean age: 
58 years (range 25 
to 94 years) 
US Colorectal  Education, 
Employment, 
Income 
K: Symptom interpretation (39.7% did not think symptom 
was serious) 
PB: Financial barriers (28.6%), fear of diagnostic tests 
(24.3%), embarrassment (11.9%) 
SP: Mean appraisal delay (4.8 months) 
K: NR 
PB: NR 
SP: NS association between time to SP 
and socioeconomic group (statistics NR) 
Medium  
Simon et al 
(2010)  
Retrospective, 
Quantitative 
2208 men (n=968) 
and women 
(n=1240). 11.4% 
(n=236) had 
experienced a 
symptom in the past 
3 months 
UK All Occupation K: Recognition (better knowledge if experienced a 
symptom previously)  
PB: Emotional and practical barriers  
 
K: NS association between symptom 
interpretation and socioeconomic 
group (statistics NR) 
PB: NR  
SP: NS association between SP and 
socioeconomic group (statistics NR) 
Good  
Smith and 
Anderson 
(1985)  
Retrospective, 
Quantitative 
82 women. Age 
range: 20 to 54 
years 
US Ovarian  Income, 
education, 
occupation 
K: Symptom interpretation (‘cancer’, 10%) 
B: Fear 
PB: Previous benign disease  
SP: Median time to symptom presentation (4 weeks) 
K: NS association between symptom 
interpretation and socioeconomic 
group (statistics NR) 
B: NR 
PB: NR 
SP: NR 
Medium  
Temoshok 
et al (1983)  
Retrospective, 
Quantitative  
106 men and 
women. Age range: 
18 to 72 years.  
US Melanoma  Education, 
occupation 
B: Melanoma not a serious disease  
PF: Lesion visible (face and neck)  
SP: Mean time to symptom presentation (4 months) 
K: No association with knowledge and 
occupation (statistics NR) 
B: NR 
PF: NR 
SP: No association with time to SP and 
occupation (statistics NR) 
Poor 
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Tod et al 
(2008)  
Retrospective, 
Qualitative 
20 men (n=12) and 
women (n=8) 
UK  Lung Occupation  K: Symptom interpretation (poor, symptoms usually 
interpreted as acute conditions)  
B: Fear, fatalism  
PB: If previously given up smoking (thought risk of lung 
cancer was nil), worry about the wasting doctors time, 
previous bad experiences with health system, blame, 
stigma, stoicism, poor health service utilisation 
PF: Active encouragement from family member  
SP: Range in time to symptom presentation (0 to 24 
months) 
N/A Good  
Tod and  
Joanne 
(2010)  
Hypothetical, 
Qualitative  
25 men (n=15) and 
women (n=10). 
Aged 50 years and 
over  
UK Lung    K: Recall (poor) 
B: Fear, fatalism  
PB: Expectation of symptoms to be extreme, stigma, blame, 
denial, self-medication, vague nature of symptoms, 
competing life priorities, too busy, don’t like to bother the 
doctor, difficulty getting an appointment 
PF: Symptom disclosure, active encouragement from a 
family member 
N/A Medium 
Tomlinson 
et al (2012)  
Retrospective, 
Quantitative 
87 men (n=56) and 
women (n=31). 
Mean age: 65 years  
Canada  Colorectal  Education  K: Symptom interpretation  
PB: Self medication  
SP: Waited over 1 month to seek medical help (51%)  
K: NR 
PB: NR 
SP: NS association between education 
and time to SP (𝑥2, p>0.05**) 
Medium  
Trivers et al 
(2011)  
Hypothetical, 
Quantitative 
2991 women. 65% 
were aged 45 years 
and over 
US Gynaecolog
ical  
Education, 
Income 
B: Concern about developing gynaecological cancer 
PB: Being premenopausal 
SP: 50% of women would seek help for most symptoms 
B: NR 
PB: NR 
SP: NS association between SP 
intentions and socioeconomic group 
(statistics NR)  
Medium  
Tyler et al 
(2005)  
Retrospective, 
Quantitative  
176 men (n=93) and 
women (n=83). 
Median age: 54 
years  
Canada Melanoma   B: Benefits of early diagnosis  
PB: Previous misdiagnosis 
PF: Symptom disclosure, active encouragement by wife, 
cosmetic appearance of lesion  
SP: Median time to symptom presentation (4 months) 
N/A Medium  
Van Osch et 
al (2007)  
Hypothetical, 
Quantitative 
459 men (49%) and 
women (51%) over 
the age of 55. Mean 
age: 68.6 years.  
Netherla
nds  
All Education K: Recognition (low to moderate, mean: 6.2)  
B: Benefits of early detection 
SP: Fair. Inconsistent for urgent symptoms, good for 
prolonged symptoms 
K: NR 
B: NR 
SP: Lower education associated with 
shorter time to SP (F(2,436) =6.084, 
p<0.01) 
 
 
Good  
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Waller et al 
(2009)  
Hypothetical, 
Quantitative  
1500 men and 
women from 
various ethnic 
minority groups 
England All Occupation   K: Recall (poor, mean: 1.2) and recognition (poor, mean: 
4.7) 
PB: Worry what doctor might find (most endorsed)  
SP: African and Caribbean groups anticipated fastest time 
to symptom presentation   
K: Higher socioeconomic group 
associated with higher recall (F(1,1487) 
=6.12, p<0.01) and higher recognition 
(F(1,1487)= 5.45, p<0.05) 
PB: NR 
SP: NR 
Good  
Walter et al 
(2014) 
Retrospective  
Qualitative 
63 men (n=31) and 
women (n=32). Age 
range: 29-93 years.  
UK Melanoma  Education  K: Symptom attributions (initially attributed to benign skin 
conditions or normal life changes) 
PB: Worry about wasting the doctors time, service barriers, 
competing life priorities, reassurance following symptom 
disclosure  
PF: Family history of melanoma, perceptions of high risk, 
symptom disclosure, symptom noticed by another person 
SP: Range 1-303 weeks  
 
 
 
 
N/A Good  
Whitaker et 
al (2014)  
Retrospective 
Quantitative 
1724 men (n=789) 
and women (n=921) 
over the age of 50$. 
Mean age: 64.4 
years. 
England  All Postcode, 
education, 
employment 
K: Symptom interpretations (2% thought symptom was 
cancer, highest interpretation for ‘unexplained lump’), 
perceived seriousness of symptoms  
SP: Symptom experience (53% experienced at least 1 
symptom in past 3 months). 59% contacted GP about 
symptom 
K: Unemployment associated with 
higher perceived seriousness of pain 
(OR 2.26, 95% CI: 1.17-4.35, p<0.05), 
tiredness (OR 2.11, 95% CI:1.23-3.64,  
p<0.05), sore throat (OR 3.56, 95% CI: 
1.10-11.45, p<0.05) and chest pain (OR 
3.56, 95% CI: 1.10-11.45, p<0.05). 
Lower education associated with higher 
perceived seriousness cough (OR 2.25, 
95% CI: 1.10-4.56, p<0.05), tiredness 
(OR 2.46, 95% CI:1.44-4.21, p<0.05), 
headaches (OR 3.80, 95% CI: 1.63-8.89, 
p<0.05), shortness of breath (OR 2.34, 
95% CI: 1.11-4.97, p<0.05), sore throat 
(OR 4.16, 95% CI: 1.14-15.22, p<0.05) 
and chest pain (OR 4.16, 95% CI: 1.13-
15.22, p<0.05) 
SP: NR  
 
 
 
Medium 
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Whitaker et 
al (2015c)  
Retrospective 
Qualitative  
48 men (n=23) and 
women (n=25) over 
the age of 50. Mean 
age: 64.4 years.  
England All  Education, 
employment  
K: Symptom interpretations (symptoms normalised or 
associated with cancer)  
PB: Stoicism, fear of diagnostic tests, worry about wasting 
doctors time, service barriers, negative attitudes towards 
HCPs, medical mistrust 
PF: Development of new symptoms, persistence of 
symptoms,  symptom disclosure, fear    
SP: Varied per symptom: 33.3% contacted GP with 
‘persistent cough’, 100% contacted GP with ‘unexplained 
bleeding’  
N/A Good  
K: Cancer symptom knowledge; B: Beliefs about cancer; PB: Perceived barriers to cancer symptom presentation; PF: Perceived facilitators to cancer 
symptom presentation; SP: Symptom presentation; NS: Non-significant; NR: Not reported;  * p-value not reported; ** other statistics not reported; 
***aggregate ORs not reported, see Table 2 in paper; ****see table 3 in paper for other aggregate statistics; *****p-value reported in Table 3 in paper; 
however, due to CI including 1, the quality of paper has been lowered; $reason for disparity between participant frequencies not reported.  
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3.5 Discussion 
 
The present review was the first to systematically explore how knowledge, beliefs and 
barriers/facilitators to symptom presentation affect actual or anticipated cancer symptom 
presentation, across all tumour sites and in relation to socioeconomic group.  
 
3.5.1 Summary of evidence 
 
Poor knowledge of non-specific cancer symptoms such as fatigue and weight loss prolonged 
medical help seeking due to misattribution of symptoms to benign conditions such as stress 
or a cold. In contrast, lump and bleeding symptoms were most frequently recalled and 
recognised, and prompted the fastest symptom presentation. A knowledge gradient was 
observed, where poorer cancer symptom knowledge was associated with low 
socioeconomic group based on multiple indices. The combination of fearful and fatalistic 
beliefs about cancer was associated with prolonged symptom presentation. There was some 
evidence to suggest that those from a low socioeconomic group were more likely to hold 
fearful and fatalistic beliefs about cancer and less likely to endorse positive beliefs about the 
benefits of early diagnosis. In addition, emotional barriers to symptom presentation such as 
embarrassment or worry what the doctor might find were more likely to be endorsed in low 
socioeconomic groups. Such poor knowledge, prevalent beliefs and emotional barriers to 
symptom presentation might account for the long actual symptom presentation times and 
later stage cancers diagnosed in low socioeconomic groups. There was some evidence to 
suggest that social norms around symptom presentation behaviour were barriers to seeking 
medical help, particularly for vague and non-specific symptoms of lung cancer. However, 
when seeking medical help for a symptom was sanctioned by a family member or friend 
following symptom disclosure, this facilitated in the decision to seek medical help, although 
there was some evidence to suggest that symptom disclosure acted as a barrier in low 
socioeconomic groups.  
 
3.5.2 Findings in the context of current literature  
 
The findings of the current review confirm that failure to appreciate the seriousness of 
symptoms (Macleod et al, 2009; Mitchell et al, 2008) and non-disclosure of symptoms (Bish 
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et al, 2005; Macleod et al, 2009) lengthened time to symptom presentation, representing 
Capability in the COM-B model. Findings accord with previous studies in which negative 
beliefs (Quaife et al, 2015a), longer time to actual symptom presentation (Macleod et al, 
2009) and low suspicion for cancer symptoms (Whitaker et al, 2015a) were associated with 
low socioeconomic group (Macleod et al, 2009). The current findings support Mitchell et al’s 
(2008) (Mitchell et al, 2008) review of colorectal cancer patients, in which fear of cancer 
either lengthened or shortened time to symptom presentation, representing Motivation in 
the COM-B model. Such findings might be explained by Type I and Type II information 
processing systems. Type I processing is a fast and automatic system, which represents an 
individual’s ‘gut reaction’ to an event (automatic Motivation), whereas Type II is a slower, 
more thoughtful and deliberative system (Reflective Motivation) (Epstein, 1994). Whilst 
most people initially experience fear in reaction to a worrying symptom (Type I processing), 
cognitions during Type II processing may influence the decision to seek medical help since 
these are slower and may help someone to rationalise the situation (Epstein, 1994). If an 
individual has had time to reflect on the benefits of seeking medical help, and based upon 
their previous beliefs about early diagnosis, such beliefs may override the Type I fear 
response. There was evidence to suggest a higher prevalence of fearful and fatalistic beliefs 
in low socioeconomic groups and some evidence for fewer positive beliefs surrounding the 
benefits of early diagnosis in low socioeconomic groups. This suggests that Type I beliefs 
may not be overridden by Type II responses relating to the benefits of early diagnosis due to 
lower knowledge or higher emotive responses. As a consequence this may prolong symptom 
presentation. Findings relating to symptom disclosure suggest that people use the ‘lay 
system’ of healthcare (consulting family and friends) before making the decision to access 
formal healthcare (Edwards, 2013; Low et al, 2015; Pescosolido & Boyer, 1999) representing 
Opportunity in the COM-B model. However, among individuals from low socioeconomic 
groups, disclosing symptoms to someone with equally poor knowledge and Type I negative 
automatic beliefs about cancer may encourage false reassurance in the benign nature of 
symptoms and consequently no urgency to seek medical help.  
 
3.5.3 Quality of studies 
 
Most included studies were of medium quality. In many studies, socioeconomic group was 
measured but only reported for selected or none of the outcome variables. Most studies 
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only reported socioeconomic group differences for symptom presentation. Twenty-nine 
studies reported socioeconomic group differences for the other outcome measures: 
knowledge, beliefs and barriers/facilitators to symptom presentation. One poor quality 
study reported a statistically significant association between socioeconomic group and time 
to symptom presentation; however, because the confidence interval includes 1.0 the 
association should not reach statistical significance. Methodological limitations included a 
long duration between cancer diagnosis and participation in retrospective studies, and 
samples biased towards high socioeconomic groups. In some studies, socioeconomic 
variation was insufficient to perform statistical analysis on all outcomes. 
 
There are methodological limitations associated with retrospective (actual symptom 
presentation) and hypothetical (anticipated symptom presentation) designs. Whilst 
retrospective studies are affected by recall bias, hypothetical studies rely on intentions 
which may not translate into actual presentation behaviour (Gollwitzer, 1993). This was 
observed in the variation between actual and hypothetical time to symptom presentation, 
where participants anticipated prompt symptom presentation but in reality reported longer 
symptom presentation times. Study designs exploring actual symptom presentation 
behaviour in a population sample are likely to reduce some of the limitations associated 
with retrospective and hypothetical symptom presentation study designs. In such study 
designs, participants disclose actual symptoms experienced in the past three months, usually 
prompted by a list (without any mention of cancer), and reasons for not consulting a doctor 
explored (Cockburn, 2003; Simon et al, 2010; Whitaker et al, 2015a; Whitaker et al, 2014). 
 
3.5.4 Strengths and limitations of review 
 
Checklists such as AMSTAR (A Measurement Tool to Assess Systematic Reviews; 
www.amstar.ca, accessed 08.02.2016) can be used to assess the quality of a systematic 
review. According to the AMSTAR checklist, the present review was of good quality because 
an ‘a priori’ design was used, studies for the present review were selected and data 
extracted by two independent reviewers, multiple databases were searched, studies were 
assessed for quality, and study characteristics were tabulated. Although appropriate 
methods (a narrative synthesis) were used to combine study findings, a meta-analysis was 
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precluded by the wide range of qualitative and quantitative data collection methods and 
outcome measures of included studies, and is a limitation of the review. 
Other limitations of this review include problems relating to retrieval of studies and analysis 
of the evidence. Due to poor indexing of studies under the MeSH indexing in this topic area, 
a high proportion of studies (n=22) was found through hand-searching. Finally, other factors 
such as age, gender and ethnicity can affect symptom presentation (Hiom, 2015; Macleod et 
al, 2009). However, interactions between these domains and socioeconomic group was 
considered to be beyond the scope of this review.    
 
3.5.5 Implications for policy and practice 
 
Cancer awareness interventions should be carefully developed to target those who are most 
likely to present with advanced stage disease: low socioeconomic groups with low symptom 
knowledge and fearful and fatalistic beliefs about cancer. Development of interventions 
targeted at people living in socioeconomically deprived communities should aim to consider 
the wider societal influences on symptom presentation behaviour including social norms 
around medical help seeking. The results of this review suggest that it is important to 
highlight the significance of vague and non-specific symptoms as potentially indicative of 
cancer, along with advice on an appropriate time in which an individual should seek medical 
help and how to access such help (Dobson et al, 2014). This should be coupled with 
information outlining the benefits of early diagnosis and improved effectiveness of modern 
treatments for cancer, in an effort to counter negative beliefs surrounding cancer.  The 
current results suggest that such an intervention could potentially utilise an individual’s 
social networks to facilitate distribution of information (Rogers, 1983).  
 
3.6 Conclusion  
 
The present review found evidence to suggest the presence of poor cancer symptom 
knowledge (Capability), high negative beliefs about cancer and emotional barriers to cancer 
symptom presentation (Motivation) in low socioeconomic groups. These factors in 
combination are likely to explain prolonged cancer symptom presentation and later-stage 
disease at diagnosis in low socioeconomic groups; however, the quality of evidence was 
limited due to the lack of socioeconomic variation within study samples. Subsequent 
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chapters will explore knowledge, beliefs and barriers to cancer symptom presentation in low 
socioeconomic groups within Wales using qualitative methods. Such insight is essential to 
understand the barriers to symptom presentation in order to develop interventions to 
encourage more timely symptom presentation in socioeconomically deprived groups.
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Chapter 4 
Understanding the barriers to cancer symptom presentation among low 
socioeconomic groups: a qualitative interview study 
 
4.1 Chapter overview  
 
This chapter reports findings from a qualitative interview study with thirty participants over 
the age of 50 from low socioeconomic groups based on multiple individual and group level 
indicators (McCutchan et al, 2016). Cancer knowledge, beliefs about cancer, barriers to 
actual or hypothetical cancer symptom presentation, and the wider social and 
environmental factors influencing actual or anticipated cancer symptom presentation were 
explored. Data were analysed using a framework approach based around the COM-B model. 
This chapter reports findings from the study and how they were used to facilitate 
understanding of the barriers and facilitators to cancer symptom presentation among 
people from low socioeconomic groups. Implications for a cancer awareness intervention 
targeted at people from socioeconomically deprived groups and the usefulness of the COM-
B model in this context will be discussed.  
 
4.2 Introduction 
 
As outlined in Chapter 1, people from low socioeconomic groups are more likely to prolong 
cancer symptom presentation and consequently receive a diagnosis of cancer in the later 
stages of disease where treatment options are limited and the chances of survival are 
reduced (Macleod et al, 2009; Lyratzopoulos et al, 2013). The reasons for prolonged cancer 
symptom presentation among low socioeconomic groups are not fully understood. An in-
depth understanding of this phenomenon is essential for the development of targeted 
cancer awareness interventions to promote timely symptom presentation among people 
from low socioeconomic groups.  
 
As outlined in Chapter 1, the updated National Awareness and Early Diagnosis Initiative 
(NAEDI) framework provides a descriptive framework for suggested reasons for prolonged 
symptom presentation including poor cancer symptom knowledge, negative beliefs about 
cancer, barriers to help seeking and difficulty accessing primary care (Hiom, 2015). In the 
most recent version, socioeconomic group was included as a risk factor for prolonged cancer 
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symptom presentation (Hiom, 2015). However, due to the descriptive nature of the NAEDI 
framework, it is unclear how knowledge, beliefs and barriers might contribute to the 
decision to seek medical help for a symptom of cancer in the context of socioeconomic 
deprivation. Findings from the systematic review in Chapter 3, provide support for the 
assumptions of the NAEDI framework, and begin to provide insight into which factors are 
most salient among low socioeconomic groups where poorer knowledge, higher negative 
beliefs, and emotional barriers such as fear of a diagnosis of cancer were more prevalent  
(McCutchan et al, 2015; Appendix 1).  However, evidence regarding the influences of 
symptom presentation has mainly been restricted to quantitative methods, involving 
samples with low socioeconomic variation and often relying on a sole socioeconomic group 
indicator. In addition, studies have typically focused on individual barriers rather than taking 
into account the wider social and environmental factors on behaviour (McCutchan et al, 
2015; Appendix 1). A detailed examination of the mechanisms underlying prolonged cancer 
symptom presentation in deprived communities is required. This will involve gaining insight 
into the formation of beliefs and knowledge of cancer and an examination of the wider 
contextual influences on symptom presentation behaviour. The use of qualitative interview 
methods enables a deeper understanding of how both individual and socioeconomic factors 
might lengthen time to cancer symptom presentation.  
 
4.2.2 The COM-B model  
 
As discussed in Chapter 2, the COM-B model offers a potentially useful insight into how the 
decision to present with a potential symptom of cancer might be influenced through the 
constructs of ‘Capability’, ‘Opportunity’ and ‘Motivation’ and their underlying theoretical 
domains (Michie et al, 2011). Where many other theories neglect the wider social influences 
on behaviour, the COM-B model takes these and other individual level constructs into 
account, and was selected to aid analysis and interpretation of the data. According to the 
COM-B model (Michie et al, 2011), in order for behaviour to occur, an individual must have 
the ‘Capability’ (physical or psychological capacity of a person to perform behaviour; having 
the knowledge and skills to direct the behaviour) as well as the ‘Opportunity’ (physical 
opportunities created by the physical environment or social opportunities created by the 
cultural environment). In addition, ‘Motivation’ to engage in the target behaviour must 
outweigh motivation to engage in competing behaviours (Michie et al, 2011). ‘Motivation’ 
may be automatic (Type 1 innate, unconscious processes e.g. habitual or emotional 
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responses) or reflective (Type 2 deliberative, slower processes e.g. conscious decision 
making) (Michie et al, 2011).  
 
4.2.2 Qualitative methods  
 
A qualitative methodology was selected to gain an in-depth understanding of how individual 
and socioeconomic factors might influence cancer symptom presentation, understand the 
formation of cancer knowledge and beliefs, and identify barriers to cancer symptom 
presentation. Through qualitative methods, the wider social and environmental influences 
on health behaviour can be explored, which as described in Chapters 2 and 3, are likely to 
affect cancer symptom presentation among low socioeconomic groups. A semi-structured 
topic guide was developed based on the results of Chapter 3 and guided by relevant theory 
identified in Chapter 2. However, issues of importance which emerge can be explored during 
the interviews due to the nature of qualitative research. Additional themes could be 
explored and the topic guide developed should they become salient. The findings were used 
to build upon the results of existing studies described in Chapter 3, attempting to 
understand how socioeconomic group factors influence knowledge, beliefs and barriers to 
cancer symptom presentation. 
 
4.2.3 Aims of the qualitative study 
 
To date, no study has sought to understand the barriers to cancer symptom presentation 
from an in-depth qualitative perspective with participants from low socioeconomic groups 
based on multiple individual and group indicators. This study aimed to explore cancer 
symptom knowledge, beliefs about cancer, the wider social determinants and barriers to 
cancer symptom presentation in a sample of participants from low socioeconomic groups 
using qualitative interview methods.  
 
4.3 Methods 
 
4.3.1 Interview topic guide 
 
Development of the topic guide was guided by the results of systematic review findings and 
relevant theory outlined in Chapter 2. The systematic review described in Chapter 3 helped  
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to identify any gaps in the evidence base and guide which topics required further 
exploration, in order to understand the formation of beliefs about cancer. Theory was used 
to identify the constructs which could potentially determine intentions to perform 
behaviour.  
 
The main topics covered at interview were: cancer knowledge, beliefs about cancer (e.g. 
treatments for cancer and survival outcomes), any barriers and/or facilitators to presenting 
with actual or hypothetical symptoms to a healthcare professional (HCP), any previous 
symptom experiences (including symptom attributions, if they sought medical help or not 
and any barriers/facilitators experienced), hypothetical symptom episodes (including 
whether the participant would seek medical help or not and why, anticipated 
barriers/facilitators), symptom disclosure (who they would or have previously spoken to 
about health concerns), a description of the community and suggestions for a cancer 
awareness intervention (see Appendix 4 for topic guide). In an attempt to gain insight into 
perceived community norms associated with all previous topics, questions such as ‘thinking 
about people in your community, do you think they know the symptoms of cancer?’ were 
asked. 
 
The topic guide was developed with lay involvement from a member of the Tenovus Cancer 
Care Patient Advisory Group, a group of lay members of the public who have previously 
been affected by cancer. In addition, the topic guide was presented to 12 qualitative 
researchers at the Division of Population Medicine qualitative research group meeting at 
Cardiff University. Amendments to the topic guide were made following comments, and 
piloted on two postgraduate students at Cardiff University.  
 
Changes to the topic guide following these piloting activities included adaptation of wording 
to ensure simple language was used and leading questions were not asked. The topic guide 
was adapted for any participants who disclosed a previous diagnosis of cancer during the 
interview. The recruitment strategy originally intended to capture members of the public 
who had not received a diagnosis of cancer, because it was thought that a previous diagnosis 
of cancer might bias cancer knowledge and beliefs. On further reflection, it was considered 
unethical to terminate an interview immediately after an individual disclosed a previous 
diagnosis and to exclude that participant. Therefore, anyone who disclosed a previous 
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diagnosis of cancer was interviewed using additional questions in the topic guide (see 
Appendix 4), in which questions were based on actual symptom presentation experiences, 
any barriers/facilitators and community level norms.  
 
4.3.2 Participant recruitment 
 
Participants were initially recruited through the International Cancer Benchmarking 
Partnership (ICBP) Welsh database (Forbes et al, 2013) which is a database of people who 
took part in the ICBP study in 2011. The ICBP study was conducted in five high income 
countries with comparable health care systems and was designed to capture population 
level data on cancer knowledge, beliefs, barriers and intentions to seek help for cancer 
symptoms in people aged over 50 years using the Cancer Awareness Measure (Forbes et al, 
2013). Demographic data including educational attainment and postcode were collected as 
measures of socioeconomic group (Forbes et al, 2013). Participants in the ICBP study were 
contacted by telephone using random digit dialling and invited to take part in the survey 
study over the phone (Forbes et al, 2013). At the end of the study, participants were asked if 
they would like to be contacted to take part in future research (Forbes et al, 2013).  
 
Participants for the present study were initially recruited from the ICBP Welsh database if 
they consented to be contacted for future research studies at the time of the ICBP study. 
Participants were selected based on Welsh Index of Multiple Deprivation (WIMD) score and 
educational attainment to ensure that those from a low socioeconomic group were invited 
to take part in the current study. Those residing in the most deprived quartile (a WIMD score 
less than 496 based on postcode; WIMD, 2011) and those with the lowest educational 
attainment (‘finished school before age 15’ or ‘no qualifications or left school at age 16’) 
were invited to take part in the study. Due to low response rates, additional participants 
were recruited using snowball sampling or were identified through Communities First 
partners. Communities First is a Welsh Government initiative designed to tackle poverty by 
supporting people who live in the most deprived areas of Wales. They employ Communities 
First partners to help delivery of government initiatives and provide face-to-face support for 
those living in the communities.  
 
The original aim of the present study was to capture the perceptions and beliefs of people 
who had not received a diagnosis of cancer in order to understand the barriers to 
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anticipated cancer symptom presentation. However, as previously described, some 
participants disclosed a previous diagnosis of cancer during the interview, whereas some 
participants reported previous symptoms which could indicate cancer, and others reported 
no previous cancer symptoms. All participants were included to allow insight into the 
barriers and facilitators to symptom presentation based on a range of symptom experience.  
 
4.3.3 Procedure 
 
Potential participants were introduced to the study via telephone using a script tailored to 
their recruitment method (Appendix 5 and 6). Those who expressed interest in taking part 
were posted an invitation letter and study information sheet tailored to recruitment method 
(Appendix 7 and 8).  Potential participants were contacted by telephone a week later to 
answer any questions about the research study, and a time and date for interview was 
arranged for those who were interested in participating in the study. All recruitment 
materials and written information were developed with lay involvement from a member of 
the Tenovus Cancer Care Patient Advisory Group and were tested using a readability formula 
to ensure that information was easy to read. Upon request, written information was 
available in Welsh.  
 
Participants were offered a face-to-face interview in their own homes or at a place of their 
choosing. Telephone interviews were offered to some participants due to geographical 
factors, suspicion associated with a researcher coming into their home to talk about cancer, 
or physical disability. At the time of interview, participants were offered the opportunity to 
ask any questions and completed a written consent form. Participants interviewed over the 
telephone were posted the consent form for completion to be returned in the post, and also 
verbally consented over the telephone prior to commencement of the interview. Upon 
completion of the interview, additional demographic data were collected: age, occupation, 
car ownership, home ownership. If the interview took place somewhere other than their 
home, participants were reimbursed for any travel expenses incurred. Response rates for 
taking part in research are usually lower among people from low socioeconomic groups, 
therefore participants were offered £10 in cash as an incentive to participate in the study.  
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Semi-structured qualitative interviews were conducted, informed by the topic guide to allow 
for additional topics to be explored using probes and prompts during interview. Interviews 
were audio-recorded with permission and transcribed verbatim.  
 
4.3.4 Ethical issues 
 
Ethical approval for this interview study was sought from Cardiff University School of 
Medicine Research Ethics Committee (ref 14/01; Appendix 9). Two amendments were 
submitted and approved for changes to participant recruitment methods, first for snowball 
sampling and second for recruitment through community partners. There were a number of 
ethical issues encountered before and during the interview study. 
 
4.3.4.1 Talking about cancer 
 
Cancer is an emotive subject and there were some ethical issues around discussing cancer 
with participants. Most participants could recall losing someone close to them to cancer and 
some participants became very upset recalling these accounts, especially as they had not 
spoken about it at such length before. In cases where the participant became upset during 
the interview, the recorder was stopped and permission was sought from the participant 
before recommencement of the interview and participants were reminded of their right to 
withdraw. In all cases, participants requested to carry on the interview and some 
participants described the process as cathartic. There are issues around recalling these 
memories, and although all participants were given the contact details for the researcher 
and a free helpline number for the cancer charity ‘Tenovus Cancer Care’, those who became 
very upset were encouraged to seek help via the helpline number. The Tenovus Cancer Care 
helpline is run by volunteers and offers a free support line for people to talk about cancer 
worries. The staff are trained to signpost people to other services such as counselling 
services if they need further support.  
 
Building rapport and gaining the trust of participants, particularly when interviewing 
individuals about cancer, is imperative due to highly emotive and often personal topics. 
Once an individual agrees to take part in a qualitative interview, although strict 
confidentiality and data protection procedures are followed to ensure no one outside of the 
research team will know they took part in the study, an individual is no longer anonymous to 
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the researcher. They might feel vulnerable as they discuss personal and emotional topics 
with someone who is in effect a stranger. Therefore, the researcher must be flexible with 
regard to the topics discussed and remind participants that they do not need to answer 
questions which make them feel uncomfortable. The interview topic guide was carefully 
designed to start with more factual knowledge of cancer, using questions designed to 
encourage the participant to talk and feel comfortable in a qualitative interview scenario. 
The topic guide then progressed onto the more emotive and personal topics later on in the 
interview. In most interviews, participants bought up previous upsetting experiences of 
cancer within their social network therefore the interview was guided by the participant. 
Building rapport was particularly challenging for those interviews conducted via telephone; 
however, efforts were made to engage in general conversation with the participant before 
commencement of the interview. For face-to-face interviews, rapport building was easier 
where general conversational questions, such as how long they had lived in the community 
or talk about recent sporting events, were used to engage participants whilst making a drink 
before the interview. Prior to the start of the interview, participants were reminded of 
confidentiality and permission to audio record was obtained to build trust. Body language 
and listening skills were important to encourage the participant to feel comfortable and be 
able to talk openly.  
 
4.3.4.2 Telephone interviews 
 
Telephone interviews were offered to four participants in situations where a face-to-face 
interview was not possible for reasons of geographical distance, physical disability or 
suspicion around talking about cancer in their home. For example, one participant needed to 
be in a horizontal position due to disability and requested a telephone interview to enable 
participation in the interview study whilst lying in bed. Another participant reported 
superstition associated with talking about cancer at length in the house and requested a 
telephone interview. Following discussion with supervisors about the ethical implications of 
interviewing someone with such strong superstitions, it was considered acceptable to 
interview this participant over the phone as the participant had requested a telephone 
interview.  
 
There are particular ethical issues associated with gaining informed consent over the 
telephone and difficulties building rapport in a telephone interview. Participants were 
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posted an information sheet and a consent form prior to the arranged interview time, asked 
to read both documents, fill in, and return the consent form in a pre-paid envelope. At the 
time of the interview, the researcher reminded the participant of what their participation in 
the interview involved and other ethical issues such as right to withdraw according to the 
information sheet. The researcher read through the consent sheet again to receive verbal 
informed consent over the phone. As previously discussed, it is more difficult to engage 
participants over the phone, when compared to a face-to-face interview. However, as the 
PhD researcher had spoken to the individual at least twice before the interview over the 
phone, making conversation to build rapport was easier, compared to speaking to someone 
for the first time.  
 
4.3.4.3 Symptom advice  
 
Participants were reminded at the start of the interview that the PhD researcher was not 
medically trained and therefore could not offer advice on symptoms, but could signpost 
participants. There were a few participants who disclosed worrying symptoms or asked 
advice on symptoms. All participants with symptoms were encouraged after the interview to 
seek help from their GP. A few participants requested more information about the 
symptoms of cancer as they were unsure where to get symptom information from, or their 
reason for taking part was to learn more about cancer. All participants who requested more 
information were posted a variety of Cancer Research UK leaflets containing advice about 
symptoms of various cancers.  
 
One participant disclosed a diagnosis of early stage dementia and discussed committing 
suicide, including details of his suicide plan if his memory became worse as he did not want 
to burden anyone with advanced stage dementia. Immediately after the interview, the 
participant was encouraged to go to the doctor to discuss all of the issues raised. Follow up 
phone calls were made to the participant in the weeks following the interview to ensure he 
had been to the doctor to discuss concerns.     
 
4.3.4.4 Researcher values and relationship to participants  
 
In qualitative research it is important to reflect upon personal values of the researcher and 
the relationship between the researcher and the participant. The researcher should have an 
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awareness of these how these might influence responses and during an interview situation 
and interpretation of findings.  
 
I am a white English middle class female with a good education. I have been given every 
opportunity to reach maximum potential socially and academically. I have an interest in the 
social determinants of health and believe we should live in a more equal society and that a 
society where people are living below the poverty line is unjust and barbaric, especially 
when the system fails to support those most in need. Although I made effort to understand 
the contextual factors in deprived communities, as I have not experienced living in a 
socioeconomically deprived community first hand I may never fully understand the wider 
social and environmental factors on behaviour. 
 
Going into interviews, I was very conscious of my social standing as a middle class English 
female and how there was a potential for a power imbalance. I was aware of how this might 
influence rapport, trust and openness from the participant during the interview and made 
every effort to make the participant feel comfortable through dressing appropriately and 
engaging in conversation to break down any potential power imbalance. In addition, I was 
aware participants might be suspicious of someone from a university asking them to take 
part in research. For example, one participant during an interview disclosed the belief that 
the researcher was working undercover from the Government to assess his disability benefit 
and realised during the interview that I was actually a student from Cardiff University.  
 
4.3.5 Analysis  
 
Participants were interviewed until data saturation was achieved, to ensure that adequate 
data were collected and the views of the target population were represented. Data 
saturation was considered to have occurred when no new themes emerged for at least the 
final three participants (no new themes emerged from participant numbers 27 to 30). 
Transcripts were analysed using a framework approach (Richie and Spencer, 2002; Green 
and Thorogood, 2011 p.208) based around each of the COM-B model constructs (Capability, 
Opportunity, Motivation - Behaviour) (Michie et al, 2011). The Theoretical Domains 
Framework (Cane et al, 2012) was used to facilitate grouping of themes under the COM-B 
model constructs.  
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Each transcript was read and re-read and themes were generated from the transcripts (see 
Appendix 10 for coding framework). Themes were grouped under each of the COM-B model 
constructs according to the definitions outlined previously. Grouping of themes was double 
checked by another member of the research team to reduce potential bias, and 
amendments made accordingly. Data were managed using the qualitative analysis software 
package NVivo (NVivo, 10). Two other members of the research team double coded two 
transcripts (four in total were double coded). Discrepancies were resolved through 
discussion between the PhD researcher and coders. Discussing discrepancies was useful to 
reduce subjectivity associated with coding and to facilitate interpretation of findings. 
 
Individual participant views were summarised and charted under each of the relevant 
themes of the COM-B model constructs, supported by Microsoft Excel (see Appendix 11 for 
an example of one charting spreadsheet). Data were analysed and charted according to 
reported cancer symptom experience and patient ID. Separate charts were produced for 
those who reported no symptom experience, previous cancer symptom experience or a 
previous diagnosis of cancer.  
 
The primary focus of this PhD thesis was to understand the factors underlying prolonged 
cancer symptom presentation among low socioeconomic groups. The topic guide and 
interview findings reflect this. However, as the PhD evolved, lung cancer was selected as an 
exemplar of prolonged cancer symptom presentation and poor survival in deprived 
communities (see Chapter 1). For this reason, additional analysis was undertaken for 
findings associated with lung cancer and presented after each of the COM-B constructs.   
 
4.4 Results  
 
4.4.1 Response rate 
 
Thirty participants were interviewed between June 2014 and March 2015. Face-to-face 
interviews (n=26) or telephone (n=4) interviews were conducted with 13 men and 17 
women, with a mean age of 66 years (range 52 to 88 years). Three interviews were 
conducted with two people at the same time due to restrictions on space precluding the 
ability to interview participants in separate rooms. Interviews were between 45 minutes and 
2.5 hours duration (mean 72 minutes).  
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Twenty participants were recruited from the ICBP Welsh database, eight participants were 
recruited through snowball sampling and two through Communities First partners (see Table 
4.1). Of the 126 names and telephone numbers extracted in total from the ICBP Welsh 
database according to WIMD score, educational attainment and permission to be re-
contacted, verbal contact was made with 84 potential participants to invite them to take 
part in the study. No verbal contact was made with the remaining 42 individuals either 
because they did not answer the telephone after multiple attempts (n=23), their phone line 
was disconnected (n=15), the number was incorrect (n=2) or the individual had died (n=2). 
Of the 84 individuals who were invited to participate after initial verbal contact was made, 
20 participants consented to interview (24% response rate). Reasons for non-participation in 
the study were: did not want to talk about cancer (n=31), too busy to take part (n=29), too ill 
to take part (n=12), did not want to take part in research (n=9), recent death in the family 
(n=3). Response rate data was unavailable for participant recruitment through snowball 
sampling and community partners.  
 
4.4.2 Sample characteristics 
 
All participants were in the most deprived quartile based on WIMD score calculated using 
postcode data. As shown in Table 4.1, all participants were of low educational attainment. 
Most participants were employed or retired from low skilled manual occupations such as 
factory work, or were entitled to receive job seeker allowance or disability benefit. The 
majority of participants did not own their own car, and rented their house or lived in a 
council owned property or sheltered housing. Although six participants owned their own 
house, they had lived in their home or community their entire lives and had inherited the 
family home.  
 
Five participants disclosed a previous diagnosis of cancer at interview, 16 reported a 
previous symptom episode during the interview and nine participants reported no prior 
cancer symptom experience.  
 
 
 
 
 
 
104 
 
Table 4.1: Sample characteristics 
Characteristics  Participants  
Recruitment source  ICBP Welsh database (n=20; 24% response 
rate calculated as a proportion of those 
eligible for the study after verbal contact 
was made) 
Snowball sampling (n=8) 
Communities First partners (n=2) 
Gender  Female (n=17) 
Male (n=13) 
Age  50-60 years (n=10) 
61-70 years (n=13) 
71-80 years (n=5) 
81-90 years (n=2) 
Symptom experience  Previous diagnosis of cancer (n=5) 
Reported cancer symptoms (n=16) 
No cancer symptom experience (n=9) 
Educational attainment  Finished school before age 15 (n=15) 
No qualifications or left school at age 16 
(n=15) 
Main source of household income 
 
Wages or salary (n=3) 
Pension (n=18) 
Benefits (n=8) 
Other (n=1) 
Home ownership  Owns home (n=6)1 
Privately rented housing (n=11) 
Housing association or sheltered housing 
(n=7) 
Council owned property (n=6) 
Car ownership  Owns car (n=9) 
Does not own car (n=21) 
1These participants had inherited the family home, where they had lived their entire lives 
 
4.4.3 Interview themes 
 
Key themes identified are presented under each construct of the COM-B model, with quotes 
as examples. Square brackets within the quotes represent inserted text to allow for 
clarification of the topic content. Where irrelevant, text was removed from quotes and 
denoted by ‘…’.  
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4.4.3.1 Capability  
Key themes relating to psychological capability were: cancer symptom knowledge, 
knowledge of the causes of cancer and communication with HCPs. No themes for physical 
capability were identified.  
4.4.3.1.1 Cancer symptom knowledge  
 
Knowledge for ‘red flag’ symptoms of cancer including blood in urine and lumps was good.  
Participants also thought that community level cancer symptom knowledge was restricted to 
lumps and sometimes bleeding. Knowledge for blood in stools was also good; however, most 
participants attributed blood in stools to benign causes such as piles in the first instance, 
therefore anticipated symptom presentation was prolonged. Most participants intended to 
seek immediate medical attention for a lump. This was reflected in those who had previously 
experienced actual lump symptoms describing how they sought medical help immediately. 
These participants were able to override any reported barriers to symptom presentation, 
seeking medical help immediately and usually requesting an emergency appointment. For 
bleeding, action planning was not quite as consistent, with the urgency to seek medical 
attention dependent on the source of bleeding. Bleeding from the bowels was often 
attributed to other causes, whereas blood in urine was considered much more serious: 
 
“I think the knowledge is there about bleeding from your back passage, lumps that 
knowledge is out there for everybody... If you bleed through the back passage you 
[think] is it piles?  I suppose you’d leave it go a week or two, but if it didn’t stop 
you’d [go]... a lump you automatically [go].”  (Female, age 67, previous diagnosis of 
cancer) 
 
“If I see there’s anything wrong with my prostate and there’s blood coming in my 
pee, I will be straight down the doctors.” (Male, age 72, reported previous cancer 
symptom) 
 
A few participants knew of other, non-specific symptoms such as weight loss or fatigue. 
Knowledge for these symptoms was usually acquired from retrospectively recalling 
symptoms experienced by family members and friends in the lead up to a diagnosis of 
cancer. However, non-specific symptoms were often attributed to existing co-morbid 
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illnesses which were highly prevalent in this group such as diabetes, or participants were 
unaware that these non-specific symptoms could indicate cancer. There was no perceived 
urgency to seek medical help for non-specific symptoms and all of those with a previous 
diagnosis of cancer reported attributing symptoms to ageing or pre-existing comorbidities. 
These participants reported being surprised upon learning their symptoms were signs of 
cancer when they went to their GP to discuss their symptoms:  
 
“I- When you were having your problems with going to the toilet a lot, did it ever 
cross your mind that it might’ve been cancer? 
P- Nuh, not in a million years because I never even heard of that there’s something 
wrong with your prostate, I didn’t even know what the prostate was…I was thinking 
about going to the toilet all the time?” (Male, age 75, previous diagnosis of cancer) 
 
“All my symptoms, because I’ve got diverticulitis, that’s one of the things, I’ve got 
acid reflux that’s another thing so I mean to say all these things could say I’ve got 
cancer so if I thought that I’d be thinking ‘I’m gonna die every day’.” (Female, age 
66, reported previous cancer symptom) 
 
A minority of participants knew the rarer and more advanced stage symptoms of cancer, 
such as pancreatic cancer symptoms, which is likely to reflect the high prevalence of these 
types of cancer among low socioeconomic groups. There was a common misconception that 
cancer is always painful and is likely to reflect seeing people in the community with 
advanced stage cancer, therefore it is likely that painless symptoms are misattributed to 
other benign causes. Some participants expressed anxiety around the belief that some 
cancers were symptomless. A few participants wanted to learn more about cancer but were 
unsure where to seek information from and this often motivated participation in the study:  
  
“The thing is how do you know when you’ve got [cancer] anyway?  You know what I 
mean?  You don’t know really, until it reacts with you know what I mean?” (Male, 
age 80, reported previous cancer symptom) 
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4.4.3.1.2 Knowledge of the causes of cancer  
 
Most participants discussed potential causes for cancer that were beyond their control and 
therefore expressed a reluctance to change ‘risky’ behaviours due to a perceived lack of 
benefit. Many participants thought “we’re all born with cancer in us” (Female, age 62, no 
cancer symptoms reported), lying dormant until trauma such as a bump, psychological 
stress, or chemicals used in food cans was required to “trigger [cancer] off” (Female, age 66, 
reported previous cancer symptom). Such beliefs were usually reinforced by people they 
knew who had previously received a diagnosis of cancer. Luck associated with developing 
cancer was discussed by many participants and is likely to contribute to the belief that 
cancer is beyond one’s control.  One participant requested a telephone interview for 
superstitious reasons, due to worry that he would jinx himself if the PhD researcher came 
into the house to discuss cancer at length. Some participants discussed family members or 
friends who received a diagnosis of cancer as “unfair” because the individual concerned was 
a “good person” (Female, age 58, reported previous cancer symptom):  
 
‘’I think too much [cancer] is made of the food though, I really do, there are a lot of 
additives and stuff that are put in foods that can cause problems…They’re spraying 
all these, it’s definitely man-made I think with all the chemicals that’s my way of 
thinking, definitely.  I think it’s food, I think it’s in the air, and I also think it’s caused 
by knocks, you know if you bump, give yourself a hard knock?...Now my cousin she 
swears that years ago when she was playing tennis, her opponent accidently hit her 
with a tennis racquet on the shoulder and that shoulder she said “left her in pain” 
she always had pain with it and she swore [the cancer] came from that.’’ (Female, 
age 69, reported previous cancer symptom) 
 
“You can’t stop [cancer], once it’s in you, it’s in you and everybody’s got a little bit of 
cancer in them and it only takes something to knock you to trigger it, to start it off.” 
(Male, age 56, no reported cancer symptoms) 
 
“[Cancer is] in everything we eat…using different fertilisers to make [food] grow to 
keep the flies and that away…You read all this in the paper, eat this, eat that, it’s 
healthy for you, but it’s the sales patter to sell it I’m sure, because it’s not doing 
anyone any good…I say “eat what you like, eat it, if you like it eat it”…[cancer is] in 
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what we eat, but you’ve got to eat, it’s as simple as that.”  (Male, age 72, reported 
previous cancer symptom) 
 
Most participants understood that smoking was a cause of cancer, although around a third 
were sceptical of the link between smoking and cancer. Current smokers and those who 
smoked throughout the interview tended to hold the latter belief that smoking was 
unrelated to cancer risk. Such claims were usually supported with examples of people they 
knew who had never smoked but were diagnosed with cancer. Some smokers recalled 
instances when they were ‘told off by the doctor’ for their smoking habit and perceived that 
HCPs used smoking to blame their symptoms rather than treating the health problem. This is 
likely to result in a reluctance to visit the doctor for symptoms in the future:  
 
“Smoking don’t cause cancer it doesn’t do you any bloody good at all, they say it 
gives you cancer and that is a lie, it does not give you cancer.” (Male, age 65, 
previous diagnosis of cancer) 
 
 “I disagree with you because they put [cancer] down to cigarettes and yes, it does 
cause a lot of problems in health and one thing and another, my mother died of 
[cancer]  and never had a smoke, his mother never smoked, she had [cancer] and 
there’s a lot of people in my family that don’t smoke that have got [cancer]...” 
(Female, age 57, no cancer symptoms reported) 
 
Some other participants who currently smoke were reluctant to give up smoking as they 
reported smoking to be the last piece of enjoyment left, although they fully understood the 
links between smoking and cancer: 
 
“When I go down [to the doctor] and she’ll say “I know you’re not drinking, but how 
about smoking?” and I say “do you want me to cut my throat?”” (Male, age 67, 
reported previous cancer symptom) 
 
4.4.3.1.3 Communication with Healthcare Professionals (HCPs) 
 
Some participants perceived themselves as having the capacity to effectively communicate 
symptoms to a HCP, sometimes using prompts such as lists to facilitate discussion and aid 
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memory recall. In addition, they felt confident about actively participating in a discussion 
with a HCP around healthcare and treatment options or would present to their GP with their 
self-diagnoses. For these participants, effective communication was perceived as important 
for access to optimal healthcare provision:  
 
 “I used to go to the doctor, and I’d go to the doctor and I’d tell them and they’d tell 
me and I’d trust them, you know I’d think they know they’re the doctor at the end of 
the day. Now I don’t ask them anymore I tell them, because you’re wasting your 
time if you just sit there, you’re wasting your time.” (Female, 66, reported previous 
cancer symptom) 
 
“Don’t be afraid of the GPs pooh-poohing you. Usually you know your body better 
than anyone else, so you know when it’s not right. Go to your GP, and don’t be 
pushed off with “oh just take this couple of tablets you’ll be alright’’. If you don’t feel 
like that push and push and push and unfortunately with GPs a lot of them, you’ve 
got to do that today…I always say to people ‘’when you go to the doctors, write a 
list, take it with you’’ because you’re in there and you come out and you think ‘’oh I 
didn’t ask so and so, or I should’ve said so and so’’- too late then.” (Female, age 68, 
no cancer symptoms reported) 
 
“I’m the type of person, I question something, [my husband] will accept it more than 
I will, he’ll say “oh well I’ve been told, listen now they’ve told me and that’s the end 
of it” [I say] “no it’s not the end of it, you disagree with it or you don’t believe it, 
question it again.” (Female, age 57, no cancer symptoms reported) 
 
Other participants preferred to take a more passive role in their healthcare, expressing 
frustration when invited to participate in a discussion with a HCP about a potential diagnosis 
and management for symptom(s). These participants perceived this approach used by 
doctors to engage patients in shared decision making or discussion about treatment options 
as disinterest in them as a patient, which is likely to put people off going to the doctors in 
the future. A passive approach to healthcare was perceived as the norm within the 
community, where people in the community preferred to present with symptoms and 
receive a diagnosis with little participation in discussion about potential causes. Some 
participants described a lack of confidence when communicating symptoms, getting to an 
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appointment and forgetting what to say, or struggling to ask questions during an 
appointment with a HCP. Problems with communication during an appointment were 
perceived as the norm within the community, and are likely to reflect literacy issues among 
low socioeconomic groups and/or a power imbalance where participants reported that 
people in the community were often “in awe of their GP” (Female, age 52, no cancer 
symptoms reported):    
 
“[The doctors] say to you “what do you think?” and as I say to them, “I’m not the 
doctor how do I know?” If it comes to diagnosing yourself why bother going to 
them?  You know, what’s the point?” (Female, age 66, reported previous cancer 
symptom) 
 
“My brother insists that [my daughter] comes to the hospital with me, I don’t listen 
to the doctor I don’t, you know. Instead of me listening to him, she was there so she 
knew what he was saying.” (Male, age 75, previous diagnosis of cancer)  
 
4.4.3.2 Motivation  
 
Key themes relating to automatic and reflective motivation were: fearful and fatalistic 
beliefs about cancer, and beliefs about the treatments for cancer and early diagnosis, and 
emotional barriers to symptom presentation.  
 
4.4.3.2.1 Fearful and fatalistic beliefs about cancer 
 
When participants were asked for their initial, automatic reactions to the word cancer, their 
reactions were all highly emotive and fearful, where participants described cancer as “evil” 
or “terrible”. There was an overall fear of receiving a diagnosis of cancer. Participants 
reported fear of the treatments for cancer and fear of dying from cancer especially as they 
associated the treatments of cancer with unpleasant and nasty side effects, and pain during 
the end stages of cancer where death was often the outcome. A diagnosis of cancer was 
feared more than other life threatening conditions, such as heart disease, due to the belief 
that cancer was a slow and painful death. There was a perception that cancer was a “dirty 
disease” (Male, age 80, reported previous cancer symptom) which is likely to contribute to 
the stigma attached to cancer. Some participants expressed cancer specific fatalistic beliefs 
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such as the belief that death was inevitable after receiving a diagnosis of cancer. These 
participants believed that there was no cure for cancer and treatment was used to prolong 
life rather than cure cancer. Such beliefs were usually based on witnessing family members 
or friends who suffered, and in most cases died, from cancer or stories of celebrities who 
had died of cancer:  
 
“I- How would you describe cancer as an illness?  
P- ((sighs)) evil, terrible, terrible yes.” (Female, 58, reported previous cancer 
symptom)  
 
“If you have cancer, you think you’re gonna die....don’t you?  You know that, that’s 
the most, that’s what you think, I don’t care who you are, that’s what you’re gonna 
think, they might be a chance these days, it is remote that you’ll survive it, but that’s 
the first thing, if anybody has been told that they’ve got cancer, that’s the first thing 
that goes through their brain.” (Male, age 80, reported previous cancer symptom) 
 
“All I know is that once you get it, that’s your lot, as far as I know there is no cure 
…it’s a dirty disease isn’t it?  That’s the description of cancer, it’s a dirty disease…you 
start thinking the worst and to be honest with you the worst is cancer!  No one 
thinks of heart attacks, or fits, or strokes, the first thing is cancer.  Phone the funeral 
director I’ve got cancer!” (Male, 80, reported previous cancer symptom) 
 
For some participants, fear prompted immediate actual or anticipated symptom 
presentation for symptoms suggestive of cancer. This was usually when fearful beliefs were 
combined with an awareness of the benefits of early diagnosis of cancer. Fear of the 
consequences of a late diagnosis of cancer prompted or would prompt participants to seek 
help quickly, and those reporting actual symptoms (usually lump) often requested 
emergency appointments. For other participants, fearful beliefs about cancer - especially 
when combined with fatalistic beliefs about cancer - were the biggest barrier to cancer 
symptom presentation. This was perceived to be the norm within the community and some 
participants could recall people they knew who were too scared to go to the doctor with 
symptoms. One participant discussed a family member who entered the healthcare system 
as an emergency case and died in intensive care two days later from a brain tumour, but had 
not been to the doctor about his symptoms. It was reported that he “put his life in order” 
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(Female, age 67, reported previous cancer symptom) for his wife before his death as the 
participant thought he was aware his symptoms were cancer but was too scared to go to the 
doctor:  
 
“It took me a long time to go [to the doctor] I know that, I was terrified…I was 
terrified of the answers…what I don’t know I can’t worry about can I?” (Female, age 
88, previous diagnosis of cancer) 
 
I – “What do you think is stopping people from going [to the doctor]? 
P- Afraid I think it is to find out the truth, they know there’s something wrong, 
they’re just afraid to actually hear the doctor come out and say the word 
‘cancer’…They’re afraid to go to the doctor’s in case they actually say “yes, you have 
got cancer” and a lot of people are afraid to hear that word you know…so a lot of 
them will just sort of put it off until they’re so ill they’ve got to go.” (Female, age 52, 
no cancer symptoms reported) 
 
“I had a lump under my arm I was straight to the doctors I was absolutely petrified, 
but it was only a blocked um oh tube...’’ (Female, age 58, reported previous cancer 
symptom) 
 
4.4.3.2.2 Beliefs about treatments and early diagnosis for cancer  
 
Most participants were fearful of treatments for cancer and some believed the treatments 
to be worse than the cancer itself. Side effects such as sickness and hair loss were the most 
prominent deterrents for accepting cancer treatment. Some participants would anticipate 
refusing treatment if diagnosed with cancer and/or recalled family members or friends who 
had refused cancer treatment in the past. Some participants believed that air getting to 
cancer from operations caused the cancer to spread, and gave accounts of people they knew 
who died from cancer shortly after an operation to investigate or remove the cancer. Beliefs 
about air causing cancer to spread could put people off receiving treatment for cancer. For 
some participants there was confusion between potentially curative treatments for cancer 
and palliative or end of life care, where participants often mistook pain relief such as 
morphine for an intervention to treat cancer.  This could reflect the vicious circle of 
participants having been exposed to people in their social network who were diagnosed at a 
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late stage. They might therefore have received less effective treatment, and were then 
moved directly into palliative care, and failing to understand the negative correlation 
between cancer stage and treatment effectiveness. In addition, low health literacy in this 
group or problems associated with communication and comprehension of medical 
information are likely to contribute to misunderstanding of the difference between 
therapeutic options and contribute to negative beliefs about cancer treatment:  
 
“My sister she had radio, whatever you call it....on her throat and that when she had 
the throat cancer and when we went to see her, she was burned inside and outside, 
and it makes them ill and sick and whatever.  Well a lot of people with cancer would 
rather die from the cancer than go through the treatment.” (Female, age 52, 
reported previous cancer symptom) 
 
“[My friend with cancer] said “I’m not, I’m not having treatment, I can’t cope with it” 
she said and within a week she was dead.” (Female, age 57, reported previous 
cancer symptom) 
 
“It is horrendous I think for a woman, when your hair goes, it’s terrible, terrible and 
being sick, she used to have this injection on the end of the month, so right she had 
it at the end of the month, she’d be sick for 2 weeks after that, then she’d sought of 
have 1 week and she would be okay and then we’d go again oh! It was awful that 
was.” (Female, age 68, reported previous cancer symptom) 
 
As each interview evolved, many participants appeared to understand the benefits of early 
diagnosis, even after expressing previous fearful beliefs about cancer. These participants 
understood that detecting cancer in the early stages through prompt medical help seeking 
could enable access to less invasive treatments and potentially cure “good” (Female, 69 
years old, reported previous cancer symptom) cancers such as breast and prostate. These 
contradictory beliefs are likely to reflect a deep-seated fear of cancer. However, participants 
thought that people in the community were generally unaware of the benefits of early 
diagnosis. Beliefs about the benefits of early diagnosis were usually reinforced by people 
they knew in the community who were diagnosed and had survived cancer, or from news 
items. For those who understood the benefits of early diagnosis, the urgency to get cancer 
diagnosed quickly was a source of anxiety and as a consequence some participants were 
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hypervigilant about symptoms and worried about cancer as a probable cause of symptoms. 
For others, anxiety stemmed from the belief that certain cancers were asymptomatic in the 
early stages. This may reflect the high prevalence of cancers in the community which are 
harder to diagnose in the early stage and have worse outcomes, such as lung or pancreatic 
cancer. As a consequence, although these participants understood the benefits associated 
with a diagnosis of cancer in the early stages, they felt that early diagnosis was beyond their 
control:   
 
“I suppose I know people who’ve survived it. I think it used to be, once you heard 
that somebody had cancer that was their lot, but I can’t say that these days you 
know and they reckon more people survive cancer now than, than, you know you’ve 
got a good chance of surviving now.” (Female, age 69, reported previous cancer 
symptom) 
 
“It all depends on what cancer it is, if it was breast cancer I think you’ve got a good 
chance, if you got it early enough, bowel cancer is a good cancer to have if you’ve 
got to have cancer, cos they tend to be able to treat that.” (Female, 69 years old, 
reported previous cancer symptom) 
 
“Well hopefully they can catch it at an early stage where it hasn’t spread and then 
you’ve got more, they can remove it…[my friend] was very lucky they just removed 
it, he didn’t even have to have any chemotherapy after it, because it hadn’t spread it 
was early stages, but then I know other people who have had it and theirs had 
already spread, it’s already started to spread so that it, the quicker you get it the 
better isn’t it?  But there again how do you know when you’ve got it?” (Female, 71, 
no cancer symptoms reported) 
 
In contrast, some participants believed there was no cure for cancer, and provided 
anecdotal accounts of family members or friends who died from cancer. A few participants 
believed that the government had found a cure but was withholding it in order to generate 
revenue for the NHS by keeping people who work in cancer services in employment. Some 
participants reported that they had seen press releases and campaigns about cures for 
cancer in the media, but struggled to believe them. This is likely to reflect repeated exposure 
to cancer-related death in the community where they saw little firsthand or ‘real’ evidence 
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of people in their community surviving cancer. This could contribute to or reinforce lack of 
trust and suspicion towards government and health services, where participants believed 
that cancer was being used as an ulterior motive:  
 
‘You’ll never get rid of it and it’s just one of those things you know. They’re on about 
‘’we’ve got cures for this, cures for that’’, I think it’s just a big money making thing to 
be honest, I think that it’s a case of they got it and ‘’we ain’t sharing it because 
there’s too much money going in....These cancer things, like I said, nuh there’s never 
going to be a cure…I don’t know I don’t hear of many that are cured, what I suppose 
they do, I think they get an extension to their life, but I don’t think they actually get 
cured, no....” (Male, age 56, no cancer symptoms reported) 
 
“As soon as you mention the ‘C’ word people will lie down and die, because they 
think there’s no cure me... what am I supposed to do?” (Female, age 70 , reported 
previous cancer symptom) 
 
4.4.3.2.3 Emotional barriers to symptom presentation  
 
Some participants reported embarrassment associated with disclosure of symptoms to a 
HCP, particularly when an examination of an intimate area was required such as a breast 
lump or the participant was required to disclose symptoms such as blood in faeces. 
Participants perceived embarrassment as a key barrier to cancer symptom presentation in 
the community, particularly among men. Many participants reported denial as a barrier to 
cancer symptom presentation in the community. For some participants, denial was 
conceptualised as individuals who believe themselves to be at low risk for cancer and have 
the attitude that ‘cancer will not happen to them’ so are reluctant to seek help for 
symptoms or change ‘risky’ behaviour such as smoking. For some participants, denial of 
symptoms was conceptualised as complete ignoring and repression of symptoms due to a 
deep-seated fear of cancer and the belief that a diagnosis of cancer would be too much to 
cope with, thereby prolonging or completely inhibiting cancer symptom presentation:       
 
“I think it depends where you think you’ve got cancer as well, some people are too 
embarrassed to go to the doctor aren’t they?” (Male, age 81, previous diagnosis of 
cancer) 
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“They think you know [cancer is] not gunna happen to them, I’m okay.” (Male, age 
64, reported previous cancer symptom) 
 
4.4.3.3 Opportunity 
 
Key themes relating to physical and social opportunity were: facilitators to cancer symptom 
presentation, barriers to cancer symptom presentation, experience of cancer, a lay system 
of healthcare, and social environment.  
 
4.4.3.3.1 Facilitators to symptom presentation  
 
Some participants reported a good relationship with their GP, where they felt their doctor 
was interested in them as a patient, listened and was easy to talk to. These participants felt 
confident in presenting to their doctor with potential cancer symptoms to discuss concerns 
and perceived this as a key facilitator. Some participants had help from family members or 
friends to book an appointment or help with transportation to an appointment. In addition, 
some participants benefited from family members or friends who would accompany them to 
an appointment to help with communication and listening during an appointment, which 
facilitated symptom presentation:  
 
“I’ve been lucky up till now because I’ve always had a lift down, there’s always been 
somebody that goes out of their way to take me, but, other than that no, [the 
surgery is] really difficult to get to.” (Female, age 62, reported previous cancer 
symptom) 
 
“I’ve got a very good doctor…my GP  walks on water…he makes out that he’s 
interested I you, you know what I mean?” (Male, age 80, reported previous cancer 
symptom) 
 
“I think if you can get a good GP you’re half way there, you know? I really do think 
90% it’s down to your GP. There’s some awful GPs out there and there’s some 
brilliant ones you know? I’ve got a good one here now in my practice…I would feel 
confident to go to him with any misgivings about anything.” (Female, age 60, no 
cancer symptoms reported) 
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4.4.3.3.2 Barriers to symptom presentation  
 
Continuity of care was described as a barrier to symptom presentation because participants 
reported often seeing a different GP on every visit. Most participants reported a preferred 
GP within their practice; however they were required to book an appointment up to three 
weeks in advance to see their preferred doctor. Participants weighed up the problems with 
seeing a different doctor on every visit, where they were required to repeatedly explain the 
same problem against waiting two to three weeks for an appointment with their preferred 
doctor. Many participants thought the receptionist at the GP practice often played a 
gatekeeper type role, where perhaps the receptionists did not understand the seriousness of 
certain symptoms and refused to issue them with an earlier appointment. For some 
participants who worked unpredictable shift patterns, planning and scheduling an 
appointment was difficult especially when they were required to book in advance. In 
addition, loss of earnings due to attending an appointment during work hours was a barrier 
to cancer symptom presentation. For some participants, the practicalities of getting to an 
appointment were barriers to symptom presentation because of a lack of transportation, 
work commitments and physical disabilities. Potential loss of earnings and difficulty getting 
to an appointment are likely to prolong presentation with symptoms that are perceived as 
non-urgent, such as vague or non-specific symptoms:  
“In fact the last 3 times I’ve been now I’ve seen 3 different doctors, but I’ve been 
going for results of blood tests and that you know.  I suppose if I was prepared to 
wait uh I could see the same one like, cos you phone up and [say] “can I see Dr so 
and so...?”  “Oh they’re not here this week they’re somewhere else’’, so you see 
anybody then, you know.” (Male, age 81, previous diagnosis of cancer) 
 
“Well they made an appointment you’ve got to wait 3 weeks!  You’d be dead by 
then, and they say you go to them like me, I, I struggle down, you go down and what 
did they do?  Nothing! No different to went you walked in, only annoyed.” (Female, 
age 66, reported previous cancer symptom) 
 
“They don’t pay you to go to the doctor, you know you’ve got to clock in and clock 
out I mean I said ‘’no I can’t afford to lose time off work’’ and I don’t drive for 
another thing, so I said “where it would take 10 minutes to get down to you, I’ve got 
to wait for a bus, get down on the bus, and then go back to work which would take 
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me an hour, which would only take somebody else I said 15 minutes.” (Female, age 
57, reported previous cancer symptom) 
 
Time limited appointments and ‘one appointment, one problem’ policies prohibited the 
disclosure of more than one symptom. This was frustrating for participants, especially when 
they took time off work, waited a few weeks for an appointment or overcame the challenges 
associated with getting to an appointment. Consequently, participants perceived there to be 
“little point” (Female, age 66, previous cancer symptom experience) in going to the doctor, 
which has the potential to stop or delay a future visit to the doctor. The pressure of a time 
limited appointment is likely to increase anxiety or prohibit full disclosure of symptoms for 
those who struggle with communication during an appointment. For participants with 
potentially embarrassing or worrying symptoms such as blood in stools, other symptoms or 
health complaints may be used to ‘test the water’, before disclosure of a symptom which 
might indicate cancer. Therefore, policies that preclude the disclosure of more than one 
health complaint may prohibit presentation of the cancer symptom:  
 
“If you don’t specifically book a week before or fortnight in advance to see a certain 
doctor you get to see a locum which, when you go in there they say ‘’I can only see 
you about 1 thing, I’ve got 5 minutes’’ and I just looked at her and I thought well it’s 
a waste of space I said ‘’It is literally just a waste of space coming to see you...cos it’s 
all related’’…I just looked at her and I thought ‘’oh forget it’’, I just went out and I 
said, I told them exactly “she’s a waste of space, she’s useless.” (Female, age 57, 
reported previous cancer symptom) 
 
“I went in there with a complaint and he’s seven minutes. I said I got something else 
and he said “you’ve already come for the one complaint, you’ll have to make 
another appointment to see me again.” (Male, age 80, reported previous cancer 
symptom) 
 
4.4.3.3.3 Experience of cancer  
 
To support beliefs about cancer or demonstrate knowledge of the symptoms and causes of 
cancer, participants almost exclusively drew upon anecdotal accounts of people they knew 
with cancer in the community, which were generally negative. Some participants reported 
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that their entire immediate family or many close family members had suffered and died 
from cancer, and were often involved in nursing them in the end stages. For some 
participants, recalling these details was upsetting and the interview was paused. One 
participant produced a list of 25 people in the local community who had recently died of 
cancer and other participants could recall numerous local community members or friends 
who had died of cancer. Such high exposure to death from cancer and seeing family 
members and friends suffer is likely to contribute to the formation of fearful and fatalistic 
beliefs about cancer:  
“I’ve had 17 in the family die of it [cancer].” (Male, age 56, no cancer symptoms 
reported) 
 
“[My father] died in agony.  I was there and he was, I’ll never forget it on [date] I 
watched him die in agony, like I watched my wife [die from cancer], through 
incompetence you know…” (Male, age 72, reported previous cancer symptom) 
 
Some participants knew one or two people in the community who survived cancer, but who 
had kept their diagnosis a secret due to perceived stigma, or perhaps due to fear of being 
treated differently or rejected by the community. In addition, the only cancer-related media 
coverage that most participants could recall was about celebrities who died from cancer. 
Some participants reported how TV soaps and films often use cancer to ‘kill characters off’ 
which is likely to further reinforce negative beliefs about cancer and its association with 
death. It is unlikely that this was the only media coverage about cancer that participants had 
seen; however, these were the most salient to participants and are likely to reinforce 
negative beliefs about cancer:  
“[My friend] never said nothing [about his diagnosis of cancer]. All he just said was “I 
haven’t had a hard on because I had prostate cancer” and that’s all he said, and 
that’s the only way I know he had cancer…and as far as I know he’s cured.” (Male, 
age 80, reported previous cancer symptom) 
 
4.4.3.3.4 Lay system of healthcare 
 
Seeking advice for symptoms from family members or friends before visiting doctors was the 
norm for participants, usually from someone they perceived as ‘knowledgeable’ such as 
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someone with cancer or the local ambulance driver who, although had received no formal 
medical training, was perceived to be knowledgeable because of regular contact with the 
hospital. A lay system of healthcare was used to seek reassurance that an appointment with 
the GP was necessary. This is likely to reflect the various practical and service barriers 
previously mentioned, such as problems receiving or accessing an appointment with the GP. 
It is likely that symptom disclosure would act as a barrier or facilitator depending on the 
quality of advice given. Some participants discussed people within the community asking 
them for advice on symptoms, or recalled noticing symptoms in others and advising that 
they seek medical help:  
 
“Well the first person I’d talk about [a symptom] to is my mate because she’s had a 
couple of scares and fortunately thank god she hasn’t got cancer and then the next 
person I would go and see is my doctor.” (Female, age 70, reported previous cancer 
symptom)  
 
“If [my husband] had a fear or thought that he might have the cancer or anything 
like that, he would either keep it to himself or confide in me, but he wouldn’t be to 
the doctors.” (Female, age 70, reported previous cancer symptom) 
 
“[My friend] had been complaining that she wasn’t well before Christmas but she’s 
so stubborn that she wouldn’t go to the doctors and we kept on saying to her “go 
<name of friend>, it’s not normal to lose this amount of weight in such a short time”, 
and she said “oh I’ll go now” and she did go now mind.” (Female, age 57, reported 
previous cancer symptom) 
 
4.4.3.3.5 Social environment  
 
For many participants, health was not perceived to be a priority. Instead, day-to-day 
problems took precedence such as finding money for food and heating the house. 
Maintaining a healthy lifestyle was challenging when financial resources were limited, for 
example eating the recommended five pieces of fruit and vegetables per day was difficult 
with limited income. It is likely that symptoms are potentially dealt with once they start to 
impact on daily life rather than when they are first noticed. This could reflect competing 
priorities associated with fulfilling daily basic needs such as eating and staying warm. There 
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was a perceived general lack of control over daily life where many factors were discussed as 
beyond their control. For example, participants discussed new housing developments within 
the community that were out of their control, and were concerned with the impact of new 
people coming in to the community on primary care and other health services that were 
perceived to be already overrun. Housing was also described as a problem for those who 
lived in council owned properties or social housing, where participants had little or no 
control over who their neighbours were: 
 
“Your health goes because myself right, I need £10 for the gas and I’ve got £20 in my 
purse to last me the week, but it’s gonna cost me £15 to get fresh veg, meat and 
fruit. Then I would leave the fruit aside and the veg, to make sure that I’ve got my 
gas to keep warm.” (Female, age 57, no cancer symptoms reported) 
 
“In this [housing association] block you keep yourself to yourself because there’s a 
bit unsavoury characters...[one] was having parties all hours of the morning. He 
wasn’t very pleasant- you’d keep out of his way because he’d be quite rude you 
know. Then downstairs in the next block there are always gangs of boys back and 
forth always and there always [drunk]...so I have put in for a transfer but I don’t 
know how long it’ll take.  (Female, age 52, no cancer symptoms reported) 
 
Many participants reported suspicion and a lack of trust associated with the government, 
reflected in statements about the government withholding the cure for cancer, or the 
government ‘playing God’ with cancer treatment postcode lotteries where access to certain 
cancer treatments was determined by the area of residence. Some participants discussed 
feeling victimised or forgotten by the government. Competing priorities, a lack of resources 
available for a healthier lifestyle and perceived lack of control over daily life are likely to 
impact on medical help seeking behaviours: 
 
“They’re on about we’ve got cures for this, cures for that, I think it’s just a big 
money making thing to be honest, I think that it’s a case of they got it and we ain’t 
sharing it because there’s too much money going in....” (Male, age 56, no cancer 
symptoms reported)  
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“I get angry because they cut everybody else’s money back except the politicians 
and they get money and some of these have got three and four houses, cars, I’m 
thinking alright, why do you need all those houses?” (Female, age 52, no cancer 
symptoms reported) 
“A government thing, yes they have cameras that watches the people coming in 
going out right…and when they wanted to take [her disability benefit] off her they 
right, they watched her coming in, and they watched her coming out.” (Male, age 
71, reported previous cancer symptom) 
 
4.4.3.4 Lung cancer and smoking behaviour  
 
Lung cancer was described as a ‘bad’ cancer. Lung cancer was often described as a “cruel” 
(Male, age 71, previous diagnosis of cancer) and “painful” (Male, age 71, reported previous 
cancer symptom) type of cancer resulting in death, often soon after diagnosis. This 
perception was supported by people they knew who had been diagnosed with lung cancer. 
One participant described lung cancer as a “silent killer” (Male, age 71, reported previous 
cancer symptom), perhaps reflecting the belief that lung cancer is a symptomless disease 
due to the vague and non-specific symptoms in the early stages. Some participants referred 
to lung cancer as a male disease, which has implications for women with symptoms as they 
may perceive themselves at low risk for lung cancer:  
 
“I think people are afraid of you know, it’s not a very nice disease like is it? Like I 
said, it’s a cruel disease, my father in law then he died with cancer as well, um, I 
think he had, he had uh, lung cancer and it was cruel.” (Male, age 71, previous 
diagnosis of cancer) 
 
“You’ve got lung cancer, it’s death isn’t it, but which is the most painful?” (Male, age 
71, reported previous cancer symptom) 
 
Most participants understood that smoking was a major cause of lung cancer and discussed 
people in the community who were smokers with a diagnosis of lung cancer. However, this 
was often qualified with statements such as “but she was a heavy smoker” (Female, age 66, 
reported previous cancer symptom), potentially reflecting blame around smoking and stigma 
towards lung cancer. A few participants were unsure of the link between smoking and lung 
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cancer, giving examples of people they knew with a diagnosis of lung cancer who had never 
smoked or used to smoke, and demonstrating a lack of understanding of the risks associated 
with being an ex-smoker:   
 
“One of my mates have died from [lung cancer], but he wouldn’t quit his drinking, or 
his smoking so it’s partly his fault....” (Male, age 58, reported previous cancer 
symptom) 
 
“I used to smoke, but I used to think well she never smoked and she had cancer of 
the lungs, why do they say it’s always you know cigarettes that do it?  I thought 
because they say I don’t know whether it’s true, it’s there in everybody, but it sort of 
it gives it something for it to come out a knock, or an illness, or something you know 
to bring it out in you, I don’t know whether that’s true, I don’t know whether that’s 
a myth?  People say these things, but no that’s what I thought well, my father 
smoked up until he was 80, didn’t do him anything like that.” (Female, age 58, 
reported previous cancer symptom) 
 
I – “Do you know what might have caused the lung cancer? 
P- With my mother we put it down, she was in an accident and they say it takes a 
knock to bring it out, but I honestly don’t really know what can cause it, they say it’s 
smoking I know, but I honestly, I’ve known people who have smoked you know, all 
their life and I mean they’re still going at 90 years of age, so I really don’t think they 
can put it down to just smoking I think it’s gotta be something else as well 
I – Did your parents smoke as well? 
P- They did, but my mother had given up and my father had given up.  They’d given 
up for years and yet they both got it...” (Female, age 62, reported previous cancer 
symptom) 
 
4.4.3.5 Suggestion for intervention 
 
Participants suggested various interventions to encourage people in the community to visit 
the doctor with symptoms of cancer. Many participants suggested talks within the 
community at local coffee mornings, community centres, sheltered housing, in local clubs or 
schools. A few participants suggested leaflets containing cancer information or integrating a 
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storyline into a TV soap where one of the characters survives cancer to overcome fear 
associated with cancer as a death sentence. Participants thought the intervention should 
include information about the symptoms of cancer and to include information to overcome 
fear of cancer using positive language to “be careful not to frighten people” (Female, age 60, 
no cancer symptoms reported). A few participants suggested using someone who had been 
diagnosed and survived cancer as part of the intervention:  
 
“I don’t know, leaflets?  I would just say general symptoms, you only have to, you 
could put various types of cancer on a leaflet and put their symptoms down 
underneath them and that’s it, that could help.” (Female, age 71, no cancer 
symptoms reported) 
“I don’t see why they shouldn’t have a community centre where once a month 
somebody came along to tell you about cancer. I think people would be interested in 
that, because they’d be treated to teas and coffee there and cakes and they’d say 
‘I’m having a day out’.” (Female, age 70, reported previous cancer symptom)  
“Just to talk about it, try to reassure people, try to reassure them… if you done one 
here and then send a few leaflets around and say we’re having a meeting in the 
centre in the coffee morning everyone is welcome to come and have a talk about 
it…I know my friend would turn up.” (Male, age 58, reported previous cancer 
symptom) 
 
4.5 Discussion  
 
This study was the first to explore cancer symptom knowledge, beliefs about cancer and 
barriers/facilitators to cancer symptom presentation using qualitative methods among 
people from a low socioeconomic group based on multiple indicators. There was evidence to 
suggest that knowledge of cancer (Capability), and fearful and fatalistic beliefs (Motivation), 
where participants associated cancer with inevitable death, were usually formed and 
reinforced by witnessing family and friends suffer and often die from cancer (Opportunity). 
The combination of fearful and fatalistic beliefs (Motivation) was reported to prolong cancer 
symptom presentation among low socioeconomic groups. In contrast, those who held 
positive beliefs about the benefits of early diagnosis (Motivation) could quickly overcome 
any reported practical and service barriers for ‘red flag’ symptoms following accurate 
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symptom appraisal (Capability). However, non-specific symptoms were not recognised by 
most participants as symptoms of cancer and were usually attributed to symptoms of other 
co-morbid illnesses (Capability). For those with non-specific symptoms, priorities such as 
work commitments (Opportunity) were often more influential on the individual’s decision 
about whether to seek help with these symptoms, in turn prolonging symptom presentation. 
Using the lay system of healthcare (Pescosolido and Boyer, 1999) to discuss symptoms with 
family members or friends before visiting the doctor was the norm for participants, and was 
considered common within the community (Opportunity), to decide whether a medical 
appointment was necessary. Disclosure of symptoms could prolong or prompt symptom 
presentation, depending on the nature of advice received (Opportunity).  
 
Findings from this qualitative interview study confirm those of previous studies which 
involved participant samples with varied socioeconomic characteristics reported in a 
systematic review in Chapter 3 (McCutchan et al, 2015; Appendix 1). In addition, findings 
from this study support the assumptions of the NAEDI framework (Hiom, 2015) and offer 
insight into how the factors identified by the NAEDI framework might influence the 
relationship between socioeconomic group and prolonged cancer symptom presentation. 
Poor knowledge of non-specific cancer symptoms (Low et al, 2013; Brain et al, 2014), fearful 
and fatalistic beliefs about cancer (McCaffery et al, 2003; Chonjnacka-Szwalowska et al, 
2013) and emotional barriers to cancer symptom presentation (Robb et al, 2009; Simon et 
al, 2010; Low et al, 2013) were identified as more prevalent among low socioeconomic 
groups in the systematic review (McCutchan et al, 2015; Appendix 1) and are supported by 
the findings from this study. Through using qualitative methods, insight and possible 
explanations for these findings were gained by exploring the wider social context 
(Opportunity) that is specific to low socioeconomic groups, and how this might influence 
cancer symptom presentation. General fatalistic attitudes were common, with individuals 
believing themselves to have little control over daily life or their fate, and are likely to 
contribute to feelings of helplessness or disempowerment. Consequently, there was a 
reluctance to change risky health behaviours, and the potential for individuals to deny or 
ignore health problems. For some, this extended to cancer-specific fatalism in which 
symptom presentation was prolonged because cancer was always believed to be a fatal 
disease. Experiences of cancer in the community were more influential on the formation and 
maintenance of such beliefs than media items, despite campaigns and news items 
promoting advances in treatments and improved cancer survival. Witnessing poor cancer 
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outcomes among family members and friends in the immediate social environment which 
counter media claims, combined with mistrust of official information sources, may 
contribute to the prevalence of fatalistic beliefs in deprived communities (Lyratzopoulos et 
al, 2015a; Quaife et al, 2015a). 
 
Lung specific findings suggest that lung cancer is conceptualised as a ‘bad’ cancer, where 
treatment options are limited and ineffective. Such beliefs are likely to contribute to fear of 
a diagnosis of lung cancer and reluctance to present to the GP with symptoms. Findings from 
a lung screening study suggested that smokers from a low socioeconomic group commonly 
hold the belief that the lungs cannot be removed, as they are a vital organ, and are therefore 
untreatable (Quaife et al, 2016a), which could explain findings relating to beliefs about 
treatment. There was evidence of the stigma attached to lung cancer, where a diagnosis of 
lung cancer was qualified with statements around smoking behaviour, suggesting diagnosis 
in smokers was self-inflicted. Stigma surrounding lung cancer is likely to prolong cancer 
symptom presentation (Chatwin and Sanders, 2013; Corner et al, 2005; Corner et al, 2006; 
Tod et al, 2008; Chapple et al, 2004). In addition, there was confusion about risk associated 
with smoking and lung cancer, where participants appeared to misunderstand that ex-
smokers were at heightened risk for lung cancer, which has the potential to prolong 
symptom presentation.  
 
Wider community influences on behaviour could indicate issues that are specific to low 
socioeconomic groups and have the potential to explain the disparities in cancer outcomes 
among socioeconomic groups through prolonged cancer symptom presentation. For 
instance, people from a high socioeconomic group are less likely to experience economic 
hardship in a similar way to people from a low socioeconomic group, such as choosing 
between heating the house and feeding the family.  Competing priorities such as the 
stresses of day-to-day living and work commitments, particularly when employed on a zero 
hours contract where no pay can be received for sickness or going to the GP, are likely to be 
more salient among low socioeconomic groups. When symptoms are vague or dismissed as 
normal in the context of other pre-existing co-morbidities, these competing priories are 
likely to take precedence over a visit to the GP.   
 
Once an individual has overcome the barriers associated with getting to an appointment, 
there was evidence of further obstacles to full and effective disclosure of symptom concerns 
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at a service and organisational level. Not being able to communicate symptom concerns 
effectively (Capability) in a time limited appointment, and reported policies that preclude 
discussion of more than one symptom during a consultation (Opportunity), are likely to limit 
presentation of a cancer symptom. This is especially likely for those who present with 
another health complaint to ‘test the water’ before disclosure of a worrying or embarrassing 
symptom, potentially prolonging disclosure of symptoms (Andersen and Vedsted, 2015).  
 
Findings relating to beliefs about cancer translating into either immediate or prolonged 
symptom presentation might be explained by Type I and Type II responses to symptoms 
(Khaneman, 2011; Epstein, 1994). All participants experienced an initial fearful, highly 
emotive response when asked to think about cancer as a disease (Type I response; 
Automatic Motivation), potentially reflecting a community wide response to cancer. 
However, after consideration, some participants expressed positive beliefs about the 
benefits of early diagnosis, which could represent participants using their slower, more 
conscious appraisal processes (Type II response; Reflective Motivation). The latter response 
may prompt symptom presentation, with fear of a late diagnosis of cancer and perceptions 
of self-efficacy around knowing what to do with a symptom and the ability to discuss 
concerns motivating the individual to seek medical help quickly (Robb et al, 2014). 
Consulting family and friends to discuss symptoms before visiting the doctor was perceived 
to be the norm in the community. A previous study found that those from lower 
socioeconomic groups were more likely to prolong cancer symptom presentation after 
disclosure of symptoms to a family member or friend (Li et al, 2012). There was evidence of 
poor knowledge and negative beliefs about cancer among low socioeconomic groups. 
Therefore it is likely that people from a low socioeconomic group who seek symptom advice 
from family or friends could receive poor quality advice and prolong symptom presentation.  
 
4.5.1 The COM-B Model  
The COM-B model (Michie et al, 2011) appeared highly applicable in the context of cancer 
symptom presentation behaviour, allowing exploration of how individual cognitive and 
affective processes and the wider social context influence behaviour. The model currently 
represents a bi-directional influence of Capability, Opportunity and Motivation on Behaviour 
and suggests that both Capability and Opportunity influence Motivation. However, this study 
also found that knowledge of the causes of cancer and symptoms of cancer (Capability) was 
influenced by the experiences of other people within their social network who have had 
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cancer (Opportunity) (Michie et al, 2011). This interaction is not currently represented in the 
COM-B model, and could be explored in future research into the social determinants of 
cancer help seeking behaviour.  
As discussed in Chapter 2, although the COM-B model was selected as the most 
comprehensive of all the theories and models identified, it was not underpinned by the 
Common Sense Model of Illness Self-Regulation (CSM; Leventhal et al, 1980). Since the CSM 
is a model of illness representations, the COM-B model does not explicitly attempt to explain 
how symptoms are attributed and illness inferred, although the TDF domains underpinning 
the Capability construct of the COM-B model are implicitly linked to symptom 
interpretations. Therefore, analysis of symptom interpretations was potentially restricted 
and is a limitation of the model.   
4.5.2 Strengths and limitations of the study 
This study used in-depth qualitative interview methods which enabled a rich insight into the 
influences on cancer symptom presentation among people from low socioeconomic groups. 
In addition, this study used multiple individual and group level indicators of socioeconomic 
group to overcome some of the issues associated with reporting single group or individual 
level indicators. However, although participants in the present study were representative of 
a low socioeconomic group, they were sampled from a database of participants who had 
previously engaged in research about cancer and the study was framed around cancer. 
Therefore those who agreed to take part in the study may not be representative of a 
community who are fearful of cancer and more likely to prolong symptom presentation. To 
overcome these limitations, questions were asked about community norms to gain an 
understanding of knowledge, beliefs and barriers to symptom presentation from a 
community perspective. Eight participants were recruited through snowball sampling due to 
low response rates through the ICBP database. Snowball sampling is often criticised for 
problems associated with representativeness through selection bias (Van Meter, 1990), 
however it is commonly used as a method to engage ‘harder to reach’ populations (Faugeier 
and Sargeant, 1997). Snowball sampling and recruitment of participants through community 
partners were useful methods for engaging a group of individuals who might otherwise not 
have engaged in this research study. However, there were no data available for the numbers 
of individuals approached, therefore response rate or reasons for refusal are unavailable.  
There are limitations associated with telephone interviews due to problems of building 
rapport and depth of analysis, since there was no opportunity to see the context in which 
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the participant lives. Interviewing two people at the same time also has its limitations, 
where certain information may be withheld by participants, particularly for a sensitive 
subject such as cancer, or one participant may dominate the interview (Kendall, 2009). 
However, telephone and dual person interviews were conducted only when necessary due 
to superstitions, disability, geographical distance or lack of space in the house. Without the 
flexibility of allowing individuals to participate on the phone or be interviewed as a pair, 
these individuals could not have been included in the study.   
There are limitations in the use of retrospectively recalled barriers to cancer symptom 
presentation, where memory might bias recall, or hypothetically anticipated barriers, where 
intentions might not reflect actual symptom presentation behaviour. Study designs 
exploring barriers to symptom presentation in a community sample who disclose symptoms, 
without mention of cancer, could overcome these limitations (Low et al, 2015; Whitaker et 
al, 2015).  
Finally, when approached to take part in the study, participants were unaware that they 
were being selected on the basis of socio-demographic group indicators. Following 
discussion with supervisors and ethical committee review, the decision to remove any 
information from study materials to indicate that participants were being selected because 
of area of residence and educational attainment was made. However, there are ethical 
implications associated for withholding information about why participants were being 
selected for the study, in relation to the extent to which participants can provide full 
informed consent.  
4.5.3 Implications for a cancer awareness intervention 
Findings from the systematic literature review (McCutchan et al, 2015; Chapter 3) and 
qualitative interviews (McCutchan et al, in press) have allowed a greater understanding of 
the barriers to cancer symptom presentation, aiding the development of a targeted 
intervention to encourage earlier presentation in people from deprived communities. An 
intervention targeted at low socioeconomic groups should take into account the wider 
influences on symptom presentation behaviour within social networks to encourage earlier 
cancer symptom presentation. Such interventions could use the strong social networks 
within the community to increase community wide knowledge about non-specific cancer 
symptoms, challenge negative beliefs surrounding cancer, and reinforce positive messages 
about the benefits of early diagnosis and advances in modern treatments. An intervention 
should seek to empower people, perhaps through offering strategies to overcome reported 
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barriers to symptom presentation and an aid for communication problems during a 
consultation. This could be delivered through a community based educational programme or 
leaflet based intervention.  
 
4.5.4 Conclusion 
 
Cancer symptom presentation behaviour among low socioeconomic groups is influenced by 
both individual and wider socio-environmental factors. Interventions which aim to improve 
symptom knowledge (Capability), modify negative beliefs (Motivation) and take into account 
the wider influences on behaviour (Opportunity) might be able to encourage earlier cancer 
symptom presentation behaviour among socioeconomically deprived groups. The following 
chapter will report findings from a focus group study with members of the public and local 
stakeholders who live or work in deprived communities. The study aims to provide 
additional insight into community norms and the wider socio-environmental influences on 
cancer symptom presentation behaviour.  
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Chapter 5 
Factors influencing cancer symptom presentation in deprived communities: a focus 
group study with members of the public and local stakeholders 
5.1 Chapter overview 
This chapter reports the results of a focus group study with members of public and local 
stakeholders (healthcare professionals and community partners) who live or work in 
deprived communities. The focus groups explored the influence of the wider social 
environment and other factors which might influence timely cancer symptom presentation 
in deprived communities. In the public focus groups, a cancer symptom attribution task was 
used to understand in greater detail how symptom interpretations might influence an 
individual’s decision to seek medical help. Findings from the focus groups and the 
implications for a cancer awareness intervention will be discussed.  
5.2 Introduction 
Understanding the factors which influence timely cancer symptom presentation is essential 
to developing effective interventions designed to overcome the barriers to symptom 
presentation and facilitate timely cancer symptom presentation, ultimately to promote 
earlier diagnosis of cancer. This is particularly important in socioeconomically deprived 
communities where cancer is often diagnosed at an advanced stage.  
Findings from a systematic review (McCutchan et al, 2015, Appendix 1) and qualitative 
interviews (McCutchan et al, 2016) described in Chapters 3 and 4 support the assumptions 
of the NAEDI hypothesis outlined in Chapter 1. These studies begin to offer useful insights 
into how knowledge, beliefs, and barriers to symptom presentation influence the decision to 
present to the doctor with a symptom of cancer.  In addition, the influence of socioeconomic 
factors on symptom presentation behaviour was explored in these studies to understand the 
factors underlying prolonged cancer symptom presentation among low socioeconomic 
groups. Lower cancer symptom knowledge, a higher prevalence of fearful and fatalistic 
beliefs about cancer, and barriers such as difficulty with communicating symptoms during a 
consultation and problems with getting to an appointment were found among low 
socioeconomic groups in the studies described in Chapters 3 and 4. These factors in 
combination were considered to prolong cancer symptom presentation in low 
socioeconomic groups.  
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In the qualitative interview study described in Chapter 4 (McCutchan et al, 2016), there was 
an indication that opportunities afforded by environmental circumstances in low 
socioeconomic groups were associated with the formation of knowledge and beliefs about 
cancer. In addition, there was evidence to suggest that environmental opportunity was likely 
to create some of the reported barriers to cancer symptom presentation such as lack of 
transport to an appointment. Furthermore, there was evidence to suggest that social 
networks had the potential to attenuate or facilitate the decision to seek medical help for a 
symptom, where discussing symptoms with family members and friends was the norm. 
Good advice was considered to prompt symptom presentation, whereas poor quality advice 
was likely to prolong symptom presentation. However, it remains unclear how symptoms 
are discussed within the community, what advice is given, and how the quality of advice 
might influence the decision to seek medical help. In addition, a broader understanding of 
the day-to-day environmental issues in deprived communities is required, and how these 
might influence symptom presentation among individuals living in deprived communities.  
To date, all studies in this PhD have focused on symptomatic or asymptomatic individuals 
seeking medical help for actual or hypothetical symptoms. All papers included in the 
systematic review described in Chapter 3 were from the patient perspective, and the 
qualitative interviews described in Chapter 4 were carried out with members of public from 
low socioeconomic groups. Local stakeholders who work closely with people in deprived 
communities are likely to offer an alternative perspective and could confirm previous 
findings, or provide new insights and explanations for mechanisms underlying prolonged 
cancer symptom presentation behaviour. It was therefore considered useful at this stage to 
involve local stakeholders (healthcare professionals and community partners) who work in 
deprived communities reflecting on barriers to cancer symptom presentation. In addition, 
how symptoms are attributed and evaluated by members of the community and the speed 
at which medical help might be sought for symptoms is unclear. Therefore, members of the 
community were included to understand these and other factors influencing cancer 
symptom presentation in a focus group setting.  
5.2.1 The Awareness and Beliefs About Cancer study 
 
The focus groups were conducted as part of an aligned study funded by Cancer Research UK, 
the Awareness and Beliefs About Cancer study (ABACus; Smits et al, 2016). ABACus is an 
ongoing study at Cardiff University involving the development and evaluation of the Tenovus 
 
 
133 
 
health check intervention. The health check is a touch screen questionnaire, designed to 
modify cancer risk behaviours, raise awareness of the symptoms of cancer and pick up any 
cancer symptoms the individual may have. The health check asks a series of questions about 
lifestyle factors such as smoking and diet, followed by symptom questions such as ‘Have you 
noticed any blood in your poo?’. Following completion of the health check, the individual is 
given their results both printed and verbally in a one-on-one session with a trained lay 
health check advisor. The individual is encouraged to visit the doctor with any reported 
symptoms and given information on what symptoms to look out for in future including 
advice on what to do should they have a symptom in the future.  
 
Tenovus Cancer Care is a Welsh based cancer charity committed to supporting those with 
cancer in the community who are in greatest need and working with work communities to 
develop and deliver innovative cancer prevention programmes. Much of their work is 
focused in deprived communities in Wales, such as Communities First areas. The Tenovus 
health check is one example of this. Focus groups were conducted for the ABACus study with 
healthcare professionals and community partners working in deprived communities and 
members of the public living in deprived communities. The aim of the focus groups was to 
understand the influences on cancer symptom presentation in deprived communities and to 
offer feedback on the Tenovus health check. The PhD researcher supported the Research 
Associate on the ABACus study in the development of the topic guide for the local 
stakeholder focus groups (healthcare professionals and community partners) and co-
moderated the local stakeholder focus groups. The PhD researcher developed and refined 
the topic guide for the members of public focus group, recruited participants into the 
members of public focus groups and lead moderated the members of public focus groups. 
All data were analysed by the PhD researcher independently of the ABACus study.  
 
5.3 Focus group methodology  
 
A focus group is designed to facilitate discussion around a certain topic in an informal 
manner, replicating an everyday conversation (Green and Thorgood, 2011 p.127). Typically, 
a group of six to twelve participants who have not previously met are selected according to 
inclusion criteria, and invited to take part in a focus group. During the focus group, a 
facilitator guides participants through a list of topics using open ended questions, prompting 
participants to discuss topics as a group. The facilitator should endeavour to create an 
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environment where everyone feels comfortable to participate in discussion. In health 
research, focus groups are most commonly used for evaluating health interventions, 
although they have been used as a method for understanding cultural norms around health-
seeking behaviour (Larkey et al, 2001).  
Whilst one-on-one interviews are useful to understand individual views and stories, 
particularly when discussing a sensitive topic like cancer, focus groups can be beneficial to 
gain insight into the views of multiple participants in a relatively short space of time. The 
overall aim of a focus group is to reach group consensus about a certain topic (Wilkinson, 
1998), and can also be helpful to identify incongruent views within the group. Gaining 
multiple views and assessing the group dynamic through the extent to which participants 
agree or disagree with one another can be useful to understand the cultural norms of a 
group. Focus groups are considered one of the best methods for accessing and collectively 
teasing out shared group norms (Bloor et al, 2001, p.6), and can be used alongside 
qualitative interviews to clarify previously discussed topics. Therefore, focus groups were 
selected to build upon the findings from the individual qualitative interviews described in 
Chapter 4 to gain further insight and clarity regarding the factors affecting cancer symptom 
presentation in deprived communities.  
Although there are benefits of using group discussion to understand group norms, there is 
the potential for discussion during a focus group to be dominated by a certain participant(s) 
within the group. When participants are from different socioeconomic groups, those from a 
higher socioeconomic group are more likely to dominate discussion (Green and Thorgood, 
2011 p.137). Therefore, for this study, separate focus groups were conducted with 
healthcare professionals, community partners and members of public to facilitate a relaxed 
atmosphere and discussion among participants.  
5.4 Method 
5.4.1 Participant recruitment  
Six focus groups were conducted across two health boards in South Wales (Cwm Taf and 
ABHUB). Focus groups were conducted with people living or working in deprived 
communities, defined as ‘Communities First’ area.  
Three focus groups were conducted in each health board and were grouped by members of 
public (males and females over the age of 40 living in a Communities First area), healthcare 
professionals (General Practitioners, GP practice nurses, GP practice managers, community 
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pharmacists and public health consultants working in a Communities First area) and 
community partners (housing association workers, Communities First workers and other 
community-based workers working in a Communities First area).  
Potential healthcare professional and community partner focus group participants were 
identified by two of the ABACus study collaborators working within in each of the health 
boards. Healthcare professionals and community partners who were interested in taking 
part in the study were contacted by telephone or email with information about the study, 
and were invited by the Research Associate to take part in the study. A date and time for the 
focus group was arranged for those who wanted to take part in the study.  
Participants for the members of public focus groups were identified through the participants 
who took part in the community partner focus groups. Those who took part in the 
community partner focus groups were contacted by the PhD researcher and asked to 
identify potential participants to take part in the study. Recruitment procedure varied per 
community partner. Some community partners identified members of public and requested 
permission for their contact details to be passed on to the PhD researcher, where potential 
participants were contacted by telephone and invited to take part in the study. Written 
information was posted to those who were interested in taking part and a time and date for 
the focus group was arranged. Other community partners preferred to personally invite 
people to take part in the study according to the inclusion criteria using a pre-arranged date 
and time for the focus group. In this case, written information was posted to the community 
partner and they were asked to pass it on to potential study participants.  
5.4.2 Procedure 
The study was ethically approved by the National Research Ethics Committee (NRES) 
Research Ethics Committee (REC reference no 14/NW/1104, see Appendix 12). All 
participants provided written informed consent to take part in the study and were reminded 
about group confidentiality. All focus groups were audio-recorded with permission.  
The first half of the focus group involved exploring the influences on cancer symptom 
presentation in deprived communities. In the second half, participants were given a 
demonstration of the Tenovus health check, and asked for their feedback on the health 
check. A semi-structured topic guide was used to facilitate discussion of similar topics across 
groups and allow issues of importance to emerge. The PhD researcher co-moderated the 
local stakeholder focus groups and lead moderated the member of public focus groups. 
 
 
136 
 
Participants were reimbursed for their time or were offered a high street shopping voucher 
to thank them for taking part in the study. All travel expenses were reimbursed. Following 
each focus group, a summary of the main points was sent to participants for approval (see 
Appendix 13 to 18 for summaries).   
5.4.3 Topic guide  
Topic guide development for the first half (influences on cancer symptom presentation) was 
guided by findings from the systematic review described in Chapter 3 and the qualitative 
interviews with people from deprived communities in Chapter 4 to identify which topics 
required further exploration. Focus group topics were aligned with each of the COM-B 
(Capability, Opportunity, Motivation Behaviour) model constructs (Michie et al, 2011) to 
facilitate analysis of data. Topics included: health and cancer as a priority in the community, 
cancer symptom presentation behaviour, barriers/facilitators to prompt cancer symptom 
presentation, symptom disclosure within the community and current cancer awareness 
campaigns in the community. Please see appendix 19 and 20 for topic guides.   
For the local stakeholder focus groups, participants were asked to discuss each topic in 
relation to the local community. The topic guide was modified for the members of public 
focus group to reflect the focus on the individual rather than the community. In the 
members of public focus groups, participants were asked to collectively recall any symptoms 
of cancer they knew and their responses were written onto individual flash cards to be used 
later in the focus group for a symptom attribution task. During the symptom attribution task, 
participants were asked to rank the symptoms in order of how long it would take them to 
seek medical help for the symptom from the fastest to the slowest. Participants were asked 
to discuss why they would seek help in this time frame and what they might consider the 
symptom to be in the first instance. In the second half of the focus group, participants 
viewed a demonstration of the health check, and were asked for their feedback on the 
health check. The PhD researcher supported the development of the topic guide for the local 
stakeholder groups and initially developed and refined the topic guide for the members of 
public focus groups.  
5.4.4 Analysis  
Data relating to the health check intervention evaluation were not analysed as this was not 
directly relevant to the aims of the PhD. Data relating to influences on cancer symptom 
presentation behaviour among deprived communities in the first part of the focus group 
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were analysed using framework analysis (Ritchie & Lewis, 2003). Framework analysis was 
selected as most appropriate in this context due to the data charting stage and depth of 
analysis. Whereas other qualitative data analysis method such as thematic analysis do not 
include charting of data, framework analysis involves production of a matrix which 
summarises focus group data per theme, and was considered a key benefit to the PhD 
researcher to facilitate comparisons of data across focus groups. Furthermore, framework 
analysis provides a deeper level of analysis in comparison to thematic analysis which was 
useful for this study. In addition, the framework can be developed around existing theory, 
unlike other qualitative analysis methods which take a more inductive approach such as 
grounded theory (Charmaz, 2006, p.2). As discussed in Chapters 2 and 4, the COM-B model 
was identified as useful for understanding cancer symptom presentation among low 
socioeconomic groups, and will be used with the Behaviour Change Wheel to guide 
intervention development. Therefore, the analytical framework was based around each of 
the COM-B model constructs to aid interpretation of findings and intervention mapping 
using the Behaviour Change Wheel (Michie et al, 2011).   
Themes were generated from the transcripts and grouped under each of the COM-B model 
constructs (Capability, Opportunity and Motivation) (see Appendix 21 for coding 
framework). The Theoretical Domains Framework (TDF; Cane et al, 2012) was used to 
provide a more granular level of understanding of each of the COM-B model constructs to 
facilitate grouping of themes. Once themes were grouped, supervisors checked the 
framework to ensure themes were placed under the appropriate COM-B model construct. 
Coding of data was managed using the qualitative analysis software package NVivo 10 
(NVivo 10, 2012). Summaries of the content of each theme per focus group were charted 
under each of the COM-B model constructs, supported by Microsoft Excel (see Appendix 22 
for an example). Framework analysis typically involves charting of data per participant; 
however, for this focus group study, data were charted according to focus group rather than 
for each individual participant. Data were charted in this way because themes were rarely 
discussed by all participants within the group; therefore, comparisons across groups rather 
than individual were considered to be most useful. In addition, the present study was 
concerned with understanding views across three different groups of individuals: members 
of public, healthcare professionals and community partners. Therefore, themes were 
summarised per focus group to facilitate analysis and interpretation of data analysis 
according to participant group.  
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5.5 Results 
The focus groups were conducted between November 2014 and March 2015 and ranged 
from 64 to 82 minutes in length. A total of six focus groups were conducted in total: two 
with healthcare professionals (n=6 participants and n=8 participants), two with community 
partners (n=8 and n=6) and two with members of public (n=6 and n=8). See Table 5.1 for 
focus group characteristics.   
Table 5.1 Focus group characteristics 
Health board 1  Health Board 2  
Healthcare professionals (n=8) 
(3 GPs, 1 GP Clinical Director, 1 community 
pharmacist, 1 practice manager, 1 Public 
Health Wales Consultant, 1 nurse) 
Healthcare professionals (n=6) 
(2 GPs, 1 Neighbourhood Care Network 
(NCN) lead, 2 Public Health Wales 
Consultants, 1 nurse) 
Community Partners (n=6)  
(3 Housing Association, 2 Communities First 
health leads, 1 Public Health Wales 
Screening)  
Community Partners (n=8)  
(2 Housing Association, 2 Communities First 
health leads, 2 Communities First staff, 1 
Community development worker, 1 adult 
community learning project coordinator)  
Members of public (n=8) 
(6 female, 2 male aged 40+)   
Members of public (n=6) 
(4 female, 2 male aged 40+)   
 
Key themes are presented under each of the COM-B model constructs (Capability, 
Opportunity and Motivation), with quotes as examples. Themes included: symptom 
attributions, communicating symptom concerns, appointment policies, crisis point care, a lay 
system of healthcare, heath norms and expectations, community interventions, fear and 
avoidance, and cultural barriers. Square brackets within the quotes represent inserted text 
to allow for clarification of the topic content. Irrelevant speech has been removed from the 
text for brevity, denoted by ‘…’.  
 
5.5.1 Capability 
5.5.1.1 Symptom attributions 
A few of the members of public could not recall any symptoms of cancer and some 
participants only knew lumps and bleeding as symptoms of cancer. Other participants could 
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recall many symptoms of cancer.  Rare or vague symptoms such as skin like orange peel and 
headaches were discussed in terms of family members or friends who had experienced 
these symptoms prior to a diagnosis of cancer. The healthcare professionals and community 
partners thought that knowledge in the community for the non-specific symptoms of cancer 
such as tiredness was poor and was often dismissed as nothing serious or completely 
disregarded, thereby prolonging symptom presentation.  
Findings during the symptom attribution task reflect longer anticipated symptom 
presentation times for non-specific cancer symptoms (Figure 5.1), where lumps and bleeding 
were associated with the most prompt symptom presentation for both members of public 
groups. Non-specific symptoms such as headaches or tiredness were associated with the 
longest times to cancer symptom presentation. Discussion about these symptoms suggested 
that non-specific symptoms are often normalised and would be attributed to benign causes 
or other pre-existing co-morbidities such as diabetes or asthma. The members of public 
discussed rationalising symptoms and attributing them to acute conditions before 
considering more serious explanations. Symptoms which worsened or were completely 
unexplained were considered more serious and would prompt more timely presentation 
behaviour. Some of the symptoms associated with lung cancer were discussed by both of 
the members of public focus groups, but were discussed in terms of general symptoms for 
cancer rather than specific to lung cancer. The frequency and prevalence of coughs in the 
community was high, where having a cough is likely to be perceived as normal and was 
considered to be a symptom of other benign health problems, which is likely to prolong 
symptom presentation. Difficulty swallowing and coughing up blood were mentioned by one 
group and would prompt a visit to the doctor sooner, as these were perceived as more 
serious.  
“Mod: A cough 
P3- That’s low down too, most people cough on a regular basis. 
P5- We get so many coughs don’t you, you live with it …  
P2- You would, if that’s the timeline it’s going to be 4 weeks before you bother isn’t 
it, so it’s going to be lower down.  If I had difficulty swallowing I’d be more likely to 
go to the doctor quicker than I would if I coughed.” (Health board 1, members of 
public)  
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Figure 5.1 Symptom attribution task. Participants in the members of public focus groups were asked to rank the previously recalled symptoms of cancer in terms of the 
time in which they would anticipate seeking medical help for the symptom. Symptoms at the top of the figure are those which participants would anticipate seeking medical 
help most promptly for. Symptoms at the bottom of the figure are those which participants would anticipate seeking medical help slowest for. 
Health board 1 
No symptoms 
Skin colour 
Hair loss 
Tiredness  
Vomiting 
Anaemia  
Increase in passing urine 
Pneumonia  Cough 
Passing blood in urine 
or bowels 
Weight loss 
Lump 
Fastest/ 
immediate 
Slowest 
Quick changes  
Breathlessness 
Changes in 
digestive system 
Weight 
loss  
Skin 
lesions 
Unexplained 
changes  
Dizziness/double vision 
Headaches  Cough  
Lumps  
Difficulty passing urine  
Skin like orange peel 
Coughing up 
blood  
Difficulty 
swallowing 
Fastest/ 
immediate 
Health board 2 
Slowest 
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Healthcare professionals and community partners thought that most cancer symptom 
knowledge was gained from people within the community who had been diagnosed with 
cancer, and a limited amount of cancer knowledge was gained from media cancer awareness 
campaigns. A community partner thought it was unlikely that people in their community 
were interested in watching TV programmes with cancer related content such as Panorama 
or the news, so cancer knowledge was almost exclusively gained through family members 
and friends in the community who in most cases died from cancer. 
 
“If you are maybe an illiterate or virtually illiterate, you may have no interest 
whatever watching a news programme.  A lot of this kind of stuff, what's good, 
what's bad, is linked to news programmes and Panorama, those kinds of week in, 
week out. And if you are not watching them, you might never realise.” (Health board 
2, community partner) 
5.5.1.2 Communicating symptom concerns 
The healthcare professionals described that patients would rarely communicate concerns 
that their symptom might indicate cancer unless prompted to do so by the doctor. This was 
considered to reflect the patient’s hope that they might seek reassurance regarding the 
benign nature of symptoms. Healthcare professional participants who were GPs reported 
that patients would usually present with a cancer symptom as part of another consultation, 
often disclosing their symptom as they were leaving the consultation. This was referred to as 
the ‘door handle diagnosis’. It was felt that patients would present with another health 
complaint to assess whether they trust the doctor enough to disclose their cancer symptom 
at the end of the consultation. This reflects the community partners’ observations, where 
they discussed that people in the community were worried they would not be taken 
seriously or dismissed by the doctor if they presented directly with cancer symptoms.  
“P7- A few years ago, I had a gentleman come in with his blood pressure and we did 
a blood pressure review on him.  Just as he was going, he said, "Can you just have a 
look at this on my back?" He had a massive lesion, a huge lesion, and it was only as a 
side thing and lots of them do that.  They are worried underneath, but they just 
can't bring it out in the first bit.  
P8- I think they're testing you out as well to see whether they can trust you with 
their more important concerns, so they test you out with something really quite 
simple to see what they think of you and whether they can trust you, I think, and 
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whether they want to then tell you more personal things or whether they'll save 
those for somebody else.” (Health board 1, healthcare professional) 
The community partners reported that people in the community found doctors difficult to 
talk to and struggled to communicate symptom concerns effectively, especially during a time 
limited appointment. They recalled occasions where they or their colleagues had previously 
offered to attend an appointment with members of the community to help communicate 
symptoms. Some of the members of public reported using prompts during a consultation 
with the doctor, such as lists, to aid memory for discussion of symptoms.  
“[It’s] ten minutes per consultation. Well, the reality is some people might need 
longer than that because perhaps…they might struggle to explain themselves or 
need longer and they don't have that time. So they feel rushed and pressured which 
I think has a bearing on things as well.” (Health board 2, community partner) 
5.5.2 Opportunity 
5.5.2.1 Appointment policies 
Some GP surgery appointment booking procedures made accessing an appointment 
challenging for some members of the community. Community partners reported that some 
people in the community do not own a phone or were busy taking the children or 
grandchildren to school around the time when you are required to ring to book an 
appointment. These issues and long wait times for an appointment with their preferred 
doctor were considered to prolong symptom presentation, especially for non-specific 
symptoms which were often perceived as not serious. Community partners reported 
occasions when they had phoned the GP surgery on behalf of someone in the community to 
book them an appointment or to get an appointment quicker than originally booked, and 
could reflect problems with communication when booking an appointment. GP surgeries 
which opened for one or two evenings a week were described as helping with scheduling of 
an appointment. 
 
“P5- I think with the surgery I'm in, you've got to either be there or ring at 8.30 am.  
And I think a lot of our tenants, for whatever reasons, they won't be up and be in a 
position where they can be ringing in or visiting a surgery at 8.30 am to get an 
appointment.  It's just not possible for some of them. 
P4- Some of them don't have telephones. 
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P5- Exactly. They take the children to school or... 
P4- Pr they can’t get up in time or... 
P5- It’s very restrictive.” (Health board 1, community partner)  
Polices which preclude the discussion of more than one symptom during a consultation and 
time limited appointments were considered to prolong cancer symptom presentation for 
those who present with another health complaint to ‘test the water’ before disclosing a 
cancer symptom. These policies were also considered to inhibit disclosure of a cancer 
symptom for those who require an appointment with the doctor in order to receive their 
benefits, for example employment and support allowance (ESA). This is likely to take 
precedence over a symptom which might be perceived as nothing serious, and as a 
consequence it is unlikely these symptoms will be discussed.  
 “We've got very, very high levels of ESA [Employment and Support Allowance] and 
they tend to go to doctors just to make sure they stay signed off. So they go with the 
one issue. And as you said, you can't go with multiple issues. You've got that 
timeslot and you know, I'll be fine, kind of thing, until it all blows up.” (Health board 
1, community partner)  
 
5.5.2.2 Crisis point care  
Health was not perceived to be a priority or concern among the community, particularly for 
younger people, and was dealt with at the point of crisis. The healthcare professionals and 
community partners considered health in the community to be more about firefighting than 
prevention, where health problems are addressed in the short term once they become a 
problem, rather than through long term maintenance of health through lifestyle choices. The 
community partners discussed how health and maintenance of health is low in priority 
compared to some of the higher priority issues faced by people in the community, such as 
paying the bills, debt and housing problems. They suggested that people engage in 
unhealthy behaviours such as smoking to cope with the adversity of day-to-day living in 
deprived communities.  
 “P4- I think [for] most of the people, health is not a concern for a lot of the time 
unless it immediately becomes a massive concern…So a lot of the time we can 
struggle to get people to engage with their health and take responsibility about their 
health.  It is frustrating quite often, their health is perhaps seen as not a problem or 
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is our problem…But then something will happen and all of a sudden, they will 
become very, very concerned. 
P5- I think you also find we have a lot of them worried as well, so if anything is going 
on, they'll be the first to do it.  But you often find the people you really want to 
target won't take anything on until there is something seriously wrong with them.  
But that's a big problem with us. 
P3- I think there's a difference between maintaining health and when people come 
and see a doctor or a nurse, it's where they develop symptoms. So sometimes it's a 
bit too late for them...So as [name] was saying, there is a lot of worried well out 
there.  But it’s probably is driven by anxiety.  “Oh, my mother had cancer of the 
ovaries.  I've got it too.”  It's a lot of fear about that.  So health in general, people are 
not maintaining health.  They come in when they've got symptoms, sometimes 
when it's too late. And a lot are driven by anxiety, really. 
P2- I'd agree with that.  I think that it varies as well between different groups.” 
(Health board 2, healthcare professional)  
 
“P1-I think a lot of people, health is at the bottom of the pile because actually paying 
the bills and the housing and all the other things come first and they don't realise 
how that impacts on their health.  Do you know what I mean? For whatever reason. 
P4- I think they deal with their health problems when it becomes a crisis rather than 
looking at prevention, than dealing with the problem, basically.  Then look for 
assistance. 
P3- And it's constantly firefighting, isn't it?  It's not sort of saying, well, I need to go 
for a check-up.  We don't see that happening very often in the community.” (Health 
board 1,  community partner)  
5.5.2.3 A lay system of healthcare  
Consulting friends, family members and support workers for advice on symptoms before 
visiting the doctor was described as the norm in the community. Members of public 
reported seeking advice from individuals who were perceived as trusted and/or 
knowledgeable, such as elders or their spouse. The community partners and healthcare 
professionals suggested that this served the function of seeking reassurance about a 
symptom. They proposed that the quality of advice given was shaped by the advice givers’ 
previous experiences within the health service, where negative past experiences such as 
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pain or embarrassment during diagnostic testing were relayed to the individual seeking 
advice, and in turn prolonged their symptom presentation. Positive experiences within the 
health service resulted in good quality advice, and pressure from family members and 
friends to seek medical help following symptom disclosure was thought to accelerate the 
help seeking process. Sometimes the advice giver would falsely reassure the individual that 
there was nothing to worry about in order to minimise anxiety about symptoms, so 
symptom presentation was prolonged.  
 
“I'd say most of our tenants who've caught cancer early have been ones with 
support in place where there has been that support worker who's noticed subtle 
changes in behaviour... “Let me make an appointment for you, I'll come with 
you”…And that has pushed it along.  I think left to their own devices, a lot of our 
tenants, particularly the men...particularly older gentlemen who don't have family 
around, are on their own.  And quite often, I've found, in sheltered, is that they 
reach quite advanced stages of cancer before [diagnosis].” (Health board 2, 
community partner) 
 
“Mod- Do you think there is anywhere else they go with concerns about potential 
symptoms, other than to the GP? 
P- Their mother. 
P- The family.  Family and friends. 
Mod- Do you think that people would go to family and friends and then call it a day 
there? 
P- Sometimes. 
Mod- And do you think that's a problem?   
P- Yes.  Because you always get the one member who always knows, whatever test 
“It was horrendous.  Needle that big.  They do this to you and they do that to you.”  
You never hear the people who had the tests or the operations, I came through it 
lovely. Had a good time.  You always have eight or nine, had the most horrendous 
time.  “I wouldn't do that, I wouldn't have that done. Not for the life of me. Because 
I know somebody who had it done and they haven't been right since”.”  (Health 
board 2, healthcare professional)  
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5.5.2.4 Health norms and expectations  
The community partners and healthcare professionals discussed that perceptions of health 
were likely to be influenced by the health of individuals in the community or the health 
norms of their community. Health among those living in the community was generally 
considered poor. If poor health is the norm, they suggested that members of the community 
are more likely to expect poor health or normalise adverse health or symptoms. The 
members of public discussed feelings of disempowerment, which were considered to 
contribute to poor health in the community.  
 
“I think social networks, social norms are particularly pervasive in terms of people's 
health behaviours. And people's expectations of their own health and the health of 
their family depending on where they live.  So living in an area where there is 
relatively low life expectancy, high levels of premature mortality, everyone that you 
know has got a chronic condition, that's probably what you expect yourself.  So 
maybe there is a lack of motivation to make changes because it just seems, it's that 
external levels of control, you just think well, these things are outside of my control.  
That's how I'm going to end up.  I think it's very difficult for people to change if you 
ignore the context in which they live their lives.” (Health board 1, healthcare 
professional)  
5.5.2.5 Community interventions 
The community partners and healthcare professionals discussed a range of health 
promotion campaigns and initiatives which had previously been implemented in the 
community. Stroke and diabetes campaigns were considered successful, but smoking 
cessation campaigns were much less successful. One of the health boards ran a cough 
campaign to encourage people who had a cough for three weeks or more to go to the doctor 
with limited success. Those who presented to the GP with symptoms following the campaign 
were generally low risk for lung cancer and represented the “worried well”. However, the 
healthcare professionals reported that some people did present with symptoms following 
the campaign who were at a higher risk and may not have previously sought help.      
 
“We did a campaign…If you had a cough longer than three weeks, go to your doctor. 
I saw a huge number of people after that.  I think that really made a big 
difference…there was a proportion of them were worried well, that the non-
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smoking, healthy robust marathon running types who just had a bit of a tickle.  But 
there was a few that came that wouldn't have otherwise and I think that that's a 
good thing.” (Health board 2, healthcare professional)  
 
“If you talk to people about smoking…they tend to put the barriers up.” (Health 
board 1, community partner) 
 
Community partners discussed a need for clearer guidance and advice on which symptoms 
to consult the doctor for and when. The community partners and healthcare professionals 
suggested using social networks to spread the messages, using a role model or someone 
who has previously had cancer as a health champion within the community. The healthcare 
professionals thought it was important to promote the benefits of early diagnosis and 
advances in survival and the treatments for cancer.  
 
“If there were guidelines, say, for example, ‘if you've got a mole and you know you 
should go to the GP, it's wider than X number of millimetres’ or whatever, I think 
those kind of actual...  You can put a clear measurement on them, that will make 
somebody more likely to go…” (Health board 2, Community partner)  
 
5.5.3 Motivation 
5.5.3.1 Fear and avoidance 
Fear of a cancer diagnosis was considered a major barrier to presenting to the doctor with 
symptoms, particularly in the older members of the community. The community partners 
and health care professionals thought this reflected a deep-seated fear for cancer, where 
cancer was associated with death and unpleasant treatment side effects. Such beliefs were 
thought to reflect the high incidence of cancer related death in the community, where 
members of the public form an expectation of what cancer is supposed to be like based on 
experience, usually witnessing family members and friends suffer and die from cancer. Lung 
cancer diagnoses within the community were often diagnosed at late stage were palliative 
treatments were the only option, and as a consequence lung cancer was associated with 
fear in the community. The healthcare professionals thought that some people in the 
community understood some of the symptoms of lung cancer, but are too scared to present 
to the doctor with the symptom due to fear of a diagnosis.  
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“Most of our lung diagnoses that comes into us because I'm made aware of all the 
cancer diagnoses, most of the lungs go straight onto a palliative care register.” 
(Health board 2, healthcare professional) 
 
“I think particularly the elderly, they've seen [cancer] in the past, maybe 30 years 
ago people dying of cancer in really a horrific way and they've seen people not 
getting very good treatment and I think the elderly are really fearful of cancer and 
they'd rather not know.” (Health board 1, healthcare professional)  
 
The healthcare professionals suggested that those who suspect but fear a diagnosis of 
cancer might prolong symptom presentation in order to allow time to process the 
consequences of being diagnosed with cancer. For some, a diagnosis of cancer would be too 
much to consider in the context of other accumulating life problems and circumstances such 
as housing or money problems, and could result in avoidance or denial of symptoms as a 
strategy for dealing with symptom concerns. Similarly, mental health problems such as 
anxiety and depression were discussed by community partners and members of the public 
as factors that are likely to facilitate denial or avoidance of symptoms, or exacerbate fear 
and worry about a diagnosis of cancer.  
 “If you live in an area where you've got housing issues and debt problems and 
employment, then a cancer diagnosis is almost too... You can't take that on as well, 
with all these wider social problems.  Some people will almost put their head in the 
sand, ignore that, hope it goes away. Because they are dealing with just trying to 
survive, week on week. How am I going to pay the rent next week, I can't deal with a 
cancer diagnosis as well.” (Health board 2, Healthcare professional)  
 
“And I think it's avoidance, isn't it?  Not hearing things as well, not bothering, not 
going.  Not dealing with it. Because I don't want to know the result.  That it could be 
bad.  And I think people put off going for checks. I know I do.  Definite.  And it's 
stupid. 
P5- My brother was like that...“I don't want to go. I don't want to know.  I'd rather 
not know.”  It wasn't until we said, well, it could affect your children, because he's 
got two daughters.  And then he went, oh okay then, I'll go.” (Health board 1, 
members of public)  
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5.5.3.2 Cultural barriers 
The embarrassment associated with disclosure of symptoms and potential examinations and 
diagnostic testing was considered to be a barrier to symptom presentation. Healthcare 
professionals could recall asking patients about whether they had noticed symptoms such as 
blood in stools, but reported that only a minority of people check their stools for blood. 
These were considered to reflect cultural issues relating to embarrassment and could result 
in symptoms being missed by patients.  
 
“I never fail to be amazed when I ask people who come with abdominal symptoms-
suspected bowel cancer is where I'm leading to. And you ask them if they've seen 
any blood in their motions. And nobody ever seems to look at their motions when 
they go to the toilet.  “Oh, I don't... I've got that blue stuff in the toilet doctor, I can't 
see.  Oh, I never look at that.” You think, really?  Do you not look at it?” (Health 
board 2, healthcare professional) 
 
Mod- “Why was he put off going [for screening]? 
P5- The process, the camera, where they put the camera.  You know?   
Mod- Do you think that's quite a normal attitude?  Would you say that people...? 
P7- A lot of people think like that, don't they?” (Health board 2, members of public) 
 
5.6 Discussion  
This study aimed to gain further insight into the mechanisms underlying prolonged cancer 
symptom presentation among low socioeconomic groups through the perspective of local 
stakeholders and members of the community who live or work in deprived communities. 
The influences of the environment in which individuals live, symptom attributions, beliefs 
about cancer and how symptoms are communicated during a consultation were explored.  
5.6.1 Summary of findings 
Non-lump and bleeding symptoms of cancer were usually attributed to symptoms of pre-
existing co-morbidities or other acute conditions, and consequently there was no perceived 
urgency to seek medical help. Health and maintenance of health were not considered a 
priority in deprived communities and were considered a problem at the point of crisis. Poor 
general health in the community was perceived to be the norm rather than the anomaly, 
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and addressing basic needs and day-to-day living such as paying the bills were prioritised 
over health-seeking behaviours. Fear of cancer and its association with inevitable death and 
unpleasant treatment side effects were based on witnessing people in the community suffer 
and in most cases die from cancer. Negative fearful and fatalistic beliefs about cancer were 
associated with the longest time to cancer symptom presentation and were discussed in 
terms of their contribution to denial and avoidance of symptoms, particularly for those with 
carer responsibilities or those with mental health problems. Symptoms were often discussed 
with family members or friends for advice on what to do or to seek reassurance, which could 
attenuate or facilitate the decision to seek medical help for a cancer symptom.  
5.6.2 Findings in relation to previous research 
Findings from the present focus group study confirm and extend those of previous studies 
which have reported associations between low socioeconomic groups and poor knowledge 
of the non-specific symptoms of cancer and low suspicion of their association with cancer 
(Capability) (Brain et al, 2014; Robb et al, 2009; Whitaker et al, 2015a), a high prevalence of 
fearful and fatalistic beliefs about cancer (Motivation) (Quaife et al, 2015), problems 
associated with effective communication of symptoms during a consultation (Capability) 
(Chapter 4; Mccutchan et al, in press) and prolonged symptom presentation following 
disclosure of symptoms to family or friends (Opportunity) (Li et al, 2012). 
In this study, expectations of health were discussed in the context of what is perceived as 
normal in relation to the local community, where individuals compare their health against 
other members of the community and make assumptions about what is normal 
(Opportunity). According to the Common Sense Model of Illness Self-regulation (Leventhal et 
al, 1984), an initial unconscious assessment of whether a bodily change is normal or 
abnormal precedes a conscious assessment of the bodily change. If the bodily change is 
unconsciously assessed as abnormal, it is assessed consciously in relation to illness schemas, 
where the individual aims to seek a common sense explanation for symptoms (Leventhal et 
al, 1984). Perceptions of illness and symptoms are likely to be influenced by social and 
cultural factors. In a community with poor general health, where non-specific symptoms 
such as a cough are common, it is likely that such symptoms are interpreted in relation to 
the norms of the community and thereby dismissed as normal (Zola, 1966). For example, 
respiratory symptoms are more prevalent, but consultation behaviour is lower for 
respiratory symptoms among low socioeconomic groups, compared to high socioeconomic 
groups (Trinder et al, 1999; Trinder et al, 2000). It is possible that symptoms are perceived as 
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normal when judged against community norms rather than in isolation, thus considered to 
not require medical help (Trinder et al, 1999; Trinder et al, 2000). If symptoms are 
normalised in the context of symptoms which are highly prevalent in the community, 
symptoms could be misattributed and dismissed as normal (Capability), prolonging 
presentation of potential cancer symptoms.  
 
Consulting family members and friends or support workers for advice about symptoms prior 
to a visit to the doctor with a symptom was the norm in the community (Opportunity). This 
is likely to reflect the problems associated with getting an appointment with the doctor or 
concerns about being taken seriously, and perhaps the need to seek reassurance about a 
symptom. Disclosure of symptoms to a family member or friend has previously been 
associated with longer medical help seeking among low socioeconomic groups (Li et al, 
2012; McCutchan et al, 2016). The present study found evidence of the types of advice 
which might be given to individuals seeking help from lay members of the community, and 
how this advice might attenuate or facilitate the decision to present to the doctor with 
symptoms. Negative beliefs about cancer and previous negative experiences in healthcare 
were likely to influence the quality of advice given to individuals seeking advice on 
symptoms from a family member or friend and prolong cancer symptom presentation. 
Conversely, when good quality advice was given to an individual along with help booking an 
appointment and communicating symptom concerns during the appointment, symptom 
presentation was often accelerated and cancer was sometimes diagnosed in the early 
stages. 
Healthcare professionals reported that patients would often present with unrelated 
symptoms and disclose a cancer symptom at the end of a consultation or as they were 
leaving. Perhaps this is related to worry about not being taken seriously by the doctor, 
perhaps due to fear of being perceived as a hypochondriac or embarrassment associated 
with disclosure of symptoms, where symptoms are disclosed only once they have 
established that they can trust the doctor. Policies which preclude the discussion of more 
than one symptom during a consultation are likely to inhibit presentation of symptoms for 
these individuals. Furthermore, time limited appointments were considered to be 
problematic for people in the community who struggle with communication during an 
appointment, as they may feel pressured to remember or discuss all symptom concerns.  
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Through the involvement of local stakeholders who work in deprived communities, 
additional insight into the day-to-day challenges faced by individuals living in deprived 
communities and how these might affect cancer symptom presentation behaviour was 
gained (Opportunity). Seeking help for symptoms perceived as not serious (Capability) was 
not considered a priority for people in deprived communities whose priorities included 
addressing debt, paying the bills and housing issues (Opportunity). Maslow’s hierarchy of 
needs (Maslow, 1943) is a theory of human motivation to achieve certain needs and 
comprises of a hierarchy of five stages from the most basic needs (biological and 
physiological needs such as food, shelter and warmth) to the higher level needs (self-
actualisation needs such as self-fulfilment and seeking personal growth). According to the 
theory, progression on to the higher needs is difficult when the basic needs at the bottom of 
the hierarchy are not met (Maslow, 1943). In this study, there was evidence to suggest that 
these basic needs were not fulfilled for some members of the community, and could explain 
why these take precedence over cancer symptom presentation and addressing other health 
concerns. In addition, this might facilitate understanding for why some individuals enter a 
state of denial or avoidance of symptoms, where they might perceive that they cannot cope 
with a diagnosis of cancer, especially when the most basic of needs are yet to be fulfilled. 
The general struggles of day-to-day living were considered by local stakeholders to reflect 
the high prevalence of health damaging behaviours such as smoking in order to cope with 
the adversity of daily life, and reflect findings of previous studies (Wilkinson et al, 1997). 
Despite numerous efforts by local stakeholders to run smoking cessation and community 
campaigns to encourage people to quit smoking, these attempts were reported as 
unsuccessful or poorly attended. This is likely to reflect a general reluctance to quit smoking, 
therefore a cancer awareness intervention targeted at deprived communities should 
consider the exclusion of smoking cessation advice to encourage attendance.  
5.6.3 The COM-B model 
The analytical framework for this study was based on the COM-B model constructs (Michie 
et al, 2011). All COM-B model constructs (Capability, Opportunity and Motivation) were 
found to be applicable in the context of cancer symptom presentation behaviour, therefore 
the COM-B model provides a useful framework for understanding cancer symptom 
presentation behaviour among low socioeconomic groups. The model currently represents a 
bi-directional influence of Capability, Opportunity and Motivation on Behaviour and suggests 
that both Capability and Opportunity influence Motivation (Michie et al, 2011) which is 
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supported by the findings from this study. There was evidence from this study and the 
interview study previously described in Chapter 4 to suggest that Opportunity can influence 
Capability, for example previous experiences of witnessing people in the community 
influenced knowledge of cancer. This relationship is currently not represented in the model. 
In the context of cancer symptom presentation behaviour, the relationship between these 
two constructs (Capability and Opportunity) appears to be key and representation of this 
relationship should be considered in the model in this context.  
Where many other theories neglect to include the influences of the environment 
(Opportunity) on behaviour, the COM-B model takes the role of the environment into 
account. The inclusion of Opportunity in this analytical framework facilitated exploration of 
the influences of the environment on cancer symptom presentation behaviour. In this 
context, there was a strong influence of environment on cancer symptom presentation 
behaviour and on the other constructs (Capability and Motivation). However, the constructs 
were overlapping in their nature, therefore there were some themes had the potential to fit 
under multiple constructs. Deciding which construct to group each theme under was in 
some cases challenging, for example, the theme ‘health norms and expectations’ which is 
discussed under the construct Opportunity could also represent Motivation. 
5.6.4 Strengths and limitations of the study 
The strong theoretical underpinning from the study design through to analysis and 
interpretation of the data in this study was a strength. The use of the COM-B model as an 
analytical framework and relevance of the COM-B model in this particular context of cancer 
symptom presentation behaviour will facilitate development of the intervention with the 
Behaviour Change Wheel. Through qualitative methods, the factors influencing cancer 
symptom presentation which cannot be explored in depth using quantitative measures were 
identified, particularly the influences of the contextual factors (Opportunity) on behaviour.  
The inclusion of local stakeholders who work closely with members of the community was a 
strength of the study, since they were able to provide an alternative perspective on cancer 
symptom presentation behaviour in the community. There are methodological issues 
associated with obtaining proxy views from local stakeholders; however, findings were 
aligned with the members of public focus groups and confirmed findings in the interview 
study with members of the public described in Chapter 4. It could be considered 
paternalistic to include local stakeholders to gain their views on symptom awareness and 
 
 
154 
 
cancer symptom presentation behaviour for people in the community. However, through 
the inclusion of local stakeholders, a broader view of the influences on cancer symptom 
presentation behaviour such as the struggles of day-to-day living could be explored. In 
addition, local stakeholder could confirm previous speculations, for example it was 
speculated in the interview study that people who disclose symptoms at the end of a 
consultation do so to test the water. There was evidence from this study to confirm these 
speculations.  
There are limitations associated with participant recruitment and potential generalisability 
of findings. Participants were recruited opportunistically, therefore those who took part in 
the study could have a particular interest in cancer and may not be representative of the 
general population. In addition, only two sites in South Wales were included in this study, 
therefore findings may not be generalisable to other deprived communities. For example, 
findings relating to appointment policies might be specific to communities in South Wales or 
UK context, where other countries and health care systems might have a different approach 
to appointment policies. However, there were some findings which are likely to reflect 
problems faced by deprived communities universally. For example, individuals living in 
deprived communities are likely to face economic hardship regardless of where they reside 
geographically. Therefore, findings associated with competing priorities and money worries 
taking precedence over medical help seeking behaviour are likely to be generalisable to all 
other deprived communities.  
The members of the public were recruited through community partners, therefore there is 
the potential for selection bias where the community partners might select those in the 
community with a particular interest in cancer or were more motivated to take part. In 
addition, a focus group may attract individuals who are confident when speaking in a group 
or have particularly strong views; therefore, participants may not be fully representative of 
the general population. Recruitment of members of the public through community partners 
meant that there are no data on response rates or reasons for non-participation. In addition, 
the criteria for inclusion were over 40s who live in a Communities First area. No further 
demographic data were collected at the focus group, which has its limitations as only one 
area-level indicator of socioeconomic deprivation was used. Whilst Communities First areas 
are the most deprived communities in Wales, residence in these areas may not fully 
represent an individual’s current socioeconomic circumstances.  
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Involvement in the ABACus study provided a good opportunity to gather data in a focus 
group setting to understand the mechanisms underlying cancer symptom presentation from 
people who live or work in deprived communities. As a consequence, the PhD researcher 
was restricted by the aims of the ABACus study, therefore lung cancer specific findings were 
limited and only half the focus group was dedicated to understanding cancer awareness and 
cancer symptom presentation behaviour.  
5.6.5 Implications for intervention  
Findings from this study provide additional support for the strength of social networks as an 
influence on cancer symptom presentation, therefore social networks could be used to 
disseminate information and facilitate good quality advice following symptom disclosure. 
Previous attempts at health related campaigns within the community suggest that 
information needs to be tailored to those who are most at risk, to reduce the number of 
‘worried well’ presenting to the doctor with symptoms. Lessons learned from previous 
smoking cessation campaigns in the community suggest that the inclusion of smoking 
cessation advice in a lung cancer awareness intervention should be carefully considered, and 
perhaps excluded in order to increase attendance. Information on the significance of non-
specific symptoms of cancer, paired with clear guidance on when to present to the doctor 
with symptoms and information about the benefits of earlier diagnosis for lung cancer, are 
important and should be included in the content of the intervention.  
5.6.6 Conclusion  
Poor knowledge for the non-specific symptoms of cancer or dismissal of symptoms as 
normal in the context of other co-morbidities and fearful and fatalistic beliefs about cancer 
can prolong cancer symptom presentation in deprived communities. The day-to-day 
problems faced by individuals living in deprived communities are likely to facilitate denial of 
symptoms and reduce the motivation to seek medical help for symptoms. More research is 
needed to understand the barriers to lung cancer specific symptom presentation. The 
findings from this focus group study and the previous two studies will be mapped to the 
Behaviour Change Wheel for intervention development. Prior to this, a scoping review of all 
available cancer awareness interventions targeted at low socioeconomic groups is required 
to understand what interventions have been implemented in deprived communities and 
which have been successful for prompting cancer symptom presentation.  
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Chapter 6 
Scoping review of interventions to encourage timely cancer symptom presentation 
among low socioeconomic groups 
 
6.1 Chapter overview  
 
Findings from a scoping review of interventions designed to promote timely cancer 
symptom presentation among low socioeconomic groups across all tumour sites will be 
presented in this chapter. The types of intervention, their mode of delivery and content will 
be described. Where the interventions were evaluated and data are available, evidence will 
be presented regarding effects of the interventions on clinical outcomes, 
psychological/behavioural outcomes, intervention reach and cost-effectiveness. 
Interventions with a lung cancer focus will be extracted and discussed in addition to findings 
from all interventions. The scoping review findings will be discussed in terms of which 
interventions appear most promising for encouraging timely cancer symptom presentation 
among low socioeconomic groups, and the implications for developing a lung cancer focused 
intervention.  
 
6.2 Introduction  
 
Cancer awareness interventions designed to shorten the patient time interval and 
encourage symptomatic individuals to visit their GP promptly to discuss symptoms have the 
potential to enable cancer to be diagnosed at an earlier stage where the chances of survival 
are greater. As outlined in Chapter 1, this is particularly important for individuals in low 
socioeconomic groups who report the longest patient intervals and who are more likely to 
be diagnosed with cancer at a late stage (Macleod et al, 2000; Macleod et al, 2009; 
Lyratzopoulos et al, 2013).  
 
In 2009, a systematic review of interventions designed to increase cancer awareness and 
encourage timely cancer symptom presentation was conducted (Austoker et al, 2009). A 
total of 15 interventions were identified for analysis across a range of different cancer types, 
countries and participant demographics (Austoker et al, 2009). Two types of intervention 
were identified: individual-level interventions (n=5) and community-level interventions 
(n=10). Individual-level interventions were defined as those tailored or targeted at 
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individuals, for example a one-to-one interaction with a healthcare professional or a leaflet 
given or posted to a specified individual (Austoker et al, 2009). Community-level 
interventions were defined as interventions delivered to communities, such as media 
campaigns or leaflets distributed in a community setting or health club (Austoker et al, 
2009).  
 
All interventions in the Austoker et al (2009) review included an intervention evaluation. The 
review concluded that individual-level interventions were more effective for increasing 
cancer knowledge when information was tailored to the individual and when they were 
more intensive (Austoker et al, 2009). However, increases in cancer knowledge were not 
sustained long term (Austoker et al, 2009). There was no evidence for the effectiveness of 
individual-level interventions in promoting earlier cancer symptom presentation behaviour 
(Austoker et al, 2009). In contrast, community-level interventions showed limited 
effectiveness in increasing cancer knowledge, but there was evidence to suggest that 
community-level interventions could promote more timely symptom presentation and 
diagnosis of cancer (Austoker et al, 2009). However, due to limited evidence and 
heterogeneous evaluation methods, the authors concluded that it was unclear which type of 
interventions work best to increase cancer awareness and promote earlier cancer symptom 
presentation (Austoker et al, 2009). 
 
The ABC-DEEP rapid review was conducted in 2014 for interventions designed to increase 
cancer awareness or promote timely symptom presentation (Campbell et al, 2014) and to 
update Austoker et al’s (2009) review. Forty-three cancer awareness interventions for a 
range of different cancer types and participant demographics, and those which included an 
evaluation, were identified from database and grey literature searches (Campbell et al, 
2014). There was evidence of a short term effect of mass media campaigns such as TV and 
radio campaigns on symptom knowledge (Campbell et al, 2014). Interventions which 
adopted a multi-faceted approach, communicating intervention messages through various 
modes of delivery, were concluded to have the most potential benefit in terms of 
effectiveness, although there is a need for more robust evaluations to assess long term 
effects of interventions (Campbell et al, 2014).  
 
Both reviews only included interventions that were formally evaluated (Austoker et al, 2009; 
Campbell et al, 2014), and the Austoker et al (2009) review was restricted by systematic 
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review methods. Systematic review methods limit the type of intervention included, for 
example smaller local community based interventions are unlikely to be published in 
academic journals, and would consequently not be identified by the review. Although the 
ABC-DEEP review included grey literature searches, the Austoker et al (2009) review did not 
include grey literature searches, potentially excluding unpublished and pilot studies. In 
addition, the reviews did not focus on interventions targeted at a particular demographic 
such as ethnic minority groups or low socioeconomic groups, where cancer outcomes are 
known to be poorer. Therefore it is unclear which interventions were implemented in these 
‘harder to reach’ groups and which were most effective for promoting timely cancer 
symptom presentation behaviour.   
 
To date, no review of cancer awareness interventions has focused solely on those targeted 
at ‘harder to reach’ groups. This PhD is concerned with promoting timely cancer symptom 
presentation among low socioeconomic groups. Therefore, this scoping review will focus 
only on interventions targeted at individuals within low socioeconomic groups defined by 
individual indicators such as educational attainment or area level indicators such as 
deprivation scores calculated from postcode data.  
 
6.2.1 The Medical Research Council (MRC) framework 
 
Intervention development for this PhD follows the MRC framework for the development and 
evaluation of complex interventions (Craig et al, 2008). As outlined in Chapter 1, four phases 
of development are outlined by the MRC framework including a development phase, which 
highlights the importance of identifying the existing evidence base for ‘what is already 
known about similar interventions and the methods used to evaluate them’ (Craig et al, 
2008). In the absence of evidence from a review of cancer awareness interventions targeted 
at individuals in low socioeconomic groups, a scoping review was conducted and the findings 
used to contribute to intervention development reported in Chapter 7.  
 
6.2.2 Aims and objectives  
 
The present scoping review aimed to identify and describe interventions which seek to 
encourage timely cancer symptom presentation among low socioeconomic groups, 
irrespective of tumour site. There were three objectives of this review: (1) to extract data 
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according to who the intervention was targeted at, what type of intervention was used, how 
the intervention was implemented, and information regarding the content and delivery of 
the intervention; (2) where available, extract evaluation data regarding effectiveness in 
raising awareness of cancer, encouraging timely cancer symptom presentation, improving 
clinical outcomes and reaching those for whom the intervention was intended, and cost-
effectiveness; and (3) describe and critically appraise intervention evaluation methods.  
Findings from this review will be used to inform intervention development for a lung cancer 
awareness intervention targeted at low socioeconomic groups, described in Chapter 7. 
Whilst the focus of the current intervention is lung cancer, interventions targeted at low 
socioeconomic groups for other types of cancers are included in the present review. The 
decision to include all cancer types was made in order to identify the types of interventions 
that have been used in low socioeconomic groups and, where possible, to extrapolate from 
evidence regarding their effectiveness in the reported outcome domains.  
 
6.2.3 Scoping review methodology 
 
A scoping review methodology was selected because many cancer awareness interventions, 
particularly smaller interventions at community level, were unlikely to be published in peer-
reviewed academic journals. A scoping review involves the synthesis and analysis of a wide 
range of research and non-research material to map the existing evidence base (Davis et al, 
2009). Although the evidence is systematically collected, a scoping review allows the 
identification of evidence from heterogeneous sources including academic databases in 
addition to grey literature searches, search engines and key websites to identify both 
published and unpublished findings (Cacchione, 2016).  
 
Other review methodologies were considered too restrictive, for example a systematic 
review methodology involves searching databases for peer-reviewed and published articles 
only. In addition, a scoping review is less restrictive in terms of inclusion criteria and 
evidence is included regardless of quality to provide an overview of the current evidence 
base and identify gaps for future research (JBI, 2015; Arksey and O’Malley, 2005). Taking into 
account the aims of the present review, a scoping review was selected to allow inclusion of 
both unpublished interventions (such as smaller community based initiatives) and published 
interventions (such as larger media interventions), regardless of whether the intervention 
was evaluated. Informal quality assessments are reported in this review. 
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6.3 Methods 
 
Scoping review followed the framework for conducting scoping reviews described by Arksey 
and O’Malley (2005). In their framework, five key stages are outlined: identification of the 
research question, identification of relevant information using search terms, intervention 
selection using an exclusion/inclusion criteria, data extraction/charting of data, and 
summarising/reporting of findings (Arksey and O’Malley, 2005). Each stage is outlined 
below: 
 
6.3.1 Stage 1: identify the research question 
 
The research questions were: what interventions designed to encourage timely cancer 
symptom presentation are available, and which of these are targeted at low socioeconomic 
groups? If evaluation data are available, how effective are these interventions? Effectiveness 
was defined in terms of improved outcomes within the following four domains:  
 
a. Psychological/behavioural domain  
 Symptom presentation behaviour (self-reported or GP read code data 
for actual symptom presentation, or self-reported hypothetically 
anticipated symptom presentation behaviour) 
 Cancer symptom knowledge (recall or recognition) 
 Barriers to cancer symptom presentation (reported actual or anticipated 
barriers to cancer symptom presentation) 
b. Clinical domain  
 Referral (number of urgent two week wait (2WW) referrals for 
suspected cancer to secondary care, number of GP requested diagnostic 
tests e.g. chest X-rays for suspected lung cancer) 
 New cancers detected (number of new cases of cancer detected) 
 Staging data (cancer stage shift observed, number of patients offered 
earlier stage treatments e.g. surgery) 
c. Intervention reach domain (outcomes relating to intervention messages 
reaching those for whom the intervention was targeted, such as whether the 
target group were aware of the intervention, and any changes in 
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psychological/behavioural or clinical outcomes observed specifically within the 
target group) 
d. Cost effectiveness domain (calculated in relation to clinical outcomes such as 
cost of intervention per new diagnosis of cancer, or quality-adjusted life-years).  
 
6.3.2 Stage 2: identification of relevant interventions 
 
Electronic database searches, reference list searches and online searches of key organisation 
and search engines were performed to identify relevant interventions up to and including 
April 2016. Terms related to ‘cancer’, ‘awareness’, ‘symptom presentation’  and 
‘intervention’ were used to identify relevant interventions.  
 
The electronic databases of MEDLINE, PsycINFO and EMBASE were searched for 
interventions and evaluations of interventions in peer reviewed papers and those published 
as conference abstracts. The de-duplicate function was used on Ovid and CINAHL before 
reviewing abstracts. Manual searches of reference lists of included papers were performed. 
Online searches of key organisation websites such as Cancer Research UK and the search 
engine ‘Google’ were used to help identify interventions using key words. If further 
information was required, the organisation, researcher or programme lead was contacted 
via email to obtain further information about the intervention. A reminder email was sent if 
the individual or organisation did not respond.    
 
6.3.3 Stage 3: intervention selection  
 
In order to identify relevant interventions for inclusion in the review, inclusion/exclusion 
criteria were applied to all search engine hits, interventions found through websites, and for 
articles found through databases and hand searching of reference lists. Criteria for inclusion 
were as follows:  
 
 An intervention development or evaluation paper designed to encourage or prompt 
timely cancer symptom presentation among recipients 
 An intervention targeted at low socioeconomic groups. A low socioeconomic group 
was defined as individuals who were in a low socioeconomic group according to 
individual socioeconomic group indicators (such as educational attainment i.e. low 
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educational attainment) or area level deprivation (such as an index of multiple 
deprivation i.e the most deprived quartile). The peer-reviewed paper or description 
of intervention gained from online searches or contact with co-ordinators or 
organisations must explicitly state that the intervention was targeted at a low 
socioeconomic group according to these criteria.  
 Interventions with or without evaluation were included. Where the intervention was 
evaluated, all study designs were included and findings reported separately. If 
evaluation data were reported in a separate peer-reviewed paper or intervention 
report, these were included and referenced.  
 Interventions implemented in high income countries classified by Organisation for 
Economic Co-operation and Development (OECD) membership (OECD, 2014) were 
included. 
 
The exclusion criteria were as follows:  
 
 Interventions which were not focused on cancer. 
 Interventions targeted at people with a diagnosis of cancer such as cancer treatment 
intervention or quality of life interventions following a diagnosis of cancer.  
 Interventions designed to promote healthier lifestyles to reduce individual cancer 
risk.  
 Interventions designed to encourage participation in cancer screening. As previously 
discussed in Chapter 1, the barriers to cancer screening are similar to those of 
cancer symptom presentation. However, the process of recognising, appraising and 
seeking medical help for a symptom of cancer is different to attending a screening 
appointment after receiving a reminder letter, therefore screening interventions 
were excluded from this review.  
 Interventions and papers not written in English. 
 Interventions implemented in low or middle income countries, classified by OECD 
membership (OECD, 2014). 
 
6.3.4 Stage 4: data extraction and charting   
 
All available data were extracted into a table according to the following headings: name of 
intervention; location of intervention (country and city); cancer type and target symptoms, 
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and intervention type (target group, method(s) of delivery, duration of intervention, cost of 
intervention, intervention content, healthcare professional element). If the intervention 
included an evaluation, data were extracted into the table according to the following 
headings: method of evaluation (study design, data collection methods, outcome measures, 
participant characteristics and sample size) and key findings (behavioural/psychological 
outcomes, clinical outcomes, reach, cost-effectiveness). Interventions were ordered 
alphabetically according to intervention name (Table 6.1).  
 
6.3.5 Stage 5: collating, summarising and reporting the results 
 
Interventions were grouped according to intervention type. An overview of the content and 
delivery of each intervention type is presented. Where data were available, the findings in 
relation to intervention effectiveness for psychological/behavioural outcomes, clinical 
outcomes, reach and cost effectiveness are reported.  
 
6.3.6 Quality Appraisal 
 
Scoping review methodology does not include a formal assessment of intervention or study 
quality, therefore interventions included in this review were not formally assessed for 
quality before or after inclusion. However, quality assessments for intervention 
development and evaluation were considered important, and quality was judged informally 
in accordance with the MRC framework guidance for intervention development (Craig et al, 
2008). Interventions which were developed in accordance with the guidance outlined by the 
MRC framework (Craig et al, 2008) and those which used appropriate evaluation methods 
were considered to be of higher quality. Quality appraisal is reported after findings from 
intervention evaluation studies.  
 
6.3.7 Lung cancer interventions 
 
Interventions of lung cancer were analysed in addition to findings for all included 
interventions, and reported after the main findings. These included interventions which 
focused solely on lung cancer or interventions targeting multiple types of cancer including 
lung cancer. Lung specific outcomes were extracted to provide insight into the types of 
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interventions previously carried out, and if data available how effective these interventions 
were to inform intervention development for this PhD.  
 
6.4 Results 
 
A total of 20 interventions or intervention programmes designed to encourage timely cancer 
symptom presentation among low socioeconomic groups were included in this scoping 
review. Some interventions reported outcome measures over a number of articles, 
therefore the number of studies or articles included in the review is higher than the number 
of interventions. The target groups were confirmed in the text of the intervention content 
documents, peer-reviewed papers or conference abstracts or in email correspondence to 
intervention managers. Interventions were identified through searches of academic 
databases and hand searching of reference lists (n=11), search engine searches (n=13) and 
key websites (n=5). After duplicates were removed, 20 interventions were included (Figure 
6.1).  
 
Nine interventions targeted multiple types of cancer, and 11 interventions focused on one 
type of cancer only: lung (n=5), oral (n=3), breast (n=2), bowel (n=1). Fifteen of the 20 
interventions reported findings from an intervention evaluation. Nineteen interventions 
were carried out in the UK (England, n=15; Scotland, n=2; Wales n=2), and one intervention 
took place in the United States.  
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Figure 6.1 Flow chart of cancer awareness interventions included in the scoping review 
 
Interventions 
identified through 
key organisation 
websites (n=5) 
Articles identified 
through academic 
databases 
(n=1128) 
Interventions 
identified 
through search 
engine searches 
(n=13) 
96 articles full 
text reviewed  
Duplicates  
removed 
(n=358) 
770 articles 
reviewed by title 
and abstract 
674 articles excluded:  
For people with cancer (n=187) 
Risk factor study/intervention 
(n=144) 
Not about cancer (n=105) 
Screening intervention (n=101) 
Cancer awareness study (n=73) 
Other (n=55) 
Not in English (n=9) 
77 articles excluded:  
Not targeted at low 
socioeconomic group (n=39) 
Screening intervention (n=21) 
Risk factor study/intervention 
(n=7) 
Targeted at HCPs (n=7) 
Other (n=3) 
11 interventions included 
from database search  and 
hand searching (21 articles) 
2 articles included through 
hand searching of reference 
lists after duplicates removed 
(n=2) 
Duplicates  
removed (n=4) 
Duplicates removed from database, key organisation 
and search engine searches (n=5) 
Total number of interventions included (n=20) 
14 interventions included from 
search engine searches and key 
organisation websites  
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6.4.1 Types of intervention  
 
The interventions were categorised into five types: community based multi-faceted social 
marketing intervention (n=12); mass media intervention (n=3), health check intervention 
(n=2), educational intervention (n=2), and roadshow intervention (n=1). The type of 
interventions included, and the content and delivery of each intervention are described 
below.  
 
6.4.1.1 Community based multi-faceted social marketing interventions  
 
Twelve community based multi-faceted social marketing (CBMSM) interventions were 
identified. Seven interventions targeted multiple cancers (Detect Cancer Early Programme, 
East Sussex Downs and Weald PCT cancer awareness project, The Early Presentation of 
Cancer Symptoms Collaborative Programme, Early Presentation of Cancer Programme, The 
Healthy Communities Collaborative, NAEDI local projects, The Small “c” Campaign). Five 
CBMSM interventions focused on one type of cancer only: lung cancer (n=3; ‘Don’t be a 
cancer chancer’ campaign, The Early Lung Cancer Detection in Corby Project, Early Lung 
cancer Intervention in Doncaster), oral cancer (n=1; Lowry et al, 2009), breast cancer (n=1; 
Painting Stroud Pink). Most interventions were carried out in England (n=11), and one 
intervention was conducted in Scotland. Two interventions of lung cancer targeted 
persistent cough symptom (Small ‘C’ campaign, Early Lung Cancer Intervention in 
Doncaster). The remaining ten interventions did not report which specific symptom(s) were 
targeted in the intervention.  
 
A CBMSM intervention incorporates multiple methods of intervention delivery to 
communicate a message to members of the public in a variety of ways. This intervention 
type typically involves media advertising such as local radio and television targeted to a 
specific geographical area, combined with poster adverts strategically placed in locations 
such as pharmacies or bus stops. The media aspects are usually supported by face-to-face 
local events such as cancer awareness stalls at supermarkets or public events, or talks in 
community venues such as community centres, hairdressers or mosques. A minority of 
interventions used a self-referral programme where individuals could refer themselves for 
diagnostic testing (n=2; The Early Lung Cancer Detection in Corby Project, and Lowry et al, 
2009).  
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Six CBMSM interventions recruited lay members of the community to become ‘cancer 
champions’ or community volunteers (Small ‘C’ campaign, Painting Stroud Pink, NAEDI local 
projects, The Early Presentation of Cancer Symptoms Collaborative Programme, Early 
Presentation of Cancer Programme, East Sussex Downs and Weald PCT cancer awareness 
project, Early Lung Cancer Detection in Corby Project). Their role varied according to each 
intervention for example some volunteers or cancer champions were recruited to replenish 
leaflets and refresh poster boards in their area. Other interventions recruit volunteers or 
cancer champions to run cancer awareness events or talks within the community. Some 
interventions recruit volunteers or cancer champions to disseminate intervention messages 
within the community, and are trained to deliver opportunistic brief behaviour change 
interventions to encourage people in the community with symptoms to consult the GP. 
Volunteers and cancer champions were usually recruited through poster advertising within 
the community, or through clinical nurse specialists or cancer support groups. The length of 
training and time commitment expected of each volunteer or cancer champion varied 
according to their role. Volunteer and cancer champion training sessions varied from a few 
hours to two days, and time commitment required was usually around two days per month.  
 
Eight of twelve CBMSM interventions were targeted at one specific geographical area (The 
Early Lung Cancer Detection in Corby Project; Don’t be a Cancer Chancer intervention in 
Manchester; Early Lung Cancer Intervention in Doncaster; The Early Presentation of Cancer 
Symptoms Collaborative in North East Lincolnshire; East Sussex Downs and Weald PCT 
Cancer Awareness Project; Lowry et al, 2009 in Newcastle and Gateshead; Painting Stroud 
Pink in Gloustershire; and the Small “c” Campaign in London). Three larger or national 
programmes allocated funding to leads within smaller target areas to develop tailored 
interventions in the most deprived areas within the larger geographical area. These include 
the Detect Cancer Early Programme in Scotland, The Improvement Foundation Healthy 
Communities Collaborative, and the NAEDI local projects which funded sixty projects at local 
level to support the larger mass media Be Clear on Cancer Campaigns.  
 
The CBMSM approach repeats the intervention message to individuals through multiple 
channels of communication. This means that individuals are likely to receive the information 
from multiple sources and exposure to the message is increased to facilitate awareness of 
the intervention and information retention. In addition, these interventions are usually 
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culturally tailored or adapted to the target group or geographical area following research 
focus groups or interviews with people from the local area to ensure the message is 
communicated in most appropriate way to bring about behaviour change. For interventions 
which engaged lay members of the community in intervention development at the early 
stages, this was considered key in the success of these interventions. Furthermore, 
interventions which trained volunteers and cancer champions to help spread cancer 
awareness messages did so to create intervention sustainability as local people can learn 
and develop skills at little cost.  
 
Seven CBMSM interventions employed ‘push-pull’ methods. The ‘push’ aspect refers to 
information to push people to go to the GP with symptoms and the ‘pull’ aspect involves a 
healthcare professional (HCP) educational element of the intervention. The HCP education 
usually involves reminding GPs of the referral guidelines for suspected cancer and/or an 
intervention in secondary care to help them prepare for increased caseload. For example, 
The Detect Cancer Early Programme in Scotland included a social marketing campaign to 
raise public awareness of cancer symptoms and screening programmes, alongside 
interventions with HCPs in primary and secondary care. In primary care, GP’s were reminded 
of the guidelines for referral of suspected cancer. In secondary care, diagnostic services were 
helped to prepare for increased case load to ensure there was sufficient capacity to provide 
patients with appropriate diagnostic testing.  
 
6.4.1.2 Mass media interventions  
 
Three mass media interventions were included in this review, each targeted at three 
different types of cancer and various symptoms: oral cancer (n=1; ulcers, sores, red/white 
patch, spots, lump(s), persistent changes, change in tongue; The West of Scotland Cancer 
Awareness Project), bowel cancer (n=1; change in bowel habit, blood in faeces; Be Clear on 
Cancer bowel cancer campaign) and lung cancer (n=1; persistent cough; Be Clear on Cancer 
lung cancer campaign).  
 
A mass media intervention involves the transmission of messages nationally or regionally 
through media channels such as television, radio or poster adverts, and is not specifically 
targeted at a particular smaller geographical area but is designed to reach larger audiences. 
Three mass media interventions were developed using wording and messaging targeted at 
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low socioeconomic groups and were therefore included in this review. These included two 
national ‘Be Clear on Cancer’ mass media interventions in England, one for lung cancer and 
the other for bowel cancer, and the West of Scotland Cancer Awareness Project, a regional 
mass media intervention for oral cancer in Scotland.  
 
The Be Clear on Cancer campaigns were targeted at those over the age of 55 from a low 
socioeconomic group and utilised radio, television and poster adverts to increase awareness 
and promote earlier symptom presentation for lung and bowel cancer respectively. These 
interventions used GPs as part of their adverts in an attempt to overcome reported barriers 
associated with timely symptom presentation such as worry about bothering the GP. Push-
pull methods were also used for both the Be Clear on Cancer campaigns to encourage 
individuals to go to the doctor with symptoms of cancer. The West of Scotland Cancer 
Awareness Project used radio, television, press, leaflets, mail drops and poster adverts to 
raise awareness of oral cancer symptoms and promote earlier symptom presentation for 
those aged 40-70 from a low socioeconomic group. The oral cancer intervention in Scotland 
adopted a testimonial approach using real cancer patients’ stories to communicate 
intervention messages.  
 
6.4.1.3 Educational interventions 
 
Two educational interventions were included in this review: one intervention was a US 
based intervention with a focus on breast cancer (target symptoms not reported; Cardarelli 
et al, 2011), and the other was a UK based intervention with an oral cancer focus (target 
symptoms not reported; Scott et al, 2012b).  
 
Educational interventions are designed to raise cancer awareness and encourage earlier 
symptom presentation in members of the public in a face-to-face setting, and delivered in a 
group or one-to-one. The US based intervention involved eight 1.5 hour group based 
educational sessions, where two sessions contained information designed to highlight the 
importance of early detection of breast cancer, the symptoms of breast cancer and 
encourage earlier presentation (Cardarelli et al, 2011). The remaining six sessions contained 
information about how to lead a healthy lifestyle, breast cancer prevention and screening, 
using breast cancer survivor stories to deliver intervention messages (Cardarelli et al, 2011). 
A UK based three arm randomised controlled trial (RCT) study evaluated a leaflet plus 
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intensive one-to-one educational intervention delivered by a trainee health psychologist 
compared with a leaflet only (Scott et al, 2012b). The one-to-one session lasted between five 
and ten minutes, and was designed to offer tailored information on how to spot the 
symptoms of oral cancer, a practical demonstration on how to perform mouth self-
examination, and to address the barriers to early symptom presentation and encourage 
participants to seek medical help early in the event of symptoms (Scott et al, 2012b). The 
leaflet contained information on oral cancer symptoms and advice on when to seek medical 
help for symptoms (Scott et al, 2012b).  
 
6.4.1.4 Health check interventions 
 
Two Welsh based health check interventions were included in this review: the Tenovus 
health check and the ‘Love Your Lungs’ campaign. Health check interventions aim to identify 
symptomatic individuals and encourage them to seek medical help for their symptoms by 
signposting to the relevant HCP or providing individuals with a letter of referral. Health 
check interventions are often used as “teachable moments”. Those who take part or are 
asymptomatic at the time of the health check are given information on what to look out for 
in the future and when to go to the doctor with symptoms.  
 
The Love Your Lungs campaign advertised a free health check for members of public for 
three target symptoms of lung cancer (cough, wheeziness, breathlessness) (British Lung 
Foundation, 2014). For those who attended the health check event, individuals were 
assessed by a respiratory specialist to pick up symptoms, and a letter of referral was given to 
individuals who required further investigation to take to their GP (British Lung Foundation, 
2014). Information leaflets were given to all individuals who attended the Love Your Lungs 
health check events (British Lung Foundation, 2014).  
 
The Tenovus health check is a touch screen questionnaire, designed to identify any potential 
symptoms of common cancer (persistent cough, lump(s), skin changes, sore or ulcer which 
will not heal, change in bowel habit, blood in faeces, problems urinating, unexplained 
bleeding, difficulty swallowing, weight loss, unexplained tiredness, loss of appetite, bloating, 
pain) and prompt medical help seeking for symptomatic individuals (Smits et al, 2016). 
Advice is given in a tailored one-to-one results session with a trained health check advisor. 
The results session is also used a teachable moment to advise individuals to look out for 
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symptoms in future, offer advice on when to go to the doctor with symptoms and highlight 
the importance of early detection. 
 
6.4.1.5 Roadshow 
 
One UK based roadshow intervention was included in this review: the Cancer Research UK 
(CRUK) Cancer Awareness Roadshow (Smith et al, 2014). A roadshow intervention involves 
travel to specific communities to provide tailored cancer awareness information in an 
opportunistic setting. There are various formats of information and resources available at 
roadshow interventions such as leaflets and/or a nurse to answer specific queries and offer 
tailored advice, therefore no specific cancer type or symptoms were targeted in this 
intervention. The CRUK Cancer Awareness Roadshow is a mobile roadshow visiting deprived 
areas to offer tailored information on cancer awareness, promote the benefits of early 
diagnosis and encourage prompt cancer symptom presentation (Smith et al, 2014). A 
qualified nurse trained in cancer awareness and various leaflets were available for attendees 
(Smith et al, 2014).  
 
6.4.2 Intervention evaluation 
 
As shown in Table 6.1, fifteen of the 20 interventions included in this review were evaluated 
in relation to one or more of the following domains: (a) psychological/behavioural; (b) 
clinical; (c) reach; and (d) cost-effectiveness. 
 
Six intervention evaluations employed both quasi-experimental and before and after study 
methodologies to assess intervention effectiveness. Before and after studies involve 
comparisons between outcome measures collected before the intervention to those during 
the intervention time period or after the intervention time period. Quasi-experimental 
methods comprise domain outcome data collections across multiple sites or communities, 
some of which were intervention target sites and received the intervention (intervention 
area) and other sites that were not targeted by the intervention and did not receive the 
intervention (control area). The control area(s) were often similar to the intervention area(s) 
on the basis of demographic characteristics of people living in the community and area level 
deprivation (Table 6.1).  
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Six intervention evaluations used before and after studies only. The time period of data 
collection varied according to intervention type and outcome measure. Clinical domain data 
were often collected yearly or monthly at various time points before, during and after the 
intervention using electronic records. Surveys were typically used to compare 
behavioural/psychological and reach domain data collected before and after the 
intervention. Time scales for data collection varied between immediately after the 
intervention up to one year post intervention (Table 6.1).  
 
Two interventions used controlled methods to assess intervention effectiveness. One 
intervention used a two arm non-randomised design, collecting survey data at three time 
points (pre and post intervention, and eight week follow-up), and another intervention used 
a three-arm randomised controlled study (RCT) design collecting survey data from 
intervention and control groups at three time points (pre and post intervention, and one 
month follow-up). One intervention assessed intervention domain outcomes in a cross 
sectional survey study, conducted post intervention only. Participants were required to self-
report perceptions of knowledge improvements following the intervention and symptom 
presentation behaviour (Table 6.1).  
 
Four interventions did not report evaluation data and were all CBMSM interventions (East 
Sussex Downs and Weald PCT cancer awareness project; Early Presentation of Cancer 
Programme; Lowry et al, 2011; Painting Stroud Pink). The Tenovus health check intervention 
is currently undergoing evaluation, therefore evaluation data were not available at the time 
of reporting. 
 
Intervention evaluation data analysed using statistical tests to assess whether the difference 
between time points, or control and intervention groups was statistically significant are 
reported where available. Where data were not analysed using statistical tests or 
significance levels not reported, percentage increases between time points, or control and 
intervention groups are reported.  
 
6.4.2.1 Community based multi-faceted social marketing intervention (CBMSM) 
 
Eight of the 12 CBMSM interventions reported evaluation data relating to the clinical (n=8), 
behavioural/psychological (n=4) and intervention reach (n=5) domains. CBMSM 
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interventions were evaluated using a combination of before and after and quasi-
experimental studies (n=5) or before and after studies only (n=3).  
 
(a) Clinical domain 
 
Clinical outcomes data were available for all CBMSM interventions that included an 
evaluation.  
 
Referral outcomes 
 
Overall, a statistically significant increase in the number of two week wait (2WW) referrals 
for suspected cancer was observed for lung cancer (9%; p<0.01) and bowel cancer (16%; 
p<0.01) in the 60 local NAEDI project intervention areas pre to post intervention (Cancer 
Research UK, 2012). There were no clinical outcome data available for breast cancer. 
However, increases in 2WW referrals were also observed in the time periods pre to post 
local NAEDI project interventions in the control areas who did not receive the intervention 
for lung cancer (7%) and bowel cancer (13%). Increases in 2WW referrals reported in 
intervention areas compared to the control areas were therefore small and not statistically 
significant (Cancer Research UK, 2012).  
 
The differences in referrals for each individual NAEDI local project intervention area in a 
before and after comparison study (data collected during intervention time period 
compared to the previous year) were extremely variable: 24 of the lung specific projects and 
25 of the bowel specific interventions reported an increase in 2WW referrals, three lung 
specific and seven bowel specific interventions reported no change in referrals, and ten lung 
specific and one bowel specific interventions reported a reduction in the numbers of 2WW 
referrals in comparison to the previous year (Cancer Research UK, 2012).  
 
The remaining CBMSM intervention evaluations reported increases in the numbers of 2WW 
referrals for suspected cancer, with the exception of breast cancer referrals for one 
intervention (Lyons et al, 2009). The Small “c” Campaign reported an increase in 2WW 
referrals for suspected lung and breast cancer of 44% and 22% respectively, pre to post 
campaign (Shankleman et al, conference poster). Time frames for the before and after study 
were not reported. The Improvement Foundation Healthy Communities Collaborative 
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reported statistically significant increases of 29.2% (p<0.01) and 27.7% (p<0.001) in 2WW 
referrals for lung and bowel cancers respectively in the first year of the intervention, in 
comparison to the same time period one year before the start of the intervention, (Lyon et 
al, 2009). The increase in breast cancer referrals was not statistically significant (Lyon et al, 
2009). The ‘Don’t Be a Cancer Chancer’ Campaign reported an increase of 51% in urgent 
referrals for suspected lung cancer during the intervention period in comparison to the 
previous year in a before and after study (Kane et al, 2009).  The Early Presentation of 
Cancer Programme reported increases in 2WW referrals ranging from 25% to 67% across all 
targeted tumour sites in a before and after study (EPOC impact report, p.5).  
 
The Early Lung Cancer Detection in Corby Project reported an increase of 63% during the 
intervention period in comparison to the previous year for chest x-rays performed following 
the intervention (Campbell et al, 2013). This was a statistically significant increase in 
comparison to control areas (p<0.001). The Early Lung Cancer Intervention in Doncaster 
observed an increase of 27% in chest x-ray referrals from GP practices in the target areas at 
six weeks post intervention compared to the previous year (Athey et al, 2012; Suckling, 
2008). This was a difference of 8% in comparison to control non-targeted practices area, 
which reported an increase of 19% referrals compared to the previous year, and represented 
a statistically significant increase in the number of chest x-rays ordered between 
intervention and control areas (p<0.001) (Athey et al, 2012; Suckling, 2008). A statistically 
significant increase of 20% (p<0.001) in chest x-ray referrals in comparison to the year 
before the Early Lung Cancer Intervention in Doncaster was maintained at one year post 
intervention (Athey et al, 2012; Suckling, 2008).  
 
New cases of cancer 
 
Findings for the number of new cancer diagnoses were variable for CBMSM interventions. 
The NAEDI local projects intervention reported overall non-significant increases of 4% and 
6% respectively in the number of new lung and bowel cancer cases diagnosed respectively in 
the intervention areas during the intervention time period in comparison to the previous 
year across all of the 60 projects (Cancer Research UK, 2012). For each of the local NAEDI 
projects, the number of new cancers diagnosed per intervention area in comparison to 
clinical domain data from the previous year was variable: some projects reported an 
increase in new cancer diagnoses for both tumour sites (lung, n=8; bowel, n=6). Only one 
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project reported a statistically significant increase in new lung cancers diagnosed (p<0.001), 
and there was no statistically significant increase at project level for new cases of bowel 
cancer diagnosed. Other local NAEDI projects reported no change in new cancer diagnoses 
(lung, n=1; bowel, n=1) and some intervention areas reported a reduction compared to the 
previous year (lung, n=10; bowel, n=5), of which two lung specific and one bowel specific 
projects reported a statistically significant decrease in new lung cancers diagnosed (p<0.05) 
(Cancer Research UK, 2012). Individual area level data were unavailable for all of the 60 local 
projects (Cancer Research UK, 2012). 
 
The Early Lung Cancer Intervention in Doncaster observed a statistically significant increase 
of 27% (p<0.001) for new lung cancer diagnoses in comparison to the previous year (Athey 
et al, 2012; Suckling, 2008). The Improvement Foundation Healthy Communities 
Collaborative reported a statistically significant increase of 27.4% (p<0.05) and 28% (p<0.01) 
of new cancer diagnoses for bowel and lung cancer respectively after the first year of the 
campaign (Lyon et al, 2009).  The ‘Don’t Be a Cancer Chancer’ intervention reported forty 
new cases of lung cancer diagnosed during the intervention period in comparison to eight 
new lung cancer diagnoses in the same time period the following year (Kane et al, 2009). The 
Early Lung Cancer Detection in Corby Project reported two new cases of lung cancer 
detected through the walk in self-referral chest x-ray programme, both of which were 
advanced stage, representing 0.5% of the total number of individuals receiving walk in chest 
x-rays (Campbell et al, 2013). 
 
Staging data 
 
Most CBMSM interventions, such as The Early Lung Cancer Intervention in Doncaster (Athey 
et al, 2012; Suckling, 2008), reported no stage shift following the interventions. The Small 
“c” Campaign reported a 1% increase in the number of new lung cancers diagnosed at an 
early stage and a 4% decrease in the number of advanced stage breast cancer diagnoses 
before and after the intervention, although data collection time scales were not reported 
(Shankleman et al, conference poster). The Detect Cancer Early Programme reported a 6.5% 
increase in the third year of the campaign for the number of people diagnosed with Stage I 
breast, lung and bowel cancer in comparison to two years preceding the intervention 
(Information Services Division Scotland, 2015c), although it is unclear the extent to which 
these findings can be attributed to the patient component of the intervention.  
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(b) Psychological/behavioural domain 
 
Psychological/behavioural domain outcome data were available for four CBMSM 
interventions.  
 
Symptom presentation behaviour 
 
The NAEDI local projects reported data for anticipated symptom presentation in before and 
after surveys involving various time scales, with little evidence of change (Cancer Research 
UK, 2012). Four NAEDI projects reported a statistically significant increase (p<0.01) pre to 
post intervention in the number of participants reporting intentions to seek help within one 
week of noticing a symptom of lung, bowel or breast cancer (Cancer Research UK, 2012). 
Nineteen NAEDI local projects reported no change, and six projects reported a decrease in 
intentions to seek medical help for symptoms pre to post intervention, two of which 
reported statistically significant decreases (p<0.01) (Cancer Research UK, 2012). The Early 
Lung Cancer Intervention in Doncaster reported a small significant 4% difference (p<0.01) in 
intentions to visit the GP with lung cancer symptoms and a 12% non significant rise in the 
number of people from the intervention area reporting that they would request a chest x-
ray from the GP pre intervention to 1 year post intervention (Athey et al, 2012; Suckling, 
2008). Those in the intervention areas for The Early Lung Cancer Intervention in Doncaster 
were 1.97 times more likely to report intentions to visit the GP with lung cancer symptoms 
in comparison to the control areas in a post intervention survey study, which reached 
statistical significance (p<0.01)  (Athey et al, 2012; Suckling, 2008). The Early Presentation of 
Symptoms Collaborative reported an 11% increase in willingness to act on symptoms in the 
intervention areas pre to post intervention, although data collection time scales were not 
reported (EPOC impact report, p.5).  
 
Symptom knowledge 
 
For the NAEDI local projects, the percentage of respondents who correctly recalled 
symptoms of cancer was assessed. There was a small increase in cancer symptom knowledge 
(recognition) for lumps, bleeding and pain pre to post interventions, with an average project 
level increase of 1-2% symptoms correctly recognised following the NAEDI local projects 
(Cancer Research UK, 2012). The Small “c” Campaign reported an increase in recall and 
 
 
177 
 
recognition of breast cancer symptoms, but not lung cancer symptoms, in a survey study 
conducted three years before the intervention and one month after the intervention 
(Shankleman et al, conference poster). The Early Presentation of Symptoms Collaborative 
reported a 15% increase in confidence in the detection of early symptoms of cancer in the 
intervention areas pre to post intervention (time scales not reported; EPOC impact report, 
p5). 
 
(c) Reach 
 
Two CBMSM intervention evaluations explored intervention recall among the target group 
for whom the intervention was intended. Thirty nine percent of those surveyed in the target 
intervention areas could recall an aspect of the local NAEDI projects in their area (range 11-
71% per project) (Cancer Research UK, 2012). However, socioeconomic group data were 
unavailable and it is unclear if those who completed the surveys were representative of a 
low socioeconomic group. The Early Lung Cancer Intervention in Doncaster reported that 
21% of those who took part in the post intervention survey and lived in the target 
communities could recall an aspect of the intervention (Athey et al, 2012; Suckling, 2008).  
 
The Small “c” Campaign evaluation reported that the intervention was effective at targeting 
those most at risk of lung cancer, however no further data were provided (Shankleman et al, 
conference poster). The Early Lung Cancer Detection in Corby project offered a free walk in 
chest x-ray and reported that 86% of those who attended were clinically eligible for chest x-
ray, and 37% were current smokers (Campbell et al, 2013). One intervention evaluated 
clinical outcomes for the intervention target group. The ‘Don’t Be a Cancer Chancer’ 
campaign reported the largest rise in GP 2WW referral rates for suspected lung cancer for 
those in the most deprived areas compared to more affluent areas (Kane et al, 2009).  
 
Summary of CBMSM interventions 
 
Overall, clinical domain outcomes following CBMSM interventions appeared to be improved. 
There is evidence to suggest that CBMSM interventions were successful in increasing the 
number of 2WW referrals and new cases of cancer diagnosed, although staging data 
suggested that CBMSM interventions had little effect on the number of new cancers 
diagnosed at an earlier stage. There was mixed evidence for the effectiveness of CBMSM 
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interventions on psychological/behavioural domain outcomes. Trends towards more timely 
cancer symptom presentation behaviour were observed following CBMSM interventions. 
Some interventions reported small symptom knowledge improvements following 
intervention exposure, while others reported no change.  
 
6.4.2.2 Mass media interventions  
 
All three mass media interventions reported evaluation data for clinical (n=2), 
behavioural/psychological (n=3), intervention reach (n=3) and cost-effectiveness (n=2) 
outcome domains. The two national Be Clear on Cancer mass media interventions were 
evaluated using before and after methods. The West of Scotland cancer awareness project 
regional mass media intervention was evaluated using before and after/quasi-experimental 
methods, comparing intervention areas to control areas and data comparisons before and 
after the intervention time period.  
 
(a) Clinical domain 
 
Both the Be Clear on Cancer Campaigns for lung and bowel cancer were evaluated in terms 
of clinical domain outcomes. 
 
Referral outcomes  
 
Referrals via the 2WW pathway rose substantially by 59% (p<0.01) during the Be Clear on 
Cancer bowel cancer campaign (Peacock et al, 2013) and 31.8% (p<0.001) during the Be 
Clear on Cancer lung cancer campaign (Ironmonger et al, 2014) in comparison to two years 
before the campaign launch. The number of GP ordered chest x-rays increased by 18.6% 
(p<0.001) during the lung campaign period compared to the previous year (Ironmonger et al, 
2014).  
 
New cases of cancer  
 
The bowel campaign reported a non significant 2% reduction in the number of new 
colorectal cancers diagnosed following the intervention (Peacock et al, 2013), whereas the 
lung campaign reported a statistically significant 9.1% (p<0.001) increase in the numbers of 
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new lung cancers diagnosed during the campaign period (Ironmonger et al, 2014) in 
comparison to the two years preceding the campaigns.  
 
Stage shift 
 
Following the lung campaign, there was a statistically significant increase of 3.1% (p<0.001) 
for the number of individuals diagnosed with non-small cell lung cancer at Stage I and a 
statistically significant 3.5% decrease (p<0.001) in the number of individuals diagnosed at 
Stage IV (Ironmonger et al, 2014) during the intervention period in comparison to the two 
years preceding the campaign. The number of surgical resections increased by 2.3% 
(p<0.001) following the lung campaign compared to the pre-campaign time period 
(Ironmonger et al, 2014).   
 
(b) Psychological/behavioural domain 
 
Both the Be Clear on Cancer Campaigns for lung and bowel cancer were evaluated in terms 
of psychological/behavioural outcomes using the Cancer Awareness Measure (CAM; 
Stubbings et al,  2009) in before and after studies. The West of Scotland Cancer Awareness 
Project used a survey measure in a before and after/quasi-experimental study design over 
three time points (pre-intervention, seven and 12 months post intervention).  
 
Symptom presentation behaviour 
 
A statistically significant increase of 63% (p<0.001) in the number of people presenting to 
the GP with a cough symptom was observed in the eight weeks during the Be Clear on 
Cancer lung campaign in comparison to GP read code data collected the previous year 
(Ironmonger et al, 2014). The West of Scotland Cancer Awareness Project mass media 
campaign reported that intentions to visit the GP with a symptom suspicious of oral cancer 
were highest among those in the intervention areas compared to control areas after the 
campaign, and were sustained at 12 month follow up among those in the intervention areas 
(p<0.001) (Eadie et al, 2009).  
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Symptom knowledge  
 
Public awareness for the symptoms targeted by both the Be Clear on Cancer Campaign 
interventions was improved after the respective intervention time period. Recall for a cough 
symptom rose by 11% (p<0.001) and recognition of a cough symptom increased by 15% 
(p<0.001) in the months following the lung campaign (Ironmonger et al, 2014) in comparison 
to survey data collected two years before the campaign.  Recall and recognition for change 
in bladder/bowel habit increased by 20% (p<0.001) and 4% (p<0.001) respectively in a 
survey study in the months following the bowel campaign compared to survey data collected 
two years before the intervention (Power and Wardle, 2015). In the same study, non-
significant increases of 2% and 3%, respectively, were observed for recall and recognition of 
unexplained bleeding after the bowel campaign (Power and Wardle, 2015).   
 
The West of Scotland Cancer Awareness Project oral cancer campaign reported that 
awareness of ulcers and lumps was highest in the intervention areas seven months post 
intervention compared to control areas who did not receive the intervention (Eadie et al, 
2009). However, improved symptom knowledge in the intervention areas was not sustained 
at 12 month follow up (Eadie et al, 2009).  
 
Barriers to symptom presentation 
 
No significant differences in the number of barriers endorsed by participants were observed 
in the survey studies conducted two years pre intervention and in the months following the 
respective Be Clear on Cancer bowel and lung cancer campaigns (Power and Wardle, 2015). 
 
(c) Reach  
 
Clinical and psychological/behavioural outcome data were evaluated in terms of reach for 
both Be Clear on Cancer Campaigns to examine their effects on cancer symptom knowledge, 
symptom presentation behaviour and referrals among the target group (over 55s from a low 
socioeconomic group) in before and after studies. For both interventions, knowledge for the 
symptoms targeted by the campaigns was slightly improved across all socioeconomic groups 
pre to post campaign (Power and Wardle, 2015; Moffat et al, 2015). However, the 
socioeconomic gradient for cancer symptom knowledge remained stable, where cancer 
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symptom knowledge decreases with increasing socioeconomic deprivation (Power and 
Wardle, 2015; Moffat et al, 2015).  Therefore, although symptom knowledge overall 
improved, cancer symptom awareness remained poorest for those in low socioeconomic 
groups when compared to high socioeconomic groups post intervention.  
 
In terms of clinical outcomes, analysis by socioeconomic group suggested that outcomes 
were most improved among high socioeconomic groups rather than low socioeconomic 
groups following the Be Clear on Cancer bowel campaign. There was evidence to suggest 
that secondary care services were accessed disproportionately by more affluent groups 
following the bowel campaign, even though the greatest increase in GP attendances for 
symptoms targeted by the intervention was observed among practices in the most deprived 
areas (p<0.001) (Hall et al, 2015). In addition, although there was an overall increase of 59% 
for bowel cancer 2WW referrals during the bowel campaign, increases in the number of new 
bowel cancers diagnosed during or after the campaign were not observed (Hall et al, 2015; 
Peacock et al, 2013). Therefore the authors concluded that the “worried well” were more 
likely to present to the GP following the intervention (Peacock et al, 2013).  
 
The greatest number of GP attendances for symptoms targeted by the Be Clear on Cancer 
lung campaign was reported in practices in the most affluent areas during the campaign 
time period (p<0.01) (Moffat et al, 2015). Those from a low socioeconomic group were less 
likely than those from high socioeconomic groups to report recognising the Be Clear on 
Cancer lung (p<0.05) and bowel (p<0.05) adverts in a post intervention survey study (Moffat 
et al, 2015). The West of Scotland Cancer Awareness Project reported that awareness of the 
intervention was higher in the intervention areas compared to control areas, but further 
data on reach to low socioeconomic groups were not reported.  
 
(d) Cost effectiveness  
 
Two studies evaluated cost effectiveness for the Be Clear on Cancer bowel and lung 
interventions. Following the bowel cancer campaign, the cost per new cancer diagnosed 
rose from £7585.58 in the year before the intervention to £9662.72 during the intervention 
time period (Peacock et al, 2013). Mathematical modelling was used to assess cost-
effectiveness of the lung campaign in terms of incremental cost-effectiveness ratios and 
costs per quality-adjusted life years (Hinde et al, 2015). An additional 178 quality-adjusted 
 
 
182 
 
life years were gained following the national campaign (Hinde et al, 2015). This was reported 
to represent an incremental cost-effectiveness ratio of £18,173 per quality-adjusted life year 
gained, which was below NICE’s threshold for cost-effectiveness (Hinde et al, 2015).  
 
Summary of mass media interventions  
 
Clinical domain outcome data suggested that mass media interventions were successful at 
increasing the number of referrals for cancer via the 2WW pathway. However, 
improvements in the number of new cases of cancer diagnosed and a stage shift were only 
observed for lung rather than bowel cancer, although there was evidence to suggest that 
these outcomes were most improved among affluent groups. Psychological/behavioural 
domain outcome data suggested that mass media interventions prompted (or would 
prompt) cancer symptom presentation behaviour and increased awareness of the symptoms 
of cancer across all socioeconomic groups. However, there was limited evidence to suggest 
that knowledge improvements were sustained long term. There was evidence that mass 
media interventions were unsuccessful in terms of modifying barriers to cancer symptom 
presentation.  
 
6.4.2.3 Educational interventions  
 
Both educational interventions were evaluated using controlled methods to assess 
intervention effectiveness. The oral cancer intervention randomised participants into one of 
three arms (Scott et al, 2012b), and the breast cancer intervention allocated participants to 
one of two arms, but did not randomise (Cardarelli et al, 2011). Both educational 
interventions reported data for psychological/behavioural outcomes. Data were not 
available for clinical, reach or cost-effectiveness outcomes. This is likely to reflect group sizes 
which were too small to report population level clinical outcome data or cost-effectiveness. 
All individuals recruited into the educational interventions were selected based on 
predefined criteria for inclusion.  
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(a) Psychological/behavioural domain 
 
Symptom presentation behaviour 
 
In the three arm RCT for oral cancer, both intervention groups were significantly more likely 
to anticipate timely symptom presentation behaviour at one month follow-up compared to 
the control group (p<0.001) (Scott et al, 2012b). There was no significant difference between 
intervention arms for anticipated symptom presentation behaviour post intervention (Scott 
et al, 2012b).  
 
Symptom knowledge 
 
Small but significant increases for cancer symptom knowledge of 0.72 points (p<0.01) were 
observed for the intervention group following an intensive eight week group based breast 
cancer educational intervention compared to the control group (Cardarelli et al, 2014). In 
the three arm RCT, increased oral cancer knowledge was observed for both intervention 
arms in comparison to the control group at one month follow up (p<0.001), although 
differences in symptom knowledge were not statistically significant for either intervention 
arm (Scott et al, 2012b).  
 
Beliefs about cancer 
 
A decrease in fearful and fatalistic beliefs about cancer was observed in both the 
intervention and control groups from baseline (before the first intervention session) to post 
intervention (after the final intervention session) (p<0.001) (Cardarelli et al, 2011). Although 
awareness of the importance of early detection was measured, findings for this outcome 
were not reported (Cardarelli et al, 2011).  
 
Summary of educational interventions 
 
Psychological/behavioural domain outcome data suggested that educational interventions 
promoted more timely cancer symptom presentation behaviour, increased cancer symptom 
knowledge and reduced negative beliefs about cancer. There was evidence to suggest that 
both targeted and tailored interventions improved knowledge and behavioural outcomes.  
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6.4.2.4 Health check intervention 
 
The ‘Love Your Lungs’ intervention health check reported data for psychological/behavioural 
outcome and reach domains in a cross sectional survey study conducted post intervention 
only (British Lung Foundation, 2014).  
 
(a) Psychological/behavioural domain  
 
The self-report survey given to participants after attending the ‘Love Your Lungs’ 
intervention included questions to evaluate perceptions of changes to cancer symptom 
knowledge and actual or anticipated cancer symptom presentation behaviour. Participants 
were asked to complete the survey immediately after attending the Love You Lungs health 
check or in a postal survey up to one month post intervention attendance (British Lung 
Foundation, 2014). 
 
Symptom presentation behaviour  
 
Eighty percent of those who attended the Love Your Lungs health check event agreed or 
strongly agreed that they would go to their GP with a symptom suggestive of lung cancer in 
the future (British Lung Foundation, 2014). Of the 463 individuals who attended the event 
and received the health check clinical examination, 133 (24%) were referred to their GP, of 
whom 22 reported going to their GP after the event with their referral letter (British Lung 
Foundation, 2014). 
 
Symptom knowledge  
 
Of those who attended the health check event, 62% agreed or strongly agreed that they 
knew more about the signs and symptoms of lung cancer than they did before the event 
(British Lung Foundation, 2014).  
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(b) Reach 
 
Fifty-one percent of those who attended the free ‘Love your Lungs’ health check were non-
smokers and 26% had previously worked in heavy industry. However, further socio-
demographic characteristics were not reported, thus it is difficult to assess whether those 
who attended the event were representative of a low socioeconomic group.  
 
6.4.2.5 Roadshow intervention 
 
The CRUK roadshow reported evaluation data for psychological/behavioural domain 
outcomes and reach in a before and after study (Smith et al, 2016). A proportion of 
participants prior to attending the roadshow were selected by the roadshow staff to 
complete a pre-roadshow questionnaire survey (Smith et al, 2016). A different proportion of 
participants who attended the roadshow were asked to complete the same survey 
immediately after attending the roadshow (Smith et al, 2016).    
 
(a)  Behavioural/psychological domain 
 
Symptom presentation behaviour 
 
For those who disclosed a symptom of cancer to staff during the CRUK cancer awareness 
roadshow, 33.6% reported intentions to book an appointment with the GP after the 
roadshow to discuss the symptom (Smith et al, 2016).  
 
Symptom knowledge 
 
A small but statistically significant 0.3 point increase (p<0.001) in cancer symptom 
knowledge (recognition) was reported pre to post roadshow intervention (Smith et al, 2016).  
 
Barriers to cancer symptom presentation 
 
Reductions in the number of barriers to symptom presentation endorsed were observed pre 
to post roadshow intervention (Smith et al, 2016). Those who completed the questionnaire 
after the roadshow were less likely to be worried about what the doctor might find 
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(p<0.001), less worried about wasting the doctor’s time (p<0.001), and more confident in 
reporting symptoms to the doctor (p<0.05) (Smith et al, 2016). 
 
(b) Reach 
 
The authors concluded that the roadshow was attended by people from a low 
socioeconomic group (Smith et al, 2016). Employment status and home ownership data 
were reported; however, almost half of respondents owned their own house and were 
employed. Employment type was not reported, therefore it is unclear whether the sample 
was truly representative of a low socioeconomic group.  
 
Roadshow intervention summary 
 
Behavioural/psychological domain data suggested that the roadshow intervention prompted 
cancer symptom presentation behaviour and reduced perceived barriers to cancer symptom 
presentation. However, small increases in symptom knowledge were observed and reach 
data suggested that the roadshow intervention may not have engaged those truly 
representative of a low socioeconomic group.  
 
6.4.2.6 Lung cancer interventions  
  
Of the 20 interventions identified in the scoping review, 13 interventions included lung 
cancer information. Five interventions focused specifically on lung cancer and were of 
various types: CBMSM intervention (n=3); mass media intervention (n=1); health check 
intervention (n=1). Eight multiple cancer interventions included a lung cancer component, 
mostly targeting persistent cough symptom. Seven were CBMSM interventions, and one was 
a health check intervention. Of the 13 lung cancer interventions, ten included an 
intervention evaluation and reported outcomes for clinical (n=7), psychological/behavioural 
(n=5), reach (n=3) and cost effectiveness (n=1) domains. Lung specific findings relevant to 
each domain are summarised below. 
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(a) Clinical domain 
 
Both mass media and CBMSM interventions were associated with improved referrals via the 
2WW pathway for suspected lung cancer (Cancer Research UK, 2014; Shankleman et al, 
conference poster; Lyon et al, 2009; Kane et al, 2009) and increases in the number of GP 
ordered chest X-rays (Campbell et al, 2013; Athey et al, 2012; Suckling, 2014; Ironmonger et 
al, 2014). Increases in the number of new cases of lung cancer diagnosed were observed 
following both mass media and CBMSM interventions (Cancer Research UK, 2014; Athey et 
al, 2012; Suckling, 2014; Lyon et al, 2009; Ironmonger et al, 2014), where a higher 
percentage of new lung cancer cases was reported following CBMSM interventions (Athey et 
al, 2012; Suckling, 2014; Lyon et al, 2009; Cancer Research UK, 2014). Both intervention 
types reported small improvements for staging data, where a stage shift towards earlier 
stage lung cancer was observed following mass media and CBMSM interventions 
(Shankleman et al, conference poster; Information Services Division Scotland, 2015c; 
Ironmonger et al, 2014) and an increase in the number of surgical resections was reported 
following a mass media intervention (Ironmonger et al, 2014). 
 
(b) Behavioural/psychological domain 
 
Improvements in lung cancer symptom knowledge were observed for both recalled and 
recognised symptoms following a mass media intervention (Ironmonger et al, 2014), and 
there were reports of lung symptom knowledge improvements after attending a Love Your 
Lungs health check intervention (British Lung Foundation, 2014). Lung symptom awareness 
remained stable post CBMSM intervention (Shankleman et al, conference poster). CBMSM 
and health check interventions reported more timely anticipated presentation for lung 
symptoms post intervention (Athey et al, 2012; Suckling, 2008; Cancer Research UK, 2014; 
British Lung Foundation, 2014), and a large 63% increase in the number of individuals 
presenting to the GP with the targeted symptoms was observed during a mass media 
intervention (Ironmonger et al, 2014).  
 
(c) Reach 
 
There was evidence to suggest that a lung cancer mass media intervention was most 
successful for improving clinical outcomes for high socioeconomic groups rather than low 
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socioeconomic groups, and that people from low socioeconomic groups were the least likely 
to recall an aspect of the intervention (Moffat et al, 2015). Reach data from a CBMSM 
intervention suggested that this method of intervention was successful for prompting lung 
cancer symptom presentation behaviour among low socioeconomic groups (Kane et al, 
2009).  
 
(d) Cost-effectiveness 
 
There was evidence to suggest that the mass media lung intervention was cost-effective in 
accordance with NICE threshold for incremental cost ratios and costs per quality-adjusted 
life years (Hinde et al, 2015).  
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Table 6.1 Table of included interventions 
Name of 
intervention  
Country 
(city) 
Cancer 
type 
(target 
symptoms) 
Intervention type  
Target group; delivery (method(s) of 
delivery, duration of intervention, cost); 
content (information included); HCPs.  
 
Evaluation  
Study design; data collection methods 
(prospective/cross sectional, questionnaire, interviews); 
outcome measures used (psychological/behavioural, 
clinical, reach); participants (sample size, age, gender, 
socioeconomic group); Cost –effectiveness  
Key findings  
Psychological/behavioural (symptom knowledge, 
actual or hypothetical symptom presentation); clinical 
(2WW referrals, number of new cancers detected, 
staging data; cost per new cancer diagnosis; surgical 
resection rate specific to lung cancer); reach (target 
group seen intervention; outcomes improved for target 
group) 
Be Clear on 
Cancer 
Bowel 
Campaign 
 
 
England 
(national 
campaign) 
Bowel 
(blood in 
poo, looser 
poo) 
National mass media intervention.  
 
Target group: Individuals over the age of 
55 from low socioeconomic groups.  
 
Delivery: Radio and TV adverts, posters, 
branded symptom cards, leaflets and 
referral cards, door drops. Used push-pull 
methods. Initial campaign ran for 8 weeks 
between February 2012 and March 2012. 
Reminder campaign between August 2012 
and September 2012.  
 
Content: Information about the 
symptoms of bowel cancer and when to 
go to the doctor with symptoms to 
promote earlier symptom presentation. 
Included wording designed to overcome 
barriers to symptom presentation.  
 
HCPs: Helped primary and secondary care 
physicians to prepare for increased 
presentations.  
Before and after study 
 
Psychological/behavioural: Participants given the CAM as 
part of the ONS survey in 2010 (pre campaign) and in 2012 
(post campaign) [1]: 
Symptom knowledge: Recall and recognition (one question 
on change in bladder/bowel habit, one question on non-
specific unexplained bleeding) [1]. Recall and recognition 
(two questions) [4].  
Barriers: Ten questions for barriers to symptom 
presentation [1] 
 
Clinical data:  
Referral data: 2WW referrals 3 months pre and 3 months 
post campaign [2].  
New cases of cancer diagnosed: Numbers of new cancer 
diagnoses 3 months before and 3 months post the 
campaign [2]. 
 
Reach: Collected occupation and educational attainment in 
CAM survey study [1].   
Door-to-door survey with a population representative 
sample of over 55’s pre and post campaign using the Bowel 
CAM [4].  
GP read codes from a sample of GP practices to examine 
the number of attendances for target symptoms [4]- 
collected socioeconomic group data (ABC1 or C2DE) for 
CAM and GP read codes [4]. 
2WW referral data analysed according to socioeconomic 
group data- 3 months pre campaign, 3 months post the first 
campaign then 8 months after the reminder campaign [3]. 
 
Psychological/behavioural:  
Symptom knowledge: Recall and recognition increased for 
change in bowel/bladder habit pre to post campaign (recall: 
21% pre-41% post, p<0.001; recognition: 87% pre-91% 
post, p<0.001). NS increase in recall and recognition for 
unexplained bleeding pre to post campaign (recall: 31% 
pre-33% post; recognition: 84% pre-87% post) [1]. Recall 
increased pre to post campaign for blood in stools (27% 
pre-42% post, p<0.001) and looser stools (10% pre-23% 
post, p<0.001) [4]. NS difference pre to post campaign for 
recognition of blood in stools, significant increase for 
recognition of looser stools from 17% pre-27% post 
campaign (p<0.001) [4].  
Barriers: NS difference between targeted barriers pre to 
post campaign [1].  
 
Clinical:  
Referral data: An increase of 59% for 2WW referrals 
observed pre to post campaign (p<0.01)* [2].  
New cases of cancer diagnosed: NS increase in the number 
of new bowel cancers diagnosed pre to post campaign [2].  
 
Reach: Low socioeconomic groups were less likely to report 
having seen the campaign adverts (47% for ABC1 vs 54% for 
C2DE; p<0.05) [4]. Symptom knowledge increased across all 
socioeconomic groups; however NS difference between 
groups [1,4]. Highest increase in the number of GP 
attendances with symptoms observed for GP practices in 
the most deprived quintile (72% vs 18%, p<0.001) [4]. 
However; secondary care services were accessed 
disproportionately by high socioeconomic groups with no 
increase in referrals among low socioeconomic groups [3].  
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Cost-effectiveness: Performed a cost analysis for cost per 
new cancer diagnosed pre to post campaign [2]. 
Cost-effectiveness: The cost per new cancer diagnosed 
rose from £7585.58 to £9662.72 pre to post campaign [2].  
Be Clear on 
Cancer Lung 
Campaign 
 
 
England 
(national 
campaign) 
Lung 
(cough for 
3 weeks or 
more) 
National mass media intervention 
 
Target group: Individuals over the age of 
55 from low socioeconomic groups.  
 
Delivery: Radio and TV adverts, posters, 
branded symptom cards, leaflets and 
referral cards, door drops. Used push-pull 
methods. Ran for 8 weeks between May 
2012 and June 2012 
 
Content: Information about the 
symptoms of lung cancer and when to go 
to the doctor with symptoms to promote 
earlier symptom presentation. Included 
wording designed to overcome barriers to 
symptom presentation. No mention of 
smoking.  
 
HCPs: Helped primary and secondary care 
physicians to prepare for increased 
presentations. 
Before and after study 
 
Psychological/behavioural:  
Symptom presentation: GP read codes collected for target 
symptoms over the 8 weeks of the campaign compared to 
the previous year, no demographic data collected [5].  
Participants given the CAM as part of the ONS survey in 
2010 (pre campaign) and in 2012 (post campaign) [1]. A 
population sample of over 55’s given the Lung CAM before 
and after the intervention [5]. Door-to-door survey with a 
population representative sample of over 55’s pre and post 
intervention using the Lung CAM [4]:  
Symptom knowledge: Recall and recognition. CAM included 
one question on cough/hoarseness, one question on non-
specific unexplained bleeding 
Barriers: 10 questions in CAM for barriers to symptom 
presentation  
 
Clinical:  
Referral data: Number of 2WW referrals to secondary care 
collected monthly from January 2010 to November 2012 
[5].   
The number of GP ordered CXRs and CT scans performed 
were collected from the intervention period and compared 
to the previous year [5].  
New cases of cancer: The numbers of new diagnoses of 
lung cancer were collected in the 2 years preceding the 
campaign and the campaign period [5]. 
Staging data: Staging data and one year survival data were 
collected in the 2 years preceding the campaign and the 
campaign period [5]. 
 
Reach: Collected occupation and educational attainment 
[4]. Collected socioeconomic group data (ABC1 or C2DE) 
[4]. GP read codes used to examine the number of 
attendances for target symptoms-collected socioeconomic 
group data by postcode [4].  
 
Cost-effectiveness: Mathematical modelling for cost-
effectiveness ratio to costs per quality-adjusted life years 
[6].  
Psychological/behavioural:  
Symptom presentation A statistically significant increase of 
63% (p<0.001) for patients visiting their GP with a cough 
symptom was observed pre to post campaign [5]. 
Symptom knowledge: Recall of cough as a symptom of lung 
cancer increased pre to post campaign (54-64%, p<0.001), 
NS increase for recall of prolonged/persistent cough (12-
15%), significant increase of recognition of 
prolonged/persistent cough (18-33%, p<0.001) [5]. Recall 
and recognition of cough/hoarseness increased pre to post 
campaign (recall: 18-26%, p<0.001; recognition: 67-78%, 
p<0.001) [1]. NS increase recall and recognition for 
unexplained bleeding pre to post campaign (recall: 31-33%; 
recognition: 84-87%) [1]. Recall of cough/hoarseness 
increase 41-50% pre to post campaign, recognition NS [4].   
Barriers: NS difference between targeted barriers pre to 
post campaign [1].  
 
Clinical:  
Referral data: Number of 2WW referrals increased by 
31.8% (p<0.001), GP ordered CXR referrals increased by 
18.6% (p<0.001) and GP ordered CT scans increased by 
15.7% pre to post campaign (p<0.001) [5].  
New cases of cancer: Number of new lung cancers 
diagnosed increased by 9.1% (p<0.001) following the 
campaign. 
Staging data: A stage shift was observed where there was 
an increase of 3.1% (p<0.001) for the number of patients 
diagnosed with non-small cell lung cancer at stage one and 
a 3.5% decrease (p<0.001) in the number of patients 
diagnosed at stage four [5].  Number of surgical resections 
was increased by 2.3% (p<0.001) after the campaign [5].   
 
Reach: People from low socioeconomic groups were less 
likely to report having seen the campaign adverts (43% for 
ABC1 vs 49% for C2DE; p<0.05) [4]. Symptom knowledge 
increased across all socioeconomic groups; however NS 
difference between groups, therefore knowledge remained 
lowest among low socioeconomic groups [1,4]. Highest 
increase in GP attendances observed in the most affluent 
GP practice areas (67% vs 48%, p<0.01) [4]. 
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 Cost-effectiveness: An additional 178 quality-adjusted life 
years were gained following the national campaign [6]. This 
represents an incremental cost-effectiveness ratio of 
£18,173 per quality-adjusted life year gained [6]. 
Cancer 
Research UK 
Cancer 
Awareness 
Roadshow 
 
England 
(Midlands, 
Northwest, 
Northeast 
England)  
Common 
cancers (no 
specific 
symptoms) 
Roadshow 
 
Target group: Members of public in 
deprived areas.  
 
Delivery: Mobile roadshow which visits 
deprived areas. Qualified nurse trained in 
cancer awareness available at the 
roadshow to answer questions and offer 
individual tailored advice. Various leaflets 
available and given to members of the 
public attending the roadshow. Ongoing 
(since 2006). 
 
Content: Information about cancer 
including: cancer symptoms, cancer 
prevention, cancer screening and the 
benefits of early diagnosis. Designed to 
increase access to health services and 
prompt or encourage cancer symptom 
presentation, and reduce barriers to 
symptom presentation.  
Before and after study 
 
Psychological/behavioural: Some participants approached 
prior to roadshow and asked to complete CAM, others 
approached immediately after the roadshow and asked to 
complete CAM [7].   
Symptom presentation: Intentions to seek medical help for 
those who reported symptoms [7] 
Symptom knowledge: Recall and recognition [7] 
Barriers: Four barriers to cancer symptom presentation 
assessed [7] 
 
Reach: Demographics of those attending the roadshow 
(occupation) [7] 
Psychological/behavioural:  
Symptom presentation: 33.3% of those in the post 
roadshow questionnaire who disclosed a symptom 
intended to book an appointment with the GP to discuss 
the symptom**[7].   
Symptom knowledge: The post roadshow group recognised 
0.3 more symptoms than the pre-roadshow group 
(p<0.001; ηρ2=0.014) [7].  
Barriers: Small improvements for barriers to symptom 
presentation observed between groups: the post roadshow 
group were less worried about wasting the doctors time 
(20.4% vs 23.1%; OR=1.66, 95% CI=1.28-2.14, p<0.001), 
were more confident in reporting symptoms (12.6% vs 
17.9%; OR=1.54, 95% CI=1.10-2.15, p<0.05) and were less 
worried about what doctor might find (27.8% vs 38.1%; 
OR0.60, 95% CI, 0.47-0.87, p<0.001) [7].  
 
Reach: It was reported that the roadshow was well 
represented by low socioeconomic groups as assessed by 
occupation, however the majority of attendees were in 
employment and there is no data available for employment 
type [7] 
Cardarelli et 
al, 2011 [8] 
US (Dallas) 
 
Breast 
(target 
symptoms 
NR) 
Educational intervention  
 
Target group: African-American women 
from low income areas aged 40 and over. 
A lay health educator within the 
community was trained to help with 
recruitment. 
 
Delivery: Eight interactive sessions, each 
1.5h long over 8 weeks. Group based 
educational sessions. The intervention 
group was compared to the control group 
who received written breast health 
information.  
 
Content: Information about breast cancer 
prevention, the importance of early 
Two arm non-randomised trial  
 
Psychological/behavioural: Questionnaire data were 
collected at baseline (at the start of the first intervention 
session) and post intervention (week 8 of the intervention- 
the final session) from 59 women in the intervention arm 
and 60 women in the control arm [8]. 
Symptom knowledge: It is reported that data for breast 
cancer knowledge were collected. No further information 
[8].  
Beliefs: It is reported that data for attitudes towards breast 
cancer were collected. No further information [8].  
 
Psychological/behavioural:  
Symptom knowledge: A significant 0.72 point increase 
(p<0.01)* in breast cancer knowledge was observed in the 
intervention group compared to the control group [8].  
Beliefs: Decreases in fearful and fatalistic beliefs observed 
across both control and intervention groups between 
baseline and follow up (p<0.001)* [8].  
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detection, and breast screening. Two 
sessions included information about 
symptoms and the importance of early 
detection. Breast cancer survival 
testimonies were used throughout the 
intervention to deliver intervention 
messages.  
Detect 
Cancer Early 
Programme  
 
Scotland  Lung, 
breast and 
bowel 
(target 
symptoms 
NR) 
Community based multi-faceted social 
marketing intervention 
 
Target group: Designed to target the 
‘unworried well’ living in deprived 
communities.  
 
Delivery: Advertising (no further 
information), health stalls in shopping 
centres, pubs, bookies. Empowerment 
intervention ran between February 2012 
and March 2012. Tumour specific 
interventions for completed December 
2015. 
 
Content: Information designed to raise 
awareness of the benefits of earlier 
diagnosis of cancer, to tackle fear 
associated with going to the doctor, and 
prompt symptom presentation. The 
intervention used real stories from local 
people with cancer to communicate 
intervention messages. Key message: ‘The 
earlier the better’.  
 
HCPs: GP’s reminded of the guidelines for 
referral of suspected cancer. Diagnostic 
services in secondary care were helped to 
prepare for increased case load and to 
ensure there was sufficient capacity to 
provide patients with appropriate testing. 
 
 
 
 
  
Before and after study 
 
Clinical:  
Staging data: Collected at baseline (2010 and 2011) 
compared to the third year of intervention (2013 and 2014) 
[9].   
 
 
Clinical:  
Staging data: An increase of 6.5% for the number of people 
diagnosed at stage 1 for breast, lung and bowel cancer 
combined in year three of the intervention compared to 
baseline was observed** [9].  
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‘Don’t Be a 
Cancer 
Chancer’ 
Campaign 
 
England 
(Mancheste
r) 
Lung 
(target 
symptoms 
NR)  
Community based multi-faceted social 
marketing intervention 
 
Target group: Members of public living in 
deprived areas.  
 
Delivery: Intervention materials 
advertised on billboards, local press, and 
football matches. Leaflets and stationary 
with intervention messages were 
distributed within the community in local 
venues such as community centres and 
hairdressers. Local events including an 
event at a football club, road show at 
local supermarkets and markets across 
the area to create noise. Key intervention 
message: “Catching it early could save 
your life”. Ran January to June 2007 and 
again March to April 2009.  
 
Content: Information about the 
symptoms of lung cancer and information 
about when to go to the doctor to 
encourage earlier presentation of 
symptoms.  
Before and after study 
 
Clinical:  
Referral data: The number of non-urgent and urgent 2WW 
referrals 1 year before the intervention, during the 
intervention and one year post intervention [10] 
New cases of cancer: The number of new lung cancers 
diagnosed 1 year before the intervention, during the 
intervention and one year post intervention [10] 
 
Reach: The number of 2WW referrals by socioeconomic 
group (area level- GP practice in deprived/affluent area) 
[10] 
 
 
 
Clinical:  
Referral data: An increase in the number of non-urgent and 
2WW referrals for lung cancer was observed during the 
intervention period compared to the previous year (non-
urgent: 18.7% increase; 2WW: 51% increase)** [10] 
New cases of cancer: During the campaign, 40 new lung 
cancers were diagnosed, 8 new cases of lung cancer were 
diagnosed in the year after the intervention** [10]. Data 
not available for previous year 
 
Reach: Largest increase in 2WW referrals observed for 
those living in the most deprived areas [10].  
The Early 
Lung Cancer 
Detection in 
Corby 
Project 
 
England 
(Corby) 
Lung (non-
specific) 
Community based multi-faceted social 
marketing intervention 
 
Target group: Over 50’s from low 
socioeconomic groups with a cough 
lasting more than 3 weeks.  
 
Delivery: Intervention materials 
advertised on bus routes, beer mats, 
flyers, posters and pharmacy bags. Media 
events, outreach events used to deliver 
intervention messages. A walk-in chest x-
ray (CXR) self-referral programme was 
available. Community health educators 
were trained to deliver intervention 
messages. Ran over a 2 month period 
(dates NR).   
 
Before and after study/quasi-experimental methods 
 
Psychological/behavioural: Number of people attending 
the self-referral facility for CXR [11].  
 
Clinical: Comparison of intervention area to control area. 
Clinical data obtained from cancer registries and 
radiography services (1 year pre intervention and during 
intervention period) for:  
Referrals: The number of CXRs performed [11]. 
New cases of cancer: The number of new cases of lung 
cancer diagnosed [11]. 
 
Reach: Demographics of the individuals attending the walk 
in CXR facility [11].  
Psychological/behavioural: An initial large uptake of self-
referred CXRs was observed when intervention was 
launched [11]. In total, 407 men and women attended the 
CXR walk in clinic [11] 
 
Clinical:  
Referrals: Number of CXRs performed increased in the 
intervention area by 63% in comparison to the year prior to 
the intervention (21% increase in the control area). 
Difference between intervention and control area was 
statistically significant (x2=212.94, p<0.001) [11]  
New cases of cancer: Two new cases of lung cancer were 
diagnosed at walk in CXR clinic (both advanced stage) in 
intervention area (0.5% of x-rays taken, NS) [11] 
 
Reach: 86% of people attending the walk in CXR clinic were 
clinically eligible for CXR, mean age 64.7 and 37% were 
current smokers [11].  
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Content: Information about the 
symptoms of lung cancer and messages 
designed to change fatalistic beliefs about 
cancer. Information encouraging target 
group to attend self-referral for CXR. 
Early Lung 
Cancer 
Intervention 
in Doncaster  
 
England 
(Doncaster) 
Lung 
(cough for 
3 weeks or 
more) 
Community based multi-faceted social 
marketing intervention 
 
Target group: Men over 50 who were 
current or ex smokers who worked in 
heavy industry and who live in 
communities in the most disadvantaged 
areas (C2DE). Six intervention 
communities identified by geo-
demographic profiling software.  
 
Delivery: Intervention materials delivered 
through local press and radio advertising, 
adverts on beer mats, pharmacy bags and 
billboards. Coughing bus stops in target 
areas.  Face-to-face events in the target 
areas. Ran over a 6 week period from 
March 2008.  
 
Content: Cancer was not specifically 
mentioned in the campaign. The 
intervention materials prompted those 
with a cough for 3 or more weeks should 
visit their GP and request a CXR. No 
smoking references were made. 
 
HCPs: Brief educational intervention for 
HCPs to help them prepare for increased 
referrals 
Before and after/ quasi-experimental study 
 
Psychological/behavioural: Six intervention areas 
compared to 1 control area.  
Symptom presentation: Questionnaire data collected by 
telephone at baseline and 12 months post intervention to 
assess interventions to visit the GP with a cough symptom 
to request a CXR [12, 13]. Participants at baseline:  801 men 
and women over 50. Current smoker (18%), past smoker 
(51.5%), never smoked (30.5%). All low SES (group C2, D or 
E). 76% response rate. Participants post intervention: 800 
men and women over 50. Current smoker (16.75%), past 
smoker (53.75%), never smoked (29.5%). All low SES (group 
C2, D or E). 76% response rate [12, 13].  
 
Clinical: Six intervention areas compared to 1 control area.  
Referrals: The number of CXR referrals 1 year before and 
after the intervention [12, 13] 
New cases of cancer: Number of new cases of lung cancer 
diagnosed 6 weeks before and 6 weeks after intervention 
[12, 13] 
Stage shift: Collected 3, 6 and 12 months after the 
intervention [12, 13] 
 
Reach: Number of individuals from intervention 
communities who could recall an aspect of the intervention 
[12, 13] 
Psychological/behavioural:  
Symptom presentation: A small difference for intentions to 
visit GP between the intervention and control area was 
observed (intervention area 1.97 times more likely to 
report intentions to visit GP with a cough symptom 
compared to control area; 95% CI 1.18-3.31, p<0.01) [12, 
13]. An increase of 4% pre to post intervention in the 
intervention area was reported those who would go to the 
doctor with a cough symptom and a 12% rise for the 
number of individuals who would request a CXR from their 
GP** [12, 13] 
  
 
Clinical:  
Referrals: A 27% increase in CXR referrals was observed pre 
to post intervention in the target areas (19% increase in the 
control areas)*. A 20% increase in CXR referrals was 
maintained 1 year post intervention in the intervention 
areas (a 2% fall in the control areas). There was a 
statistically significant increase in the number of CXR 
referrals over time between intervention and control areas 
(IRR 1.22 (95% CI 1.12-1.33, p<0.001) [12, 13]. 
New cases of cancer: An increase of 27% new cases of lung 
cancer diagnoses was reported pre to post intervention in 
the target areas. A 10% fall in the number of new cases of 
lung cancer was observed in control practices. Comparison 
of change in diagnosis rates between intervention and 
control areas over time was NS (IRR 1.42 (95% CI 1.83-2.43, 
p=0.119) [12, 13].   
Stage shift: NS stage shifts (3m, 6m or 1 year), but increases 
in case loads were observed at all stages compared to the 
previous year [12, 13].  
 
Reach: 21% of those living in the target communities could 
recall an aspect of the intervention [12, 13].  
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East Sussex 
Downs and 
Weald PCT 
cancer 
awareness 
project  
 
England 
(East 
Sussex 
Downs and 
Weald) 
Prostate, 
lung, bowel 
(target 
symptoms 
NR) 
Community based multi-faceted social 
marketing intervention 
 
Target group: Men over the age of 45 
who were manual/routine workers, living 
in deprived areas.  
 
Delivery: Intervention messages delivered 
on posters, leaflets and toilet stickers. 
Intervention messages emailed to local 
workplaces. Health champions (members 
of the community) were recruited 
through focus groups and at work places. 
These tended to be key people in the 
community e.g. football coaches, pub 
landlords etc. and were trained to deliver 
cancer awareness sessions in the 
community and provide members of 
public with intervention information. Ran 
from April 2010- June 2010.   
 
Content: Information about the 
symptoms of bowel, lung and prostate 
cancer with clear messaging on when to 
go to the GP with symptoms and 
information designed to reduce the 
barriers to symptom presentation.  
 
HCPs: An adapted version of the cancer 
awareness training given to members of 
public was delivered to local GPs  
No evaluation reported  
The Early 
Presentation 
of Cancer 
Symptoms 
Collaborativ
e 
Programme  
England  
(NHS North 
East 
Lincolnshir
e) 
Core 
tumour 
sites: 
Bowel, 
Prostate, 
Gynaecolo
gical 
cancers, 
Lung.  
Temporary 
tumour 
sites: 
Community based multi-faceted social 
marketing intervention 
 
Target group: People living in deprived 
communities.  
 
Delivery: Volunteers (cancer champions) 
from the community were recruited to 
deliver brief interventions 
opportunistically with members of the 
community (cancer champions received a 
2 day brief intervention training). Leaflets 
Before and after/quasi-experimental study 
 
Psychological/behavioural: Used the CAM in 2010 with 
members of public in the intervention area and control 
areas. Also conducted a post intervention study using the 
CAM. Time scale not reported:  
Symptom presentation: Willingness to act on symptoms 
(anticipated symptom presentation behaviour) [14] 
Symptom knowledge: Recall and recognition measured by 
CAM [14] 
 
Clinical:  
Psychological/behavioural:   
Symptom presentation: Those in the intervention areas 
were more proactive in terms of seeking medical help for 
symptoms than those in the control areas (no further data 
reported) [14]. 11% increase in willingness to act up on 
cancer symptoms pre to post intervention**[14].  
Symptom knowledge: Those in the intervention areas were 
more aware of the symptoms of cancer (no further data 
reported). 15% increase in confidence to identify early 
cancer symptoms pre to post intervention** [14] 
 
Clinical:  
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Throat and 
Upper GI. 
(target 
symptoms 
NR) 
and posters were available with 
intervention messaging from community 
venues such as pubs and community 
centres. Ongoing (started in 2007). Grant 
awarded to the programme: £50,000.  
 
Content: Intervention materials and 
cancer champions were used to tackle 
taboo around cancer in the community to 
help people talk more about cancer, 
provide information for the symptoms of 
cancer and encourage individuals to seek 
medical help quickly with symptoms.  
Referrals: 2WW referral data for gynaecological, bowel, 
prostate and lung cancer was reported at baseline (3 years 
preceding intervention) and during the intervention 
(reported monthly) [14] 
 
 
 
 
Referrals: A substantial increase in 2WW referrals for 
gynaecological, bowel, prostate and lung cancer was 
reported (between 25 and 67% increase in 2WW referrals) 
**[14].  
 
 
Early 
presentation 
of Cancer 
Programme 
 
 
England 
(Lincolnshir
e)  
Breast, 
bowel, 
cervical, 
prostate 
and lung 
(target 
symptoms 
NR) 
Community based multi-faceted social 
marketing intervention 
 
Target group: People living in deprived 
communities  
 
Delivery: Full time paid development 
workers and trained lay volunteers 
recruited to communicate intervention 
messages and encourage people in the 
community to go to the doctor with 
symptoms (volunteers received a 10 hour 
accredited training course). Leaflets and 
posters in community venues e.g. 
workplaces, pubs. Included intervention 
messages and were replenished by lay 
volunteers. Some communities hosted 
cancer stalls at local markets, events at 
local community venues such as libraries 
or hairdressers; other communities ran 
awareness sessions. Symptom check lists 
given to members of the community to 
take to the doctors. Ran from 2009-2014.  
 
Content: Information about the 
symptoms of cancer and when to go to 
the doctor with symptoms to prompt 
more timely cancer symptom 
presentation. Messaging to reduce 
negative beliefs about cancer and to 
No evaluation findings. It is reported that cancer awareness 
questionnaires were carried out at baseline and 6 month 
follow up. Contacted but no reply.   
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reduce stigma associated with cancer.   
 
HCPs: Worked with GPs to raise 
awareness of the symptoms of cancer and 
to increase the use of 2WW referrals.  
The 
Improvemen
t Foundation 
Health 
Communities 
Collaborativ
e 
Programme  
England 
(20 Primary 
Care Trusts 
in 60 
specific 
communiti
es)  
Lung, 
Breast, 
Bowel 
(target 
symptoms 
NR) 
Community based multi-faceted social 
marketing intervention 
 
Target group: People living in one of 60 
deprived communities in England  
 
Delivery: Community nurses recruited to 
deliver locally tailored programmes in the 
area. Mode of delivery varied per area, 
examples include: symptom awareness 
games, face-to-face events in community 
centres, pubs, bingo halls. Posters in GP 
surgeries to encourage people to talk 
about symptom concerns. Ran from April 
2002 to February 2010 
 
Content: Information designed to 
increase cancer symptom knowledge, 
information on when to seek medical help 
for symptoms, the benefits of early 
diagnosis and information to modify 
negative beliefs about cancer 
 
HCPs: Work with GP’s to improve earlier 
diagnosis and increase referrals to 
secondary care 
Before and after study  
 
Clinical:  
Referrals: Baseline (12 months before intervention) and 1 
year into the intervention GP 2WW referrals to secondary 
care [15].  
New cancers diagnosed: Number of new cases of cancer 
collected  at baseline (12 months before intervention) and 
1 year into the intervention [15].  
 
 
Clinical:  
Referrals: A significant increase of 2WW referrals for bowel 
(27.7%; x2=22.193, df=1, p<0.001) and lung (29.2%; 
x2=8.886, df=1, p<0.01) cancer from baseline to during the 
intervention. A NS 7.3% increase for 2WW referrals for 
breast cancer [15].  
New cancers diagnosed: The number of new cancers 
diagnosed increased significantly from baseline to during 
the intervention for bowel (27.4%; x2=4.687, df=1, p<0.05) 
and lung (28%; x2=9.178, df=1, p<0.01) cancer. A NS 3.5% 
increase for new breast cancers diagnosed [15].  
Love your 
Lungs 
campaign  
Wales 
(South 
Wales) 
Lung 
(cough, 
wheezi-
ness, 
breathle-
ssness) 
Health check 
 
Target group: Areas where incidence was 
highest for lung cancer, mainly areas of 
deprivation.  
 
Delivery: Three events offering a free lung 
health check to members of the public 
(spirometry test) by local respiratory 
HCPs. Event advertised through local GP 
practices and pharmacies in the target 
areas on flyers and posters and local press 
Post intervention questionnaire 
 
Psychological/behavioural: Individuals who received a free 
health check were sent an evaluation form in the post (23% 
response rate):  
Symptom presentation: Self-report if they had been to the 
GP with their referral letter [16] 
Symptom knowledge: Self-report if they believed their 
knowledge of cancer symptoms had improved after 
attending the health check [16] 
 
Reach: Health check attendee demographics collected 
Psychological/behavioural:  
Symptom presentation: 85% of those who returned the 
questionnaire and received a referral letter had been to see 
their GP [16] 
Symptom knowledge: 60% of those who were screened 
agreed or strongly agreed they knew more about lung 
cancer following the intervention**[16]. 62% of those who 
were screened agreed or strongly agreed that the event 
helped them to learn more about the signs and symptoms 
of lung cancer* [16].  
 
Reach: 72% of those screened were over 50. 51% were 
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(local TV, local newspapers) and social 
media. Health check event dates in 
October 2014 and November 2014.  
 
Content: Event advertising contained 
information about the health check event 
with 3 target symptoms (cough, 
wheeziness, breathlessness), information 
about the benefits of early diagnosis and 
advice to get the symptoms checked by 
GP or go to the local event. For those who 
attended the event and received the 
health check, a referral letter was given to 
them to take to the GP if necessary and 
symptom awareness leaflets. Those who 
were not screened were given a leaflet 
with lung cancer symptoms and when to 
go the doctor with symptoms.  
(smoking status and occupation) [16] 
 
non-smokers, 34% were ex-smokers, 15% were current 
smokers. 26% had previously worked in heavy industry. (no 
further demographics reported) [16] 
Lowry et al, 
2009; Lowry 
et al, 2011  
England 
(Newcastle 
and 
Gateshead) 
Oral (non-
specific) 
Community based multi-faceted social 
marketing intervention 
 
Target group: Individuals from low 
socioeconomic groups who were over 40 
and current smokers who drink more than 
the recommended allowance of alcohol 
and do not attend regular dentist check-
ups.   
 
Delivery: Intervention messaging 
delivered through local press, regional TV 
news, radio, posters in pharmacy 
windows, medical practices and 
community centres. Free oral cancer 
screening service. 
 
Content: Information about the 
symptoms of oral cancer and the voucher 
based system for target group to receive a 
free oral cancer clinical examination.  
 
HCPs: Sent training DVDs to improve 
communication and clinical examination 
skills  
No evaluation data for the outcomes of interest available   
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NAEDI local 
projects  
 
England 
(109 PCTs) 
Breast, 
bowel and 
lung (target 
symptoms 
NR) 
 
 
Community based multi-faceted social 
marketing intervention  
 
Target group: Defined areas within 109 
PCTs across England. Most projects were 
targeted at over 50’s. All projects were 
targeted at low socioeconomic groups.  
 
Delivery: Fifty-three individual projects. 
Most projects used high level advertising 
such as local TV, radio and press adverts 
to raise awareness. This was followed by 
more targeted face-to-face community 
outreach activities for specific sub groups. 
Most projects used information leaflets 
and posters combined with local events 
such as stalls or exhibitions in public 
spaces or supermarkets (34 projects), or 
talks in the community (29 projects). 29 
projects trained and recruited local 
community volunteers/ cancer champions 
to run stalls, deliver brief opportunistic 
behaviour change interventions with 
people in the community or top up 
leaflets/ poster displays in the 
community. Ran between October 2010 
and July 2011. Most projects ran for 6-8 
weeks. Cost: £9,000,000 for all projects. 
Each project could bid for up to £100,000. 
Successful projects ranged from £22,750 
to £100,000. 
 
Content: Local projects were designed to 
support the National Be Clear on Cancer 
campaigns at community levels and 
contained information about the 
symptoms of cancer and when to go to 
the doctor with a symptom. Most 
campaigns used the ‘Be Clear on Cancer’, 
‘Cough Cough’ and ‘Don’t be a cancer 
chancer’ materials. Some projects 
modified them to more relevant to the 
target community e.g. include local 
Before and after/quasi-experimental methods 
 
Psychological/behavioural: Used the CAM or Early 
Diagnosis of Cancer (EDC) survey. Survey timings for each 
are varied, but each PCT conducted a pre and post 
intervention CAM or EDC with all age groups or only over 
50’s within their target area depending on PCT area:  
Symptom presentation: Anticipated symptom presentation 
behaviour [17] 
Symptom knowledge:  Percentage of individuals correctly 
recalling symptoms (using an open question) [17] 
 
Clinical: Compared the 76 intervention PCTs to 73 PCT 
control areas for lung cancer. Compared the 77 
intervention PCT areas to 74 PCT control areas for bowel 
cancer. No data available for breast cancer. Also collected 
before and after clinical data (intervention period 
compared to the previous year):  
Referrals: 2WW referral data [17] 
New cases of cancer: Number of new cases of cancer from 
2WW referrals [17] 
 
Reach: Awareness of intervention content [17] 
Psychological/behavioural:  
Symptom presentation: Intentions to visit the GP within 1 
week of symptom experience remained stable pre to post 
intervention [17]. Four projects reported increased number 
of participants reporting intentions to visit the GP within 1 
week of symptom experience (range 4-24%; statistically 
significant increase for all 4 projects p<0.01), 6 projects 
reported a decrease in intentions (range 1-10%; a 
statistically significant decrease for intentions was reported 
for 2 projects, p<0.01) [17].  
Symptom knowledge: Symptom knowledge for lumps, 
bleeding and pain improved pre to post intervention 
(average changes of 1-2% more individuals recalling these 
symptoms post campaign)** [17].  
 
Clinical:  
Lung cancer 
Referrals: 9% increase in the number of individuals referred 
via the 2WW for suspected lung cancer (p<0.01) [17]. The 
control areas reported an increase of 7% in the number of 
individuals referred via the 2WW for suspected lung cancer 
[17]. At an area level, 24 projects reported an increase of 
2WW referrals from intervention period to the previous 
year (range: 2-44%), 10 projects reported a decrease (range 
2-17%), 3 projects reported no change [17].  
New cases of cancer: A 4% increase in the number of new 
lung cancer diagnoses following 2WW referral was 
reported compared to the control area which reported a 
1% increase [17]. At area level, 8 projects reported an 
increase in new lung cancers diagnosed (range 2-111%; 
statistically significant increase for one project, p<0.001); 
10 reported a decrease (range: 3-31%; statistically 
significant decrease for two projects, p<0.05), 1 project 
reported no change [17]. Western Cheshire and Cheshire 
West reported the best clinical results in terms of number 
of new lung cancer cases diagnosed [17].  
 
Bowel cancer  
Referrals: 16% increase in the number of individuals 
referred via the 2WW for suspected bowel cancer (p<0.01). 
In the control area a 13% increase in 2WW referrals was 
reported [17].  
At an area level, 25 projects reported an increase in 2WW 
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statistics.  
 
HCPs: 96% of projects included activity 
targeted at GPs to inform them of the 
intervention activity and ask them to 
display intervention materials in their 
practice. Some projects updated GPs with 
the signs and symptoms of cancer and 
reminded them of referral pathways and 
ensured they had capacity to cope with 
the impact of the project (increased 
patient presentations).  
 
referrals (range: 1-49%), 7 projects reported a decrease (1-
33%) [17].  
New cases of cancer: A 6% increase for the number of new 
diagnoses of bowel cancer was reported in the intervention 
PCTs compared to the control area PCTs which reported an 
increase of 0.6% [17]. At project level, 6 projects reported 
an increase in the number of people diagnosed with bowel 
cancer (range: 5-86%; NS), one project reported no change, 
5 reported decreases in the numbers of new diagnoses 
(range: 1-57%; statistically significant decrease for one 
project, p<0.05) [17]. Great Yarmouth and Waveney was 
most successful in increasing number of new cancers 
diagnosed [17].  
 
Reach: For projects which assessed awareness of 
campaigns, respondent awareness ranged from 11-71%. On 
average 39% of participants reported seeing an aspect of 
the intervention [17] 
 
 
Painting 
Stroud Pink 
England 
(Stroud, 
Gloustershi
re)  
Breast 
(target 
symptoms 
NR) 
Community based multi-faceted social 
marketing intervention 
 
Target group: Women from low 
socioeconomic groups.  
 
Delivery: Leaflets with intervention 
messaging. Pop up beauty salons called 
‘ladies lounges’ to recruit volunteers and 
create buzz about the project. Recruited 
32 volunteers from the community to 
help spread intervention messages 
through word of mouth, and run local and 
high street events (3 half day events). Ran 
from May 2010 to June 2010. Cost: 
£35,000 
 
Content: Information about early signs for 
breast cancer, when to go to the doctor 
with symptoms and to encourage others 
to go the GP if they have symptoms.  
 
 
No evaluation data available 
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The Small 
“c” 
Campaign  
 
England 
(London 
:Tower 
Hamlets, 
Hackney, 
Newham, 
Waltham 
Forest) 
Breast and 
lung 
(cough)  
Community based multi-faceted social 
marketing intervention 
 
Target group: Residents living in areas of 
deprivation. For breast: women aged over 
40 years old. For lung: smokers and ex-
smokers over 50.  
 
Delivery: Launch event, local and regional 
newspaper advertising, local TV and press 
releases. Interviews with oncologists and 
cancer survivors. In two areas, GP 
practices identified target groups and 
mailed letters, information sheets and 
symptom checkers to individuals. Printed 
resources included leaflets in pharmacies 
and stickers for cough medicine bottles. 
Local staff and volunteers were trained to 
deliver brief interventions 
opportunistically with members of the 
public. Various organisations of places in 
the community held local events  with 
information stalls or giving talks e.g. cafes, 
hairdressers.  Ran from June 2011-March 
2012. Cost £400,000 
 
Content: Information about the 
symptoms of cancer and the importance 
of going to see the doctor promptly with a 
symptom.  
 
HCPs: Pharmacists contacted to promote 
cancer awareness. GPs given information 
about the campaign, given health 
promotion materials and NICE guidelines 
reminders. Training and practice visits 
were performed.  
Before and after/quasi-experimental study  
 
Psychological/behavioural: CAM survey before 
intervention (2010) and after the intervention (2015).  
Symptom knowledge: Recall and recognition [18] 
 
Clinical: Time periods for clinical data collection not 
reported 
Referrals: 2WW referrals pre to post intervention [18] 
Staging data: Staging data collected pre to post 
intervention [18] 
 
Reach: No explanation for how reach was measured [18] 
Psychological/behavioural:  
Symptom knowledge: Increase in cancer symptom 
knowledge reported for the target communities [18]. 27% 
increase in recognition of breast cancer symptoms**[18]. 
NS difference in knowledge for lung cancer symptoms [18].    
 
Clinical:  
Referrals: Number of 2WW referrals for suspected lung and 
breast cancer increased by 44% and 22% respectively from 
pre to post campaign** [18] 
Staging data: 1% increase in the number of lung cancers 
diagnosed at an early stage reported, 4% decrease in the 
number of breast cancers diagnosed at advanced stage** 
[18] 
 
Reach: Reported that the intervention was effective at 
targeting those most at risk (no further data) [18] 
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Scott et al, 
2012b  
England 
(London) 
Oral (target 
symptoms 
not 
reported) 
Educational intervention  
 
Target group: Smokers living in a deprived 
area. Aged between 45 and 65.  
  
Delivery: Three arm trial: Leaflet only vs 
5-10 minute one-on-one session with 
trainee health psychologist and leaflet vs 
usual care.  
 
Content: Leaflet contained information 
about oral cancer symptoms, how to spot 
oral cancer and how to perform mouth 
self-examination (MSE). The one-on-one 
session assessed the individuals 
understanding of oral cancer symptoms, 
addressed individual barriers to help 
seeking, allowed the individual to practice 
MSE and encouraged timely cancer 
symptom presentation for symptoms.   
Randomised controlled trial (leaflet vs leaflet & one-to-one 
session vs control) 
 
Psychological/ behavioural:  
Questionnaire data (Knowledge and beliefs about Mouth 
Cancer scale and the temporal measure of help-seeking. 
Participants: leaflet only (n=42), leaflet & one-on-one 
(n=46), control (n=24). Men and women, mean age: 54 
years. All current smokers, 55% high alcohol dependency. 
Collected at baseline, post intervention and 1 month follow 
up to assess:  
Symptom presentation: Intentions to seek medical help 
with symptoms and confidence to seek medical help. 
Symptom knowledge: Recognition  
  
 
Psychological/ behavioural:  
Symptom presentation: Both intervention groups were less 
likely to anticipate delay and reported higher confidence in 
seeking medical help post intervention [19]. Compared to 
the control group (45%), those in the leaflet group (5%; 
X2=14.88, df=1, p<0.001) and those in one-on-one group 
(7%; X2=13.67, df=1, p<0.001) were less likely to anticipate 
delay; however this was not sustained at 1 month (NS 
difference between intervention groups) [19]. 
Symptom knowledge: Knowledge in both intervention 
groups was significantly higher at follow up compared to 
control group (leaflet: U=91.0, z=-4.9, p=0.00; one-on-one: 
U130.5, z=-4.4, p=0.00) (NS difference between 
intervention groups) [19].  
The Tenovus 
Health Check  
Wales 
(evaluation 
in South 
Wales) 
Common 
Cancer 
(persistent 
cough, 
lump(s), 
skin 
changes, 
sore or 
ulcer which 
will not 
heal, 
change in 
bowel 
habit, 
blood in 
faeces, 
problems 
urinating, 
unexplaine
d bleeding, 
difficulty 
swallowing, 
weight loss, 
Health Check 
 
Target group: Men and women, over 40’s 
living in deprived areas in Wales. 
 
Delivery: Intensive face-to-face, one-to-
one tablet based intervention and tailored 
consultation with a trained lay advisor. 
Ongoing, amended in 2015.   
 
Content: Questions to assess cancer-risk 
related behaviour and questions designed 
to identify current symptoms the 
individual has. In the one-on-one section, 
the individual is prompted to seek medical 
help for reported symptoms and given 
advice on what symptoms to look out for 
in the future and what to do if they 
experience a symptom. Information 
designed to reduce negative beliefs  about 
cancer.  
Evaluation ongoing.   
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unexplaine
d tiredness, 
loss of 
appetite, 
bloating, 
pain) 
The West of 
Scotland 
Cancer 
Awareness 
Project 
 
Scotland 
(West of 
Scotland)  
Oral 
(ulcers, 
sores, red 
or white 
patch, 
spots, 
lump(s), 
any 
persistent 
changes, 
change to 
the tongue) 
Regional mass media intervention.  
 
Target group: People aged 40-70  from 
low socioeconomic groups (C2DE) 
 
Delivery: TV and radio adverts, local and 
national press adverts, posters, leaflets 
and mail drops.  
 
Content: Oral cancer awareness, promote 
timely symptom presentation, early 
detection methods. Used a testimonial 
approach (using real people to tell their 
stories). Cost: £264,000 
 
Before and after/quasi-experimental methods 
 
Psychological/behavioural: Comparison of target area and 
control area. Participants: men and women from low 
socioeconomic groups (C2DE); baseline, (n=922), 7 month 
(n=934), 12 month (n=944). Age range: 40-70 years. A 3-
stage cross sectional tracking survey (baseline- before the 
campaign was launched, 7 month and 12 months post 
campaign). Face-to-face quantitative survey to assess:   
Symptom presentation: Intentions to seek medical help for 
symptoms targeted by the intervention [20] 
Symptom knowledge: Recognition of oral cancer symptoms 
targeted by the intervention [20] 
 
Reach: Awareness and recall of campaign materials.  
Psychological/ behavioural:  
Symptom presentation: At 12 month follow up, participants 
in the intervention group were more likely to report 
intentions to visit a GP with a symptom compared to 
control group (86% intervention area vs 77% in the control 
area; p<0.001)[20]. No difference in intentions to visit a 
dentist were observed between intervention groups [20]. 
Symptom knowledge: Awareness of ulcers and lumps as 
symptoms increased in the intervention group at both 
follow ups compared to control group (p<0.001). For other 
symptoms, short term knowledge was improved at first 
follow up compared to baseline in the intervention group, 
but this was not sustained at 12 month follow up [20]. 
 
Reach: Awareness of the campaign was higher in the 
intervention group compared to control group. TV 
advertising accounted for the largest media coverage [20]. 
 
[1] Power and Wardle, 2015; [2] Peacock et al, 2013; [3] Hall et al, 2015; [4] Moffat et al, 2015; [5] Ironmonger et al, 2014; [6] Hinde et al, 2015; [7] Smith et al, 2016; 
[8] Cardarelli et al, 2011; [9] Information Services Division Scotland, 2015c; [10] Kane et al, 2009; [11] Campbell et al, 2013; [12] Athey et al, 2012; [13] Suckling, 2008; 
[14] EPOC impact report; [15] Lyon et al, 2009; [16] British Lung Foundation, 2014; [17] Cancer Research UK, 2012; [18] Shankleman et al, conference poster; [19] 
Scott et al, 2012b; [20] Eadie et al, 2009; NS: Non-significant; *No further statistics reported; ** Statistics not reported
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6.4.3 Quality of included interventions 
 
In line with scoping review methods, intervention quality was not formally assessed using 
critical appraisal checklists such as the CASP tool. However, the quality of intervention 
development and evaluation was assessed in relation to the MRC framework for developing 
and evaluating complex interventions (Craig et al, 2008).  
 
6.4.3.1 Intervention development  
 
Interventions which conducted needs assessment studies prior to intervention 
development, in order to understand the processes underlying delayed cancer symptom 
presentation among those in the target group, were considered to be of higher quality. 
Needs assessments typically involved survey, interview or focus group studies to identify the 
barriers and facilitators to timely cancer symptom presentation and identify gaps in 
symptom knowledge among individuals in the target group or community. In addition, pre-
intervention studies that co-produced new intervention materials or adapted existing 
materials with participants from the target community or group, in order to increase the 
relevance and acceptability of the intervention, were of higher quality. Most interventions 
conducted pre-intervention studies with members of the target group, and were therefore 
judged to be of higher quality. Three lower quality interventions bypassed the development 
stage due to time and budget restrictions. These interventions often used intervention 
materials which were previously reported as successful in other similar communities. 
 
Interventions which explicitly identified and used relevant theory to develop the 
intervention were considered to be of higher quality. Five interventions reported 
intervention development using various theoretical frameworks such as Social Cognitive 
Theory (Bandura, 1991) and the Common Sense Model (Leventhal et al, 1980). One 
intervention used multiple behaviour change theories to underpin an oral cancer 
educational intervention (Scott et al, 2012b). These higher quality interventions provided a 
rationale for the choice of theory and a description of how theory was used to guide 
intervention development and content.  
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6.4.3.2 Intervention evaluation 
 
Higher quality studies involved efforts to conduct either RCTs or pragmatic controlled 
evaluations with a control area and/or control time period for comparison. Two higher 
quality studies comparing intervention with control areas reported demographic data to 
ensure that comparisons between similar areas were conducted (Eadie et al, 2009; Athey et 
al, 2012). Eight higher quality intervention evaluations collected data at multiple time points 
including baseline, during the intervention and at follow up (usually 3, 6 or 12 months post 
intervention) to assess longer term information retention and/or behaviour change. Six 
lower quality interventions collected evaluation data at one time point, or included a short 
term follow up measure (immediately post-intervention, up to one month post 
intervention), precluding comparisons between different time points to assess intervention 
effectiveness or assessments of long term retention of information.  
 
Questionnaire based intervention evaluations used a range of different measures, some of 
which were developed for the purposes of the study, therefore it was difficult to draw direct 
comparisons between interventions. Six higher quality evaluations used standardised 
measures such as the CAM (Stubbings et al, 2009). Two lower quality studies used methods 
of evaluation such as self-reported retrospective perceptions of symptom knowledge prior 
to the intervention, or did not collect or report follow up data regarding whether 
symptomatic participants made or attended an appointment with their GP. One lower 
quality evaluation compared questionnaire measure scores for a sample of participants who 
completed the measure before attending the Roadshow intervention, to a sample of 
participants who completed the measure after attending the Roadshow. One lower quality 
evaluation reported knowledge score increase; however did not report the total score or 
knowledge items assessed.  
 
Six lower quality intervention evaluations did not report participants’ socioeconomic or 
demographic characteristics, therefore it was unclear if those included in the intervention 
evaluation were representative of the target group or if the intervention was successful in 
terms of reach to low socioeconomic groups.  
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6.5 Discussion 
 
The present scoping review aimed to identify interventions designed to encourage timely 
cancer symptom presentation among low socioeconomic groups. The review included 
twenty interventions that used various methods of delivery to disseminate intervention 
messages. The majority of interventions included information about cancer symptoms 
and/or advice on when to visit the GP with symptoms. Few interventions aimed to explicitly 
break down barriers to cancer symptom presentation through campaign messaging or to 
modify negative beliefs about cancer. Finally, some interventions used push-pull methods to 
pull symptomatic individuals into primary care and push individuals to secondary care 
through incorporating HCP education into the intervention to increase referrals to secondary 
care and help prepare HCPs for increased capacity. The majority of interventions adopted a 
CBMSM approach, delivering intervention messages to members of the public using multiple 
methods of communication to increase intervention awareness and facilitate retention of 
intervention messages.  
 
CBMSM interventions and mass media interventions were successful for increasing the 
number of referrals for suspected cancer to secondary care, especially when push-pull 
methods were used. However, evidence for improvements in the number of new cases of 
cancer diagnosed and stage shift was mixed. Mass media interventions reported no or small 
increases in the number of new cases of cancer diagnosed and stage shift. Improved clinical 
outcomes were only observed among more affluent groups and there was evidence that the 
number of referrals was disproportionally biased towards more affluent groups (Hall et al, 
2015). There was limited evidence of reach and improved clinical outcomes for CBMSM 
interventions, since data were only reported from an intervention evaluation that reported 
an increase in referrals among the most deprived practice areas (Kane et al, 2009). CBMSM 
interventions were most successful for increasing the number of new cases of cancer 
diagnosed. There was evidence to suggest that the most successful interventions employed 
multiple methods of intervention message delivery and used push-pull methods.  
  
Evidence for improved psychological/behavioural outcomes was mixed, with small or no 
increases in symptom knowledge or anticipated symptom presentation reported across all 
intervention types. This could reflect the difficulties of measuring symptom presentation 
behaviour and the limitations associated with using proxy measures of symptom 
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presentation behaviour. CBMSM, educational and road show interventions reported limited 
success in improving cancer symptom knowledge, and there was evidence to suggest that 
knowledge was not sustained long term. Mass media interventions maintained the 
socioeconomic gradient for knowledge, where symptom knowledge remained poorest 
among low socioeconomic groups. There was evidence to suggest that the roadshow 
intervention reduced barriers to cancer symptom presentation, and that an educational 
intervention modified negative beliefs about cancer.  
 
One explanation for why outcomes were more improved for certain types of intervention 
than others is that interventions which are not targeted to a specific group or geographical 
area, such as mass media interventions, engage the ‘worried well’ rather than the target 
group or those at higher risk for developing cancer. There is evidence from other non-cancer 
health interventions which adopt a mass media approach that such interventions are 
unreliable in reaching the most disadvantaged groups (Hill et al, 2005). In addition, a review 
of public health interventions found evidence to suggest that mass media campaigns 
increased health inequalities for a range of health behaviours (Lorenc et al, 2012). The same 
review concluded that educational interventions and multi-component school and 
community based interventions were equivocal in terms of reducing health inequalities 
(Lorenc et al, 2012). Mass media interventions may fail to bring about change amongst low 
socioeconomic groups because they ignore the wider socio-environmental influences on 
health, thus not supporting behaviour change among these groups (Bambra et al, 2009; 
Hawe et al, 2009). In the context of cancer symptom presentation, it is likely that providing 
information about the symptoms of cancer and when to go to the doctor is not sufficient to 
effect change among a group of individuals who may report emotional barriers, such as 
fatalism, fear of what the GP might find, and difficulties with communication about 
symptoms. Therefore, Motivational aspects of the COM-B model must be addressed 
alongside Capability. In addition, a lack of risk information could prompt symptomatic 
individuals who are at low risk for cancer to present to the GP with symptoms, therefore 
improvements in clinical outcomes such as new cases of cancer diagnosed are not observed. 
Interventions which are not developed based on a theoretical and practical understanding of 
the needs and preferences of the target audience (Craig et al, 2008), and those that do not 
include relevant risk information, are likely to engage and prompt symptom presentation 
amongst the worried well. 
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Face-to-face tailored and targeted interventions, such as educational or health check 
interventions, or interventions which are targeted at individuals within a specific community 
and deliver intervention messages thorough multiple channels, such as CBMSM 
interventions, are likely to be most successful for targeting low socioeconomic groups. 
Through face-to-face interventions, messages can be tailored to the individual to overcome 
specific barriers and offer practical tailored advice about how to overcome barriers. CBMSM 
interventions can also be targeted to be culturally relevant to a specific community, 
delivered in a way that is culturally acceptable and involving repetition of messages to 
increase retention and salience of intervention messages.  
 
The use of volunteers or cancer champions to disseminate messages and deliver brief 
interventions with people in the community at local events is likely to be successful in 
offering tailored information, and has the potential to target those who are hardest to reach 
(Opportunity). Findings from Chapters 3, 4 and 5 suggested that social networks were a key 
barrier or facilitator to cancer symptom presentation, depending on the quality of advice 
given. There was evidence to suggest that seeking advice from family members or friends is 
the norm among participants, and can prolong cancer symptom presentation due to poor 
advice given as a result of poor knowledge, previous negative experiences in the health 
service or negative beliefs about cancer. Interventions included in the present review that 
used volunteers or cancer champions to deliver brief interventions tended to utilise 
opportunistic interactions with people at supermarkets or events, encouraging symptomatic 
individuals to visit the GP with symptoms. This strategy could be adapted to target harder to 
reach groups through their social networks through Opportunity, rather than 
opportunistically approaching them in the community. This peer educator approach has 
been used in various public health interventions to promote condom use among gay men in 
the United States and reduce smoking behaviour among school children in England and 
Wales (Hart and Elford 2003; Campbell et al, 2008). This approach was most successful for 
reducing smoking behaviour among school age children in the Welsh Valleys because of the 
strong social networks within the close-knit community (Campbell et al, 2008).  
 
6.5.1 Strengths and limitations of the current review  
 
The scoping review method was considered to be less restrictive than other review method 
such as systematic review, therefore allowing for the inclusion of interventions that would 
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otherwise be excluded. Although interventions from high income countries other than the 
UK were identified by the search, these were subsequently excluded because they focused 
on the whole population rather than low socioeconomic groups, harder to reach ethnic 
minority groups rather than specifically low socioeconomic groups, or screening uptake 
among low socioeconomic groups. Fewer smaller interventions of other high income 
counties were identified through search engine or key organisation websites. It is therefore 
possible that smaller interventions from other high income countries were not identified, 
since the search engine platform used was based in the UK. In addition, other social science 
academic database search engines were not searched, thus it is possible that further 
interventions were not identified by this review.  
 
6.5.2 Implications for intervention  
 
6.5.2.1 Content and mode of intervention delivery 
 
A more strategic and innovative approach is required for engaging people from a low 
socioeconomic group in a lung cancer awareness intervention or delivering intervention 
messages to them. Information provision alone may be insufficient to bring about behaviour 
change through increased Capability in this group. Symptom and action planning 
information should be coupled with information designed to modify negative beliefs about 
cancer and emphasise the benefits of early diagnosis (Motivation), educate regarding who is 
most at risk for developing lung cancer (Capability), and provide strategies to overcome 
reported barriers to symptom presentation and empower individuals to seek medical help 
for symptoms (Opportunity). An intervention could utilise strong social networks by actively 
encouraging individuals to disseminate intervention messages within the community 
(Opportunity). Such a strategy has the potential for intervention messages to reach 
individuals who are unlikely to attend a cancer intervention, and potentially increase 
intervention sustainability.   
 
6.5.2.2 Implications for intervention evaluation outcome methods and measures 
 
There is a need for controlled evaluations that measure and compare outcomes at various 
time points: before the intervention, at short term follow-up (up to 1 month post 
intervention) and in the longer term (6 or 12 months and beyond). Intervention evaluation 
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at long term follow up is not feasible within the boundaries of the current PhD, therefore 
data collection over two time points (before and after intervention) should be considered for 
intervention user testing. In addition, a controlled evaluation is desirable, although out of 
remit for this PhD.   
 
Choosing which domain outcome measure(s) to use to assess intervention effectiveness is 
complex and each measure has limitations. Interventions designed to target large audiences 
can measure clinical outcomes in a given community or area, assessing actual symptom 
presentation behaviour. Smaller scale interventions such as educational interventions which 
target few people in a community preclude the measurement of clinical outcomes, such as 
the number of new cancers diagnosed or actual symptom presentation behaviour through 
GP read codes, due to the relatively small number of cancer diagnosed per community. 
Instead, proxy measures which influence time to symptom presentation can be used to 
assess intervention effectiveness such as symptom knowledge, beliefs about cancer and 
barriers to cancer symptom presentation using standardised measures such as the CAM 
(Stubbings et al, 2009). These proxy measures can be used in combination with anticipated 
cancer symptom presentation behaviour, although there are limitations associated with 
measuring anticipated cancer symptom presentation where intentions may not accurately 
reflect actual behaviour. If the evaluation includes a long term follow up, self-reported 
actual symptom presentation behaviour can be measured.  
 
Findings from the present chapter will be used in combination with findings from Chapters 3, 
4 and 5 to develop an intervention designed to promote timely lung cancer symptom 
presentation among low socioeconomic groups. Intervention development will be guided by 
the Behaviour Change Wheel and MRC framework, described in Chapter 7.   
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Chapter 7 
Development of a community based group educational intervention designed to 
encourage timely lung cancer symptom presentation 
 
7.1 Chapter overview  
 
This chapter aims to describe the development of a community based group educational 
intervention designed to encourage timely lung cancer symptom presentation. Findings from 
the intervention development process using the Behaviour Change Wheel to facilitate 
selection of the format and content of the intervention are reported. Finally, the Behaviour 
Change Wheel will be critically evaluated for its usefulness as a framework for intervention 
development in the context of behaviour change for cancer symptom presentation.  
 
7.2 Introduction 
 
In 2015 the need to improve lung cancer outcomes was prioritised by the Welsh 
Government where lung cancer was considered a national priority, and was high on the 
policy agenda (Welsh Government, 2015). In the absence of a national lung cancer screening 
programme, encouraging individuals to present to their primary care doctor promptly with 
symptoms suggestive of lung cancer is a potential strategy to improve survival outcomes 
through earlier diagnosis. The rationale is that better lung symptom awareness and more 
positive beliefs about lung cancer may shorten the patient interval, which currently accounts 
for the longest period of time in the pathway from noticing a symptom and the start of 
cancer treatment (Lyratzopoulos et al, 2015).  
 
Findings from Chapter 6 suggested that lung specific mass media interventions using TV, 
radio or posters to distribute intervention messages to a large audience are ineffective at 
targeting those from low socioeconomic groups and have the potential to widen 
socioeconomic inequalities in cancer outcomes (Moffat et al, 2015). In order to encourage 
people from low socioeconomic groups to present to the doctor with symptoms of lung 
cancer, more targeted and innovative methods such as community group based educational 
interventions could be used to engage this group.  
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Lung cancer incidence is highest among low compared to high socioeconomic groups 
(WCISU, 2015a; Riaz et al, 2011) and in individuals over the age of 40 (Malhotra et al, 2016). 
Smoking is the leading cause of lung cancer (Malhotra et al, 2016), accounting for 
approximately 86% of cases (Cancer Research UK, 2015e). Lung cancer risk increases with 
the quantity of cigarettes smoked and the duration that an individual has smoked (Doll et al, 
2005; Pope et al, 2011). In comparison to never smokers, lung cancer risk is 39 times higher 
among individuals who smoke 42 cigarettes per day, and risk decreases as the number of 
cigarettes smoked per day is lowered (Pope et al, 2011). Although the risk of lung cancer is 
reduced for former smokers, they are still at increased risk in comparison to never smokers 
(Malhotra et al, 2016). Other non-smoking risk factors include working with occupational 
exposures such as asbestos and air pollutants such as coal fuelled fires in poorly ventilated 
houses in both smokers and never smokers (Malhotra et al, 2016). There is evidence to 
suggest that certain medical conditions which cause chronic inflammation, such as asthma 
or chronic obstructive pulmonary disease (COPD), increase lung cancer risk (Malhotra et al, 
2016).  
 
Intervention target group for this PhD were selected based the group of individuals for 
which lung cancer is most common (Malhotra et al, 2016) and the NICE guidelines for 
referral of suspected lung cancer (NICE, 2015). Although current or former smokers with pre-
existing lung co-morbidity are most at risk for lung cancer, they are often already 
symptomatic and potentially engaged in clinical interventions. Therefore the decision to 
target the intervention at current smokers, former smokers or family members of smokers 
who over the age of 40, living in deprived communities in Wales was made. Family members 
of smokers were included in order to utilise social networks to facilitate spread of 
knowledge gained from the intervention through social networks, and will be discussed in 
more detail later in this chapter.  
 
7.2.1 The Medical Research Council (MRC) framework  
 
The MRC framework was used to guide intervention development (Craig et al, 2008). This 
PhD reports findings from the first two MRC phases: intervention development and 
feasibility and piloting. Chapters 2 to 6 reported findings from the development phase, with 
relevant theories identified in Chapter 2, and the remaining chapters reported data from 
primary and secondary sources to identify the evidence base and understand what is driving 
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symptom presentation behaviour in low socioeconomic groups. The present chapter will 
report the development of the intervention using the Behaviour Change Wheel process 
(Michie et al, 2011). 
 
Whilst the MRC framework provides guidance on the processes which should be included at 
each stage of intervention development, there is little guidance within the framework on 
exactly how to develop and implement an intervention, how to select theory and what 
content should be included (Craig et al, 2008). Various checklists such as MINDSPACE 
(Institute for government, 2011) or frameworks such as intervention mapping (Bartholomew 
et al, 1998; Bartholomew et al, 2011) are available to support and guide intervention 
development. However, a systematic review of intervention development frameworks and 
checklists reported that most of the 19 included frameworks lacked comprehensiveness 
and/or coherence (Michie et al, 2011). Furthermore, few of the frameworks were 
underpinned by a model of behaviour and/or failed to involve adequate initial analysis of the 
target behaviour, which could explain the variable success of behaviour change 
interventions (Michie et al, 2011). In an attempt to overcome these issues, the Behaviour 
Change Wheel was developed from the existing frameworks and checklists to provide a 
comprehensive, coherent and theoretically grounded framework which can be applied to a 
wide range of behaviour change intervention contexts.  The Behaviour Change Wheel 
provides a systematic framework for the development of behaviour change interventions, 
underpinned by a single model of behaviour created from 83 theories of behaviour change 
(the COM-B model; Michie et al, 2011).  
 
7.2.2 The Behaviour Change Wheel  
 
As discussed in Chapter 1, the Behaviour Change Wheel provides researchers with a suite of 
tools to facilitate intervention development in three key stages (Michie et al, 2011). The 
systematic framework and comprehensive theoretical underpinning of the Behaviour 
Change Wheel were considered to be benefits of using this approach to intervention 
development. Therefore, the Behaviour Change Wheel was selected to facilitate 
intervention development for this PhD.  
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7.2.3 Aims and objectives 
 
This chapter aims to describe the development of a community group based educational 
intervention using the Behaviour Change Wheel in accordance with the MRC framework. 
There were three objectives: (1) to develop an intervention using the Behaviour Change 
Wheel and MRC framework; (2) to create intervention materials based on the results of the 
Behaviour Change Wheel intervention development exercise, and (3) to critically evaluate 
the Behaviour Change Wheel for its usefulness as a framework for intervention development 
in the context of cancer symptom presentation behaviour. 
 
7.3 Intervention development using the Behaviour Change Wheel 
 
There are three key stages in the intervention development process using the Behaviour 
Change Wheel (Figure 7.1).  Each of the processes involved at each stage are outlined in 
Table 7.1. 
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Figure 7.1 The Behaviour Change Wheel for intervention development (Michie et al, 2014) 
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Table 7.1 Stages of the Behaviour Change Wheel and processes involved at each stage   
Behaviour Change Wheel stage Processes involved at each stage 
Stage 1: Sources of behaviour (inner most 
circle)  
Identify target behaviour 
Understand the barriers and facilitators to 
the behaviour  
Map behavioural barriers and facilitators to 
TDF and COM-B model constructs 
Stage 2: Intervention functions (middle 
circle to identify intervention type). Use 
Behaviour Change Techniques Taxonomy 
(Michie et al, 2013) to identify intervention 
content  
Apply APEASE (Affordability, Practicability, 
Effectivenss and Cost-efffectiveness, 
Acceptibility, Side-effects/safety, Equity; 
Table 7.3) criteria to applicable intervention 
functions 
Apply APEASE criteria to relevant Behaviour 
Change Techniques Taxonomy (Michie et al, 
2013) 
Stage 3: Policy categories (outer most circle 
to identify how to implement the 
intervention and mode of delivery) 
Apply APEASE criteria to applicable policy 
categories 
Apply APEASE criteria to all modes of 
delivery   
 
Figure 7.1 is a pictorial representation of the Behaviour Change Wheel (Michie et al, 2011) 
and corresponds to each of the stages in Table 7.1. The researcher is required to start with 
the inner most circle (sources of behaviour) to identify the potential sources of behaviour. 
The researcher is then required to work their way out to the outer circle to identify 
intervention type (intervention functions) and finally how to implement the intervention 
(policy categories). The results from each stage determine which aspects are considered at 
the next stage. These will be outlined below alongside findings from each stage. 
 
7.3.1 Stage 1: Sources of behaviour 
 
A ‘behavioural diagnosis’, defined as an analysis of the target behaviour, was performed to 
identify the potential sources of behaviour and to understand what drives behaviour in the 
context of timely lung cancer symptom presentation among low socioeconomic groups. 
Behavioural diagnosis involved mapping barriers and facilitators to lung cancer symptom 
presentation to the TDF and COM-B model constructs. The TDF provides a more granular 
level to facilitate understanding of the COM-B constructs and mapping of 
barriers/facilitators to each COM-B construct. Findings from studies of the barriers and 
facilitators to cancer symptom presentation among low socioeconomic groups were used in 
this part of the Behaviour Change Wheel process. These included the systematic review 
(Chapter 3), and findings from qualitative interviews (Chapter 4) and focus groups (Chapter 
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5). Although the latter studies were not specific to lung cancer, lung-specific barriers and 
facilitators were extracted and used in the present intervention development study. All 
barriers and facilitators to lung cancer symptom presentation were listed and grouped under 
sub-headings, for example ‘fear of a diagnosis of lung cancer’ and ‘shame associated with 
lung cancer’ were grouped under the sub-heading ‘emotional barriers’ (see Appendix 23 for 
all barriers/facilitators). A total of 77 barriers and facilitators to the target behaviour (timely 
lung cancer symptom presentation among low socioeconomic groups) were identified 
through data sources (see Appendix 23). These were grouped under eight sub-headings (see 
Appendix 23). 
 
All barriers and facilitators to behaviour were categorised as ‘modifiable’ or ‘non-
modifiable’. Modifiable barriers and facilitators were those which could be targeted during 
the intervention, for example a modifiable barrier might be ‘poor knowledge of the 
symptoms of lung cancer’ which can be addressed by provision of information about lung 
cancer symptoms. Non-modifiable barriers were those which were considered beyond the 
scope of the current intervention, for example ‘interpersonal skills of GP’ (see Appendix 23 
and Table 7.2 for the modifiable barriers/facilitators).  A total of 50 barriers/facilitators to 
the target behaviour were considered to be modifiable, therefore 27 barriers/facilitators 
were excluded (see Appendix 23 and Table 7.2).  
 
Each modifiable barrier and facilitator to lung cancer symptom presentation was then 
individually mapped to at least one of the 14 domains in the TDF described in Chapter 2 
(Cane et al, 2012) and the corresponding COM-B model construct (Michie et al, 2011), 
according to definitions provided in Chapter 2. For example ‘fear of a diagnosis of lung 
cancer’ was mapped to the TDF domains of ‘emotion’ and ‘beliefs about consequences’ and 
the COM-B constructs of automatic and reflective motivation, respectively. The mapping 
process was undertaken using a Microsoft Excel spreadsheet. No dual coding of 
barriers/facilitators was performed; however, supervisors checked findings once barriers 
and enablers were mapped to the TDF and COM-B constructs. The sources of behaviour 
refer to the modifiable barriers and enablers which have been identified under the TDF 
domains and corresponding COM-B model constructs (Table 7.2).  
 
Frequencies of modifiable barriers/facilitators according to TDF domain headings were as 
follows: knowledge (n=16); skills (n=11); memory, attention and decision processes (n=16); 
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behavioural regulation (n=11); social influences (n=6); environmental context and resources 
(n=4); reinforcement (n=0); emotion (n=14); social/professional identity (n=1); beliefs about 
capabilities (n=7); optimism (n=1); beliefs about consequences (n=18); intentions (n=8); 
goals (n=1). For the corresponding COM-B construct, frequencies were as follows: Capability 
(n=57: psychological capability, n=57; physical capability, n=0), Opportunity (n=12: social 
opportunity, n=8; physical opportunity, n=4) and Motivation (n=51: automatic motivation, 
n=14; reflective motivation, n=37).  
 
The findings suggested that psychological capability, social and physical opportunity, and 
automatic and reflective motivation are relevant sources of behaviour in the context of 
timely lung cancer symptom presentation, and could potentially be modified in order to 
bring about behaviour change (Table 7.2).  
 
Table 7.2 Modifiable barriers and facilitators to timely lung cancer symptom presentation 
behaviour and corresponding TDF domain and COM-B model constructs (sources of 
behaviour) 
Barrier/facilitator to timely lung 
cancer symptom presentation 
behaviour 
TDF domain(s) COM-B model 
construct(s) 
Individual characteristics  
Smoking behaviour Knowledge; Skills; Behavioural regulation Psychological Capability 
Stoicism  Social/professional identity Reflective Motivation 
Cancer knowledge   
Knowledge of the symptoms of lung 
cancer 
Knowledge  Psychological Capability 
Perceptions of symptom severity Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Lack of pain associated with lung cancer 
symptoms 
Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Belief lung cancer is symptomless Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Number of symptom(s) Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Worsening of symptom(s)/symptom(s) 
impacting on daily life 
Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Duration of symptoms(s) Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Symptom type (vague e.g. persistent 
tiredness vs specific e.g. haemoptysis) 
Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Attribute symptom(s) to smoking habit Memory, attention and decision processes Psychological Capability 
Attribute symptom(s) to co-morbidity Memory, attention and decision processes Psychological Capability 
Attribute symptom(s) to age Memory, attention and decision processes Psychological Capability 
Perceptions of the causes of symptoms Knowledge Psychological Capability 
Perceptions of individual risk of 
developing lung cancer 
Knowledge; Memory, attention and 
decision processes 
Psychological Capability 
Self-efficacy/skills 
State specific self-efficacy Skills Psychological Capability 
Confidence when communicating Skills; Beliefs about capabilities Psychological Capability; 
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symptoms to the GP  Reflective Motivation 
Listening skills during an appointment 
with the doctor 
Skills; Beliefs about capabilities Psychological Capability; 
Reflective Motivation 
 
Ability to articulate symptom concerns  Knowledge; Skills; Beliefs about 
capabilities 
Psychological Capability; 
Reflective Motivation 
Knowledge of what to do when the 
individual experiences a symptom(s) 
Knowledge; Skills; Memory, attention and 
decision processes; Behavioural 
regulation; Beliefs about capabilities 
Psychological Capability; 
Reflective Motivation 
Knowing how to book an appointment 
with the doctor  
Knowledge; Skills; Beliefs about 
capabilities 
Psychological Capability; 
Reflective Motivation 
Health information seeking Knowledge; Skills; Beliefs about 
capabilities 
Psychological Capability; 
Reflective Motivation 
Health service factors  
Concerns about wasting GP time Skills; Social influences; Beliefs about 
capabilities 
Psychological Capability; 
Social Opportunity; 
Reflective Motivation 
Perception the GP cannot help/resolve 
the symptom(s) 
Knowledge; Memory, attention and 
decision processes; Optimism 
Psychological Capability; 
Reflective Motivation 
Worry about being perceived as a 
hypochondriac  
Social influences; Beliefs about 
consequences  
Social Opportunity; 
Reflective Motivation 
Worry about being told to stop smoking Beliefs about consequences Reflective Motivation 
Beliefs about lung cancer/treatments  
General fatalistic beliefs about cancer 
(no cure, death sentence, bad luck) 
Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
The belief that lung cancer is a fatal 
disease 
Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
The belief that there is no treatment for 
lung cancer 
Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
Fear of the treatments for lung cancer  Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
Beliefs about early diagnosis Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
Community factors/competing priorities 
Using a lay system of 
healthcare/symptom disclosure 
Skills; Memory, attention and decision 
processes; Social influences; 
Environmental context and resources  
Psychological Capability; 
Social Opportunity; 
Physical Opportunity 
Cultural messages to reduce GP 
consultation behaviour 
Social influences; Beliefs about 
consequences 
Social Opportunity; 
Reflective Motivation 
Emotional barriers 
 
Shame Emotion; Social influences Automatic Motivation; 
Social Opportunity 
Stigma associated with lung cancer  Social influences; Beliefs about 
consequences 
Social Opportunity; 
Reflective Motivation 
Fear of a diagnosis of lung cancer  Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
Worry about what the doctor might 
find  
Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
Fear of diagnostic tests  Emotion; Beliefs about consequences Reflective Motivation; 
Automatic Motivation 
Embarrassment around disclosure of 
symptoms 
Social influences; Emotion; Beliefs about 
consequences 
Social Opportunity; 
Reflective Motivation; 
Automatic Motivation 
Fear of the unknown  Emotion Automatic Motivation 
 
Responses to symptoms/behavioural response 
Avoidance Behavioural regulation; Emotion Psychological Capability; 
Automatic Motivation 
Denial  Behavioural regulation; Emotion Psychological Capability; 
Automatic Motivation 
Watchful waiting Memory, attention and decision Psychological Capability; 
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processes; Behavioural regulation; 
Intentions 
Reflective Motivation 
Self-management/self-medication  Behavioural regulation; Beliefs about 
consequences; Intentions 
Psychological Capability; 
Reflective Motivation 
Use of over the counter medicines Behavioural regulation; Beliefs about 
consequences; Intentions 
Psychological Capability; 
Reflective Motivation 
Belief that the symptom will resolve on 
its own without medical intervention  
Behavioural regulation; Beliefs about 
consequences; Intentions 
Psychological Capability; 
Reflective Motivation 
Use of traditional herbal medicines Behavioural regulation; Beliefs about 
consequences; Intentions 
Psychological Capability; 
Reflective Motivation 
Appointment booked for another 
reason (piggybacking) 
Behavioural regulation; Environmental 
context and resources; Intentions 
Psychological Capability; 
Physical Opportunity; 
Reflective Motivation 
Wait for another symptom/health 
complaint to appear  
Behavioural regulation; Environmental 
context and resources; Intentions 
Psychological Capability; 
Physical Opportunity 
Reflective Motivation 
Intention to act on symptom(s) (if 
symptom persists for three weeks) 
Knowledge; Skills; Memory, attention and 
decision processes; Behavioural 
regulation; Social influences; 
Environmental context and resources; 
Emotion; Beliefs about consequences; 
Intentions; Goals 
Psychological Capability; 
Social Opportunity; 
Physical Opportunity; 
Automatic Motivation; 
Reflective Motivation 
 
7.3.2 Stage 2: Interventions functions and content 
 
Stage 2 of the Behaviour Change Wheel process involves identification of the potential type 
and content of the intervention. The types of interventions considered at Stage 2 are 
determined by the findings at Stage 1 where according to the framework, certain types of 
interventions should be considered depending on which sources of behaviour are relevant in 
this context. The intervention functions matrix (Figure 7.2) was used to identify which of the 
nine intervention functions should be considered according to the sources of behaviour. 
Psychological capability, Physical Opportunity, Social Opportunity, Automatic Motivation and 
Reflective Motivation were identified as sources of behaviour (Table 7.2). The intervention 
functions ‘education’, ‘persuasion’, ‘incentivisation’, ‘coercion’, ‘training’, ‘restriction’, 
environmental restructuring’, ‘modelling’ and ‘enablement’ were therefore considered 
(Figure 7.2, shaded boxes).  
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Psychological 
capability x        x        x 
Physical 
opportunity          x  x  x    x 
Social 
opportunity            x  x  x  x 
Automatic 
motivation    x      x    x  x  x 
Reflective 
motivation  x  x               
Shading represents the intervention functions that were considered against the APEASE criteria based on findings 
at Stage 1. Each ‘x’ represents intervention functions considered most relevant in this context using the APEASE 
criteria. 
Figure 7.2 Intervention functions matrix of links between COM-B and intervention functions 
(adapted from Michie et al, 2014, p116).  
 
The APEASE criteria (Table 7.3) were applied to all potential intervention functions (Figure 
7.2). This means that each intervention function type identified by the matrix was 
considered and a judgement made to assess the suitability of intervention type according to 
affordability, practicality, cost effectiveness, acceptability to relevant stakeholders, whether 
it would produce any unwanted side effects, and whether it would create disparities in 
health between different sectors in society.  
 
 
 
 
 
222 
 
Table 7.3 The APEASE criteria and definitions (adapted from Michie et al, 2014, page 23-24)  
Criterion  Description 
Affordability An intervention is affordable if within acceptable budget it can 
be delivered to, or accessed by, all those whom it would be 
relevant or of benefit.  
Practicability  The extent that the intervention can be delivered as designed 
through the means intended to the target population. E.g. an 
intervention may be effective when delivered by highly 
selected and trained staff and extensive resources, but in 
routine clinical practice this may not be achievable.  
Effectiveness and cost-
effectiveness  
Effectiveness refers to the effect size of the intervention in 
relation to the desired objectives in the real world context. It is 
different from efficacy which refers to the effect size of the 
intervention when delivered under optimal conditions in 
comparative evaluations.  
Cost-effectiveness refers to the ratio of effect (in a way that 
has to be defined, and taking into account of differences in 
timescale between intervention delivery and intervention 
effect) to cost. If two interventions are equally effective then 
clearly the most cost-effective should be chosen.  
Acceptability  The extent to which an intervention is judged appropriate by 
relevant stakeholders (public, professional and political). 
Acceptability may differ for different stakeholders. 
Interventions that appear to limit acceptability on the part of 
the target group are often only considered acceptable for 
more serious problems.  
Side-effects/safety An intervention may be effective and practicable, but have 
unwanted side-effects or unintended consequences. These 
need to be considered when deciding whether or not to 
proceed.   
Equity  An important consideration is the extent to which an 
intervention may reduce or increase the disparities in standard 
of living, wellbeing or health between different sectors of 
society.  
 
Incentivisation was considered unaffordable, impractical and not cost-effective. Coercion 
was considered to be not acceptable or practical. According to the APEASE criteria, 
therefore, it was considered that the intervention functions of education, persuasion, 
training, enablement, modelling and environmental restructuring could be used in the 
context of encouraging early lung cancer symptom presentation in low socioeconomic 
groups (Figure 7.2).  
 
Intervention functions that were considered suitable according to the APEASE criteria were 
then used to identify potential intervention content using the Behaviour Change Techniques 
Taxonomy.  The Behaviour Change Techniques (BCT) Taxonomy (Michie et al, 2013; Michie 
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et al, 2014, p259-283) is a list of techniques which can be used in interventions to bring 
about behaviour change. It is a separate tool developed from existing taxonomies and 
checklists (Michie et al, 2013), and is formally linked to the Behaviour Change Wheel 
through the intervention functions.  Suggestions for which behaviour change techniques to 
consider are based on the intervention functions identified in Stage 2 of the Behaviour 
Change Wheel. The BCT Taxonomy lists the most frequently used behaviour change 
techniques for each intervention function.  Potential behaviour change techniques for each 
candidate intervention function were considered against the APEASE criteria to assess 
suitability of that particular behaviour change technique in the context of promoting timely 
lung cancer symptom presentation behaviour.  
 
Thirteen behaviour change techniques were identified which could be used in this context 
(Table 7.4). These were as follows: goal setting (behaviour), problem solving, action 
planning, self-monitoring of behaviour, monitoring of outcome(s) of behaviour by others 
without feedback, social support (unspecified), social support (practical), instruction on how 
to perform behaviour, information about health consequences, salience of consequences, 
information about social and environmental consequences, prompts and cues, and credible 
sources. For example, for ‘action planning’ information could be provided on when is an 
appropriate time to consult the doctor with a symptom. Table 7.4 displays each selected BCT 
and its corresponding intervention content. 
 
7.3.3 Stage 3: Policy categories and mode of delivery 
 
How the intervention could be implemented and its mode of delivery were considered in the 
final stage of the Behaviour Change Wheel (Michie et al, 2014). The policy categories 
considered at this stage were determined by the findings at stage 2. The policy categories 
matrix (Figure 7.3) was used to identify which policy categories should also be considered 
against the APEASE criteria (Table 7.3). The intervention functions of education, persuasion, 
training, enablement, modelling, and environmental restructuring were considered at stage 
2 to be appropriate according to the APEASE criteria. Therefore, the policy categories 
‘communication/marketing’, ‘guidelines’, ‘fiscal measures’ ‘regulation’, ‘legislation’, 
‘environmental/social planning’ and ‘service provision’ (Figure 7.3, shaded boxes) were 
assessed for suitability against the APEASE criteria (Table 7.3).  
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Guidelines, regulation and environmental/social planning were considered impractical. Fiscal 
measures and legislation were considered impractical and unacceptable. The policy 
categories of service provision and communication/marketing could be used in this context 
(Figure 7.3). For example, information about lung cancer could be communicated to 
individuals; however, a mass media campaign would not be affordable and would not create 
equity in this context.  
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Guidelines         
 
  
 
  
 Fiscal measures                 
 Regulation 
  
              
Legislation 
 
      
 
      
 Environmental/social 
planning                   
Service provision  x  x      x      x  x 
Shading represents the policy categories that were considered against the APEASE criteria based on findings at 
Stage 2. Each ‘x’ represents policy categories that were most relevant in this context using the APEASE criteria. 
Figure 7.3 Policy categories matrix of links between interventions functions and policy 
categories (adapted from Michie et al, 2014, p.138).  
 
The mode of delivery matrix was then used to guide how the intervention might be 
delivered (Figure 7.4). Each of the 13 suggested modes of delivery (Figure 7.4) were assessed 
by the APEASE criteria to decide which would be most suitable in this context (Table 7.3). 
Using the APEASE criteria at this stage takes into account funding constraints and findings 
from previous research, for example the potential for mass media interventions to increase 
socioeconomic disparities in lung cancer outcomes, and limited budget for the intervention. 
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All population level modes of delivery were considered not affordable for this PhD. 
Telephone (text and helpline) and computer programme modes of delivery were considered 
to be impractical and not affordable for this PhD, and are currently available through the 
Welsh based cancer charity Tenovus Cancer Care. Face-to-face individual and group 
intervention modes of deliveries were considered the most appropriate in the current 
context. Due to the potential cost effectiveness of targeting multiple recipients in one 
session, a group based face-to-face intervention was selected (Figure 7.4).  
 
Mode of delivery  
Does the mode of 
delivery meet the 
APEASE criteria 
(Table 7.3)? 
Face-to-face Individual    
Group x 
Distance Population-
level 
Broadcast 
media 
TV   
Radio   
Outdoor 
media 
Billboard   
Poster   
Print media 
Newspaper   
Leaflet   
Digital media 
Internet   
Mobile phone app   
Individual-
level Phone 
Phone helpline   
Mobile phone text   
Individually accessed computer 
programme    
Shading represents modes of delivery that were considered against the APEASE criteria. The ‘x’ represents the 
mode of delivery that was selected to deliver the intervention in this context using the APEASE criteria.  
Figure 7.4 Mode of delivery matrix (adapted from Michie et al. 2014, p.178).  
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7.3.4 Intervention design 
 
The intervention was developed to reflect the results from each stage of the Behaviour 
Change Wheel. Intervention content was developed in accordance with the results from 
Stage 2, using findings from the intervention functions matrix, the Behaviour Change 
Techniques Taxonomy and the barriers to lung cancer symptom presentation highlighted in 
the previous studies and sources of behaviour matrix. The mode of intervention delivery was 
developed in conjunction with the results from the review of interventions described in 
Chapter 6 and the mode of delivery matrix. These helped to identify which intervention 
mode of delivery was most appropriate in this context. A draft intervention specification and 
protocol was then developed. 
 
The findings of the Behaviour Change Wheel mapping and draft intervention specification 
were presented at the Healthcare Quality group weekly meeting comprising of a mixture of 
healthcare professionals and academic researchers with expertise in health psychology, 
social sciences and epidemiology. This meeting was used to gain feedback at an early stage 
regarding the concept and feasibility of the intervention, and intervention content. The 
intervention content was developed and amended following this meeting and discussion 
with supervisors. Intervention content was developed in accordance with the updated NICE 
guidelines for referral of suspected lung cancer (NICE, 2015) and information on key 
websites such as NHS Choices (www.nhs.uk, accessed 18.04.2016) and CRUK 
(www.cancerreseachuk.org, accessed 18.04.2016) to ensure that messaging was consistent 
with current guidelines. Intervention content was fact checked for clinical accuracy by a GP 
working in a deprived area and a secondary care respiratory physician. The near-final version 
was piloted with two lay members of the public. Adjustments were made accordingly to 
reduce the length of the intervention. The cancer charity Tenovus Cancer Care who funded 
this PhD approved the intervention and allowed their logo to be used on intervention slides 
and materials.  
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Format and target group 
 
A community based “lung health information session” group educational intervention 
designed to encourage earlier lung cancer symptom presentation was developed. The 
intervention was intended to be delivered to up to ten attendees per session via a scripted 
PowerPoint presentation (see Appendix 24 for slides and corresponding script). The group 
size was limited to ten to ensure that the group was small enough for attendees to feel able 
to participate in the group, as a group larger than ten could be considered intimidating for 
participants.  
 
As previously discussed, the intervention target group was selected to reflect the population 
in which lung cancer is most common. The intervention was targeted at individuals living in 
deprived communities in Wales, defined as individuals living in a Communities First area. 
Those who are over the age of 40 were eligible to take part in the intervention to reflect the 
NICE guidelines (NICE, 2015) for referral of suspected lung cancer. Current smokers, former 
smokers and family members of smokers were eligible to attend the intervention due to the 
increased risk associated with smoking and lung cancer. Smokers are a difficult group to 
engage in health interventions and are often more isolated (Hiscock et al, 2012; Rutten et al, 
2011). In order to reach those most in need, usually in the “hardest to reach” contexts, 
social networks were used as a strategy to reach these people, therefore family members of 
smokers were included as part of this intervention.  
 
Content 
 
Intervention content was developed to reflect the behaviour change techniques identified 
from the Behaviour Change Wheel (Table 7.4). Intervention content included information 
about the basic biology of lung cancer, who is most at risk for developing lung cancer, 
information to combat negative beliefs about lung cancer, the benefits of early diagnosis, 
the symptoms of lung cancer, when to go to the GP with symptoms of lung cancer, 
information about what happens at primary care and secondary care, strategies to 
overcome reported barriers to symptom presentation, strategies to facilitate 
communication of symptoms during a consultation, how to notice symptoms of lung cancer 
other people in the community and what advice to give them. For example, ‘information 
about health consequences’ was selected as a behaviour change technique; therefore, the 
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intervention content was developed to include information about what to expect when an 
individual presents with symptoms of lung cancer at primary and/or secondary care, in 
addition to information about the importance of early diagnosis. Table 7.4 includes a full list 
of identified behaviour change techniques and corresponding intervention content and 
examples of slides.  
 
At the end of the session, attendees were given a handout to take away with them which 
included information about the symptoms of lung cancer, when to go to the doctor and 
information about the benefits of early diagnosis (see Appendix 25). Attendees were 
encouraged to take this to their GP, if or when they were attending about a relevant 
symptom, to facilitate communication during a consultation. Information about smoking 
cessation was not included in the intervention content. It was felt smoking cession 
information may act as a potential deterrent for participation in the intervention, following 
findings from the focus group study (Chapter 6) where people in the community were 
reluctant to give up smoking or attend smoking cessation sessions. However, acceptability of 
including information about smoking cessation was incorporated into the user testing focus 
group, and stop smoking service information was provided at the end of the session for 
those who requested it.  
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Table 7.4 Selected behaviour change techniques (adapted from Michie et al, 2014, p259-283) and corresponding intervention content with relevant 
intervention materials.  
Behaviour Change 
Technique  
Intervention content Slides (Appendix 24 for corresponding script/ Appendix 25 for handout) 
1.1 Goal setting 
(behaviour)  
Definition: set or agree a 
goal defined in terms of 
the behaviour to be 
achieved   
-Set a goal for participants: to tell 
the doctor about symptom 
concerns at a consultation  
-Set a goal for participants: ask 
participants to advise others in the 
community to go to the doctor with 
a symptom(s) of lung cancer if they 
notice symptom(s) in others 
      
 
1.2 Problem solving 
Definition: Analyse or 
prompt the person to 
analyse factors 
influencing the 
behaviour and generate 
or select strategies that 
include overcoming 
barriers and/or 
increasing facilitators 
-Highlight the difficulty associated 
with knowing when to present with 
vague symptoms (to overcome this 
give participants advice on how to 
know which and when symptoms 
need medical help e.g. knowing 
what is normal for you, multiple 
symptoms) 
-Suggest participants go to an 
appointment with the symptomatic 
family member/friend as a strategy 
to overcome barriers to symptom 
presentation 
-Present various strategies to 
overcome the commonly reported 
barriers to symptom presentation 
in the barriers section 
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1.4 Action planning  
Definition: prompt 
detailed planning of 
performance of the 
behaviour (must include 
at least one of context, 
frequency, duration and 
intensity). Context may 
be environmental 
(physical or social) or 
internal (physical, 
emotional or cognitive)  
-Clear information about when to 
go to the GP with a symptom on 
session slides and hand-out 
-Information on what advice 
participants might give someone 
with symptoms in the hypothetical 
scenarios, followed by appropriate 
advice (see script, Appendix 24) 
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2.3 Self-monitoring of 
behaviour  
Definition: Establish a 
method for the person 
to monitor and record 
their behaviour(s) as part 
of a behaviour change 
strategy  
-Encourage participants to 
understand what is ‘normal’ for 
them when talking about symptom 
detection (developing awareness of 
self and others) 
-Encourage participants to write a 
list of symptoms and duration of 
symptoms to take to the GP 
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2.5 Monitoring 
outcome(s) of behaviour 
by others without 
feedback 
Definition: Observe or 
record outcomes of 
behaviour with the 
person’s knowledge as 
part of a behaviour 
change strategy  
-Information on how participants 
can monitor whether the 
symptomatic family member/friend 
they told to go to the GP with a 
symptom has been to the GP or not 
(see script for corresponding slides, 
Appendix 24) 
-Encourage participants to notice 
any changes to symptoms/new 
symptoms in symptomatic family 
member/friend in the community 
at two different time points (from 
when you first noticed symptoms 
to the next time the participant 
sees them) 
    
 
 
3.1 Social support 
(unspecified)  
Definition: Advise on, 
arrange or provide social 
support (e.g. from 
friends, relatives, 
colleagues, buddies, or 
staff) or non-contingent 
praise or reward for 
performance of the 
behaviour. It includes 
encouragement and 
counselling, but only 
when it is directed at the 
behaviour.  
-Information on when participants 
should encourage symptomatic 
family member/friends in the 
community to go to the doctor with 
a symptom(s) 
-Advice giving in the scenario 
exercise  
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3.2 Social support 
(practical)  
Definition: Advise on, 
arrange, or provide 
practical help (e.g. from 
friends, relatives 
colleagues, buddies or 
staff) for performance 
on behaviour 
-Advise the participant to offer 
practical help to symptomatic 
family member/friends in the 
community to get to an 
appointment or accompany 
someone to an appointment (see 
script for corresponding slides, 
Appendix 24)    
4.1 Instruction on how 
to perform behaviour 
Definition: Advise or 
agree on how to perform 
the behaviour (includes 
skills training)  
-Information on how to detect 
coloured or bloody phlegm 
-Advice on what to say during a 
consultation and what participants 
can take with them to aid 
communication 
-Advice on how to request an 
earlier appointment from the 
receptionist if particularly worried 
about symptom  
   
What will happen if I 
go to the doctor?
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5.1 Information about 
health consequences 
Definition: Provide 
information (e.g. written, 
verbal, visual) about 
health consequences of 
performing the 
behaviour  
-Information about early diagnosis 
and survival outcomes (throughout 
the presentation and during the 
true/false activity) 
-Information about diagnostic 
testing for lung cancer and what to 
expect at primary and secondary 
care 
-Information about the treatment 
for lung cancer 
-Advise that being upfront about 
symptom concerns during a 
consultation with the GP can help 
in the longer term 
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5.2 Salience of 
consequences 
Definition: Use methods 
specifically designed to 
emphasise the 
consequences of 
performing the 
behaviour with the aim 
of making them more 
memorable (goes 
beyond informing about 
consequences)  
-Similar to ‘Information about 
health consequences’ but more 
emphasis on earlier diagnosis to 
save their lives and later stage 
disease at diagnosis means a cure is 
less likely 
-Information about why it is 
important to go to the GP quickly 
with a lung cancer symptom and 
the consequences of early diagnosis 
(improved chances of survival and 
better access to treatment options) 
‘My friend or someone in 
my family told me to 
come to the doctor 
about this symptom’
 
‘There is no treatment 
for lung cancer’
True or false?
 
 
 
 
 
5.3 Information about 
social and 
environmental 
consequences 
Definition: Provide 
information (e.g. written, 
verbal, visual) about the 
social and environmental 
consequences of 
performing the 
behaviour  
-Intervention content associated 
with a ‘community responsibility’ 
type intervention. Information 
about earlier diagnosis of lung 
cancer in the community can 
promote better lung cancer survival 
in the community and this can be 
achieved through noticing 
symptoms in symptomatic family 
member/friends in the community 
and encouraging them to go to the 
doctor with symptoms 
‘My friend or someone in 
my family told me to 
come to the doctor 
about this symptom’
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7.1 Prompts and cues  
Definition: Introduce or 
define environmental or 
social stimulus with the 
purpose of prompting or 
cueing the behaviour. 
The prompt would 
normally occur at the 
time or place of 
performance.  
-Hand out with simple information 
on what symptoms to look out for 
and when to go to the doctor with 
these symptoms.  
 
 
 
9.1 Credible sources 
Definition: Present 
verbal or visual 
communication from a 
credible source in favour 
of or against behaviour  
-Information and some pictures 
from CRUK, NICE or NHS website. 
Fact checking by clinicians. 
-Tenovus and Cardiff University 
logo on hand out and slides 
All slides and handout created with credible sources 
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Intervention delivery  
 
Throughout the intervention session, information was delivered to attendees through 
various activities and verbal presentations of information. For example, attendees were 
asked to participate in a true/false activity which was designed to modify negative beliefs 
about lung cancer. Attendees were presented with a quote such as ‘there is no treatment 
for lung cancer’ and asked if they believed the statement to be true or false. This was 
followed by the correct answer and verbal information about why each statement is true or 
false. The session was designed to be as interactive as possible, and slides were developed 
with visual images and minimal text for participants who were likely to have low literacy 
levels.  
 
The intervention content was delivered entirely in the third person as a community 
responsibility intervention. For example ‘if you know someone in the community who has a 
symptom of lung cancer…’ was used rather than ‘if you have a symptom of lung cancer…’. 
Information was framed in the third person in an attempt to avoid placing any potential 
blame on the individual attending the intervention, particularly if they smoke or used to 
smoke, and to mobilise social networks. Findings from Chapters 3, 4 and 5 suggested that 
people utilise a lay system of healthcare before seeking medical help from their GP, which 
can be problematic among low socioeconomic groups if advice is sought from someone in 
the community with poor knowledge and negative beliefs about cancer. The intervention 
attempted to use these strong social networks to disseminate intervention messages within 
the community and ask attendees to encourage high risk individuals in the community to go 
to their GP with symptoms. This strategy was used in an attempt to prompt other 
symptomatic individuals who may not have attended an intervention about lung cancer to 
present to the GP with symptoms.  
 
This follows the approach used by “gay hero” and ASSIST interventions, based around the 
diffusions of innovations theory (Rogers, 1983), where the most popular members of a 
defined community are recruited as peer educators (Hart and Elford, 2003; Campbell et al, 
2008). The peer educators receive a training educational session designed to provide 
information about the dangers of unprotected sex and smoking  and are asked to 
communicate these messages to peers within their network (Hart and Elford, 2003; 
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Campbell et al, 2008). For the school based ASSIST intervention, teachers are asked to 
identify who is the most popular in a given year group and for the safe sex intervention with 
gay men, the bartenders of a local gay bar are asked to identify who is the most popular 
(Hart and Elford, 2003; Campbell et al, 2008). It was considered unfeasible to identify a 
community champion from a Communities First area, since the geographical area is large 
and usually the number of people living in a given area is too big to take a percentage of 
those to recruit as peer educators. Therefore, the decision was made to engage higher risk 
individuals or family members of high risk individuals to deliver key messages in the 
community.  
 
After attendees were given information about the symptoms of lung cancer and when to go 
to the GP with symptoms, the group was given three hypothetical scenarios which included 
information about symptomatic individuals, their age, gender and smoking status. Attendees 
were asked to discuss what information they would give each individual, followed by 
information from the facilitator about what the symptoms could indicate and what 
appropriate advice should be given. Two scenarios were designed to fit the NICE guidelines 
for referral (NICE, 2015) where symptomatic individuals were high risk, and one scenario 
was designed to not fit the NICE guidelines for referral where the symptomatic individual 
was low risk (the individual was age 25). The scenario exercise was intended to simulate 
what might happen in a normal situation and facilitate good, accurate advice to be given to 
people in the community.  
 
7.4 Discussion 
 
A community based group educational intervention was developed to encourage earlier lung 
cancer symptom presentation among low socioeconomic groups. Capability, Motivation and 
Opportunity were identified as influences on lung cancer symptom presentation behaviour 
among low socioeconomic groups. Based on these findings, the intervention functions of 
education, persuasion, training, enablement, modelling and environmental restructuring 
were considered most relevant to encouraging timely lung cancer symptom presentation 
behaviour. The intervention session content was developed in accordance with thirteen 
selected behaviour change techniques and contained information about lung cancer, who is 
most at risk for lung cancer, the symptoms of lung cancer, when to go to the GP with a 
symptom of lung cancer, information to combat negative beliefs about cancer and strategies 
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to overcome the barriers to lung cancer symptom presentation. PowerPoint slides and a 
corresponding script (Appendix 24) were created in accordance with the behaviour change 
techniques identified from the Behaviour Change Techniques Taxonomy (Michie et al, 2013). 
The intervention was scripted and framed in the third person in order to reduce stigma and 
remove any potential perceptions of blame away from the individuals attending the group, 
particularly if they smoke or used to smoke. In addition, the intervention was designed to 
utilise strong social networks within the community and was framed in the third person as a 
‘community responsibility’ intervention to disseminate intervention messages (Rogers, 
1983). This approach was selected in order for intervention messages to reach people in the 
community who are unlikely to attend such an intervention and encourage higher risk 
symptomatic individuals to present quickly to the GP with symptoms suggestive of lung 
cancer. However, it is possible that the third person approach could have unintended 
consequences. For example, those who attend the intervention may not relate to the 
intervention messages and consequently overlook symptoms. Alternatively, symptomatic 
friends and family may not be receptive to advice from those who attended the intervention 
with the intention of promoting a visit to the doctor.  
 
7.4.1 The Behaviour Change Wheel as a framework for intervention development 
 
The systematic nature of the Behaviour Change Wheel and strong theoretical underpinning 
of the framework were strengths. In addition, the inclusion of an analysis of the target 
behaviour using the COM-B model was a strength of the Behaviour Change Wheel due to the 
applicability of the model in this context as discussed in Chapters 2, 4 and 5. This enabled a 
broad and full range of behaviour change techniques, mode of delivery and intervention 
type to be considered for intervention development in the context of promoting timely 
cancer symptom presentation among low socioeconomic groups. The APEASE criteria were 
particularly useful when helping to narrow down the options identified at each stage of the 
Behaviour Change Wheel, facilitated by clear definitions of the criteria. In addition, the 
systematic process by which intervention components are selected or rejected using the 
APEASE criteria was useful. The APEASE criteria provided a framework for reporting 
rationale for the decisions for why certain components were included or excluded, 
increasing research rigour.  
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Although there were a number of strengths of the Behaviour Change Wheel, some 
limitations regarding usability of the framework were identified. The Behaviour Change 
Wheel was developed to be applied to all behaviour change interventions contexts, and as a 
consequence, many of the definitions and aspects of the framework were vague, similar or 
overlapping, which presented difficulty with mapping at each stage. Specifically, definitions 
for the Behaviour Change Techniques Taxonomy, policy categories and intervention function 
categories were short and often supported with only one example. In addition, many of the 
behaviour change techniques outlined in the Taxonomy were similar, and choosing between 
which behaviour change techniques to select for the intervention was challenging due to 
sometimes vague and overlapping definitions. Since its initial development, validation 
studies of Behaviour Change Wheel have highlighted 12 of the behaviour change techniques 
definitions which require further refinement and clarity in future revisions (Michie et al, 
2015). Therefore, amended versions of the Behaviour Change Techniques Taxonomy are 
likely to overcome some of the problems experienced in the present intervention 
development study. Furthermore, studies suggest that formal training in the Behaviour 
Change Wheel can improve coder reliability (Michie et al, 2015). The PhD researcher did not 
undergo any formal training using the Behaviour Change Wheel, instead the researcher 
relied on the Behaviour Change Wheel book (Michie et al, 2014), published papers (Michie 
et al, 2011; Michie et al, 2015; Cane et al, 2015), and supervision in the Behaviour Change 
Wheel process in the boarder ABACus study. However, the ABACus intervention was not 
specific to intervention development for this PhD. Using the Behaviour Change Wheel 
resources presented difficulty at times as it was unclear how some of the stages linked with 
one another, since the written documents were challenging to follow and understand how 
they linked. For example, it was unclear at which point the Behaviour Change Techniques 
Taxonomy should be used. 
 
Finally, mapping components and information at each stage of the Behaviour Change Wheel 
is subjective in nature. The researcher is required to make subjective assessments based on 
guidelines outlined in the Behaviour Change Wheel to guide selection of intervention 
components at each stage. As previously discussed, many of the definitions were vague 
which has implications for increased subjectivity during the Behaviour Change Wheel 
process. Future revisions of the intervention should seek to dual code each stage of the 
mapping process to reduce subjectivity.  
 
 
 
242 
 
7.4.2 Strengths and limitations  
 
Intervention development followed the MRC framework and Behaviour Change Wheel 
which are both highly regarded frameworks for the development of interventions. When 
mapping the sources of behaviour, only the lung specific barriers and facilitators to timely 
symptom presentation were extracted from data sources that were not restricted or specific 
to lung cancer only.  Therefore, it is possible that some of the barriers and facilitators 
specific to lung cancer could have been missed or some of the more general barriers were 
not specific enough in this context. Future research should explore lung specific barriers to 
cancer symptom presentation, particularly among smokers. In addition, dual coding was not 
performed at any stage of the Behaviour Change Wheel, which as previously discussed has 
potential implications for subjectivity and potential for miscoding. In order to increase 
rigour, each stage of the Behaviour Change Wheel should be dual coded. Finally, selection of 
relevant aspects at each stage of the Behaviour Change Wheel was carried out by the PhD 
researcher using the APEASE criteria. Local stakeholders could provide additional input with 
regard to which aspects of intervention format, delivery and content would be most 
appropriate. Future intervention development using the Behaviour Change Wheel should 
consider completing the process with local stakeholders.   
 
7.5 Conclusion  
 
The Behaviour Change Wheel was a useful framework for the development of a lung cancer 
awareness intervention targeted at smokers and former smokers from a low socioeconomic 
group. A community group based educational ‘lung health information session’ intervention 
was developed to increase lung cancer symptom knowledge, modify negative beliefs, offer 
practical strategies to overcome barriers to cancer symptom presentation and encourage 
timely symptom presentation by utilising strong social networks in the community. 
Intervention acceptability testing with a group of potential users will be reported in Chapter 
8.  
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Chapter 8 
Intervention acceptability testing with a group of potential users 
 
8.1 Chapter overview  
 
The ‘lung health information session’ was carried out with two groups of potential 
intervention users identified and recruited through community partners. Findings from the 
intervention acceptability testing study, which used a multiple methods approach, will be 
reported in this chapter. Implications and recommendations for the intervention in the 
future will be explored.  
 
8.2 Introduction  
 
The development of a ‘lung health information session’ using the Behaviour Change Wheel 
(Michie et al, 2014) in accordance with the Medical Research Council (MRC) framework 
guidance (Craig et al, 2008) was reported in Chapter 7. The group based educational session 
was designed to improve lung cancer symptom knowledge, modify negative beliefs about 
lung cancer and empower individuals to seek medical help for symptoms to promote timely 
lung cancer symptom presentation behaviour. In addition, a community responsibility aspect 
was integrated into the intervention to mobilise social networks and facilitate good quality 
advice following symptom disclosure or noticing of symptoms.  
As discussed in Chapter 1, the MRC framework highlights the importance of conducting 
feasibility and pilot studies before controlled evaluation studies and/or implementation are 
considered. Feasibility studies require testing the intervention with potential users to gain 
views on the acceptability of the intervention format, content and delivery, and evaluation 
outcome measures used. In addition, feasibility studies can be used to highlight potential 
recruitment issues before further pilot studies and controlled evaluation are carried out.  
This chapter presents findings from an intervention acceptability testing study with a group 
of potential users. As discussed in Chapter 7, the target group was defined as adults aged 
over 40 years living in socioeconomically deprived areas, who are current smokers or ex-
smokers, or are family members of smokers. Potential users were recruited opportunistically 
via community partners to participate in the intervention session, and a multiple methods 
approach was used to assess intervention acceptability. Focus groups and observational 
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methods were used to gain views on the intervention format and content, and assess group 
attentiveness. An adapted version of the Lung Cancer Awareness Measure (CAM; Simon et 
al, 2012a) was selected as the quantitative measure to assess changes in outcomes 
measured pre to post intervention and acceptability of outcome measures. The Lung CAM is 
a validated tool designed to assess lung cancer knowledge, confidence in detecting a 
symptom and anticipated lung symptom presentation behaviour, and was selected because 
most of the items aligned well with the aims of the lung health information session. In the 
absence of relevant Lung CAM items, additional items adapted from the Awareness and 
Beliefs about Cancer Measure (ABC; Simon et al, 2012b) were included in the pre and post 
questionnaire measures in order to reflect intervention content designed to modify negative 
beliefs about lung cancer and provide information on how to detect symptoms in others. In 
order to reduce the burden on participants, items that were not directly relevant to the 
content of the intervention were removed (for example, environmental risk factors for lung 
cancer such as radon gas).  
Lung CAM items to assess knowledge of lung cancer symptoms using both prompted 
recognition and unprompted recall remained in the adapted version were used for the 
current study. Although the intervention content was limited to nine potential lung cancer 
symptoms (NICE, 2015), all 14 Lung CAM symptoms listed in the recognition task were 
retained in order to measure change in knowledge of symptoms that were targeted by the 
intervention, as well as to observe potential response bias associated with those symptoms 
that were not targeted. In addition, some symptoms targeted by the intervention were 
specific, such as haemoptysis, and others were non-specific, such as persistent cough and 
tiredness. Non-specific symptoms of lung cancer are the most poorly recalled or recognised 
in comparison to specific symptoms (Crane et al, 2016; Simon et al, 2012a), and often are 
misattributed to other benign causes and medical help seeking prolonged (Carter-Harris, 
2015; Tod and Joanne, 2010). It was therefore considered important to assess change in 
knowledge of both specific and non-specific lung cancer symptoms.  
8.2.1 Aim and hypotheses  
The aim of the present study was to test the lung health information session for 
acceptability with a group of potential users. It was hypothesised that recognition and recall 
of symptoms (both specific and non-specific) that were targeted by the intervention would 
improve after exposure to the intervention, compared to non-targeted symptoms. In 
addition, it was hypothesised that participants would report higher confidence in detecting 
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symptoms in themselves and others, and more positive beliefs about lung cancer, and that 
anticipated lung symptom presentation would be aligned with the NICE guidance and 
intervention messaging after exposure to the intervention.  
8.3 Methods 
8.3.1 Participants 
 
The final version of the intervention (Appendix 24) was piloted with potential users to assess 
acceptability. Ethical approval was obtained from the School of Medicine Ethics committee 
(SMREC Ref 16/11, see Appendix 26). Community partners were contacted through existing 
Communities First links from the Awareness and Beliefs About Cancer (ABACus) focus group 
study, and via a GP and staff member in a local hospital Research and Development 
department. Community partners were contacted to request assistance with recruiting 
members of the community to take part in the study according to the following criteria: 
individuals living in a Communities First area, over the age of 40 and who were current or ex-
smokers, or family members of smokers. As described in Chapter 7, these criteria were 
selected in order to identify participants who would be most likely to represent the 
intervention target group. Community partners were given study information sheets and 
flyers to distribute to potential participants with detailed information about the study (see 
Appendix 27 and 28). All participants were given a £15 shopping voucher to thank them for 
their time.  
 
8.3.2 Procedure  
 
After the community partner invited potential participants to take part in the intervention, 
the PhD researcher was notified of those who were interested in taking part. A mutually 
convenient time and date for the intervention user testing study was arranged. The 
community partner passed the time, date and venue details on to potential participants on 
behalf of the researcher. Intervention user testing took place in community centre venues 
within the community partners’ area, to ensure that the study took place close to where 
participants lived. Conference or meeting rooms in the community centre were hired to 
conduct the intervention.  
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On the day of the study, participants provided written informed consent and were then 
asked to complete an adapted Lung CAM (Simon et al, 2012a) at baseline before the 
intervention session started, and directly after the intervention session (see Appendix 29 
and 30). After completion of the baseline questionnaire, participants took part in the 
intervention session. After completion of the post intervention questionnaire and a break 
for lunch, participants took part in a focus group. All participants were fully consented and 
debriefed. Permission to audio record the intervention session and focus group was 
obtained.  
 
8.3.3 Ethical issues  
 
During the intervention introductory slides, participants were reminded that the facilitator 
was not medically qualified to provide advice for symptoms on an individual basis. Those 
who asked for advice on symptoms were signposted to the appropriate medical service. All 
participants were given the Tenovus Cancer Care phone number and PhD researcher’s 
contact details should they have any further questions about cancer after the intervention. 
Individuals who appeared upset during the intervention were reminded that they could 
leave at any point.  
 
8.3.4 Data collection  
 
Three types of data were collected during user testing: questionnaire data, qualitative focus 
group data and group observational data.  
 
8.3.5.1 Questionnaire measures 
 
As previously discussed, the questionnaire was adapted from the Lung CAM (Simon et al, 
2012a) to include questions that were targeted by the intervention (Appendix 29 and 30). 
The Lung CAM has shown good internal reliability (Cronbach’s α=0.88) and test-retest 
reliability (r=0.81, p<0.001) (Simon et al, 2012a). Two additional questions (seven 
statements in total) which were not previously included in the Lung CAM were included to 
assess confidence in detecting a symptom in others, and beliefs about lung cancer (Appendix 
29 and 30). Measures included:  
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(a) Symptom knowledge  
Participants were asked one open-ended question and a set of closed questions to 
measure lung cancer symptom awareness. The open-ended question measured 
symptom recall as follows: “There are many warning signs and symptoms of lung cancer. 
Please name as many as you can think of”. The closed question measured symptom 
recognition: “The following may or may not be warning signs of lung cancer. We are 
interested in your opinion”. Fourteen symptoms were listed, all of which are possible 
symptoms of lung cancer generated from a review of the literature and cancer websites 
(Simon et al, 2012a). Response options for each symptom were ‘yes’, ‘no’, ‘don’t know’. 
Each closed question response was dichotomised into correct (response ‘yes’) or 
incorrect (response ‘no’/’don’t know’). ‘No’ and ’don’t know’ responses were grouped 
together due to a small number of ‘don’t know’ responses. Responses to the open ended 
recall questions were recorded verbatim and analysed thematically, and grouped into 14 
categories to accord with the 14 symptoms listed in the recall question. Responses were 
classed as correct or incorrect based on the NICE guidelines for suspected lung cancer 
and the symptoms listed in the recognition section. Correct responses for both questions 
were summed to create recall and recognition scores, respectively (total score range 0-
14). 
Nine of the 14 symptoms included in the questionnaire were targeted by the 
intervention: persistent cough, change/worsening of cough, shortness of breath, 
unexplained weight loss, chest infection that won’t go away, persistent tiredness or lack 
of energy, chest pain, loss of appetite, and coughing up blood. The remaining five 
symptoms were not targeted by the intervention: high pitched sound when breathing, 
painful cough, change in shape of fingers/nails, shoulder pain, and ache/pain when 
breathing. Correct responses were summed for both recall and recognition of targeted 
symptoms (score range 0-9) and non-targeted symptoms (score range 0-5). 
 
Of the nine lung cancer symptoms targeted by the intervention, five were non-specific 
(persistent cough, change/worsening of cough, unexplained weight loss, persistent 
tiredness/lack of energy, loss of appetite), and four were specific (shortness of breath, 
chest infection that won’t go away, chest pain, coughing up blood). Correct responses 
were summed for recall and recognition of non-specific symptoms (score range 0-5) and 
specific symptoms (score range 0-4) to assess change pre to post intervention.   
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(b) Anticipated symptom presentation behaviour 
Participants were asked one closed question to assess anticipated time to lung cancer 
symptom presentation: “If you had a symptom which you thought might be a sign of 
lung cancer, how soon would you go to your doctor to talk about it?” There were six 
response options: ‘I would go as soon as I noticed the symptom’, ‘I would go within 1 
week’, ‘I would go between 1 and 2 weeks’, ‘I would go between 2 and 3 weeks’, ‘more 
than 1 month’, and ‘I would not contact my doctor’.  
For analysis purposes, response options were grouped into categories that mirrored as 
closely as possible the advice given during the intervention, i.e. to seek medical help if a 
symptom persisted for three weeks or more. Since the Lung CAM response options were 
not directly aligned to intervention content, responses were grouped into three 
categories: under two weeks (including responses ‘I would go as soon as I noticed the 
symptom’, ‘I would go within 1 week’ and ‘I would go between 1 and 2 weeks’), over two 
weeks (‘I would go between 2 and 3 weeks’ and ‘more than one month’), and I would not 
contact my doctor.  
(c) Confidence in noticing a symptom of lung cancer  
Confidence in noticing a symptom of lung cancer was assessed using two closed 
questions: “How confident are you that you would notice a symptom of lung cancer?” 
and “How confident are you that you would notice a symptom of lung cancer in someone 
else?” There were four response options to both questions: ‘not at all confident’, ‘not 
very confident’, ‘fairly confident’, and ‘very confident’. Response options were merged to 
create binary variables reflecting higher confidence (‘fairly confident’ or ‘very confident’) 
and lower confidence (‘not very confident’ or ‘not at all confident’) in self and others, 
respectively   
(d) Beliefs about lung cancer  
Beliefs about lung cancer were measured using a list of six statements which were 
anchored to the question: “For each statement below can you tell us how much you 
agree or disagree with each item”. The six statements were: ‘Lung cancer can often be 
cured’, ‘Most lung cancer treatment is worse than the cancer itself’, ‘I would not want to 
know if I have lung cancer’,  ‘Going to the doctor as quickly as possible after noticing a 
symptom of lung cancer could increase the chances of surviving’, ‘People who are 
important to me would want me to go to the doctor if I had a symptom of lung cancer’, 
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and ‘I have no control over whether or not I get lung cancer’. Response options to each 
statement included: ‘strongly disagree’, ‘tend to disagree’, ‘tend to agree’, and ‘strongly 
agree’. Responses to each of the belief statements were dichotomised for purposes of 
analysis, where ‘agree’ included responses ‘tend to agree’ and ‘strongly agree’, and 
‘disagree’ included responses ‘tend to disagree’ and ‘strongly disagree’.  
(e) Demographic data 
Demographic data including age and gender were collected post intervention only. 
Socioeconomic group was measured using three questions including educational 
attainment (“What is your highest level of education?”, six response options), home 
ownership (“Please tick the box that best describes your home/living arrangement”, six 
response options), and employment status (“Are you currently”, nine response options). 
See Table 8.1 for the full list of response options. Postcode data were used to derive 
Welsh Index of Multiple deprivation scores (WIMD, 2014). Smoking status was assessed 
by a closed ended question: “What statement best describes your smoking status?” 
There were four response options: ‘I currently smoke’, ‘I used to smoke’, ‘I have never 
smoked’, and ‘Other (please specify)’. Those who currently or used to smoke were asked 
to complete the number of cigarettes they smoke/d per day: ‘0-9 per day’, ‘10-19 per 
day’, ‘20-29 per day’ and ‘30 or more per day’.  
8.3.5.2 Observational data 
 
Observational data were collected during delivery of the intervention session by one of the 
supervisory team via an observation sheet (see Appendix 31). The observational data were 
used to provide information on the group dynamics during the intervention and activities, 
note any questions people asked and comments during the group activities, and collect non-
verbal information such as group attentiveness. The questions asked during the intervention 
were collated to inform potential additional information to be included in the intervention in 
the future, and to produce a list of frequently asked questions with suggested responses to 
complement the manualised content for future intervention facilitators.  
 
8.3.5.3 Qualitative focus group data 
 
The focus group was designed to explore acceptability and potential feasibility of the 
intervention. A semi-structured topic guide with probes was used during the focus group 
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(see Appendix 32). Topics included: perceived usefulness of intervention session, feasibility 
of intervention, content of intervention (including information about smoking cessation), 
comprehension of intervention content, delivery of the session, improvements for the 
intervention, and recruitment into the intervention.  
 
8.3.6 Data analysis  
 
Demographic characteristics of the sample were analysed using frequencies. Due to the 
small number of participants, questionnaire data including symptom recognition and recall 
(for targeted and non-targeted symptoms), anticipated symptom presentation, confidence 
and beliefs about lung cancer were analysed at baseline and post intervention using 
descriptive statistics (means and frequencies, as appropriate). Two participants entered the 
study half way through the intervention session, therefore it was not possible to collect 
baseline measures for these individuals. Assessment of change in outcomes was therefore 
only conducted for 12 participants who completed both pre and post intervention 
questionnaires. Item non-response, or when more than one response option was selected, 
were treated as missing. Responses for each measure were grouped into categories to 
facilitate data analysis and comparisons between participants.  
 
Observational data collected during the intervention session were analysed thematically to 
identify recurrent questions, group attentiveness and engagement in the session. Focus 
group data were transcribed verbatim and analysed thematically to look for similar and 
disparate themes, supported by NVivo (NVivo 10, 2012).  
 
8.4 Results  
 
Eight community partners from Communities First areas in South Wales were contacted with 
information about the study and the study inclusion criteria to request help for study 
recruitment. Two of the six community partners forwarded the study details on to a total of 
12 staff in their community area to facilitate study recruitment.  
 
Fourteen members of the community were recruited in two areas to take part in the study 
according to the inclusion criteria (site 1, n=7; site 2, n=7). The remaining six areas were 
unsuccessful, mainly due to community partners being too busy to recruit people in the 
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community or not being able to find people to take part in the study. Reasons for members 
of the public not taking part in the study were reported by communities partners as not 
being resident in a Communities First area or being under the age of 40 years, and therefore 
not meeting the study inclusion criteria, or being unable to take part due to work 
commitments or childcare issues. 
 
8.4.1 Sample characteristics 
 
Participants from site 1 were all members of an existing mental health peer support group 
who met weekly at the community centre. They were approached by the Communities First 
partner and agreed that the study could take place instead of one of their weekly meetings. 
Participants from site 2 were recruited through an existing volunteer network in the 
community. Fourteen participants took part in the intervention in total across the two sites. 
As shown in Table 8.1, most participants were female and were ex-smokers, finished school 
at or before age fifteen, were retired, owned their house outright, and lived in the most 
deprived quartile. Thirteen out of 14 participants were over the age of 40.  
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Table 8.1 Sample characteristics for acceptability testing with a group of potential users 
Variable  Number of participants (N=14) 
Gender Male (n=4) 
Female (n=10) 
Age (years) Mean: 63.5 (range 34-86) 
Educational attainment  Finished school at or before age of fifteen (n=6) 
No qualifications/left school at age 16 (n=1) 
Completed CSEs, O-levels or equivalent (n=2) 
Completed A levels or equivalent (n=0) 
Completed further education but not degree (n=4) 
Completed a Bachelors degree/masters/PHD (n=0) 
Prefer not to say (n=0) 
Missing data (n=1) 
Employment  Employed full-time (n=1) 
Employed part-time (n=1) 
Full-time homeowner (n=0) 
Retired (n=10) 
Unemployed (n=2) 
Self-employed (n=0) 
Still studying (n=0) 
Disabled or too ill to work (n=0) 
Prefer not to say (n=0) 
Home ownership  Own outright (n=7) 
Own mortgage (n=0) 
Rent from local authority/housing association (n=6) 
Rent privately (n=0) 
Living with family/friends (n=1) 
Prefer not to say (n=0) 
Deprivation quartiles  1 (Most deprived) (n=8) 
2 (n=1) 
3 (n=0) 
4 (Least deprived) (n=0) 
Missing/incomplete data (n=5) 
Smoking status  Current smoker (n=3) 
Former smoker (n=6)  
Never smoked (n=5) 
Number of cigarettes smoked per day 
(current and former smokers) 
0-9 (n=3) 
10-19 (n=3) 
20-29 (n=1) 
30 and over (n=0)  
Missing data (n=2) 
 
8.4.2 Questionnaire data  
 
Symptom knowledge  
 
As shown in Table 8.2, overall knowledge of the symptoms of lung cancer at baseline was 
good for both recall and recognition scores. For symptoms that were targeted by the 
intervention, recall and recognition scores were generally higher than those for symptoms 
not targeted by the intervention at both baseline and post intervention (Table 8.2).  
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Table 8.2 Symptoms correctly recalled and recognised at baseline and post intervention 
Symptom Baseline (n=12) Post intervention (n=14) 
Recognition Recall  Recognition Recall  
Overall symptom knowledge, mean (range) 8.3 (4-13) 2.5 (0-4) 10 (8-14) 4 (0-7) 
Targeted by the intervention, n 
Mean (range) 
Persistent cough 
Change/worsening of cough 
Shortness of breath 
Unexplained weight loss 
Chest infection that won’t go away 
Persistent tiredness/lack of energy 
Chest pain 
Coughing up blood 
Loss of appetite 
 
6.2 (3-9) 
10 
8 
8 
8 
10 
7 
6 
12 
5 
 
3 (0-8) 
8 
0 
4 
1 
0 
5 
4 
5 
0 
 
8.7 (5-9) 
13 
14 
11 
14 
13 
13 
11 
13 
11 
 
5 (0-10) 
10 
1 
5 
7 
0 
5 
7 
6 
4 
Not targeted by the intervention, n 
Mean (range) 
High pitched sound when breathing 
Painful cough 
Change in shape of fingers/nails 
Shoulder pain 
Ache/pain when breathing 
 
4.2 (2-7) 
6 
7 
2 
2 
4 
 
0 (0) 
0 
0 
0 
0 
0 
 
7.4 (2-12) 
8 
11 
2 
4 
12 
 
0 (0) 
0 
0 
0 
0 
0 
 
For individual symptoms, the non-specific symptom ‘persistent cough’ was the most 
frequently recalled symptom at both baseline and follow-up, and was targeted by the 
intervention (Table 8.2). The specific symptom ‘coughing up blood’ was correctly recognised 
by all participants at baseline, whereas the non-specific symptoms of ‘change/worsening of 
cough’ and ‘unexplained weight loss’ were recognised by all participants post intervention 
(Table 8.2), and were all targeted by the intervention. A ‘chest infection that won’t go away’ 
and ‘change/worsening of cough’ were poorly recalled symptoms at both baseline and post 
intervention (Table 8.2). None of the five non-targeted symptoms were correctly recalled at 
either time point. All five symptoms not targeted by the intervention, with the exception of 
‘ache/pain when breathing’ and ‘painful cough’, were the most poorly recognised symptoms 
post intervention (Table 8.2).  
 
In twelve participants who completed both questionnaires, an increase was observed pre to 
post intervention for both recall (two point increase) and recognition (three point increase) 
of lung cancer symptoms targeted by the intervention (Table 8.3). Recognition of symptoms 
not targeted by the intervention was also improved post intervention (two point increase), 
although no change was observed for recall (Table 8.3).  
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Table 8.3 Assessment of change for participants who completed both baseline and post 
intervention questionnaires   
Measure Baseline (n=12) Post intervention 
(n=12) 
Overall symptom knowledge, mean (range) 
Symptom recall  
Symptom recognition 
 
2.5 (0-4) 
8.3 (4-13)  
 
4 (0-7)  
11 (8-14) 
Knowledge of symptoms targeted by the intervention, mean 
(range) 
Recall of symptoms targeted by the intervention 
Recognition of symptoms targeted by the intervention 
 
 
3 (0-8) 
6.2 (3-9)  
 
 
5 (0-10) 
9.2 (5-9) 
Knowledge of symptoms not targeted by the intervention, 
mean (range) 
Recall of symptoms not targeted by the intervention 
Recognition of symptoms not targeted by the intervention 
 
 
0 (0) 
4.2 (2-7)  
 
 
0 (0) 
6.2 (2-10)  
Anticipated time to lung cancer symptom presentation, n          
    Under two weeks  
    Over two weeks  
    Would not contact doctor  
    Missing/incomplete  
 
9 
2 
1 
0 
 
6 
5 
0 
1 
Confidence in detecting symptom of lung cancer – self, n 
    Higher confidence 
    Lower confidence 
    Missing/incomplete 
 
5 
7 
0 
 
10 
2 
0 
Confidence in detecting symptom of lung cancer - someone 
else, n 
    Higher confidence 
    Lower confidence 
    Missing/incomplete 
 
 
5 
7 
0 
 
 
10 
2 
0 
Beliefs about lung cancer, n 
‘Lung cancer can often be cured’  
    Agree  
    Disagree  
    Missing/incomplete 
‘Most treatments for lung cancer are worse than the cancer 
itself’ 
    Agree 
    Disagree 
    Missing/incomplete 
‘I would not want to know if I had lung cancer’  
    Agree 
    Disagree 
    Missing/incomplete 
‘Going to the doctor quickly with a symptom of lung cancer 
increases the chance of survival’ 
    Agree 
    Disagree 
    Missing/incomplete 
 ‘People important to me would want me to go to the doctors 
with a symptom of lung cancer’ 
    Agree 
    Disagree 
    Missing/incomplete 
‘I have no control over if I get lung cancer or not’ 
    Agree 
    Disagree 
    Missing/incomplete 
 
 
4 
8 
0 
 
 
7 
3 
2 
 
3 
9 
0 
 
 
10 
1 
1 
 
 
11 
1 
0 
 
6 
6 
0 
 
 
10 
2 
0 
 
 
5 
5 
2 
 
3 
9 
0 
 
 
11 
1 
0 
 
 
10 
2 
0 
 
4 
8 
0 
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For individual symptoms targeted by the intervention, recall and recognition were improved 
from baseline to post intervention for all symptoms (Figure 8.1 and Figure 8.2), with the 
exception of recognition of the specific symptom ‘coughing up blood’ due to a ceiling effect 
(Figure 8.1) and recall for the specific symptom ‘chest infection that won’t go away’ and 
non-specific symptom ‘persistent tiredness/lack of energy’ (Figure 8.2) where no change was 
observed. The greatest improvements in symptom knowledge were observed for ‘loss of 
appetite’ and ‘unexplained weight loss’ (Figure 8.1 and Figure 8.2), both of which were 
targeted by the intervention and were non-specific symptoms. Three symptoms that were 
not targeted by the intervention were more likely to be recognised post intervention: painful 
cough, shoulder pain, and ache/pain when breathing (Figure 8.1). 
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Figure 8.1: Change for the number of individual symptoms correctly 
recognised pre to post intervention  
baseline
post-intervention
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Figure 8.2: Change for the number of individual symptoms correctly 
recalled pre to post intervention 
baseline
post-intervention
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Anticipated time to lung cancer symptom presentation 
 
Anticipated time to lung cancer symptom presentation varied at baseline, with most 
participants anticipating shorter time intervals (Table 8.4). For those who completed both 
questionnaires, the majority of participants anticipated shorter symptom presentation 
intervals at both time points. However, a shift towards lengthened, more appropriate 
anticipated symptom presentation times (in line with NICE guidelines for suspected lung 
cancer) was observed pre to post intervention (Table 8.3).  
 
Confidence noticing a symptom of lung cancer  
 
At baseline, most participants reported lower confidence in detecting symptoms in 
themselves and others (Table 8.4). Confidence to detect a symptom of lung cancer in 
themselves and others appeared to be improved pre to post intervention (Table 8.3). At 
follow-up, the majority of participants reported higher confidence that they could detect a 
symptom of lung cancer in themselves and others (Table 8.3).  
 
Beliefs about lung cancer  
 
At baseline, most participants endorsed the benefits of early diagnosis, thought that those 
close to them would want them to seek medical help for lung cancer symptoms, and would 
want to know if they had lung cancer (Table 8.4). Participants at baseline were more likely to 
hold negative beliefs about the treatments for lung cancer, and half of the sample perceived 
themselves to have no control over getting lung cancer (Table 8.4).  
 
For the 12 who completed both questionnaires, small improvements towards more positive 
beliefs were observed pre to post intervention for four statements (Table 8.3). After the 
intervention, there appeared to a small shift towards participants endorsing positive beliefs 
about lung cancer curability and the benefits of early diagnosis, and fewer negative beliefs 
about lung cancer treatments and lack of control over getting lung cancer (Table 8.3). There 
was no change pre to post intervention observed for those wanting to know if they had lung 
cancer (Table 8.3). There was a small decrease in perceived social norms, where participants 
were less likely to agree that important others would want them to seek medical help for a 
symptom of lung cancer (Table 8.3). 
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Table 8.4 Anticipated time to presentation, confidence and beliefs at baseline and post 
intervention 
Measure Baseline 
(n=12) 
Post intervention 
(n=14) 
Anticipated time to lung cancer symptom presentation, n          
    Under two weeks  
    Over two weeks  
    Would not contact doctor  
    Missing/incomplete  
 
9 
2 
1 
0 
 
7 
5 
1 
1 
Confidence in detecting symptom of lung cancer – self, n 
    Higher confidence 
    Lower confidence 
    Missing/incomplete  
 
5 
7 
0 
 
12 
2 
0 
Confidence in detecting symptom of lung cancer - someone 
else, n 
    Higher confidence 
    Lower confidence 
    Missing/incomplete 
 
5 
7 
0 
 
11 
3 
0 
Beliefs about lung cancer, n 
‘Lung cancer can often be cured’  
    Agree  
    Disagree  
    Missing/incomplete 
‘Most treatments for lung cancer are worse than the cancer 
itself’ 
    Agree 
    Disagree 
    Missing/incomplete 
‘I would not want to know if I had lung cancer’  
    Agree 
    Disagree 
    Missing/incomplete 
‘Going to the doctor quickly with a symptom of lung cancer 
increases the chance of survival’ 
    Agree 
    Disagree 
    Missing/incomplete 
‘People important to me would want me to go to the doctors 
with a symptom of lung cancer’ 
    Agree 
    Disagree 
    Missing/incomplete 
‘I have no control over if I get lung cancer or not’ 
    Agree 
    Disagree 
    Missing/incomplete 
 
 
4 
8 
0 
 
 
7 
3 
2 
 
3 
9 
0 
 
 
10 
1 
1 
 
 
11 
1 
0 
 
6 
6 
0 
 
 
11 
3 
0 
 
 
7 
5 
2 
 
5 
9 
0 
 
 
13 
1 
0 
 
 
12 
2 
0 
 
6 
8 
0 
 
 
8.4.3 Observational data 
 
Participants were a close-knit group who met weekly as a mental health peer-support group 
(site 1) and a group of volunteers in the community (site 2). Three participants became upset 
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talking about cancer, because they had previously experienced bereavement associated with 
cancer. Two participants arrived half way through the session, therefore they missed out on 
the beliefs and symptom section. However, they were given the handout which contained 
most of the information discussed in the first half of the session and helped them to 
participate in the second half of the session. 
 
Participants were generally engaged throughout the intervention session and participated 
well in all group activities, particularly the symptom slides and barriers section, where 
participants could relate to most of the barriers discussed. Lack of GP access was key and 
discussed throughout the session, where getting an appointment to see the GP was 
described as challenging, and preclusion of discussion of more than one symptom was 
frustrating for participants. Participants appeared to understand the scenario section and 
would offer appropriate advice to each individual. The relationship with the person was 
perceived as most important, where participants would feel most comfortable giving advice 
to those closest to them and would in most cases not mention cancer as a possible cause of 
their symptoms. Two to three participants in each group tended to dominate discussion, 
however all participants engaged in discussion at some point throughout the intervention 
session. Questions from participants were mainly focused around lung cancer risk, 
particularly risk factors such as air pollution, breathing in secondary cigarette smoke, genetic 
risk factors and age. There was some discussion about the need for a lung cancer screening 
service and the safety of e-cigarettes.   
 
With permission from participants, the community partner from site 2 who helped to recruit 
participants to take part in the session observed the intervention. Although the presence of 
the community partner in the session did not appear to affect participation from those who 
attended the session, the community partner was fairly disruptive throughout the session. 
The community partner was seated outside of the main group, and reminded not to 
participate in the session; however, the community partner asked questions throughout and 
told stories which were irrelevant to the intervention content.  
 
 
 
 
 
 
 
261 
 
8.4.4 Focus group data  
 
Themes were generated from the data regarding intervention acceptability and feasibility in 
the community, format of the intervention as a ‘community responsibility’ intervention, 
intervention delivery, content, length and suggestions for changes to the intervention.   
 
(a) Acceptability of the intervention 
 
The intervention was well received by both groups and feedback for the intervention was 
generally positive. Participants described the intervention as “informative”, particularly the 
symptom section, and thought that the intervention was pitched at the right level for the 
target audience. Participants found all elements of the intervention useful and would 
recommend lengthening the intervention session to include more information about risk 
factors for lung cancer, other potential causes of symptoms (rather than lung cancer only), 
and more images. Participants found the handout useful and would take it to their GP to aid 
communication of symptoms:  
 
P2- “You’ve got to pitch it at the level of your audience really… It wasn’t too 
simplistic but it was written in such a way that absolutely everybody could look and 
understand and take in what was written there” (Site 1) 
 
Mod1- “What did everyone think about the session? 
P3- Very informative. 
P2- Yes, I was just going to say that. 
P4- Very interesting.   
P6- A good help, yes.   
P4- It was just straight to the point, telling us about different symptoms.  Like some 
of them I didn’t even know was the symptoms.  So it was a big eye-opener for me on 
understanding the symptoms.  Yes, so it was good. 
Mod1- What were the stand out bits?  Everyone’s saying “yes, I liked it”.  Was there 
any stand out bits that you particularly liked?  
Multi- Symptoms. 
P3- Yes, symptoms, information, that was the main thing.  (Site 2) 
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Mod1- “What do you think of the hand out that everyone got at the end? 
P2- Very good, something to take away and something to remind you.  
P1- I would take it [to the doctors] myself if I thought I was in that condition or had 
problems, put it that way.  
P3- It’s a useful memory jogger, isn’t it?” (Site 1) 
 
(b) Intervention content 
 
Participants understood the community responsibility aspect of the intervention. They 
described how they would feel comfortable advising people in the community to go to the 
GP with symptoms, but would not mention cancer as a potential cause of symptoms. 
Participants held mixed views on the inclusion of smoking cessation information. Some 
participants at site one thought there should be a small section at the end with information 
about how to stop smoking. The majority of participants thought that people had their “own 
way of quitting” and were sceptical about the inclusion of smoking cessation advice, 
especially as smoking cessation support services are already available in the community. 
Current smokers thought that signposting to stop smoking services was adequate, and some 
non-smokers discussed how smoking session information was irrelevant to them and could 
potentially disengage non-smokers in the session. Two participants reported asking family 
members who smoke to come along to the intervention but were reluctant to attend, 
although the reasons for this were unclear:  
 
“P2- I don’t think you need to be saying [symptoms could indicate lung cancer] but if 
they’ve got worrying symptoms, best advice is they need to go and get checked out 
with a GP. You don’t need to give any other details. 
P1- Yeah  
P7-You don’t have to say “I think you’ve got…” 
P6- No, no  
P7- Cos you’re not a doctor are you?” (Site 1) 
 
P4- “Well, obviously you did say about the non-smoking, and all you said was there 
is advice, if anybody needed advice afterwards then ask. I think you should just leave 
it at that, because there’s quite a few stop smoking services. If they want to give up 
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they can go to their local GP, they can go to like support groups or whatever, and 
they can do it that way. So I think you should just leave it, like you’ve explained it.   
P1- You’re offering them extra literature and contacts, so I think that’s enough. 
P7- If interested, suggest that they come to the smoking session.” (Site 2)  
 
Mod2- “One of the things we deliberately didn’t include was stop smoking advice 
because I suppose we were worried that it would just for smokers completely put 
them off.  
P5- Yes, they don’t want to know. 
Mod2- I just wondered what you think about whether we should do that [include 
stop smoking advice?] 
P2- You could do that at the end couldn’t you? 
P3- I think you’ve got a good balance at the minute 
P4- Yeah” (Site 1) 
 
(c) Feasibility of the intervention 
 
Participants thought the intervention was something which would fit in with their 
community and that people in the community would attend. Participants thought the size of 
the group was good, and there was discussion about the benefits of having a group that was 
small enough to facilitate sharing of experiences and participation in group discussion.  
Participants at site one were happy with the intervention taking up one of their support 
group meeting sessions and suggested using similar groups to deliver the intervention. Other 
suggestions for advertising the intervention in future were via posters, on the community 
website or in doctors’ surgeries. The importance of delivering the intervention in close 
proximity to their house in community centres or similar venues was discussed, reflecting 
difficulties with transportation for some members of the community. Holding the 
intervention at different times of the day was considered important, to give people who 
work the opportunity to attend. Participants reported that they would recommend the 
intervention to family and friends. There was discussion around adapting the intervention 
for delivery to school age children:  
 
Mod1- “How do you feel about the size of the group we’ve had today here? 
P1- I wouldn’t have thought much more, because I think you could get lost in there. 
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Multi: Yes. 
P2- I’ve enjoyed it today with us all giving like different opinions.   
P3- I think it’s comfortable for people here, because pretty much everybody knows 
everybody and, therefore, they’re willing to share something that might otherwise 
be confidential to them.  If you’ve got 500 people in a room there’s often somebody 
who just will not speak when they’ve got a perfectly valid question, partly out of 
embarrassment, I suppose.  And so I think smaller groups probably get a better 
response.  A manageable size, I would say 10 to 12, that’s my view.” (Site 2) 
 
P5- “I don’t do evening things because the buses stop in this area, don’t they? I 
won’t get a bus on a Sunday. 
P2- It only goes as a far as the corner. Doesn’t go up to the top of the valley does it? 
Mod1- So it is important that [the session] is near to where you are? 
P5- Yeah” (Site 1) 
 
Some participants reported feeling apprehensive about attending a session about cancer, 
and for some this almost completely deterred participation in the session. These participants 
reported that others encouraged them to go to the intervention session. A few participants 
reported efforts to persuade family and friends to come with them to the session, but were 
reluctant to attend as talking about cancer was considered “daunting” (P4, site 2). “Word of 
mouth” (P7, site 2) was considered important, where positive feedback from others about 
the intervention session would increase and encourage attendance to future sessions:  
 
P7- “Well, <name of other participant> , she phoned me about the [session], my 
words were, I’m not sure I want to go there, I said. 
P2- That’s right.  
P7-And I said, I don’t want people talking about cancer, didn’t I? 
P2- Yes, you did.  
P7- I said, I’m not sure I can deal with it.  
P2- And what did I say to you, I went to the last one and I found it really interesting.   
P7- Yes, I know, but I still …  
Mod 1- So what would you say now if someone rang you up to say they were going 
to come to this session, would you recommend it? 
P7- Yes, I think it was totally different to what I thought.  
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P1- It’s informative and not gruesome, isn’t it. 
P7- That’s right.  
P6- That’s right, yes, that’s a good way of putting it, that, yes.” (Site 2) 
 
8.5 Discussion 
Findings from feasibility testing with a group of potential users suggested that group 
education was an acceptable method of delivering information about lung cancer, and that 
the lung health intervention session could fit in with the local community. Participants 
appeared to understand the community responsibility aspect and described feeling 
comfortable about prompting someone close to them to go to the GP with symptoms, but 
would not usually mention cancer as a potential cause. Small improvements for lung cancer 
symptom knowledge, beliefs about cancer and confidence in detecting symptoms were 
observed post intervention. The greatest improvements for symptom knowledge were 
observed for symptoms targeted by the intervention and non-specific symptoms. Although 
some participants anticipated longer symptom presentation times after exposure to the 
intervention, intentions to seek help were more aligned to the NICE guideline of three weeks 
and to advice given during the session. This finding might be explained by background 
characteristics of the groups involved in acceptability testing. Site one was a group of 
individuals who were already engaged in a health peer support group. They may previously 
have been more comfortable about seeking medical help and therefore motivated to seek 
medical help as soon as they noticed something suspicious. Most symptoms included in the 
intervention were coupled with advice to seek medical help for symptoms if they persisted 
for three weeks or more. It is likely that following advice from the intervention, participants 
were more likely to anticipate monitoring symptoms to see if they persisted, rather than 
seeking medical help immediately.  
Lack of GP access was a key barrier for participants. Although participants were given 
strategies to overcome reported barriers, there is a need for healthcare professional 
intervention at primary care level. In the review of interventions reported in Chapter 6, 
some interventions used ‘push-pull’ methods to ‘push’ symptomatic patients to primary care 
and ‘pull’ patients through primary care and secondary care using interventions delivered to 
healthcare professionals. Although out of the remit and budget of this PhD, a ‘pull’ strategy 
involving reminders of the NICE guidelines and preparations for increased case load could be 
considered for the intervention in future.  
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8.5.1 Limitations of the study 
 
There was poor representation from current smokers at the intervention acceptability 
testing, therefore it is unclear if the intervention is acceptable to current smokers. Gaining 
views from current smokers is important since they are most at risk of lung cancer. Family 
members who attended the intervention reported efforts to encourage smokers within the 
family to attend. It is unclear why more smokers did not attend or why participants’ family 
members who were smokers were not willing to attend. However, it is possible that this 
reflects smokers’ reluctance to engage in lung cancer awareness interventions, perhaps due 
to the stigma associated with smoking and lung cancer. Engaging never-smokers or former 
smokers who have people within their social networks who are current smokers may be a 
potential strategy for delivering messages to smokers, or encouraging current smokers to 
attend intervention sessions in the community.  Similar strategies have been used in other 
peer educator interventions (Kim et al, 2015). Kim et al (2015) used a friend nomination 
approach to identify people in the community to receive the intervention next, rather than 
identifying who is the most popular in the community. In this study, the intervention could 
run a few times within a given community and intervention attendees were asked to 
nominate someone within their social network to receive the intervention (Kim et al, 2015). 
Future pilot work could assess the feasibility of adopting the friend nomination approach in 
the context of the lung health information session. 
 
The small sample size of 14 participants who were recruited over two sites to take part in 
intervention acceptability testing was a key weakness of the study, and limits the 
generalisability of study findings. It remains unclear whether community group based 
education is an acceptable method of intervention, and whether it could be scaled-up for 
delivery to a larger audience. In addition, although both groups met the criteria for inclusion, 
one group were already members of a peer support group who were accustomed to 
discussing health issues and may not be representative of a typical group of individuals 
within the community.  
 
Both groups were recruited through community partners, with potential for selection bias 
where community partners choose participants to take part in the intervention study based 
on previous experiences of cancer, or a perception that the selected group had an interest in 
health and were therefore more likely to engage in the intervention. Furthermore, 
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recruitment through community partners meant that it was not possible to calculate 
response rates based on the number of people invited to participate in the intervention, and 
limited data were available regarding reasons for non-participation.  
 
Future feasibility and pilot intervention testing should take place over multiple sites, 
preferably across various geographical sites such as deprived communities in Scotland and 
England. In addition, future pilot testing could explore appropriate alternative methods of 
recruiting people into the intervention such as work places or poster adverts in the 
community, with a particular emphasis on engaging smokers in the intervention.  
 
8.5.2 Measures  
 
An adapted version of the Lung CAM was used in the present study. There was minimal 
missing data, suggesting that the format and wording used in the questionnaire measure 
was acceptable. Missing data were most frequent for the postcode question used to derive 
WIMD score. It is likely that participants felt uncomfortable providing such personal 
information, suggesting that other measures of socioeconomic group may be more 
acceptable. In addition, most participants were retired thus it was not possible to gaining an 
understanding of their current or previous social circumstances. Further revisions could 
measure occupation prior to retirement.   
 
There were some problems associated with using a standardised measure. For example, the 
anticipated time to symptom presentation intervals did not match the messages used in the 
intervention. For most of the symptoms, the advice given to participants in the intervention 
was to seek medical help for symptoms if they persisted for three weeks or more. However, 
this was not reflected in the standard Lung CAM response options. In addition, three pain 
related symptoms that were not targeted by the intervention were more likely to be 
recognised post intervention, and could reflect response bias associated with recognition 
measures of symptom knowledge. Alternatively, It is possible that because ‘chest pain’ was 
included in the intervention content, participants were aware of ‘pain’ as a general symptom 
of lung cancer irrespective of the site of the pain.  
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8.5.3 Implications and recommendations for the intervention   
 
The content, format and mode of delivery of the intervention were found to be appropriate 
and acceptable in the context of promoting timely lung cancer symptom presentation 
among low socioeconomic groups. Framing of the intervention from a third person 
‘community responsibility’ aspect could be considered a low cost and sustainable method 
for disseminating intervention messages among the community. Findings suggest that the 
community responsibility aspect is an acceptable way of delivering intervention messaging 
and could be used as a method for disseminating information to smokers who are unlikely to 
attend an intervention about lung cancer, although this would be challenging to evaluate.  
 
In an attempt to increase sustainability of the intervention and frequency of the intervention 
sessions, key members of the community such as a Communities First partner could be 
trained to deliver the intervention for future sessions and should be explored in future 
research. The intervention should be modified to include more images, more information 
about the risks associated with developing lung cancer and other potential causes of 
symptoms. The inclusion of a healthcare professional component to remind GPs of the 
referral guidelines for suspected lung cancer could be considered in future research.  
 
In addition, there is potential for the intervention to be carried out with higher risk groups: 
current and former smokers with pre-existing lung co-morbidity such as COPD. As outlined in 
Chapter 7, this group are at increased risk for lung cancer in comparison to current or former 
smokers without lung co-morbidity, but are often already symptomatic and potentially 
under clinical intervention. Further research should seek to understand the barriers to lung 
cancer symptom presentation among this group to understand perceptions of new or 
changing symptoms with potential adjustments made to intervention content.  
 
8.5.4 Reflections from user testing 
 
Community partners are often trusted, key members of the community, and were valuable 
assets to facilitate participant recruitment for this user testing study, enabling access to 
groups of people who may otherwise not engage in research. Both community partners who 
successfully helped to recruit participants for the study were enthusiastic and supported the 
study, facilitating the planning and organisation of the session. However, there were some 
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challenges encountered during the study, where as previously discussed, one community 
partner observed the session, often discussing issues during the session which were 
irrelevant. This could potentially reflect perceptions of ownership of the session from the 
community partner, where they became involved with the session from an early stage. In 
addition, their involvement might also reflect almost paternalistic feelings towards the group 
of individuals who have agreed to take part in the session, where the community partner 
perceived themselves to have a certain amount of responsibility towards those who were 
recruited to take part in the session. Although community partner participation in the 
session did not appear to affect study participant responses, it was difficult to balance 
community partner involvement in a time limited session, especially considering their 
contribution to the session was often off-topic. In future, procedures should be clearly 
outlined for the inclusion of community partner, and boundaries clearly defined before the 
intervention. Alternatively, there is potential to harness this enthusiasm and train 
community partners to deliver the intervention.  
 
8.6 Conclusion  
A community based educational intervention to promote timely symptom presentation by 
utilising strong social networks in the community was tested for acceptability with a group 
of potential users. Group-based education was an acceptable mode of intervention delivery, 
and can be used to engage the target group in lung cancer early detection. Further pilot 
testing across multiple sites is required to explore feasibility and acceptability of the 
intervention in the future, including methods for engaging smokers.  
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Chapter 9 
General discussion  
9.1 Chapter overview 
This chapter presents an overview of the PhD findings. A summary of how these findings 
were used in combination with findings from a scoping review study and intervention 
development exercise using the Behaviour Change Wheel is presented. Each phase of work 
is summarised and discussed in relation to existing evidence. The methodological strengths 
and weaknesses of the PhD are discussed, along with the future implementation and 
evaluation of the intervention.  
9.2  Summary of thesis findings  
This PhD aimed to (1) understand the barriers to cancer symptom presentation among 
people from low socioeconomic groups, and (2) develop a cancer awareness intervention 
targeted at people from a low socioeconomic group. Initially, it was envisaged that the 
intervention would have a generic cancer focus; however, in response to changes in policy 
regarding the need to improve lung cancer outcomes as a national priority (Welsh 
Government, 2015) the decision was made to focus the intervention solely on lung cancer 
symptom awareness.  
There were five objectives of the PhD: (1) identify relevant theory for cancer awareness, 
beliefs about cancer and symptom presentation behaviour; (2) identify studies of cancer 
symptom knowledge, beliefs about cancer, barriers to cancer symptom presentation and 
actual or anticipated cancer symptom presentation behaviour using systematic review 
methods; (3) identify the factors influencing cancer symptom presentation among people 
from low socioeconomic groups using qualitative methods; (4) identify and review 
interventions designed to encourage earlier cancer symptom presentation among people 
from low socioeconomic groups; (5) develop an intervention to encourage earlier cancer 
symptom presentation among people from low socioeconomic groups and examine its 
acceptability with a sample of potential users. Each aim and objective will be addressed and 
discussed.  
Objectives 1 to 3 contribute to the first aim of the PhD to understand the barriers to cancer 
symptom presentation among low socioeconomic groups. Theories and models considered 
relevant to cancer symptom presentation behaviour were identified in Chapter 2 (objective 
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1) and the COM-B model was presented as a potentially useful framework for understanding 
cancer symptom presentation behaviour (Michie et al, 2011). The COM-B model was used 
throughout this PhD thesis and provided a useful framework for analysing qualitative data to 
explore individual and socio-environmental influences on behaviour, and to guide 
understanding of these influences on cancer symptom presentation behaviour among low 
socioeconomic groups. A systematic review described in Chapter 3 was used to identify 
relevant literature relating to cancer symptom knowledge, beliefs about cancer, barriers to 
cancer symptom presentation, and actual or anticipated cancer symptom presentation 
behaviour (objective 2) (McCutchan et al, 2015; Appendix 1). The systematic review was 
useful to understand which of these factors could prolong cancer symptom presentation 
behaviour and which were most prevalent among low socioeconomic groups. Findings 
suggested that lower knowledge, negative fearful and fatalistic beliefs about cancer and 
emotional barriers to symptom presentation were more prevalent among low 
socioeconomic groups, and contributed to prolonged cancer symptom presentation. The 
systematic review helped to identify the need for a more in depth understanding of how 
these and other factors might influence symptom presentation among low socioeconomic 
groups, which was essential for the development of an intervention targeted at low 
socioeconomic groups and could be achieved through qualitative methods.  
A qualitative exploration of cancer knowledge, beliefs about cancer and barriers as 
influences on cancer symptom presentation among low socioeconomic groups, using 
interview and focus group methods, was reported in Chapters 4 and 5 (objective 3). Findings 
were used to confirm those of previous studies, and to gain in depth insight into the barriers 
to cancer symptom presentation among low socioeconomic groups. The qualitative studies 
were useful for identifying and understanding the influences of both individual and wider 
social and environmental factors on cancer symptom presentation behaviour, highlighting 
the role of broader social determinants of health on behaviour. Social networks were 
identified as key to the acquisition and maintenance of cancer knowledge and beliefs and 
the decision to seek medical help. Symptom advice was often sought from family and friends 
prior to a visit to the GP, with the potential to prolong cancer symptom presentation 
following poor quality advice. Furthermore, the influence of organisational barriers such as 
GP policies and wider socio-environmental factors, such as the struggles of day-to-day living 
in a socioeconomically deprived community where health was not perceived as a priority, 
contributed to prolonged symptom presentation.  
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The final two objectives 4 and 5 relate to the second aim to develop a cancer awareness 
intervention targeted at low socioeconomic groups. A scoping review of existing cancer 
awareness interventions was presented in Chapter 6 (objective 4). The review was useful for 
understanding what types of interventions had previously been implemented and which 
interventions were most effective in terms of behaviour change among low socioeconomic 
groups. Intervention messages communicated through mass media channels were least 
effective, and more culturally targeted interventions such as community based multi-faceted 
or educational interventions were most effective. In addition, the scoping review helped to 
identify the most and least frequently included intervention content. Most interventions did 
not include any cancer risk information and/or information on strategies to overcome 
barriers to symptom presentation. This highlighted the need for more targeted, 
interventions that included factual symptom, belief and risk related information, and 
practical advice on how to overcome barriers to cancer symptom presentation to empower 
individuals from low socioeconomic groups to seek medical help for symptoms.  
In Chapter 7, findings from an intervention development exercise using the Behaviour 
Change Wheel were reported (objective 5). The intervention was developed in accordance 
with the MRC framework for complex intervention development and findings from studies 
using primary and secondary data reported in Chapters 3 to 6. An intensive, community 
based group educational intervention was developed, containing information to combat 
negative beliefs about lung cancer, and to inform about the symptoms of lung cancer, when 
to go to the doctor with a symptom of lung cancer, who is most at risk for lung cancer, 
strategies to overcome barriers to symptom presentation, what advice to give other people 
in the community with symptoms, and what to expect from the GP and in secondary care if 
they present with symptoms. The intervention was tested for acceptability with a group of 
potential users who included current smokers, former smokers and family members of 
smokers over the age of 40 from socioeconomically deprived communities (objective 5). 
Overall, findings from the user testing study (Chapter 8), suggested that the intervention 
was an acceptable method for engaging members of the community in an intervention 
about lung cancer. Preliminary evidence suggested that the intervention may have the 
potential to increase lung cancer symptom knowledge, modify negative beliefs and increase 
confidence in detecting symptoms. However, there was poor representation from current 
smokers in the user testing studies, and the quantitative findings suggested that anticipated 
symptom presentation increased after exposure to the intervention. These limitations will 
be discussed later in the chapter.  
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9.3 Understanding the barriers to cancer symptom presentation among low 
socioeconomic groups  
The NAEDI framework (Hiom, 2015) described in Chapter 1 was used to guide understanding 
of potential influences on cancer symptom presentation in this PhD. The NAEDI framework 
suggests that low cancer knowledge, negative beliefs about cancer, and barriers to symptom 
presentation contribute to prolonged cancer symptom presentation. In addition, 
socioeconomic factors are included in the NAEDI framework as a risk factor for prolonged 
symptom presentation (Hiom, 2015); however, due to the descriptive nature of the 
framework, it was unclear how these factors in combination with socioeconomic deprivation 
can prolong cancer symptom presentation. This PhD was concerned with exploring how the 
factors identified by the NAEDI framework and other factors might prolong cancer symptom 
presentation among low socioeconomic groups.  
Findings from the systematic review reported in Chapter 3 supported the assumptions of the 
NAEDI framework (McCutchan et al, 2015, see Appendix 1). There was limited evidence to 
suggest that the influence of socio-environmental factors such as symptom disclosure could 
prolong cancer symptom presentation among low socioeconomic groups (Li et al, 2012). In 
addition, how socioeconomic factors could influence knowledge, beliefs, and barriers to 
cancer symptom presentation lacked clarity.  
Qualitative findings from an in-depth interview study with people from a low socioeconomic 
group (McCutchan et al, 2016; Chapter 4) and a focus group study with people who live or 
work in deprived communities (Chapter 5) supported the findings of previous studies 
(McCutchan et al, 2015; Chapter 3) and the assumptions of the NAEDI framework (Hiom, 
2015). There was evidence to suggest that cancer knowledge and problems of 
communicating of symptom concerns during a consultation (Capability) could influence 
cancer symptom presentation. Fear in combination with fatalistic beliefs about cancer, was 
associated with prolonged symptom presentation, whereas fear combined with positive 
beliefs about early diagnosis prompted symptom presentation (Motivation). The inclusion of 
members of the public from low socioeconomic groups helped to identify some of the 
personal issues faced by individuals, and to reveal social norms within their community 
network (Opportunity). Inclusion of local stakeholders who live or work in deprived 
communities facilitated insight into ‘upstream factors’ on behaviour, defined as wider social 
influences and social inequalities that contribute to poor health (Bharmal et al, 2015), where 
the broader issues and challenges of living in a deprived community such as unemployment 
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and housing problems were discussed (Opportunity). In addition, community level norms 
and barriers to cancer symptom presentation specific to low socioeconomic groups could be 
explored with local stakeholders (Opportunity).Through qualitative methods, the ways in 
which socioeconomic factors (Opportunity) could influence Capability and Motivation to 
potentially prolong cancer symptom presentation behaviour were identified. Social 
Opportunity was a key influence on Capability and Motivation, where previous experiences 
contributed to the formation of knowledge and beliefs about cancer. In addition, social 
Opportunity was found to influence symptom presentation through symptom disclosure and 
the quality of advice given. Physical Opportunity influenced symptom presentation through 
the wider social determinants of health, where the contextual factors associated with living 
in a deprived community such as lack of resources and competing priorities could prolong 
cancer symptom presentation behaviour.  
There was evidence of poor knowledge for the non-specific symptoms of cancer and a high 
prevalence of negative fearful and fatalistic beliefs about cancer (Marcu et al, 2016; Quaife 
et al, 2015; Chonjnacka-Szwalowska et al, 2013; Grunfield et al, 2002; Marlow et al, 2014) 
among those from low socioeconomic groups. Using qualitative methods, a rich 
understanding was obtained regarding how knowledge and beliefs were acquired and 
maintained in the community, where experience of cancer within one’s social network was 
most influential. There was evidence that cancer-related knowledge and beliefs were almost 
exclusively gained from exposure to people in the community who had died and in most 
cases suffered with cancer, which could explain the high prevalence of negative beliefs 
among low socioeconomic groups. Knowledge of non-lump symptoms and bleeding was 
often based on people with cancer known in the community, with participants often 
describing the symptoms of advanced stage cancer. In addition, non-specific symptoms of 
cancer such as tiredness were often misattributed to symptoms of pre-existing co-
morbidities such as diabetes, which were common in this group (Rachelle et al, 2016). Two 
studies found that people from low socioeconomic groups hold lower suspicions than higher 
socioeconomic groups that their symptoms could indicate cancer (Whitaker et al, 2015a) or 
were more likely to down play the seriousness of symptoms (Marcu et al, 2016). 
Misattribution to pre-existing co-morbidities could explain this finding, and has implications 
for seeking medical help for cancer symptoms (Carter-Harris et al, 2015; Ristvedt et al, 2014; 
Siminoff et al, 2014; Tod et al, 2008). These findings highlighted the need for an intervention 
to inform people in socioeconomically deprived communities about the symptoms of cancer, 
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explain the importance of multiple symptoms and changes to normal symptoms, and 
challenge negative beliefs about cancer.  
In the qualitative interview study (McCutchan et al, 2016; Chapter 4), there was additional 
evidence regarding the influence of social networks on cancer symptom presentation 
behaviour through the quality of advice received following symptom disclosure to family 
members or friends (Li et al, 2012). The influence of norms around using a lay system of 
healthcare before a visit to the GP was confirmed in the focus group study (Chapter 5), 
where symptom advice was often sought from people deemed as ‘knowledgeable’, close to 
them or well respected within their social network (Edwards et al, 2013; Low et al, 2015; 
Pescosolido and Boyer, 1999). Although seeking symptom advice from family and friends is 
common (Pedersen et al, 2011; Whitaker et al, 2015a; Whitaker et al, 2014; Marlow et al, 
2014; Kakagia et al, 2013), it is likely to be problematic for people from a low socioeconomic 
group.  There is a potential to receive poor quality advice from someone who has poor 
cancer symptom knowledge, negative beliefs about cancer, or previous negative experiences 
in the health service which could deter or prolong cancer symptom presentation. Using 
strong social networks to educate and facilitate dissemination of intervention messages was 
identified as a potential strategy for promoting earlier cancer symptom presentation in the 
community (Hart and Elford 2003; Campbell et al, 2008; Rogers, 1983).  
Both qualitative studies confirmed the existence of emotional barriers to cancer symptom 
presentation among low socioeconomic groups such as embarrassment and worry about 
what the GP might find (Niksic et al, 2015; Quaife et al, 2015a; Robb et al, 2009), and 
provided insight into how emotional barriers might prolong cancer symptom presentation. 
Embarrassment about undergoing intimate examinations and anticipating pain during 
diagnostic testing were discussed as barriers to cancer symptom presentation, and were 
usually gained from people in the community discussing negative experiences of such 
testing. Again, this highlights the significance of social networks for influencing symptom 
presentation behaviour. Fear of receiving a diagnosis of cancer and worry about what the GP 
might find were reported as key barriers to cancer symptom presentation in the community 
(Robb et al, 2009; Whitaker et al, 2015c; Waller et al, 2009; O’Mahoney et al, 2011). Fear 
and worry are likely to reflect perceptions of inevitable death after a diagnosis of cancer, 
based on experiences of cancer in the community. Findings from the focus group study 
suggested that, for some, a potential diagnosis of cancer was too much to cope with in the 
context of other day-to-day challenges, pushing these individuals into a state of denial and 
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prolonged symptom presentation. There appears to be a vicious circle associated with fear 
or denial of cancer based on previous experience, which acts as a barrier to cancer symptom 
presentation. These individuals might present with a late stage diagnosis of cancer, further 
reinforcing negative beliefs about cancer in the community. This highlights the importance 
of earlier cancer diagnosis to ‘break the circle’ and promote earlier symptom presentation, 
in order to provide ‘real’ first-hand evidence of cancer survival in the community.  
Other barriers to going to the GP with a symptom of cancer that were identified in the 
qualitative studies highlighted the significance of the pressures of living in a 
socioeconomically deprived community as influences on symptom presentation behaviour. 
Exploration of the wider social environment was used to understand the struggles of day-to-
day living in a deprived community (Steptoe and Feldman, 2001; Ellen et al, 2001), and how 
these might influence cancer symptom presentation behaviour. As outlined in Chapter 1, 
The Health Map (Burton and Grant, 2006) identifies multiple determinants of health both in 
the immediate environment and the wider physical, social and economic environment in 
which an individual lives. There was evidence from this PhD of the wider upstream 
determinants of health influencing cancer symptom presentation behaviour among low 
socioeconomic groups. For example, economic hardship meant that fulfilling basic needs 
day-to-day, such as finding money for food or heating the house, were prioritised over 
seeking medical help for symptoms, particularly when symptoms were perceived as non-
serious.  
Through qualitative methods, various barriers at an organisational level and problems with 
full and effective disclosure of symptoms during an appointment with the GP were 
identified. Some GP practice policies which preclude discussion of more than one symptom 
during a consultation (McCartney, 2014) and time limited appointments had the potential to 
prolong cancer symptom presentation and were considered to be a key barrier to disclosure 
of a cancer symptom, since patients rarely presented their cancer symptom first (Corner and 
Brindle, 2010; Andersen and Vested, 2015). Instead, other benign symptoms were often 
used to test the water and build trust with the GP, or appointments were used to discuss 
other non-health issues such as getting Employment and Support Allowance (ESA) forms 
signed off to ensure benefits were paid on time. In the context of socioeconomic 
deprivation, where individuals are struggling to live day-to-day with little money, getting ESA 
forms signed is likely to be perceived as more important than discussion of cancer 
symptoms.  
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A lack of confidence when communicating symptoms, especially during time limited 
appointments, was found to influence discussion of symptoms. There is evidence from non-
cancer contexts that people from a low socioeconomic group are generally less likely than 
those from a high socioeconomic group to actively engage in a GP consultation (Willems et 
al, 2005). Studies suggest people from low socioeconomic groups more often spend time 
during the consultation discussing other non-health related issues and take a more passive 
approach to health care than those from a high socioeconomic group (Willems et al, 2005). 
In addition, those from low socioeconomic groups are more likely to perceive power 
imbalance between themselves and the GP, which can impair full disclosure of symptoms 
during a consultation (Scambler and Britten, 2001; Greenhalgh et al, 2015; Ward and Coates, 
2006). These findings highlighted the need for an intervention to offer practical advice on 
strategies to overcome barriers to symptom presentation, providing individuals with the 
tools to effectively communicate symptom concerns during an appointment.  
There were additional upstream social influences on behaviour, through which 
socioeconomic deprivation is likely to prolong cancer symptom presentation. Feelings of 
victimisation and suspicion towards authority and government were reported (Ward and 
Coates, 2006; van Ryan and Burke, 2000). There was a general sense of lack of control over 
day-to-day living, and general fatalistic beliefs such as the belief that everything is out of 
one’s control were often reported including feelings of helplessness. These in addition to the 
stigma of being associated with a deprived community are likely to reflect feelings of 
disempowerment, which are linked to poor health and feelings of not being worthy 
(Marmot, 2015), and could impact on cancer symptom presentation behaviour. This 
highlighted the need for an intervention to empower individuals to seek medical help, and 
legitimise presenting to the doctor with symptoms of cancer. Furthermore, using a trusted 
and reliable source to endorse intervention material was considered important.  
9.4 Theoretical underpinning using the COM-B model  
In Chapter 2, the COM-B model (Michie et al, 2011) was identified as a potentially useful 
framework for understanding cancer symptom presentation among low socioeconomic 
groups. Where many other psychological theories neglect emotional factors and the wider 
social and environmental influences on behaviour, the COM-B model includes these and 
other individual factors, which were considered relevant to this context. The COM-B model 
was used throughout the PhD thesis to guide analysis for the qualitative studies, using a 
framework approach based on the COM-B model constructs. In addition, the COM-B model 
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underpinned the framework of the Behaviour Change Wheel, which was selected to guide 
intervention development. There are benefits associated with using the COM-B model as the 
basis for the framework analysis in the qualitative studies, as this facilitated exploration of 
the wider social environmental influences on behaviour. In addition, an in depth 
understanding of the COM-B model was beneficial when performing the analysis of the 
target behaviour around the first stage of the Behaviour Change Wheel.  
Findings from the qualitative studies reported in Chapters 4 and 5 suggested that the COM-B 
model was useful for understanding how the constructs of Capability, Opportunity and 
Motivation influence cancer symptom presentation behaviour among low socioeconomic 
groups. As previously discussed, Opportunity was identified as a key influence on cancer 
symptom presentation behaviour in this context. Therefore, the inclusion of Opportunity 
was a strength of the model, considering that many other psychological theories do not 
include the wider social and environmental factors. Opportunity was found to directly 
influence behaviour, as well as indirectly influence behaviour through Capability and 
Motivation. For example, lack of transportation to get to an appointment with the GP and 
competing priorities such as work commitments directly influenced behaviour, where 
working to earn money or not being able to get time off work (Opportunity) prolonged 
symptom presentation (Behaviour). There was evidence to suggest that both Motivation and 
Capability influenced the relationship between Opportunity and Behaviour. For example, 
cancer knowledge (Capability) and beliefs about cancer (Motivation) were almost exclusively 
gained from seeing people in the community with cancer (Opportunity), and both poor 
knowledge and negative beliefs prolonged cancer symptom presentation (Behaviour). The 
influence of Opportunity on Capability is currently represented in the COM-B model. 
However, the influence of Opportunity on Capability is not represented in the model, and 
there was evidence to suggest the existence of this bi-directional relationship. Future 
revisions of the model should consider representing the relationship between Opportunity 
and Capability, where bi-directional arrows could represent the influence of Opportunity on 
Capability.   
Basing the qualitative studies’ framework analysis around the COM-B model could be 
considered reductionist and potentially limiting. As previously discussed, the COM-B model 
was chosen due to its breadth, which combined a range of theories of behaviour, to create a 
single model of both individual and environmental influences on behaviour. However, in 
order for the model to be applicable to various behavioural contexts, some of the definitions 
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for each construct were limited and vague. Vague definitions presented difficulty when 
assigning a theme to a construct, however; when used in combination with the Theoretical 
Domains Framework (TDF), sorting of themes under each of the COM-B model constructs 
became clearer, and any ambiguity was overcome through double checking of themes by 
supervisors.  Two theories which did not formally underpin the COM-B model were 
identified in Chapter 2 as useful for understanding influences on cancer symptom 
presentation behaviour. This has the potential to exclude or limit analysis of factors 
identified in these theories as relevant to the context of cancer symptom presentation. For 
example, the Common Sense Model of Illness Self-Regulation (CSM; Leventhal et al, 1984) 
attempts to explain how illness is inferred, understood and acted upon, but was not used to 
underpin the COM-B model. Consequently, symptom interpretations are not explicitly 
represented in the COM-B model, but are important when deciding to seek medical help for 
a symptom (Noonan et al, 2014; Walter et al, 2012). However, the domains of ‘knowledge’ 
and ‘memory attention and processes’ in the TDF are implicitly similar to the construct of 
identity in the CSM; therefore, in both qualitative studies, symptom attributions were 
discussed under Capability in the context of symptom knowledge.   
9.5 Study methodology strengths and limitations  
9.5.1 Qualitative methods 
Qualitative methods were selected to enable an in-depth examination of the barriers to 
symptom presentation among low socioeconomic groups. Qualitative methods were 
considered most appropriate in this context, since quantitative methods such as a 
questionnaire survey would preclude a detailed analysis. Two qualitative methods were 
chosen: qualitative interviews and focus groups. Face-to-face interview methods were used 
to facilitate in-depth exploration of the topic under investigation, providing a deep 
understanding of an individual’s experiences, and examination of the wider environmental 
factors and how these might influence cancer symptom presentation behaviour. Focus 
group methods were considered most suitable for further exploration of themes that 
emerged from the interview study, to validate interview findings and to allow insight into 
shared group norms around symptom presentation behaviour, and to engage members of 
public participants in a group activity of symptom attributions.  
Although qualitative methods were most suitable for understanding the wider social and 
environmental influences on symptom presentation behaviour, there are limitations. 
Qualitative methods are often critiqued for a lack of generalisabilty, where in depth 
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examinations of individuals on a case-by-case basis may not be generalisable to wider 
populations or other contexts. For example, GP appointment policies precluding the 
discussion of more than one symptom might be specific to a UK context or certain areas in 
the UK. However, it is likely that barriers related to economic hardship are universal to low 
socioeconomic groups regardless of geographical location. In addition, qualitative methods 
are often criticised for limitations associated with subjectivity during data analysis and the 
potential for influence of researcher bias or values on the interpretation of findings, 
although some argue that this is a strength of qualitative research (Ratner, 2002). Measures 
were taken to reduce potential subjectivity by involving the supervisory team in data 
analysis through double coding.  
In addition, I was reflexive throughout data collection and analysis in terms of how the 
potential influences of my own values might influence on interpretation of findings.  I made 
efforts to reduce any potential influences of my own social standing during interviews 
through rapport building and taking time to make the participant feel comfortable. During 
data analysis, I was aware of how my own experiences of growing up in an environment 
where I was given every opportunity to succeed might influence interpretation of findings. It 
is likely that I will never fully understand the day-to-day struggles and economic hardship 
faced by those who took part in the studies. Ethnographic methods could be considered in 
future to provide further insights into the complexities and issues of deprived communities. I 
would integrate myself fully into a community to understand the social and economic issues 
encountered by deprived communities.  
9.5.2 Anticipated and actual symptom presentation behaviour 
In the qualitative interview study (McCutchan et al, 2016; Chapter 4), participants were 
asked to recall actual cancer symptom presentation behaviour and any barriers to symptom 
presentation experienced, or to hypothetically predict cancer symptom presentation 
behaviour and potential barriers to symptom presentation. There are methodological 
limitations associated with both methods, where retrospective recall of symptoms and 
associated behaviour relies on memory and there is potential for recall bias. Conversely, 
hypothetical study designs require the individual to estimate behaviour and might be biased 
by good intentions, so predicted behaviour may not accurately reflect actual behaviour in 
the future. A prospective study, following individuals over a long period of time to wait for 
them to become symptomatic and then record actual symptom presentation behaviour, is 
unfeasible due to the prohibitively large sample that would be required. Instead, study 
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designs using a community sample of currently symptomatic individuals and inviting them to 
take part in a study without the mention of cancer, may overcome some of these limitations 
(Cockburn et al, 2003; Whitaker et al, 2015a; Whitaker et al, 2014). In such studies, 
symptomatic individuals would be asked to complete a questionnaire and/or interviewed 
about their symptom experience and perceptions and the reasons for seeking medical help 
or not would be explored.  
9.5.3 Review methods 
Two types of review method were used in the PhD thesis. Systematic review methods were 
used to identify studies relating to knowledge, beliefs, barriers to symptom presentation and 
symptom presentation behaviour, and was considered most appropriate due to the high 
amount of published articles in this context. Systematic reviews are considered to be the 
highest level of research evidence due to inclusion of good quality evidence, replicability and 
low bias through double coding at all stages.  However, due to the wide range of outcomes 
measures and heterogeneous research methods used for the included studies, meta-analysis 
was precluded and is a limitation of the systematic review study.  
A scoping review methodology was considered most suitable for the review of cancer 
awareness interventions in order to allow for inclusion of grey literature reporting 
interventions that had not been evaluated, interventions of lower quality, and community-
level interventions that were not published in peer reviewed journals. There are some 
limitations associated with scoping review methodology. Double coding at each stage of the 
search, study selection and data extraction is not compulsory, therefore there is potential 
for subjectivity at each stage. In addition, scoping review methodology does not include a 
formal quality assessment of included studies. Without quality assessment in the study 
selection stage, there is potential for conclusions to be drawn based on methodologically 
flawed studies or untrustworthy evidence. This has implications when making intervention 
or policy recommendations if advice is based on evidence whose risk of bias is unclear. 
However, without the flexibility of scoping review methodology, as opposed to more 
rigorous methods such as systematic review, many of the smaller community based 
interventions would not be included in the review. Since the primary aim of the review was 
to identify all existing interventions targeted at low socioeconomic groups, a scoping review 
was useful and most appropriate in this context. Some of the intervention evaluation studies 
were of lower quality, and conclusions were drawn regardless of the quality of evaluation. 
 
 
282 
 
Analysis of intervention effectiveness by strength of evidence may have been more useful 
when drawing conclusions regarding intervention effectiveness.    
9.5.4 Acceptability testing  
A multiple methods approach was used for the intervention acceptability user testing study. 
Quantitative data were collected before and immediately after exposure to the intervention 
to measure knowledge, beliefs, anticipated symptom presentation behaviour and 
confidence in detecting symptoms. A qualitative focus group method was considered most 
appropriate for assessing acceptability of the intervention and suggestions for changes, and 
observational data were collected to record non-verbal feedback and group attentiveness. 
Using a multiple methods approach was beneficial to assessing intervention acceptability 
through qualitative and observational methods, in addition to quantitative measures to 
assess potential for change following participation in the intervention. However, there are 
limitations of assessing outcome measures directly after the intervention session. Using 
quantitative measures immediately after the intervention is likely to bias findings, 
potentially overestimating the potential for the intervention to improve the outcome 
measures of interest. In addition, immediate follow-up precludes assessment of information 
retention. A follow-up questionnaire at least one month post intervention, and ideally 
longer-term, would be desirable to assess retention of intervention messages. Limitations 
associated with sampling for the user testing study will be discussed. 
9.6 Strengths and limitations of sampling methods 
 
9.6.1 Qualitative studies 
Using multiple individual and area level indicators to ensure that participants included in the 
qualitative interview study (Chapter 4) were representative of low socioeconomic groups, 
was a strength of this study. However, there were limitations associated with sampling 
participants through the ICBP Welsh database study who were individuals previously 
engaged in research about cancer. This has the potential to bias the sample towards people 
who were more motivated to take part in research or talk about cancer. In addition, framing 
the study around cancer might encourage people who were less negative about cancer, and 
more likely to seek medical help quickly with a cancer symptom, to take part in the interview 
study.  
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To overcome some of these limitations, community norms regarding knowledge, beliefs, 
barriers and cancer symptom presentation behaviour were elicited, although there are 
limitations associated with gaining proxy views. It is likely that an individual’s perception of 
community norms may not accurately reflect reality, particularly when cancer is considered 
a taboo subject and is not often discussed with peers. In addition, opportunistic recruitment 
methods involving snowball sampling via community partners and previous participants 
recruited through the ICBP database were used to invite further participants to take part in 
the interview study. There are limitations associated with snowball sampling and it is often 
considered as a last option due to limitations associated with selection bias (van Meter, 
1990). For example additional participants are often recruited through ones social network, 
which places limits of validity. However, in this context it was a useful method for gaining 
access to and engaging participants who may otherwise not have been included in the study 
(Faugeier and Sargeant, 1997).  
In the focus group study (Chapter 5), community partners and healthcare professionals were 
able to provide insight into community level norms and the challenges of day-to-day living. 
This enabled insight to be gained into community and organisational level barriers of which 
members of the public may not be aware. Participants in the public focus groups were 
recruited through community partners, which was considered to be a good recruitment 
strategy, as they are a trusted source who are likely to provide access to people in the 
community who might not otherwise engage in research. However, there are issues 
regarding selection bias, where the community partner may select participants based on 
previous experiences of cancer, such as a losing a spouse to cancer. This is problematic as 
those who have particularly negative experiences of cancer or a higher knowledge of cancer 
in comparison to the rest of the community could be selected. In addition, data were 
unavailable on the numbers of individuals invited to take part or their reasons for refusal. 
Therefore, the response rate and reasons for non-participation in the focus group study 
were unknown. Finally, additional socioeconomic indicators were not collected at the time 
of the public focus group study. The only measure of socioeconomic group was residence in 
a Communities First area. Although those who live in a Communities First area reside in the 
most deprived areas of Wales, this may not accurately represent an individual’s current 
socioeconomic circumstances (Galobardes et al, 2006b). Assessing additional individual level 
indicators such as education and employment are likely to overcome these issues 
(Galobardes et al, 2006a).  
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9.6.2 Intervention acceptability testing  
The intervention was tested for acceptability on two small groups of potential users. Whilst 
the aim of the user testing study was to explore acceptability and feasibility of the 
intervention, there are limitations with using a small sample of individuals from two 
communities. Small sample size has limitations of generalisability and precludes inferential 
statistical analysis. Therefore, conclusions cannot be drawn regarding potential for change in 
the outcomes measured.  
Both groups were recruited opportunistically through community partners and there is 
potential for recruitment bias. It is likely that those recruited to take part in the acceptability 
testing study were selected by the community partner based on an interest in health or 
were more active members of the community, which has implications for 
representativeness. One group was recruited through an existing peer support group for 
mental health, and the other group were mainly recruited from the volunteer network in the 
community. Those who attend a weekly peer support group may be more likely to engage in 
help seeking behaviour or feel able to discuss health concerns. This could explain the 
findings related to increased anticipated time to symptom presentation after completing the 
intervention. In addition, those who are members of a local volunteer network may be the 
more active, key or outspoken members of the community. Although piggybacking on 
similar existing groups is likely to be a useful method for recruiting individuals into an 
intervention session, such groups may not be truly representative of the target population. 
However, holding the intervention with a pre-existing group for the first time in a 
community, and subsequently running multiple sessions in the same area could be used as a 
strategy for encouraging participation. Encouraging future participation in the intervention 
will be discussed later in this chapter. Finally, recruiting people to take part in the 
intervention through community settings was time-intensive. This is likely to have 
implications for the intervention in future and evaluation due to the amount of time 
required to identify and invite individuals to take part in an intervention session, in addition 
to the time required to organise and co-ordinate a session.  
9.7 Intervention development using the Behaviour Change Wheel 
The Behaviour Change Wheel was used in accordance with the MRC framework to guide 
intervention development for this PhD and was useful in this context. The Behaviour Change 
Wheel was selected to guide intervention development due to its systematic framework and 
theoretical underpinning of the COM-B model and TDF. As previously discussed, the COM-B 
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model was identified as a useful model for understanding cancer symptom presentation 
behaviour among low socioeconomic groups (Chapters 2, 4 and 5). Therefore, using an 
intervention development framework underpinned by the COM-B model was a strength.   
The Behaviour Change Wheel provides researchers with a step-by-step guide to intervention 
development, facilitating replicability and research rigour, and was a key benefit of the 
framework. Researchers are required to consider a broad range of intervention constructs 
(type, content and mode of delivery), using the APEASE criteria to narrow down construct 
selection. Starting with a wide and comprehensive range of intervention constructs was 
useful to consider all available options, thus at no point was the framework limiting. The 
APEASE criteria were particularly useful when choosing appropriate intervention constructs 
throughout the Behaviour Change Wheel process. Each of the six APEASE criteria was clearly 
defined, facilitating systematic selection of intervention components, ensuring the selection 
process did not rely on researcher preference. This process reduced potential bias when 
deciding which constructs were most suitable in the present context, enabling accurate 
reporting of the decision making process for why certain aspects were included or excluded. 
In future it could be beneficial to undergo the intervention development process using the 
Behaviour Change Wheel with local stakeholders. When applying the APEASE criteria to each 
stage, it would be useful to gain their views in relation to acceptability of certain aspects and 
ongoing local policy and initiatives in the community.  
Although the breadth of the Behaviour Change Wheel was a benefit, its applicability to a 
wide range of behaviour change contexts posed limitations in the present intervention 
development study due to vague and overlapping construct definitions. For example, the 
intervention functions of training and education were similar, and the definitions provided 
for each intervention function did not overcome the ambiguity between the two 
intervention functions. Although the APEASE criteria were useful for systematic construct 
selection, fully understanding each intervention construct was challenging without 
comprehensive definitions.  
The Behaviour Change Wheel textbook is designed to provide researchers with a step-by-
step guide to the development of behaviour change interventions (Michie et al, 2014). 
However, the textbook guide lacked clarity in places with regard to how each of the 
Behaviour Change Wheel stages linked and personal judgement was required to understand 
the process. For example, it was unclear that the Behaviour Change Techniques (BCT) 
Taxonomy should be consulted after selection of the intervention functions. There were 
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additional problems encountered when using the BCT Taxonomy. Firstly, it was unclear if all 
the BCTs should be considered for intervention content or just the most frequently used 
BCTs as listed in the taxonomy. Secondly, although the BCT Taxonomy was created with the 
aim to provide researchers with a clear and simple standardised taxonomy, some definitions 
were vague, making selection of relevant BCTs difficult. Many of the BCTs outlined in the 
taxonomy were similar, with limited information in the definitions on the difference 
between the BCTs in practice, where often only one example of how the BCT could be used 
was provided. Often, limited examples did not reduce the ambiguity of the definition. For 
example ‘information about health consequences’ and ‘salience of health consequences’ 
were similar. The definition for ‘salience of health consequences’ in part states that this BCT 
‘goes beyond informing about health consequences’ with little guidance on how to go 
beyond proving information about health consequences. A recent study suggests that other 
researchers have experienced similar problems when selecting 13 of the 93 BCTs (Michie et 
al, 2015; Abraham et al, 2015), which are likely to be resolved through further revisions of 
the framework and provision of formal training (Wood et al, 2016).  
Finally, all stages of the BCW mapping process involve subjective assessments, which were 
complicated by imprecise construct definitions. Each definition is subject to potential bias 
through interpretation and selection bias of each component, potentially excluding key 
components at each stage. Although this can be reduced by using the APEASE criteria and 
reporting reasons for exclusion, additional steps can be taken to reduce subjectivity. Dual 
coding at each stage, followed by discussion between coders can limit any potential bias. 
However, dual coding was not performed as part of this PhD thesis which is a limitation. 
9.8 Development of a community lung health intervention targeted at people from a 
low socioeconomic group 
The initial aim of this PhD was to develop a cancer awareness intervention for common 
cancers. However, in response to changes in Welsh Government policy in 2015, the decision 
was made to focus the intervention on lung cancer. For intervention development, lung 
specific barriers identified in Chapters 3, 4 and 5 were extracted and mapped to the 
Behaviour Change Wheel. These studies were designed to understand the barriers to 
symptom presentation among low socioeconomic groups regardless of tumour site. 
Consequently, there are limitations associated with designing an intervention targeted 
specifically at lung cancer on the basis of preliminary work to understand the barriers and 
facilitators to general cancer symptom presentation. It is likely that some lung specific 
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barriers and facilitators were overlooked, and that some of the more general 
barriers/facilitators to cancer symptom presentation may not be applicable to lung cancer. 
For example, there is evidence to suggest that smoking habit can act as an additional barrier 
to symptom presentation. Smokers are more likely than non-smokers to prolong or not seek 
medical help for symptoms of lung cancer (Friedemann-Smith et al, 2016; Corner et al, 2006; 
Chatwin and Sanders, 2013). There is evidence to suggest that lung cancer symptom 
knowledge is equal for smokers and non-smokers (Simon et al, 2012a), therefore prolonged 
symptom presentation is likely to be a consequence of misattribution of symptoms and 
social factors such as stigma.  
Lung cancer symptoms are often misattributed and dismissed as normal in the context of 
smoking habit (Corner et al, 2006; Chatwin et al, 2014; Birt et al, 2014a; Birt et al, 2014b). In 
addition, as smoking prevalence falls in higher income countries, the stigma attached to 
those who smoke increases (Stuber et al, 2008; Farrimon and Joffe, 2006). The association 
between smoking and lung cancer is commonly understood, leading to the stigmatisation of 
lung cancer as a self-inflicted or ‘dirty disease’ (Simon et al, 2012a; Marlow et al, 2015; 
Chambers et al, 2012; Chapple et al, 2004a). Smokers may report a reluctance to seek 
medical help for symptoms through feelings of blame and guilt associated with their 
symptoms caused by smoking habit, which in part can be due to the stigma attached to 
smoking (Quaife et al, 2016; Chatwin and Sanders, 2013; Corner et al, 2005; Corner et al, 
2006; Tod et al, 2008; Chapple et al, 2004a). In addition, there is evidence to suggest that 
smokers prolong symptom presentation due to fear of being refused treatment or being 
judged by the healthcare professional (Tod et al, 2010; Corner et al, 2006).  
Around a third of those who took part in the qualitative interviews (Chapter 4) were current 
smokers and there were no data available on smoking status for the focus group study 
(Chapter 5), therefore it is unclear how many of the sample currently smoked or used to 
smoke . Smoking related barriers to symptom presentation behaviour were only explored if 
mentioned by the participant. Therefore, the influence of smoking in the context of cancer 
symptom presentation behaviour was not fully explored, and certain smoking specific 
barriers potentially excluded from the intervention. On reflection, if the focus of this PhD 
had been on lung cancer from the outset, the interviews might only have been carried out 
with smokers or ex-smokers, and the topic guide adapted to focus in part on smoking 
related barriers to cancer symptom presentation. For example, this might include whether 
and how smoking habit influences symptom interpretation and the decision to seek medical 
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help. In addition, questions designed to understand how smoking status affected previous 
interactions in a healthcare setting would be asked. A more in depth understanding of lung 
specific symptom presentation barriers and facilitators among current and former smokers 
is required before further pilot testing or controlled evaluations are considered. In addition, 
an understanding of how smoking status and comorbid lung conditions such as COPD might 
influence interpretation of potential lung cancer symptoms is needed.  
9.9 Future of the intervention 
The secondary aim of this PhD was to develop an intervention to encourage timely lung 
cancer symptom presentation among low socioeconomic groups to promote early detection 
and diagnosis of lung cancer. An intensive community group based educational session 
intervention was developed, targeted at those who are most at risk for lung cancer. Family 
members of smokers were invited to take part in the intervention to utilise strong social 
networks in the community and promote good quality advice following symptom disclosure 
or noticing of symptoms in the community. The intervention contained information about 
the symptoms of lung cancer, when to go to the GP with symptoms, lung cancer risk 
information, information to modify negative beliefs about lung cancer, what to expect when 
presenting to primary and secondary care, and strategies to overcome barriers to symptom 
presentation. 
The MRC framework for complex intervention development outlines various stages in the 
development of interventions before implementation (Craig et al, 2008). After intervention 
development, feasibility and pilot testing should be conducted before larger scale 
intervention evaluation and finally implementation. Acceptability testing with a small group 
of potential intervention users was conducted as part of this PhD, however further feasibility 
and pilot studies are required before a controlled evaluation and implementation is 
considered. This section will outline the future for the intervention, including suggestions for 
further feasibility and pilot testing, and evaluation, including potential implementation 
considerations and challenges. Finally, the potential role of the intervention will be 
discussed in relation to policy initiatives for lung cancer prevention and early detection.  
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9.9.1 Recommendations for further evaluation  
 
9.9.1.1 Feasibility testing 
Preliminary findings from a small user testing study suggested that the intervention is an 
acceptable method for delivery; however, further feasibility testing is required before pilot 
testing. The MRC guidance highlights the importance of conducting feasibility testing across 
multiple sites (Craig et al, 2008), so that the extent to which the intervention is acceptable 
and feasible in other communities can be evaluated. Therefore feasibility testing of the 
intervention should be carried out in socioeconomically deprived areas of the UK.  
Feasibility testing should be conducted to estimate sample size for a larger study, and assess 
appropriate methods of participant recruitment. This would include estimates of the 
number of people in the community who are eligible for the intervention, and willingness of 
staff in the community to help identify participants to take part in the intervention study. In 
addition, the acceptability and suitability of questionnaire measures should be assessed. The 
distribution of incomplete or multiple responses to questions or statements would be 
observed, and a think-aloud method could be used for questionnaire completion with a 
proportion of participants to assess comprehension of questions and views on 
appropriateness of response options. Adjustments to questionnaire measures would be 
made accordingly. In addition, response rates to follow up questionnaires would be 
calculated to assess compliance. Finally, the time required to collect and analyse data would 
be recorded to estimate time scales for a larger study.  
9.9.1.2 Pilot testing  
Before scaling up to a controlled evaluation, pilot testing of the intervention is required 
across multiple sites (Craig et al, 2008). At pilot testing, the intervention study is designed to 
replicate a larger controlled trial on a smaller scale. Pilot testing is conducted to ensure the 
various components of the intervention study run as intended such as participant 
recruitment, randomisation, and completion of baseline and follow-up measures. In 
addition, pilot testing has the potential to offer preliminary insights into intervention effects. 
It is envisaged that the controlled evaluation would ideally take the form of a randomised 
control trial (RCT); therefore, participants at pilot testing would be randomised to one of 
three arms: an intervention arm where individuals take part in the lung health information 
session; a leaflet arm where individuals receive information such as the CRUK lung cancer 
leaflet, and a control arm where individuals receive no intervention.  
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Measures used for intervention pilot testing could include proxy measures of the factors 
which contribute to prolonged cancer symptom presentation. An adaptation of the lung 
Cancer Awareness Measure (CAM; Simon et al, 2012a) could be used to assess lung cancer 
symptom knowledge, beliefs about lung cancer, barriers to cancer symptom presentation 
and anticipated lung cancer symptom presentation behaviour. Intervention session 
observations and qualitative interviews can be used to explore intervention preferences. 
Measuring actual symptom presentation behaviour using GP read codes, number of new 
referrals to secondary care or numbers of new lung cancers diagnosed are not useful at pilot 
testing. This is due to relatively low numbers of new cases of lung cancer diagnosed in each 
community and small numbers from each community in each intervention session; however, 
these measures of actual symptom presentation behaviour could be used to assess 
intervention effectiveness for a larger scale RCT.  
Preliminary acceptability testing from this PhD included a post intervention questionnaire 
directly after the intervention which precluded assessment of information retention. It 
would be preferable for post intervention follow-up questionnaires to be completed at least 
one month post intervention. Longer time periods for follow-up questionnaire such as six 
months would be desirable; however, due to time and funding restrictions, six month follow 
up may not feasible, instead opting for a shorter follow up time of one, two or three months.  
9.9.1.3 Controlled evaluation 
Depending on the outcome from pilot and feasibility testing, a controlled evaluation could 
be considered if the intervention was acceptable and amendments were made to the 
intervention following pilot testing. This could take the form of a RCT where individuals are 
randomised into one of three arms outlined above. Measures collected during controlled 
evaluation might be similar to those at feasibility and pilot testing phase, and are likely to 
involve a survey based measure such as the Lung CAM at baseline and follow up. As 
previously discussed, depending on the scale of the intervention implementation, collecting 
clinical data such as two week wait referrals, GP read codes and new cases of lung cancer 
could be considered. If the intervention is effective, intervention implementation can be 
considered.  
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9.9.2 Intervention implementation: considerations and challenges  
9.9.2.1 Encouraging participation in the intervention 
Encouraging participation in the lung health intervention, particularly among smokers, is 
likely to present the greatest challenge for intervention implementation. This was reflected 
in the difficulties of recruiting people to take part in intervention user testing. Recruiting 
current smokers into an intervention about lung cancer was predictably challenging, and 
there was low representation from current smokers in the intervention user testing. There 
was evidence that current smokers were apprehensive about attending the intervention. In 
addition, some non-smokers who took part in the intervention reported unsuccessful 
attempts to persuade family members who smoke to attend the intervention.  
There are two potential strategies which could be used to encourage smokers to attend the 
intervention or facilitate intervention messages to reach smokers. Firstly, the intervention 
could be repeated a few times in any given community on different days and at different 
times. At the end of the session, intervention attendees could be given a list of the 
additional intervention sessions and asked to tell family members or friends who currently 
smoke about the session and encourage them to attend. There was evidence to suggest that 
positive feedback through word of mouth is important, where attendees would recommend 
the intervention to family and friends in the future. Secondly, current smokers could be 
targeted through social networks using the current intervention strategy where family 
members of smokers attend the intervention and look out for warning signs by proxy, 
prompting high risk symptomatic individuals to go to the GP with symptoms. Social support 
and legitimisation of symptoms requiring medical help from family and friends has been 
found to prompt lung cancer symptom presentation in smokers (Birt et al, 2014b; Chatwin 
and Saunders, 2013).  
Targeting individuals through social networks has the potential for intervention messages to 
reach individuals who might otherwise not engage in an intervention about cancer (Rogers, 
1985). Giving people in the community information to facilitate good quality advice upon 
symptom disclosure or noticing symptoms could promote earlier symptom presentation. In 
addition, asking people to notice symptoms in others and prompt symptomatic individuals 
to seek medical help from their GP is likely to create intervention sustainability. Providing 
individuals with the skills and knowledge to notice symptoms in others and offer good 
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quality advice has the potential for the intervention messages to reach members of the 
community even after the intervention is no longer implemented.  
Other reasons for non-participation which could be overcome included childcare issues and 
problems with timing. In addition, there was interest in taking part in the intervention from 
a younger age group and perhaps the intervention in future could explore reducing the age 
to the over 30s and run the intervention session at different times of the day to allow those 
who work to attend.  
There were problems associated with engaging most of the communities contacted to help 
with recruitment for the intervention. As previously discussed, recruiting participants 
through community partners as a ‘trusted source’ was a good method to enable access to 
members of the community who may not usually take part in research. However, relying 
entirely on help for recruitment through community partners was problematic when 
community partners could not recruit participants because they were too busy, since finding 
people to take part was time consuming. Future pilot and feasibility studies should explore 
alternative recruitment methods, perhaps through social media groups or poster boards in 
the community, or snowballing through community partners in other areas. 
9.9.2.2 A multi-level intervention approach  
Findings from acceptability testing suggested that GP access was a key barrier to presenting 
promptly with symptoms. In Chapter 6, interventions which adopted a push-pull method 
were most effective in terms of behaviour change, pushing symptomatic individuals to go to 
the GP through intervention messaging and pulling individuals into secondary care using HCP 
interventions. It was beyond the scope of this PhD to develop an intervention for both HCPs 
and members of the public; however, the feasibility of combining this intervention with an 
intervention targeted at HCPs could be explored in future, adopting a multi-level approach 
to behaviour change. For example, since development of the intervention, there has been 
interest from a GP working in a Communities First area in South Wales who has developed 
an intervention targeted at HCPs. The intervention was designed to remind HCPs of the 
referral guidelines for suspected lung cancer and encourage them to refer patients with 
symptoms for chest x-ray.  
In the context of upstream factors such as employment problems resulting in economic 
hardship which influenced symptom presentation behaviour, interventions targeted at the 
individual or community level may have limited impact. As outlined in Chapter 1, attempting 
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to modify the wider social determinants of health was beyond the scope of this PhD. 
Education at the community level was therefore selected as the focus of the intervention to 
promote behaviour change. Education was used to enable individuals to feel empowered to 
detect and report symptoms to the GP to promote earlier detection of lung cancer. 
Interventions at the individual level are most likely to be effective when local and national 
policy addresses the social determinants of health inequality through improvements in living 
and working conditions.  
9.9.2.3 Policy considerations 
Consideration of how the lung cancer intervention could fit with local and national policy on 
lung cancer early detection and prevention is important for implementation. The need to 
improve health outcomes, including cancer, in the most deprived communities is one of the 
strategic aims of Communities First, the Welsh Government initiative to tackle poverty. In 
addition, recent changes to policy where the need to improve lung cancer outcomes became 
a national priority (Welsh Government, 2015) support the need for interventions targeted at 
those who are most at risk to promote earlier lung cancer detection. 
Promoting timely presentation with potential symptoms through cancer awareness 
interventions is one potential strategy for improving lung cancer outcomes through earlier 
detection. Based on the English Be Clear on Cancer lung cancer public awareness campaign, 
an eight week mass media TV and radio campaign was launched in July 2016 across Wales to 
encourage people with a cough symptom lasting three weeks or more to go to their GP. As 
reported in Chapter 6, mass media interventions are the least beneficial in terms of 
encouraging symptom presentation behaviour among low socioeconomic groups. However, 
mass media campaigns could be used in combination with targeted interventions such as the 
lung health information session developed in this PhD.  
An alternative strategy for detecting lung cancer in the early stages is screening high risk 
individuals using low-dose computed tomography (LDCT). LDCT lung screening is currently 
undergoing implementation in the United States following the success of the National Lung 
Screening Trial, which reported a 20% reduction in lung cancer mortality (Aberle et al, 2011). 
Although not routinely available in the UK, trials are ongoing across Europe to assess 
feasibility, acceptability and effectiveness of LDCT screening among high risk groups (Brain et 
al, 2016; Field et al, 2015; van Klaveren et al, 2009). Based on these findings, the National 
Screening Committee will decide whether LDCT screening will become the standard of care 
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in the UK among high risk groups. Paradoxically, however, participation in lung screening 
trials is lowest among those at highest risk, including current smokers from a low 
socioeconomic group (Aberle et al, 2010; Hestbech et al, 2011). If stratified LDCT screening is 
introduced in the UK NHS, interventions targeted at those who are most at risk are essential 
to encourage participation. Studies suggest that smokers from a low socioeconomic group 
place lower value on the benefits of lung cancer screening, hold fatalistic beliefs about lung 
cancer as an untreatable disease, or report stigma as a barrier to screening participation 
(Quaife et al, 2016a; Aberle et al, 2011; Patel et al, 2012). Group education aimed at current 
or past smokers in the community setting could potentially be used to provide information 
about lung screening among high risk groups, providing information to modify fearful and 
fatalistic beliefs, minimise the stigma surrounding lung cancer, and emphasise the benefits 
of earlier diagnosis and treatment. Family members of smokers could be included to 
promote engagement with lung screening through social networks. In the primary care 
setting, an information leaflet mailed through GP practices inviting high risk individuals to 
attend a nurse led lung health check is currently undergoing evaluation as a potential 
strategy to engage individuals in lung screening (Quaife et al, 2016b).  
As the main primary prevention option for lung cancer, smoking cessation advice is 
recommended for use in conjunction with LDCT screening (Moyer, 2014). Smoking 
prevalence is highest among low socioeconomic groups (Riaz et al, 2011; Hiscock et al, 
2012), and despite an overall decline in smoking among developed countries, smoking rates 
have remained stable among low socioeconomic groups (Hiscock et al, 2012). There is 
evidence to suggest that people from low socioeconomic groups are just as likely as those 
from a high socioeconomic group to attempt to quit smoking, but less likely to be successful 
(Kotz and West, 2009), possibly due to social norms for smoking among low socioeconomic 
groups (David et al, 2010; Paul et al, 2010) and lack of social support required for a quit 
attempt (Fisher, 1997; Hiscock et al, 2012). In addition, stressful living environments and 
higher nicotine dependence are more likely to result in relapse (Baker et al, 2007; Tsourtos 
et al, 2008). Smoking cessation interventions which provide behavioural and 
pharmacological support and are targeted at individuals from low socioeconomic groups 
appear to show promising results, although further research is needed to understand how 
best to engage high risk groups (Hiscock et al, 2012; Bryant et al, 2011).  Findings from 
intervention acceptability testing during this PhD suggested that integrating smoking 
cessation advice may deter engagement with lung cancer early detection strategies. Positive 
feedback of the intervention to family and friends in the community was discussed as 
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important for the future of the lung health intervention because recommendations would 
encourage other members of the community to attend the intervention. The inclusion of 
smoking cessation advice in a LDCT lung screening service should be carefully considered, 
and perhaps offered as an option to those who are motivated to quit smoking in order to 
minimise the potential for negative feedback through word of mouth of lung screening 
services in the community.  
9.10 Conclusion  
There is a complex interplay between individual factors (Capability and Motivation) and 
wider social and environmental factors (Opportunity) on cancer symptom presentation 
behaviour among low socioeconomic groups. Social networks (Opportunity) were most 
influential on the formation and maintenance of cancer knowledge (Capability) and beliefs 
(Motivation), and social networks had the potential to prolong or prompt cancer symptom 
presentation through symptom disclosure. The environmental factors associated with living 
in a deprived community were found to influence cancer symptom presentation 
(Opportunity). Specifically, competing priorities as a consequence of economic hardship took 
precedence over medical help seeking behaviour, especially when symptoms were perceived 
as not serious in the context of other pre-existing co-morbidities. A community group based 
educational intervention designed to empower high risk individuals to seek medical help for 
lung cancer symptoms was developed to encourage earlier lung cancer symptom 
presentation. This was considered by participants to be an acceptable method for 
intervention delivery, although further pilot and feasibility testing are required. There is 
potential for the lung health information session intervention developed for this PhD to fit 
with future policy initiatives to introduce LDCT lung cancer screening and integrated 
smoking cessation, creating a package of interventions to encourage earlier diagnosis and 
prevention of lung cancer among high risk groups.  
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Appendix 2: SPIDER search strategy 
SPIDER Description Equation used for search  
Sample Adults (18+) male and female  Sample: ‘‘Adult’’ OR ‘’18 and over’’ OR 
‘’over 18’’ OR ‘’male’’ OR ‘’female’’ OR 
‘’deprived area(s)’’ OR ‘’socioeconomic 
status’’ OR ‘’deprived’’, OR ‘’NOT child’’ 
Phenomenon 
of Interest 
How cancer symptom 
knowledge, beliefs about 
cancer and 
barriers/facilitators to 
symptom presentation affect 
actual or anticipated cancer 
symptom presentation 
Cancer: ‘’Cancer’’ OR ‘‘Malignancy’’ OR 
‘’Tumour’’ OR ‘’Sarcoma’’ OR ‘’Melanoma’’ 
OR  ‘’Disease’’ 
Knowledge: ‘’Awareness’’ OR ‘’Cancer 
awareness’’ OR ‘’knowledge’’ OR 
‘’knowledge of cancer symptoms’’ OR 
‘’passive detection’’ OR ‘’recognition’’ OR 
‘’recall’’ OR ‘’appraisal’’ OR ‘’appraisal of 
symptom*’’ 
Symptoms: ‘’symptom’’ OR ‘’cancer 
symptom’’ OR ‘’cancer sign’’ OR ‘’sign’’ OR 
‘’warning sign’’ OR ‘’early warning sign’’ OR 
‘’suspected symptom*’’ 
Beliefs: ‘’beliefs’’ OR ‘’attitudes’’ OR 
‘’thoughts’’ OR ‘’feelings’’ OR ‘’negative 
beliefs’’ ‘’negative attitudes’’ OR ‘’fear’’ OR 
‘’anxiety’’ OR ‘’worry’’ OR ‘’concern’’ OR 
‘’Embarrass*’’ OR ‘’fatalism’’ ‘’positive 
beliefs’’ OR ‘’positive attitudes’’ OR  ‘’hope’’ 
OR ‘’optimism’’ OR ‘’benefit’’ OR ‘’spiritual’’ 
Perceived barriers: ‘’barriers to present*’’ 
OR ‘’service barrier*’’ OR ‘’emotional 
barrier*’’ OR ‘’practical barrier*’’ 
Symptomatic presentation:  ‘’help seeking 
behaviour’’ OR ‘’help seeking’’ OR ‘’health 
seeking behaviour’’ OR ‘’health seeking’’ OR 
‘’early presentation’’ OR ‘’late 
presentation’’ OR ‘’presentation’’ OR 
‘’delay’’ OR ‘’patient delay’’ OR ‘’delay in 
help OR health seeking’’ OR ‘’behaviour’’ 
OR ‘’intentions’’ OR ‘’intentions to seek 
help’’ 
Design Both qualitative and 
quantitative methods 
Study design: ‘’questionnaire’’ OR ‘’survey’’ 
OR ‘‘interview’’ OR ‘’focus group’’ OR ‘’case 
study’’ OR ‘’observ*’’ 
Evaluation Outcome measures. Cancer 
symptom knowledge, beliefs 
about cancer, 
barriers/facilitators to 
symptom presentation and 
symptom presentation.   
Outcome measures: ‘’help seeking 
behaviour’’ OR ‘’experinec*’’ OR  ‘’view’’ OR 
‘’opinion’’ OR ‘’perce*’’ OR ‘’belie*’’ OR 
‘’feel*’’ OR ‘’know*’’ OR ‘‘understand*’’ 
Research 
Type 
Qualitative, quantitative or 
mixed methods 
Methods: ‘’qualitative’’ OR ‘’quantitative’’ 
OR ‘’mixed methods’’ 
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Appendix 3: Adapted CASP tool 
Quantitative study design Qualitative study design 
1.Was there a clear statement of the aims of the 
research?  
-Was the goal stated? 
-Why is this important? 
-How relevant is it? 
1.Was there a clear statement of the aims of 
the research?  
-Was the goal stated? 
-Why is this important? 
-How relevant is it? 
2.Is a quantitative methodology appropriate? 
-does the research aim to illuminate the 
characteristics/ demographics of participants or 
assess their opinions/attitudes? 
2.Is a qualitative methodology appropriate? 
-Does the research aim to illuminate the 
characteristics/ demographics of participants or 
assess their opinions/attitudes? 
Is it worth continuing? Yes/no Is it worth continuing? Yes/no 
3.Was the research design appropriate to 
address the aim of the research? 
-Has the research design been justified? 
-Was the timing of the study appropriate i.e. if 
study was conducted with participants with a 
diagnosis of lung cancer, 12 months post 
diagnosis would be inappropriate due to poor 
long term survival? 
-Was the study theoretically underpinned? 
3.Was the research design appropriate to 
address the aim of the research? 
-Has the research design been justified? 
-Was the timing of the study appropriate i.e. if 
interview was conducted with participants with 
a diagnosis of lung cancer, 12 months post 
diagnosis would be inappropriate due to poor 
long term survival? 
-Was the study theoretically underpinned? 
4.Was the recruitment strategy appropriate to 
the aims of the research study? 
-Has it been explained how participants were 
selected? 
-Has it been explained why participants were 
appropriate to provide answers to the research 
questions? 
-Has the researcher discussed response rate? 
-Has the researcher discussed how the control 
group was selected and why (if appropriate)? 
-Were demographic variables of respondents 
discussed? 
-Has the researcher discussed non-participation 
and their reasons for non-participation? 
4.Was the recruitment strategy appropriate to 
the aims of the research study? 
-Has it been explained how participants were 
selected? 
-Has it been explained why the participants 
were appropriate to provide answers to the 
research questions? 
-Has the researcher discussed non-participation 
and their reasons for non-participation? 
5.Were the data collected in a way that 
addressed the research issue? 
-Has the researcher considered their own role, 
potential bias and influence? 
   -During formulation of research questions 
   -During recruitment and data collection (if any 
data collected from p's through face-to face or 
telephone survey) 
-Has the researcher considered the implications 
of any changes in the research deign and events 
during the study? 
-Were participants aware the study was about 
cancer? Symptomatic individuals without 
mention of cancer/ actual/anticipated study 
designs? 
-What measure of symptom 
awareness/beliefs/symptom presentation was 
used? Was it a standardised measure? 
5.Were the data collected in a way that 
addressed the research issue? 
-Was the setting for the data collection 
justified? 
-Is it clear how data was collected? 
-Has the researcher made methods explicit? 
-Is the form of data clear? 
-Has the researcher discussed saturation of 
data? 
-Were participants aware the study was about 
cancer? Symptomatic individuals without 
mention of cancer/ actual/anticipated study 
designs? 
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6.Have ethical issues been taken into 
consideration? 
-Were ethical standards maintained (if enough 
info provided)? 
-Have ethical approval been sought from ethics 
committee? 
-If disclosed symptoms during the study, what 
was the process of advising participants to seek 
medical help/not? 
6.Have ethical issues been taken into 
consideration? 
-Were ethical standards maintained (if enough 
info provided)? 
-Have ethical approval been sought from ethics 
committee? 
-If disclosed symptoms during the study, what 
was the process of advising participants to seek 
medical help/not? 
7.Was the data analysis sufficiently rigorous? 
-Has an in-depth description of data analysis 
been provided? 
-Is it clear which statistical tests were used/ were 
the tests appropriate to answer the research 
question? 
-Is sufficient data presented to support the 
findings? 
-To what extent was contradictory data taken 
into account? 
7.Has the relationship between researcher and 
participants been adequately considered? 
-Has the researcher considered their own role, 
potential bias and influence? 
   -During formulation of research questions 
   -During recruitment and data collection (if 
any data collected from p's through face-to 
face or telephone survey) 
-Has the research considered the implications 
of any changes in the research deign and 
events during the study? 
8.Is there a clear statement of findings? 
-Are the findings explicit? 
-Is there adequate discussion of the evidence for 
and against the researcher's arguments? 
-Has the researcher discussed the credibility of 
their findings? 
-Are findings discussed in relation to other 
research? 
8.Was the data analysis sufficiently rigorous? 
-Has an in-depth description of data analysis 
been provided? 
-Is it clear how categories/ themes were 
derived (if used)? 
-Has the researcher explained how data 
extracts were selected? 
-Is sufficient data presented to support the 
findings? 
-To what extent was contradictory data taken 
into account? 
9.How valuable is the research? 
-Has the researcher discussed the contribution 
his study makes to existing knowledge? 
-Does the researcher identify areas for further 
research? 
-Has the researcher discussed whether findings 
can be transferred to their populations or 
considered ways the research can be used? 
9.Is there a clear statement of findings? 
-Are the findings explicit? 
-Is there adequate discussion of the evidence 
for and against the researcher's arguments? 
-Has the researcher discussed the credibility of 
their findings? 
-Are findings discussed in relation to other 
research? 
Further comments 10.How valuable is the research? 
-Has the researcher discussed the contribution 
this study makes to existing knowledge? 
-Does the researcher identify areas for further 
research? 
-Has the researcher discussed whether findings 
can be transferred to their populations or 
considered ways the research can be used? 
Further comments 
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Appendix 4: Interview topic guide  
Prologue 
1. Introduce myself, explain where I am from, ensure they are comfortable etc.  
2. Check understanding of reason for meeting and give an opportunity for questions:  
‘’Before we start, do you have any questions about the study or about what I’ve 
come to talk to you about today?’’ 
Set the focus of the interview. Base this around the following script: 
‘‘Thank you for agreeing to take part in my study. Just to remind you, I am 
interested in what people from Wales think about cancer. At the end of the study, 
we aim to develop better cancer services for people living in Wales. There are no 
right or wrong answers to my questions, I am interested in what you think.’’ 
3. After establishing what is understood about the study and answering any questions, 
explain that the interview will be recorded:  
‘’I would like to record what you say as that saves me having to scribble when 
you’re talking, which means that I can concentrate on what you’re saying. The 
recording will only be heard by people who are working on this project. The 
interview will be typed, but your name and the name of any person, or places you 
talk about today will never be typed in any published work. Is that okay with 
you?” 
4. Obtain consent for the interview and for the recording [go through the consent form 
with participant]. If not already done, set up and switch on the recording equipment 
while the participant signs the consent form.  
5. Explain how the interview will work:  
“I’ve planned some ideas about the sorts of things I’d like us to talk about today, 
and if it’s okay with you we’ll try and base our conversation around those points. 
Having said that, if you want to tell me about anything that I don’t ask about, 
please just tell me. Also, if you find a question difficult to answer or you don’t 
understand it, please say and we can move on or I can try to ask it in a different 
way. Of course, if you’d prefer not to answer a question, that is absolutely fine. 
There are no right or wrong answers to any of the questions I ask you, I am just 
interested in your own opinions and experiences. Does that all sound alright to 
you?’’ 
6. Obtain demographic information: 
“Before we start, I’d like to ask you some questions about yourself…..” 
 
[Build rapport: ask questions about how long they have lived in the community etc] 
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Knowledge of cancer 
Q1: I’d like to get an idea about what you know about cancer. Can you tell me what you 
know about cancer? 
Probes:  
-How would you describe cancer as an illness? 
-What do you think causes cancer?  
-How do you think cancer compares to other illnesses like heart disease, diabetes 
etc.?  
-Do think there anything people can do to stop them getting cancer?  
-[If smoking comes up probe: why do you think smoking does/does not cause 
cancer?/ Smoking behaviour in the community] 
-Can you think of any symptoms of cancer?  
-Thinking about people in your community, do you think they know the symptoms of 
cancer? 
 
 
 
 
 
Attitudes and beliefs about cancer 
 
Q2: I would like to know a little more about your feelings towards cancer. What comes to 
mind when you hear the word ‘cancer’?  
Probes: 
- Can you tell me why you feel this way?/ Can you tell me more about that? 
- Can you think of anything that has happened that might make you feel this way? 
- Thinking about people in your community, how do you think they feel about 
cancer? 
-Can you remember the first time you heard about cancer?  
-Some people say that if you get cancer, there is nothing you can do to stop it. They 
say ‘oh I was going to get it anyway’. What do you think about this?  
-Can you tell me more about why you think this? 
-Can you tell me what you know about the treatments for cancer?  
-What do you think about the treatments for cancer? 
-Do you think some treatments are better or worse than others? 
-Some people think that there is ‘no cure for cancer’ whereas others think that you 
can cure cancer. What do you think?  
-Do you mind me asking why you think that? 
-What do you think people in your community think about the treatments/a 
potential cure for cancer? 
 
 
 
Rationale: Establish what they know and how much the 
participant knows about cancer and its causes. 
Rationale: Participants attitudes and beliefs about 
cancer a treatments for cancer. Understand fast 
processing (initial reactions) vs slow processing 
(more deliberative) systems underlying attitudes 
and beliefs about cancer and treatments for cancer. 
Touch on fearful/fatalistic beliefs.  
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Personal experience of cancer  
 
Q3: Have you ever had cancer, or had close family or close friends who have been 
diagnosed with cancer?  
 
Or: Earlier you mentioned [person/people] [had/has] cancer, would you mind if I asked 
you some more questions about them? 
 
[If participant discloses a previous diagnosis of cancer, go to Q7] 
 
Probes: 
-Would you mind telling me more about [that/them]? 
-Can you remember what type of cancer they [have/had]? 
-Thinking back to when [person] had cancer. Do you remember what was going on 
before they were diagnosed as having cancer?  
Probe:  
-Had they been obviously unwell before being diagnosed? 
-Can you tell me about if/when they went to the doctor? 
-Can you tell me about any tests they had? 
-Can you remember anything about their treatment, what happened to them during 
treatment?  
 
 
 
Appraising and Acting upon a potential symptom of cancer   
Q4: You mentioned earlier some symptoms which you think could be cancer, what would 
you do if you had one of these symptoms which you thought might be cancer? 
Probes: 
-How do you think you might feel? 
-Would you mind telling me more about that?  
-[If they say they would go to the doctor] How long do you think it would take for 
you to visit your doctor?  
Probe: 
-Can you tell me a little more about why you would wait [length of time]? 
-What do you think people in your community would do if they had a symptom 
which they thought might be cancer? 
 
Rationale: To clarify if they, themselves have had 
cancer and establish any ‘first hand’ experiences of 
cancer. To understand if/how such experiences have 
shaped their attitudes/beliefs about cancer. 
Rationale: Perceived behavioural control over correctly appraising 
and acting on a symptom of cancer. Who they would go to, to seek 
help should they suspect they have a symptom of cancer. If they 
would confide in others before seeking medical help, who would 
they be and what would they advise. 
P’s might get upset here. If this happens 
suggest a break or move on to the next 
question. Ask if they would like to 
terminate the interview or carry on.  
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-[If not previously mentioned] Have you ever had a symptom which you think might 
be something like cancer? 
Probe:  
-Can you tell me more about it?  
-What was the symptom/How long did you have the symptom for/ what did 
you think it was?  
-How did you feel? 
-What did you do? 
-[If went to the doctor] Can you remember how long it took you to go to the 
doctor? Why did you decide to go [period of time]? 
-Would/did you tell anybody about your symptom? 
-Why would/did you tell this person? 
-What do you think they would say if you told them you had a symptom that you 
thought was cancer?/ What did they tell you to do? 
-Is this what you think your friends would do, or do you think they would do 
something different? 
-[if different] What would they do?  
-How confident would/did you feel noticing that something might be a symptom of 
cancer?  
-Would/did you do anything to keep track of your symptoms?  
 
 
 
 
 
Medical help seeking: acting upon a symptom of cancer  
 
Q5: I would like to know some more about your doctor. Are you registered with a 
doctor? 
 
Probes: 
-If you could describe your GP practice in a few words, what would they be? 
Probes:  
-What is it like getting an appointment? 
-How often do you visit your GP? 
-What is your GP like? 
-How confident do you feel talking to your GP? 
 
 
 
 
Medical Help seeking barriers and facilitators 
 
Q6: If you had a symptom that you thought might be cancer, can you think of anything 
that would make it hard for you to visit your GP?  
 
Probes:  
-What might make it easier? 
-What might you do before going to the doctor e.g. search online, speak to someone 
from a charity? 
Rationale: Explore the length of time in which people anticipate 
seeking help for a symptom of cancer, social norms around medical 
help seeking,  
Rationale: Identify any barriers or facilitators  to medical help 
seeking. Gain a deeper understanding of why participants have 
such barriers. Ask about anticipated regret. 
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-Some people say they are embarrassed about talking to the doctor with symptoms. 
-What do you think about this? 
-Can you tell me more about why you might feel this way?  
-Can you tell me about how you might get to an appointment with the doctor?  
Probe:  
-If transport is a problem/ get help from family and friends 
-Thinking about people in your community, can you think of anything which might be 
stopping them going to their doctor with a symptom of cancer? 
 
[Go to Q8] 
 
 
Participants with a previous diagnosis of cancer 
Q7: You mentioned you had previously been diagnosed with cancer. Do you mind if I ask 
you some questions about your cancer?  
-Can you take me through what happened before you were diagnosed with cancer? 
-Can you remember what symptoms you had before you were diagnosed? 
-At the time can you remember what you thought these symptoms were? 
-Did you tell anyone about your symptoms? 
[If yes] What did they say? 
-Can you remember if you went to the doctor? 
[If yes] Probes: 
-Can you remember how long it took you to go to the doctor from when you 
noticed your symptoms? 
-Can you tell me about what the doctor said to you? 
-Can you remember how many times you went to the doctor with this 
symptom? 
-Can you think of anything that helped you to go to the doctor quicker than 
usual? 
-Can you think of anything that stopped you going to the doctor? 
-Can you tell me about what happened after that? 
-Can you remember the point at which you thought you might have cancer? 
-How did this make you feel? 
-Can you remember how your friends and family reacted to the news that you had 
cancer? 
-Can you tell me about the treatment you had/are having for your cancer? 
-What was it like? 
 
 
 
Awareness campaigns  
Q8: Can you tell me about any cancer awareness campaigns that you have seen? [describe 
what a cancer awareness campaign if they don’t understand what this is] 
-Did anyone tell you about a campaign they saw? 
Rationale: Anything that stands out in memory. Details that 
should be avoided in the intervention/ details which might be 
useful when designing an intervention  
Rationale: Explore the length of time in which those 
with a previous diagnosis of cancer sought medical help  
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-How did they make you feel about cancer? 
-Can you tell me what you thought was good about the campaign? 
-Can you think of anything that was bad about the campaign? 
-Do you have any ideas for a cancer awareness campaign in your community?  
 
Description of community 
Q9: Can you tell me what your community is like? 
Future research  
Q10: Finally, we might be doing future studies in this area. Would you like to be contacted 
again for this research? 
Debrief: 
 
‘Thank you for taking part in this study. The purpose of this study was to understand what 
people who live in Wales think about cancer. Your thoughts have been very helpful in 
helping us to understand this and we hope the results of this study will help to develop 
better cancer services in Wales. Do you have and questions or concerns about the study? [if 
yes: answer any questions. If no: continue]. Here are my contact details in case you do have 
some questions in the future. Many thanks again.’  
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Appendix 5: Telephone script for study recruitment through the ICBP database  
Hello, my name is Grace, I’m a researcher calling from Cardiff University on behalf of 
Tenovus, the cancer charity. Please may I speak to [name].  
If they are not there: I would like to invite [name] to take part in a research study. Do you 
know when would be a good time for me to ring back so I can speak to [him/her] about 
taking part in the study? [Take time and date and thank the person on the phone. Ring back 
at a later date and follow script again] 
If they are on the phone: I would like to invite you to take part in a research study. You may 
or may not remember, as it was a couple of years ago, but you took part in a study over the 
phone, and my colleagues asked you some questions about cancer.  
This was a national survey of people from across Wales who are aged over 50. 
We are interested in speaking to you again because at that time you agreed to be contacted 
again for future research. Your responses from that study were very helpful, and we are 
carrying out some more research on this topic.  
I would like to tell you a little bit about the study before you decide whether to take part or 
not. This will take a few minutes. Would you like me to continue? I can call back another 
more suitable time if you wish.  
If no: Would you mind telling me why? [enquire gently without insisting on an answer] Thank 
the participant for their time.  
If they would like a call back: No problem, when would be more suitable for me to ring you 
back? [arrange a time and date for me to ring back, thank them for their time] 
If yes: Thank you. I will take you through some brief information now about the study and 
what it would involve, to help you decide if you would like to receive some more 
information about the study through the post. You don’t need to decide today if you would 
like to take part or not.  
Cardiff University and Tenovus would like to carry out some interviews to understand more 
about people’s awareness and beliefs about cancer symptoms in some areas of Wales. The 
results of these interviews will help us develop better services and campaigns to increase 
early diagnosis of cancer in communities like yours.  
If you do decide to take part I will come and visit you at a time and in a place that is best for 
you. I will ask you some questions about cancer, which will take around an hour in total.  
To thank you for your time we would like to give you £10 cash.  
Taking part is voluntary. This means it is entirely up to you whether you decide to take part 
or not. If you do decide to take part, you are still free to stop the study at any point and 
without giving a reason.  
Do you have any questions? [Answer any questions] 
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Is this study something you might be interested in?  
If yes: Before you decide to take part or not, I would like to send you some more 
information in the post about the study so you can have some time to decide whether to 
take part or not and discuss it with others, for example your family or friends.  
[Ask for their name and address and say you will send them the information].  
I will ring you again in about a week’s time to answer any questions you have about the 
study. [Arrange a date and time for ring back]  
When I phone, if you would like to take part I will arrange a date, time and place for us to 
meet that is best for you. This can be in your own home or another place of your choosing.  
In the meantime, if you have any questions, here are my contact details [give my contact 
details]. These will also be on the information that I will send out to you today.  
If unsure: Would you like me to send you some information in the post about the study so 
you can have a think about it and discuss it with family or friends? I can then ring you back in 
a week’s time to answer any questions you have about the study. Then, if you would like to 
take part we can arrange a time and date to meet for the interview. [Take postal details if 
they would like information]  
If no: No problem [Thank the participant for their time] 
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Appendix 6: Telephone script for study recruitment through snowball sampling/community 
partners 
Hello, my name is Grace, I’m a researcher calling from Cardiff University on behalf of 
Tenovus, the cancer charity. Please may I speak to [name].  
If they are not there: I would like to invite [name] to take part in a research study. Do you 
know when would be a good time for me to ring back so I can speak to [him/her] about 
taking part in the study? [Take time and date and thank the person on the phone. Ring back 
at a later date and follow script again] 
If they are on the phone: I would like to invite you to take part in a research study. I was 
given your details by your [friend/family member], [insert name] as they thought you might 
be interested in taking part in this study.  
I would like to tell you a little bit about the study before you decide whether to take part or 
not. This will take a few minutes. Would you like me to continue? I can call back another 
more suitable time if you wish.  
If no: Would you mind telling me why? [enquire gently without insisting on an answer] Thank 
the participant for their time.  
If they would like a call back: No problem, when would be more suitable for me to ring you 
back? [arrange a time and date for me to ring back, thank them for their time] 
If yes: Thank you. I will take you through some brief information now about the study and 
what it would involve, to help you decide if you would like to receive some more 
information about the study through the post. You don’t need to decide today if you would 
like to take part or not.  
Cardiff University and Tenovus would like to carry out some interviews to understand more 
about people’s awareness and beliefs about cancer symptoms in some areas of Wales. The 
results of these interviews will help us develop better services and campaigns to increase 
early diagnosis of cancer in communities like yours.  
If you do decide to take part I will come and visit you at a time and in a place that is best for 
you. I will ask you some questions about cancer, which will take around an hour in total.  
To thank you for your time we would like to give you a £10 voucher or cash, whichever you 
prefer.  
Taking part is voluntary. This means it is entirely up to you whether you decide to take part 
or not. If you do decide to take part, you are still free to stop the study at any point and 
without giving a reason.  
Do you have any questions? [Answer any questions] 
Is this study something you might be interested in?  
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If yes: Before you decide to take part or not, I would like to send you some more 
information in the post about the study so you can have some time to decide whether to 
take part or not and discuss it with others, for example your family or friends.  
[Ask for their name and address and say you will send them the information].  
I will ring you again in about a week’s time to answer any questions you have about the 
study. [Arrange a date and time for ring back]  
When I phone, if you would like to take part I will arrange a date, time and place for us to 
meet that is best for you. This can be in your own home or another place of your choosing.  
In the meantime, if you have any questions, here are my contact details [give my contact 
details]. These will also be on the information that I will send out to you today.  
If unsure: Would you like me to send you some information in the post about the study so 
you can have a think about it and discuss it with family or friends? I can then ring you back in 
a week’s time to answer any questions you have about the study. Then, if you would like to 
take part we can arrange a time and date to meet for the interview. [Take postal details if 
they would like information]  
If no: No problem [Thank the participant for their time] 
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Appendix 7: Invitation letter and study information sheet for study participants recruited 
through the ICBP database  
                                                                            
 
 
Dear [insert name],  
 
 
I phoned you on [insert date] to talk to you about taking part in a study. The study is funded 
by Tenovus, the cancer charity. The aim is to help make better services for cancer in Wales.  
The study involves an interview to find out what you think about cancer. The interview will 
take about 1 hour.  
The next few pages tell you more about the study. This is to help you decide whether or not 
to take part. If you like, you can talk to members of your family or friends about the study.  
If you do decide to take part, we would like to offer you £10 cash to say thank you.  
I will phone you again on [insert date]. I will answer any questions and ask if you would like 
to take part in the study.  
If you have any questions before then, please contact me on 02920 687639 or 
mccutchangm@cardiff.ac.uk. 
 
[insert signature] 
 
Grace McCutchan 
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What is the study all about? 
I am from Cardiff University, and I want to find out what people think about cancer. This is a 
study funded by the charity Tenovus. 
You took part in a study in 2011. This study found differences in how much people know 
about cancer and what they think about cancer. We would like to know more by asking you 
and other people some questions in an interview.  
If you would like to take part in the study, I will arrange to come and talk to you at a time 
and place that is best for you.  
Why have I been chosen and how did you get my details?  
In 2011 you took part in a study over the phone to find out how much people know about 
cancer. At the end of the phone call, you said you would like to be contacted again for future 
studies- thank you!  
Do I have to take part? 
No. It is up to you to decide to take part in this study or not.  
I will contact you on [insert date]. I will answer any questions you have and ask if you would 
like to take part.  
This will give you some time to think about if you would like to take part. You can talk to 
your family and friends about this. They might be able to help you decide if you want to take 
part or not.  
If you have any questions before, please contact me. My contact details are at the end of 
this letter. 
Before the interview starts, you will be asked to sign a consent form. I will go through this 
form with you. This is to say that you agree to take part in the study.  
If you do take part, you can stop the study at any time. You will not need to tell me why you 
would like to stop.   
What will happen to me if I take part and what do I have to do? 
I will ring you to arrange a date and time for us to meet. You can choose where the interview 
will take place. This can be at your home or somewhere else that you have chosen. If the 
interview takes place somewhere that is not your home, we will pay for your travel to that 
place.  
The interview will take about 1 hour. I will ask you questions about cancer. This will include 
symptoms of cancer, your thoughts about cancer and visiting your doctor.  
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There are no right or wrong answers to the questions. I am just interested in what your 
thoughts are. All you need to do is talk about your thoughts and feelings about cancer.  
If you feel uncomfortable with my questions, you can decide not to answer those questions. 
If it is OK with you, the interview will be recorded.  
To thank you for your help, we would like to offer you £10 cash at the end of the interview. 
What will happen after the interview? 
After the interview, I will type what you said. This means we will be able to compare what 
people say in their interviews.  
Your name will not be typed on any interviews. Some of what you say might be used in 
written research. No one outside of the research team will know you took part in the study.  
The final results will be used to help make better services for cancer in Wales.  
What happens to my personal details? 
This study is carried out by a team at Cardiff University. Your name and contact details will 
be stored on secure, password protected university computers. Your name and contact 
details will only ever be seen by members of the research team.  
Your details will not be used for anything other than contacting you as part of this study.  
Anything you say in the interview will be confidential. This means no one outside of the 
research team will know that you were in the study. Your name will not be linked to 
anything you have said in the interview. 
What are the potential risks or disadvantages in taking part in the study? 
This study involves talking about cancer. It is possible that some of the things we talk about 
may be upsetting. If you are upset during the interview please talk to the researcher about 
this.  
You can also stop the interview at any point without giving a reason.  
If you want to talk to someone else, you can contact Tenovus on the number at the end of 
this letter.  
How can I take part? 
I will phone on [insert date] to answer any questions. I will also ask if you would like to take 
part in the study. 
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Contact for further information
Grace McCutchan 
PhD researcher 
Institute of Primary Care and Public Health  
3rd floor, Neuadd Meirionydd 
University Hospital of Wales 
Cardiff  
CF14 4YS 
Phone: 02920 687197 
Email: mccutchangm@cardiff.ac.uk 
 
If there are any issues that I have not been able to resolve, please contact:  
 
Dr Kate Brain (supervisor) 
Institute of Primary Care and Public Health  
3rd floor, Neuadd Meirionydd 
University Hospital of Wales 
Cardiff  
CF14 4YS 
 
 
The research is funded by the charity ‘Tenovus’ through Cardiff University 
 
Helpline 
 
Tenovus cancer support line 
 
0808 808 1010 
 
The support line is open 8am-8pm, 7 days a week.  
 
This is a free number from BT landlines. From mobiles, your network may charge. 
 
Website: www.tenovus.org.u
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Appendix 8: Invitation letter and study information sheet for study participants recruited 
through snowball sampling or community partners  
                                                                       
 
 
Dear [insert name],  
 
 
I phoned you on [insert date] to talk to you about taking part in a study. The study is funded 
by Tenovus, the cancer charity. The aim is to help make better services for cancer in Wales.  
The study involves an interview to find out what you think about cancer. The interview will 
take about 1 hour.  
The next few pages tell you more about the study. This is to help you decide whether or not 
to take part. If you like, you can talk to members of your family or friends about the study.  
If you do decide to take part, we would like to offer you £10 cash to say thank you.  
I will phone you again on [insert date]. I will answer any questions and ask if you would like 
to take part in the study.  
If you have any questions before then, please contact me on 02920 687639 or 
mccutchangm@cardiff.ac.uk. 
 
[insert signature] 
 
Grace McCutchan 
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What is the study all about? 
I am from Cardiff University, and I want to find out what people think about cancer, so we 
can improve cancer services in Wales. This is a study funded by the charity Tenovus. 
If you would like to take part in the study, I will arrange to come and talk to you at a time 
and place that is best for you.  
Do I have to take part? 
No. It is up to you to decide to take part in this study or not.  
If you have any questions please ring me on 02920 687639.  
You can talk to your family and friends about the study. They might be able to help you 
decide if you want to take part or not.  
Before the interview starts, you will be asked to sign a consent form. I will go through this 
form with you. This is to say that you agree to take part in the study.  
If you do take part, you can stop the study at any time. You will not need to tell me why you 
would like to stop.   
What will happen to me if I take part and what do I have to do? 
I will come to you to interview you on [date].   
I will ring you to arrange a date and time for us to meet. You can choose where the interview 
will take place. This can be at your home or somewhere else that you have chosen. If the 
interview takes place somewhere that is not your home, we will pay for your travel to that 
place.  
The interview will take about 1 hour. I will ask you questions about cancer. This will include 
symptoms of cancer, your thoughts about cancer and visiting your doctor.  
There are no right or wrong answers to the questions. I am just interested in what your 
thoughts are. All you need to do is talk about your thoughts and feelings about cancer.  
If you feel uncomfortable with my questions, you can decide not to answer those questions. 
If it is OK with you, the interview will be recorded.  
To thank you for your help, we would like to offer you £10 cash at the end of the interview. 
What will happen after the interview? 
After the interview, I will type what you said. This means we will be able to compare what 
people say in their interviews.  
Your name will not be typed on any interviews. Some of what you say might be used in 
written research. No one outside of the research team will know you took part in the study.  
The final results will be used to help make better services for cancer in Wales.  
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What happens to my personal details? 
This study is carried out by a team at Cardiff University. Your name and contact details will 
be stored on secure, password protected university computers. Your name and contact 
details will only ever be seen by members of the research team.  
Your details will not be used for anything other than contacting you as part of this study.  
Anything you say in the interview will be confidential. This means no one outside of the 
research team will know that you were in the study. Your name will not be linked to 
anything you have said in the interview. 
What are the potential risks or disadvantages in taking part in the study? 
This study involves talking about cancer. It is possible that some of the things we talk about 
may be upsetting. If you are upset during the interview please talk to the researcher about 
this.  
You can also stop the interview at any point without giving a reason.  
If you want to talk to someone else, you can contact Tenovus on the number at the end of 
this letter.  
Contact for further information
Grace McCutchan 
PhD researcher 
Institute of Primary Care and Public Health  
3rd floor, Neuadd Meirionydd 
University Hospital of Wales 
Cardiff  
CF14 4YS 
Phone: 02920 687197 
Email: mccutchangm@cardiff.ac.uk 
 
If there are any issues that I have not been able to resolve, please contact:  
Dr Kate Brain (supervisor) 
Institute of Primary Care and Public Health  
3rd floor, Neuadd Meirionydd 
University Hospital of Wales 
Cardiff  
CF14 4YS
 
The research is funded by the charity ‘Tenovus’ through Cardiff University 
 
Helpline 
Tenovus cancer support line 
0808 808 1010 
The support line is open 8am-8pm, 7 days a week.  
This is a free number from BT landlines. From mobiles, your network may charge. 
Website: www.tenovus.org.uk 
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Appendix 10: Coding framework 1 
Coding framework onto COM-B 
Capability 
Both the physical and psychological capacity of a person to perform behaviour 
Physical (includes skills, strength, stamina) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
No codes  
Psychological (having the knowledge and the skills to perform the behaviour and the capacity to 
engage and direct behaviour) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
Knowledge of 
the symptoms of 
cancer  
Identification of what the participant thinks 
are the symptoms of cancer (correct or 
incorrect) or if they think there are no 
symptoms/ say they don’t know symptoms. 
Also code here if in the context of 
symptoms they themselves have had or in 
other people with cancer/ cancer scare.  
When they talk about how this knowledge 
was acquired, use the code ‘acquisition of 
knowledge’.  
If they are speculating about community 
knowledge, double code under 
‘community’. 
‘A lump is a symptom of cancer’  
‘Yeah there are symptoms you look for 
lumps and you get blood but, when 
you’ve got bowel cancer, if you haven’t 
got the symptoms what, and like if it’s 
in the oesophagus what do you look 
for?’ 
‘I coughed and spit into a handkerchief, 
uh toilet roll to see if there was blood 
there, thinking it was cancer’  
 
Knowledge of 
the types of 
cancer 
Any knowledge of the different types of 
cancer (tumour sites). Also code here when 
the participant describes a person they 
know with cancer- only code the part that 
they say what type of cancer they had as it 
shows knowledge of the different types of 
cancer. 
 
‘I have heard of breast cancer’ 
‘Well I know it can attack every part of 
the body’  
‘My friend’s husband had bowel 
cancer’ 
Knowledge of 
the biology of 
cancer  
Knowledge of the biology of cancer (correct 
or incorrect). Include here when they talk 
about cancer spreading. Include any 
knowledge about secondary cancers.  
‘From what I understand, it is when 
your cells go wrong’  
‘It can spread so quickly can’t it?’ 
‘I think they can become secondary 
can’t they?’ 
‘it’s a bloody nuisance disease it’s get’s 
there it kills your immune system… well 
it kills your metabolism, it kills your 
body function...’ 
 
Knowledge of 
the causes of 
cancer  
Knowledge of what causes cancer (correct 
or incorrect). 
If talking about someone else with cancer 
and they speculate what caused their 
cancer, double coded here with ‘experience 
of cancer (knowing someone with cancer)’. 
Code here when they say about genetic 
causes of cancer. If they talk about their 
familial risk being high or low for cancer, 
code under ‘personal perceptions of cancer 
risk’ 
‘It is the chemicals in our food that 
cause cancer’ 
‘my father died of stomach cancer 
because he was attacked and he was 
on the bus and he had those, big bus 
ticket issue machine, that went though 
his stomach and that actually caused 
the cancer’ 
‘I know you can get a cancer of the 
throat from drinking’ 
‘But with smoking I don’t think it’s 
anything to do with cancer’ 
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Knowledge of 
treatments for 
cancer 
Knowledge of the types of treatments for 
cancer available. If talking about someone 
else with cancer double code what 
treatment that had with ‘experience of 
cancer (knowing someone with cancer)’.  
If they express an opinion about the 
treatments for cancer, code under ‘beliefs 
about treatments’ 
‘Chemotherapy, and what’s the other 
one, radiotherapy, and tablets, that’s 
all I know, operations obviously to cut 
things out’ 
‘He’s taking medication because there 
was something to do with they didn’t 
want to operate so they medicated 
him’ 
Self-examination 
behaviour or 
checking for 
symptoms 
Knowledge of self-examination behaviours. 
Code here when the participant says that 
they do or don’t check or themselves for 
symptoms or they self-examine or look out 
for symptoms. 
If talking about someone else, double code 
under ‘community’ 
‘I do check myself you know. In the 
shower every now and again you know’ 
‘I think you know we’re all keen on 
checking your breasts’  
Communication 
with Health care 
professionals  
When they mention anything about how 
they communicate with their GP or any 
other HCPs. Include any dialogue between 
themselves and HCPs. Include any strategies 
people use to aid communication with 
HCPs.  
Double code under ‘community’ if talking 
about someone else.   
‘I just push push push until I get the 
answer I want’ 
‘And she'd say, “well what do you want 
us to do about it?” and I’d go “well it’s 
not up to me to tell you what I want 
you to do about it, it’s what you think 
isn’t it’’  
Screening 
behaviour and 
diagnostic 
testing 
(performance of) 
 
Any mention of taking part or not taking 
part in screening behaviour in primary care 
or diagnostic testing in secondary care. For 
emotional reactions to screening or 
experiences of screening, code under 
‘emotional experiences screening’.  
Double code under ‘community’ if talking 
about someone else.   
'I do those kits they send through the 
door, for your bowels you know' 
‘I go for regular smears as well’ 
‘She’s gotta go for another scan now, 
but they’ve had, they’ve given her an 
internal’ 
 
 
Hypothetical 
symptom 
experience  
When the interviewer asks the participant 
what they would do if they found a 
symptom which they thought might be 
cancer.  
For potential emotional reactions to the 
symptoms, code under ‘Emotional reactions 
or impact of people who have cancer and 
emotional reactions to an actual or 
potential cancer diagnosis’ 
When they offer an action plan for a certain 
symptom without prompting for intentional 
behaviour, code under ‘knowing what to do 
with a symptom of cancer’ 
Double code under ‘community’ if talking 
about someone else.   
‘Straight away you would think, cancer’ 
‘I’d think about it for a while and then 
if it didn’t go away I’d go to the doctor’ 
‘It would be scary, all you can think of 
is how will I tell the kids’ 
Knowledge as a 
barriers  
Any mention of if/how cancer knowledge 
is/was a barrier to medical help seeking e.g. 
code here when they mis-attribute 
symptoms for other benign causes/ co-
morbid conditions or hope the symptom 
will go away. 
If the doctor diagnoses the symptom as 
benign or says it is another condition, code 
under ‘service barriers’ 
Double code under ‘community’ if talking 
about someone else.   
‘I should have gone back sooner 
shouldn’t I?....I accepted that HRT was 
God’ – lady with kidney cancer who 
was put on HRT for 11 months.  
‘Diabetes, diabetes...that’s a symptom 
of diabetes as well weight loss’ 
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Knowledge as a 
facilitator  
Any mention of how knowledge for cancer 
or other health problems acts as a facilitator 
to medical help seeking. Code under 
‘emotional facilitators’ when the participant 
talks about going to the doctor because 
their fear it might be cancer facilitates help 
seeking. Also code here when they talk 
about ‘knowing their body’  
Double code under ‘community’ if talking 
about someone else.   
‘He was having prostate problems, they 
kept saying nothing was wrong with 
him so he found it in the newspaper, 
the symptoms and he took it to the 
doctor and said ‘’that’s what I’ve got’’  
Opportunity  
All factors extrinsic to a person that either prompt the behaviour or allow enactment of the 
behaviour 
Physical opportunities (created by the environment e.g. time, financial resources, access and 
cues) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
Practical/physical 
barriers to 
medical help 
seeking (general 
or cancer specific) 
Anything that acts as a practical or physical barrier to 
help seeking behaviour (HSB). E.g. being too busy, 
not being able to get to an appointment, disability 
Double code under ‘community’ if talking about 
someone else.   
‘I got work and a family, I 
don’t have time to be 
making an appointment to 
go down the GP’ 
‘I’ve got to wait for a bus, 
get down on the bus, and 
then go back to work which 
would take me an hour, 
which would only take 
somebody else I said 15 
minutes’ 
Practical/physical 
facilitators to 
medical help 
seeking (general 
or cancer specific) 
Any practical or physical facilitators to HSB e.g.  
someone going with them to the doctors or the 
participant themselves took someone else to the 
doctors, having regular contact with GPs, home visits  
Double code under ‘community’ if talking about 
someone else.   
‘The doctor, he came to the 
house’ 
‘I do give an offer and say 
“well I’ll come with you if 
you want me to” 
 
 
Service barriers to 
medical help 
seeking (general 
or cancer specific) 
Anything that acts as a barrier to HSB is to do with 
the health service. E.g. not being able to get an 
appointment, perceptions of not wanting to waste 
the docs time, 1 appointment 1 problem, time 
limited appointments, not liking a specific doctor. If 
it is about a general dislike for doctors, code under 
‘cultural barriers’  
Double code under ‘community’ if talking about 
someone else.   
‘You have to wait 3 weeks if 
you want to see a specific 
doctor’ 
‘If you don’t specifically 
book a week before or 
fortnight in advance to see 
a certain doctor you get to 
see a locum which, when 
you go in there they say 
you’ve got 5 minutes to see 
them, I thought what 5 
minutes?  
 
 
Service facilitators 
to medical help 
seeking (general 
or cancer specific) 
Anything that acts as a facilitator to HSB that is to do 
with the health service e.g. knowing they can ask for 
a different doctor, knowing that they can take the 
emergency appointments, piggy backing symptom, 
requesting an appointment earlier than the one 
given, liking their doctor.  
Double code under ‘community’ if talking about 
someone else.   
 
 
‘Well my GP is brilliant, he 
listens to everything I say, 
so I feel OK about going to 
him you know’ 
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Description  and 
comments about 
GP 
Descriptive information about their GP surgery or 
staff. Comments which describe their GP or GP 
practice in a positive or negative light. Double code if 
they mention that anything to do with their surgery 
is a barrier or facilitator to HSB  
‘It is just up the road and 
has 3 doctors’  
‘My doctor is fantastic’ 
‘They are very good 
actually, I have a good GP’ 
‘Well I don’t know about 
them really, I have never 
been to this new one, I 
didn’t like my old surgery’ 
Description and 
comments about 
other healthcare 
services (not GP) 
Any mention of other services used e.g. secondary 
care services, pharmacy, community care services, 
care homes, practice nurses.  
Any comments positive or negative about the NHS. 
This usually about the level of service provided or 
about drugs not being available on the NHS etc. If 
they mention anything about funding cuts or higher 
level organisational problems etc., double code 
under ‘comments about politics or government’  
‘health care at home was 
used to help people stay at 
home if they were ill’ 
‘My pharmacist is brilliant, I 
ask him about everything 
before going to the doctor’ 
‘the problem with the NHS 
is there is are people 
making decisions who are 
not on the ground’ 
Current 
awareness 
campaigns  
When the participant mentions any cancer 
awareness campaigns or if they have not seen 
anything. For how these campaigns made them feel 
code under ‘emotional reactions to awareness 
campaigns’ 
‘I saw an advert about 
coughing’ 
‘no I can’t really say I have 
seen anything’ 
Current places to 
talk about cancer  
Anywhere people can currently ring or go to talk 
about cancer concerns or if there is nothing 
available. This can include any counselling service 
available for people who have been affected by 
cancer.  
‘there is this phone line you 
can ring’ 
Comments about 
government or 
politics 
Anything that is political or when the participant 
talks about the government. This can be in relation 
to health or not. Also include information on policy 
etc. This is usually mentioned in the context of 
money, or participates refer to ‘they’ or ‘them’. Code 
here any superstition about withholding cures for 
cancer etc.  
‘I seen my sister on the 
Tamoxifen which we can’t 
really afford in our country 
now’ 
 ‘They’re on about we’ve 
got cures for this, cures for 
that, I think it’s just a big 
money making thing to be 
honest, I think that it’s a 
case of they got it and we 
aint sharing it because 
there’s too much money 
going in....’ 
 
Cancer in the 
media  
Any mention of cancer related articles or pieces in 
the media. E.g. news items, celebrities with cancer, 
newspaper articles on cancer risk etc.   
For social media, code under ‘comments about social 
media’ 
‘I mean you read the 
newspapers and this week 
they’re telling you for 
example, that vinegar is 
excellent for you...”you 
must use vinegar, there’s 
this, this, and this in it and 
it’s good for you, vitamin 
marvellous” 3 weeks later, 
“don’t have so much 
vinegar because....” and 
this is happening 
continually isn’t it?’ 
‘It’s like Linda Bellingham 
isn’t it she died this 
morning didn’t she?’ 
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Acquisition of 
cancer symptom 
knowledge 
Any mention of knowledge for how cancer symptom 
knowledge was acquired e.g. because they knew 
someone who had the symptoms, looked don the 
internet, campaigns etc 
‘I do read about it you 
know’ 
‘Going over the past that 
I’ve seen with my parents 
and 2 late brothers and my 
wife, you know late wife 
you know all the signs’ 
‘I know you can get stuff of 
the internet and all that’ 
Other health in 
the media 
Any other mention of health related issues in the 
media- this can be anything else health related e.g. 
heart problems,. Include celebrities with health 
problems 
‘I read these things because 
half of it I don’t believe, you 
know I think oh...you know 
they’ll say like I’m on 
cholesterol tablets now a 
couple of times they’re 
claiming they make...oh 
they make your bones 
ache’ 
Comments about 
social media  
Any mention of social media (Facebook or twitter). 
Code what they think of it/ if they use it or don’t use 
it and how they use it. If they say that people put 
their cancer diagnosis on Facebook, double code 
under ‘talk about cancer within the community’  
‘My wife uses facebook, I 
don’t use Facebook’  
Barriers to 
changes in risk 
behaviour 
Any barriers to changes in health risk behaviours e.g. 
changes in healthy eating might be due to a lack of 
availability in healthy foods or the inability to afford 
it. Include personal barriers but also the wider 
societal barriers to changes in risk behaviour e.g. 
school provision.  
Double code under ‘community’ if not about the 
participant.  
‘I had myself, right, I need 
£10 for the gas and I’ve got 
£20 in my purse to last me 
the week, but it’s gunna 
cost me £15 to get fresh 
veg, meat and fruit, then I 
would leave the fruit aside 
and the veg to make sure 
that I’ve got gas to keep me 
warm’ 
Social opportunities (created by cultural environment) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
 
 
Symptom 
disclosure  
When the participant is asked or says that they would 
tell anyone about a symptom. Code all aspects of the 
interaction: who, why and advice given.  
Also code here when they say they would not disclose a 
symptom. 
 
‘I told my wife about 
when I found some 
blood in my pee’ 
Symptom 
disclosure 
(recipient) 
When the participant says they have been asked for 
advice by another person about a symptom or when the 
participant has noticed someone’s symptoms and they 
give them advice on what to do (e.g. go to docs). Code 
all aspects of the interaction: who, why and advice 
given.  
Also code here when they say people don’t ask them 
about symptoms. 
 
‘I always tell them to go 
straight to the doctor’ 
‘I’m like the hospital, 
people come to me 
with everything heath 
related’ 
Symptom 
disclosure (3rd 
party) 
When the participant describes an incidence of 
someone they know disclosing symptoms to another 
person they know or when another person notices their 
symptoms. Code here who, why and what was said.  
‘He begged her to go to 
the doctor, her 
daughter begged her to 
go to the doctors’ 
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Experience of 
cancer (knowing 
someone with 
cancer) 
There is a lot of coding and double coding here. Code all 
information gathered a person they know who had 
cancer. E.g. type of cancer, treatments, descriptions of 
the side effects of treatment, the symptoms they 
experienced and other information about their cancer 
journey.  
For actual HSB when they noticed symptoms, double 
code under ‘symptom experience family and friends’.  
For anything about how this experience has influenced 
how they think about cancer or how the individual 
reacted to their diagnosis of cancer, code under 
‘Emotional reactions or impact of people who have 
cancer and emotional reactions to an actual or potential 
cancer diagnosis’ .  
‘He had cancer of the 
stomach’ 
‘He had a cough for 
ages, I kept saying you 
need to go to the 
doctor, but he 
wouldn’t. Eventually he 
did and the doctor sent 
him away for tests’ 
 
Concentric circles/ 
social networks  
 
When p’s are asked about their social networks using 
the concentric circles. Code all aspects under this code 
and double code under ‘symptom disclosure’ or 
‘symptom disclosure (recipient) for the parts when they 
talk about who in their circle has come to them with a 
symptom or who they would go to with a symptom. 
‘I – okay so first off I’d 
just like to get to 
know  you, a bit more 
about you what I’ve 
been doing with 
people is saying 
“imagine this is you in 
the middle” and this 
is your closest circle 
of friends or family.  
These are people you 
talk to most or you 
see most and you just 
feel the closest to.  
Who do you think 
you’d put in your 
circle here? 
EH.DS2 F – well I got 
family and friends…’ 
Cultural BARRIERS  Anything that might act as a cultural barrier (things 
afforded by the environment) e.g. being male (stoic), a 
general dislike of doctors, having low general trust in 
doctors, age as a barrier (feeling too old to seek help), 
societal norms around medical help seeking.  
When they talk about communication with doctors code 
under ‘Communication with HCPs’ or if it is a barrier, 
double code under ‘Service barriers’.  
Double code gender differences under ‘gender 
differences’ 
Double code under ‘community’ if talking about 
someone else.   
‘but a man won’t [go], 
they tend not to think 
it’s me, it’ll go, but it 
doesn’t’  
‘nothing, I’ve got no 
faith in doctors at all’ 
Cultural 
facilitators 
Anything that might as a cultural facilitator (things that 
are afforded by the environment) e.g. being female 
(more likely to discuss health problems), seeing people 
in social environment with cancer, having general good 
trust in doctors 
If they talk about liking a specific doctor code under 
‘service facilitator’  
Double code gender differences under ‘gender 
differences’ 
Double code under ‘community’ if talking about 
someone else.   
 
 
‘local people dying from 
it will make others think 
oh I’d better go and see 
about it’. 
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Talk about cancer 
within the 
community  
Any mention of how people within the community talk 
about cancer to one another, or if they don’t want to 
talk about cancer. This can be face to face talk about 
cancer or talk about cancer on social media etc. Code 
what is said and why.  
Also code here if they talk about keeping their cancer 
diagnosis a ‘secret’ or telling other people about their 
cancer diagnosis in the community. 
If social media is mentioned, double code under 
‘comments about social media’. When they talk about 
cancer within the mass media, code under ‘cancer in the 
media’   
Double code for the latter under ‘experience of cancer 
(knowing someone with cancer)’ as well.  
Double code under ‘community’ if talking about 
someone else.   
‘I – why do you think 
people don’t like talking 
about it? 
P – it’s never going to 
happen to me 
hopefully’  
‘they sort of hide 
cancer don’t they, you 
know what I mean?  It’s 
something “oh don’t 
talk about it” you know 
you mean, I wouldn’t 
normally talk about it 
like I have with you, you 
know what I mean’ 
 
 
 
Gender 
differences  
Anything about gender differences relating to talk about 
cancer/ health etc.  
‘It’s very depressing for 
the men innit? 
((laughs)) 
I – ((laughs)) men don’t 
really like talking about 
cancer do they? 
No, they don’t’ 
Motivation 
The processes in the brain that energise and direct behaviour. This includes conscious decision 
making and habitual processes, emotional responses or processes involving analytical decision 
making.  
Reflective processes (involving evaluations and plans) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
Personal 
perceptions/ 
Perceptions of 
cancer risk  
When the participant mentions how far they believe 
themselves to be at risk of getting cancer or not at risk 
of getting cancer. This might be discussed in terms of 
familial risk.  
They might talk about other people they know and their 
perceptions of risk, code here and double code under 
‘community’ 
If they worry about their risk of getting cancer, double 
code under ‘cancer worry’ 
‘Cancer is my side, 
heart is his side, it does 
worry me thinking am I 
gunna be alright, is it 
going to happen to 
me?’ 
‘they want to block it 
out and say “well it’s 
not gonna happen to 
me”  
‘I asked was it sort of 
hereditary because my 
brother had prostate 
cancer, would I have it?  
And they said “there’s a 
possibility that you 
could develop it”  touch 
wood, I haven’t.’  
 
 
Symptom tracking 
and evaluations 
Anything the participant has done or would do to keep 
track of their symptoms before going to visit the doctor 
e.g. looking on the internet, keeping a symptom diary 
Double code under ‘community’ if talking about 
someone else.   
 
‘I get on the internet 
have a look’ 
‘I mean most people 
have got computers 
today you can 
google…your symptoms 
so it will come up’  
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Beliefs about 
early diagnosis  
Any beliefs about early diagnosis of cancer. E.g. some 
participants might highlight the importance of 
diagnosing cancer early, others might say it doesn’t 
make a difference. Code here when participant stalk 
about ‘going to the doctors early/ straight away’, 
‘catching cancer early’.  
For anything about cancers ‘spreading’ in relation to late 
diagnosis, double code under ‘biology of cancer’ 
If in relation to knowing someone with cancer, double 
code under ‘experiences/ knowing someone with 
cancer’  
‘The earlier you get 
cancer diagnosed, the 
more likely to you are 
to survive’  
‘If it is not found early it 
spreads to other organs 
with terrible results’  
‘If you’ve got cancer 
and you don’t get it 
looked at straight away 
because it can, it can 
happen where they 
don’t diagnose it 
straight away, it can 
spread so quickly can’t 
it’ 
Beliefs about 
treatments for 
cancer   
The participants opinions about the treatment for 
cancer e.g. any language used to describe what they 
think are the side effects of cancer treatments, how 
effective treatments are.  
When p’s talk about cancer being ‘treatable’ or 
‘curable’, code under ‘beliefs about curability of cancer’  
For knowledge of the types of treatments for cancer, 
code under ‘knowledge of the treatments for cancer’ 
If in relation to knowing someone with cancer, double 
code under ‘experiences/ knowing someone with 
cancer’  
 
‘The treatments can 
make you very ill, 
sometimes the 
treatment is worse than 
the cancer’ 
 
Beliefs about 
curability of 
cancer 
The p’s opinions and beliefs about the curability of 
cancer (if it can or can’t be cured) e.g. how treatable 
cancer(s) are or if they believe they can be cured.  
A lot of p’s talk about how the mind can help curability 
of cancer (being determined, fighting cancer, staying 
positive)- code these here.  
When they use language relating to how early diagnosis 
can aid curability of cancer, double code under ‘beliefs 
about early diagnosis of cancer’.  
If in relation to knowing someone with cancer, double 
code under ‘experiences/ knowing someone with 
cancer’  
‘Look on the bright side, 
there is a cure out there 
somewhere’ 
‘Because a lot of 
cancers today are 
treatable thank 
goodness’  
‘Well once you’ve got it 
it’s like a death 
sentence isn’t it really 
then it’s very rare 
someone having cancer 
and beating it’ 
‘He don’t think they’ll 
ever find a cure [for 
cancer]’  
 
Knowing what to 
do with a 
symptom of 
cancer  
This is different to ‘hypothetical symptom experience’ 
as they are asked what they would hypothetically do if 
experiencing a symptom. For this code, the participant 
lists off almost a set of rules (or action plans) about 
what one should do when faced with a symptom- like an 
action plan rather.  
Double code under ‘community’ if talking about 
someone else.   
‘Bleeding is another 
sign of it and you must 
go straight to the 
doctor and sort it’- she 
was not prompted or 
asked what she would 
do if experiencing 
bleeding from the 
bowels, instead she 
demonstrated 
symptom knowledge 
and then what you 
should do if 
experiencing that 
symptom 
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Smoking 
behaviour 
Any detail about smoking behaviour (or lack of smoking 
behaviour) from the participant or members of the 
community. E.g. why they or people in the community 
smoke even if they know the risk associated with 
smoking, descriptions of how many people smoke, 
insight into why people take up smoking, stop smoking, 
general information about smoking behaviour.  When 
they explicitly say if they think smoking causes cancer or 
not, code under ‘knowledge of the causes of cancer’.  
If they talking about people in the community, double 
code under ‘community’  
‘I – why do you think 
people still smoke even 
though they know the 
risks 
P- there’s a certain 
intellect of people 
whatever you tell them 
about anything they 
won’t accept it’ 
Motivation to 
learn more about 
cancer or health  
Any mention of motivations to know or learn more 
about cancer symptoms/ cancer or general health. 
When they talk about how acquire the information, 
code under ‘acquisition of knowledge’  
If the motivation to learn more is because of seeing 
people with cancer, code under ‘experiences/knowing 
someone with cancer’ 
‘I’m learning all the 
time and this is why 
with health, I’m more 
into that than anything 
else, because seeing 
what’s happened in the 
past to me’ 
 
Automatic processes (emotions and impulses that result from innate dispositions or associative 
learning) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
Beliefs about 
cancer  
Any language used to describe cancer and what they 
think about cancer as a disease. e.g. attitudes or beliefs 
towards cancer, folk beliefs, fearful beliefs and fatalistic 
beliefs.  
For beliefs about the curability of cancer, treatments for 
cancer or early diagnosis, code under relevant codes 
above under ‘reflective processes’ or double code if it 
such beliefs relate to how they think about cancer as a 
disease.  
‘It is a horrendous 
disease’  
‘it is it’s a dirty disease 
isn’t it?  That’s the 
description of cancer, 
it’s a dirty disease, and 
once you’ve got it that’s 
your lot, isn’t it....’ 
 
 
Emotional barriers 
to medical help 
seeking (general 
or cancer specific) 
Anything that acts as a barrier to symptom presentation 
that is emotive. These might be quite similar to beliefs 
or cancer worry, but only code here when the 
participant explicitly states that these emotions will act 
as a barriers to their or others HSB. E.g. fear and worry 
of what they symptom might be, embarrassment. 
Double code under ‘community’ if talking about 
someone else.   
 
‘I think for him perhaps 
fear, I think perhaps 
might be a lot to do 
with some people, fear.  
Fear of the unknown 
isn’t it?’ 
‘I think a lot of them are 
too terrified to see 
about it mind, I used to 
be anyway....’ 
 
 
 
Emotional 
facilitators to 
medical help 
seeking (general 
or cancer specific) 
 
Things that make it easier for the person to seek 
medical help that is emotive. E.g. their fear motivates a 
visit to the doctor, anxiety, help seeking for reassurance 
Double code under ‘community’ if talking about 
someone else.   
‘What’s the point in 
worrying about it, go 
and get it checked out- 
put’s your mind at rest’ 
‘You just go down there 
[to the doctors] hoping 
he would tell you ‘’go 
away all you’ve got is a 
cough’’ 
‘I’d be afraid to leave it 
you know and I 
wouldn’t hesitate in 
going to my GP’ 
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Cancer worry How much the participant or people in their community 
worries about getting cancer or does not worry about 
getting cancer  
Double code under ‘community’ if talking about 
someone else.   
‘yeh it do worry me, it’s 
not good saying it 
don’t’  
I’m afraid of long term 
infection of the chest 
that could cause cancer 
right’ 
‘The cancer I must be 
honest it never worried 
me’ 
Cancer compared 
to other life 
threatening 
diseases  
Some participants described cancer compared to other 
diseases e.g. diabetes, heart disease etc. Code here 
what their opinions and comparisons. 
 ‘You can’t compare 
them, cancer is just 
terrible, it’s like death, 
others you can live 
with’ 
‘To be honest with you 
out of all the disease I 
would prefer cancer 
believe it or 
not…because I’m 
suffering from memory 
loss’ 
Difference 
between cancer 
now and in the 
past  
Comments about the difference between cancer in the 
past and now. Can be anything to do with survival, 
attitudes, treatments etc- double codes under relevant 
codes if about these e.g. if about differences in 
treatments for cancer, double code under ‘beliefs about 
treatments for cancer’.  
For differences in how people talk about cancer 
nowadays, double code under ‘talk about cancer in the 
community’  
‘I don’t think the word 
cancer was ever used 
when I was…I can’t 
remember if they ever 
used it’ 
‘Years ago it was the big 
‘’C’’ they’d whisper the 
word or mouth the 
word, not for anybody, 
you know…but to day 
they put it on 
Facebook’ 
‘I mean they’re coming 
up with different things 
all the time if there is a 
chance, there is more 
survival rates now than 
it was going back 10 
years ago’ 
Religious beliefs 
and cancer  
Any religious views and how they change beliefs or form 
the basis of beliefs about cancer  
‘I don’t think God has 
got anything to do with 
it’ 
Emotional 
reactions or 
impact of people 
who have cancer 
and emotional 
reactions to an 
actual or potential 
cancer diagnosis 
How someone would react or has reacted to someone 
having cancer and how a diagnosis of cancer has 
impacted the family/ participant.  
Also code here if the p has/had cancer and they are 
talking about the impact of their cancer on family 
members or friends or how they felt about their cancer 
diagnosis e.g. accepting the diagnosis of cancer, the 
family not being able to cope, offering support, people 
pussyfooting around the person etc.  
Also code here when the p talks about emotional 
reactions to a potential cancer diagnosis.  
Double code under ‘community’ if talking about 
someone else.   
If they describe their own cancer, code under 
‘description of their cancer’ or if they describe someone 
else who has cancer code under ‘experiences/knowing 
someone with cancer’. 
‘support, support as 
much as they want’ 
‘Oh it was terrible 
[when he got cancer’]’ 
‘he do joke about it, he 
do say “well I can have 
a false ball if I want” 
‘you don’t know what 
to say you’re um, 
you’re dumbstruck, and 
that’s it....yeah, you 
don’t know how to 
react’ 
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Emotional 
reactions to 
screening/ 
diagnostic tests 
 
Any opinions thoughts on screening programmes, 
emotional reactions to taking part or not taking part in 
about screening, details of positive or negative 
experiences for screening or diagnostic testing.  
 ‘I went for a smear 
once and I have never 
been again, the whole 
experience was just 
awful’ 
Emotional 
reactions to 
awareness 
campaigns/ in the 
media 
Any emotional reactions or opinions about any 
campaigns to raise cancer awareness or how any 
reporting of cancer related info in the media has made 
them feel e.g. cancer in the news or on TV.  
‘I think they ones on TV 
are very scary, they 
scare people away from 
thinking about it’ 
Emotional 
reactions to actual 
or hypothetical 
cancer symptoms 
How the participant reacted to an actual symptom 
experience- even if the diagnosis was benign. Also code 
here if they predict how they would feel for a 
hypothetical symptom.  
‘I went home very 
upset, cus when he said 
‘’lump’’ you 
automatically think 
cancer’ 
Behaviour 
Performance or intentions to perform a behaviour 
Actual symptom 
experience 
When the participant experiences a symptom of cancer. 
Code the description of the symptom, what they did and 
any symptom attributions made. Code here even if they 
don’t explicitly say they thought could be cancer.  
For general descriptions of their cancer double code 
under ‘description of their cancer’.  
For emotional reactions to symptoms code under 
‘Emotional reactions or impact of people who have 
cancer and emotional reactions to an actual or potential 
cancer diagnosis’ 
For symptom experience in another person, code under 
‘symptom experience for friends and family’.  
For any barriers or facilitators to HSB, double code 
under relevant codes.  
For anything about communication symptoms to HCPs, 
double code under ‘Communication with HCPS’  
‘Well I went short of 
breath, no other illness 
just short of breath.  I 
went to the surgery and 
he sent me for a chest 
x-ray’ 
 
 
 
Symptom 
experience for 
family and friends 
Any information about symptom experience in someone 
else. Code the description of the symptom, what they 
did and any symptom attributions made. Code here 
even if they don’t explicitly say they thought could be 
cancer. If they report that they experienced any barriers 
or facilitators to help seeking, double code under 
appropriate codes and double code under ‘community’.   
For anything about communication symptoms to HCPs, 
double code under ‘Communication with HCPS’ 
‘She lost a tremendous 
amount of weight, and 
she really wasn’t well 
she just kept on saying 
“I can’t eat, I can’t 
swallow” and he just 
said to her “it’s a virus, 
it’s to do with your 
throat” she said have I 
really?’  
 
 
Changes in risk 
behaviour  
Any disclosure that the participant or someone else has 
stopped or attempted to stop risky health behaviours 
e.g. smoking or has made changes to their lifestyle in 
order to reduce their risk of cancer. Also code here if 
they express or reluctance to give up behaviours that 
increase the risk of cancer and what it was like to 
change risk behaviour.  
If about smoking behaviour, double code ‘smoking 
behaviour’  
Double code under ‘community’ if talking about 
someone else.   
 
‘I said we try and eat 
healthy you know and 
all these different 
vitamins and things like 
that 
‘My son he smokes and 
he’s 52 he’s smoked 
since he was 14 that I 
know of, right he 
stopped smoking 12 
months ago’ 
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Medical help 
seeking for non-
cancer symptoms 
Any mention of medical help seeking for symptoms that 
are not related to cancer or other medical health 
conditions e.g hip replacement or diabetes. Code a 
description of the condition, who they went to, 
symptom attributions etc.  
When they disclose that they have a co-morbidity or 
health condition, double code under ‘information about 
the participant’.  
For anything about communication symptoms to HCPs, 
double code under ‘Communication with HCPS’ 
‘I knew you know my 
throat wasn’t right, and 
then they sent me for a 
test, “no it’s fine” and 
then they said to me 
then “oh yes it is, you 
have got underactive 
thyroid, so we’ll put 
you on tablets now” 
you know’ 
 
 
Other codes that do not fit under COM-B 
Community  Code here when the participant has been asked to 
imagine what their friends/ family/ community know 
or believe about cancer or what they would do if they 
experienced a symptom. These questions were used 
to get a feel of the social norms in the community 
surrounding knowledge and beliefs about cancer. 
When using this code, double code under the 
relevant other code. E.g. symptom knowledge  
 
Description and 
comments about 
community  
When the participant is asked to describe the 
community they live in or the facilities available in 
their community. Or any stories about the 
community or neighbours that live in their 
community.  
 
 
‘It’s very close knit, 
everybody knows 
everybody’ 
‘It’s mainly Asians down 
there now…and their 
line broke…So I made a 
line for these people’ 
Community health  
 
Any description about the status of health in 
members of the community in which they live in or 
friends and family and how people talk about health 
within the community or if health is a priority etc. 
also code if they talk about health habits (not cancer 
related) of friends and family 
 
 
e.g. ‘no its vascular 
stuff she got’, ‘2 days 
after that my sister 
died’ 
Suggestion for an 
intervention  
When the participant is prompted to generate any 
ideas for an intervention to encourage more timely 
symptom presentation. Or any suggestions for 
interventions that they don’t think would work.  
 
 
‘You could try doing a 
talk in the community 
centre’ 
Information about 
the participant 
Any demographic information and information about 
general health. Also code here any contextual 
information about family.  
 
 
 
 
 
I’m 76 now’ 
My memory is terrible, 
its just getting worse’ 
‘My grandson is 23 and 
uh he is old enough for 
me to want him to have 
a job’ 
Talk not related to 
topic of interest 
 
Code anything here that is not related to anything the 
interviews are trying to capture.  
 
 
 
‘is it raining? Yeh let the 
dog in then’ 
 
 
396 
 
Description of 
their cancer (or 
benign cancer 
diagnosis) 
Code anything here about the participant if they, 
themselves had cancer or was referred for cancer 
tests and it turned out to be benign. Any info they 
give about having cancer/ cancer journey. If they talk 
about how they were diagnosed and went to seek 
medical help etc, double code under ‘actual symptom 
experience’.  
For any barriers and facilitators to medical help 
seeking, double code using appropriate barrier and 
facilitator codes.  
When they talk about any emotional reactions to 
their cancer or potential cancer diagnosis, code under 
‘Emotional reactions or impact of people who have 
cancer and emotional reactions to an actual or 
potential cancer diagnosis’ 
 
Talk about 
charities  
Any talk about charitable organisations. Include any 
talk about them giving to the charity or the work a 
charity does etc. Or any talk about the community 
raising money for charities 
‘It’s very important that 
people  keep giving, 
because where would 
we be without the 
voluntary, the 
McMillan’  
 
Comments about 
euthanasia 
Any mention of euthanasia and their opinions 
surrounding it  
‘I don’t know whether 
I’m for euthanasia or 
against it’  
Taking part in 
future research  
If the participant says that they do or don’t want to 
take part in future research  
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Appendix 11: Charting of data 1. Example: psychological capability- participants with a previous diagnosis of cancer  
Previous 
diagnosis 
of cancer Theme (Psychological Capability) 
Participant 
ID Knowledge of the symptoms of cancer  Knowledge of the types of cancer  
Knowledge of the biology of 
cancer  
1   
Aware of lump as a symptom of cancer and weight 
loss.   
Aware that cancer is when the cells 
in the body 'go wrong'. 
9 
Aware of shortness of breath and vomiting as 
symptoms of cancer. Believes cancer to be painful. 
Lack of pain and vomiting for symptoms prior to 
diagnosis therefore cancer was not considered a 
probable cause of symptoms.  
Aware of multiple types of cancer- lists 
bowel, lung, breast and pancreas. Says you 
can get cancer anywhere.  
Did not tell anyone about his 
cancer diagnosis because he 
thought people in the community 
might think he was contagious and 
they would refuse to sit next to 
him/come and see him. 
10 
Thinks that people in the community are unaware 
of the symptoms of cancer.     
18 
Symptoms prior to diagnosis were frequency of 
going to the toilet- was unaware this was a 
symptom of cancer and was surprised to receive a 
diagnosis of cancer. Was surprised the symptoms 
were painless. Aware of weight loss as a symptom 
of cancer but thinks some cancers are 
symptomless.  
Had never heard of prostate cancer until 
diagnosed with prostate cancer. Aware of 
pancreatic cancer because father was 
diagnosed with pancreatic cancer. Also 
aware of breast and lung cancer.  
Aware that the cancer can spread 
to other parts of the body 
27 
Was surprised to receive a diagnosis of cancer as 
were unaware that the symptoms could indicate 
cancer. Expected cancer to be painful. 
Aware you can get cancer in any part of the 
body   
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Previous 
diagnosis 
of cancer Theme (Psychological Capability) 
Participant 
ID Knowledge of the causes of cancer  
Knowledge of the treatments for 
cancer  
Self-examination 
behaviour/checking for 
symptoms  
1  
Thinks there is an increase in the prevalence of cancer. 
Attributes this to chemicals used in food- from the chemicals 
used in the food for animals (so they are ingesting the 
chemicals) and chemicals used to grow food crops- so humans 
ingest these chemicals which causes cancer. Aware that 
smoking is a major cause of cancer.    
Self-examines but could 
not self-examine to find 
her tumour. 
9 
Could not cite any potential causes of cancer- unaware of the 
causes of cancer 
Aware of chemotherapy, radiotherapy 
and surgery as treatments for cancer.   
10 
Could not cite any potential causes of cancer- unaware of the 
causes of cancer 
Aware of hormone tablets as 
treatments for cancer.   
18 
Aware of the link between smoking and cancer, but slightly 
sceptical because he could think of some people in the 
community with a diagnosis of cancer who did not smoke. 
Thinks other people in the community are sceptical of the link 
between smoking and cancer.    
Reminds his family to 
check themselves for 
cancer regularly- think 
self-examination is very 
important.  
27 
Believes cancer 'lies dormant' in everyone, and that a physical 
hit or psychological trauma i.e. death in the family will 'shock 
start it off'. Thinks smoking does not cause cancer- says that 
this is an excuse the medical profession use to blame 
symptoms on smoking habit. Knows some people who smoked 
their whole life and never received a diagnosis of cancer. Does 
not believe what the media report about the link between a 
poor diet and cancer- says this link has 'never been proven'. 
Aware of four different treatment 
options because he was offered these- 
surgery, radiotherapy injection, 
hormone injection, radiotherapy   
 
 
399 
 
Previous 
diagnosis 
of cancer Theme (Psychological Capability) 
Participant 
number Communication with HCPs 
Screening behaviour 
(performance of) 
Hypothetical 
symptom 
experience  Knowledge as a barrier  
Knowledge as a 
facilitator  
1  
Thinks the problem people in 
the community have with 
communicating with the 
doctors is that they get a 
telling off about their diet 
and weight so they don’t 
listen to the doctor. 
Up to date with regular screening, 
but needs to 'nag' husband to do 
screening. Reports that he refused 
to do the bowel screening test 
and thinks this is typical for men- 
they won't engage with screening.  
N/A Previously 
diagnosed with 
cancer. 
Unaware symptoms could 
indicate cancer, therefore did 
not seek medical help for 11 
months.    
9    
Has regular colonoscopy. Used to 
be embarrassed but is used to it 
now.  
N/A Previously 
diagnosed with 
cancer. 
If attributed symptom to 
cancer he would have gone to 
the doctors sooner   
10 
Finds asking the doctor 
questions difficult.    
N/A Previously 
diagnosed with 
cancer. 
Aware symptom (lump) could 
indicate cancer so prolonged 
symptom presentation   
18 
Finds it difficult to listen to 
the doctor during a 
consultation. Member of 
family accompanies the 
participant to appointments 
to help with listening.  
Aware that blood tests and MRI 
scans can be used to screen for 
cancer.  
N/A Previously 
diagnosed with 
cancer. 
Didn't attribute symptoms to 
cancer otherwise would been 
to the doctor sooner   
27 
Participant is passive when 
talking to HCPs, wife more 
proactive.  
Found his first colonoscopy very 
painful and embarrassing.  
N/A Previously 
diagnosed with 
cancer. 
Unaware symptoms were 
cancer otherwise would have 
sought medical help quicker 
Would go straight 
to the doctor in 
future if attribute 
symptom to 
cancer  
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Appendix 13: Focus group summary 1 
Healthcare professional focus group Site 1 
Overall, the Tenovus health check was viewed positively as a useful tool for encouraging 
people living in Communities First areas in [place] to engage with their health. However, 
weaknesses and areas for improvement were also discussed. A number of barriers and 
facilitators to cancer awareness and early help-seeking were also highlighted. 
Barriers to timely GP presentation 
The group discussed that people in Communities First areas are aware of cancer, but tend to 
be less aware of the risk factors for cancer. There was a view that many people in the 
community do not have an accurate perception of personal risk and do not understand that 
engaging in risky behaviours (smoking, poor diet, lack of exercise etc) influences their risk of 
cancer. 
Long-term health was perceived not to be a priority for many people in the local community. 
The group felt that people often come to see the GP once health problems have been 
experienced for a while and reach a point where they can no longer be avoided. GP practices 
were described as playing a ‘firefighting’ role, with only a small amount of work being about 
prevention. 
Negative beliefs and fears about cancer were thought to be widespread within the 
community, with cancer perceived as a non-treatable disease that is a death sentence. These 
beliefs were thought to be particularly prevalent in older people, who also have concerns 
about bothering the doctor. 
Facilitators of timely GP presentation 
People living in Communities First areas were thought to be receptive to large scale cancer 
awareness campaigns, with discussions about increases in concerned patients following such 
campaigns. However, the group was concerned that such campaigns may result in increased 
visits by the ‘worried well’ rather than those who are most at risk. 
Discussing symptoms with family members was considered by the group to be a prompt for 
people in the local community, with family members often encouraging people to visit the 
GP and in some cases ringing to make the appointment. 
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Health check content 
The Tenovus health check was described as comprehensively covering a wide range of 
cancer symptoms and risk factors. The health check was considered to be easy to use and 
understand, with the traffic light system praised for making the results clear. The printability 
of the condensed results section was viewed positively, as was the prominence of the 
helpline number throughout the health check.  
The group agreed that the health check could be strengthened by making the questions 
more specific, especially the diet and family history related questions. It was felt that the 
answer options were too restrictive, with the potential for inaccurate results. The results 
section was viewed as being negative, overwhelming and lacking a motivational tone. It was 
suggested that the results section could be improved by priming the positive results and by 
including more motivational language. The advantages of motivational interviewing 
techniques were discussed, with the group expressing that the results could be improved if 
they encouraged people to make plans and set goals to change one or two behaviours. 
Diagrams and graphs could also be utilised in the results section to break up the text. 
Suggestions were made to include a statement at the end of the health check informing 
people when they should re-do the health check, with consideration given to what would be 
an appropriate time frame. It would also be beneficial to add a statement informing people 
that the health check is not exhaustive, and that results do not give the ‘green light’ for all 
aspects of health. 
How to conduct the health check 
Overall, involving a trained advisor was considered preferable to people doing the health 
check alone because it would allow hands-on support, advice and signposting to relevant 
services. Signposting to relevant services was considered very important, and the advisor 
could help to ensure that the individual is aware of the appropriate places to go for help and 
support. 
Places to conduct the health check 
It was thought that the health check could be carried out in a range of community venues 
including supermarkets, shopping centres, sports venues, job centres, gyms, and local events 
such as healthy living days. Communities First was mentioned as a potential way to 
implement the health check via health and wellbeing events in the local community.  
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Community pharmacies and GP practices were also described as good locations for providing 
a ‘captive audience’ who could complete the health check whilst waiting. Lack of privacy was 
considered an issue in these environments, but could be overcome by booking a room for an 
afternoon and conducting an advertised afternoon drop session. 
Implementation and sustainability of the health check 
Media campaigns (newspapers, TV, radio) were considered important for the 
implementation and take up of the health check, as GPs had noticed increases in 
presentations following similar media campaigns. If such an approach is used, consideration 
needs to be given to how to identify the target audience to ensure that the correct people 
are presenting. 
The pathways to presentation and signposting to relevant services needs to be clarified in 
the health check, in order to help people access the right services at the right time and 
reduce the number of people incorrectly presenting to the GP.  
Practice nurses and community pharmacists are frequently involved with health promotion, 
so the health check could be promoted through these existing channels with further 
signposting to the GP where relevant. 
Involving and engaging health professionals in development and implementation processes 
was considered key to successful uptake and impact of the health check (e.g. going through 
a local medical committee). This will be particularly useful for GPs as it will help increase 
awareness of the health check and prepare them for potential consultations where patients 
present after completing the health check. 
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Appendix 14: Focus group summary 2 
Healthcare professional group Site 2 
The Tenovus health check was discussed as a tool for encouraging people living in 
Communities First areas in [place] to engage with their health. Many weaknesses of the 
health check and areas for improvement were discussed. A number of barriers and 
facilitators to cancer awareness and early help-seeking were also highlighted. 
Barriers to going to the GP 
Anxiety over symptoms and what might happen as a result of a medical consultation were 
perceived by the group to discourage people in the local community from going to see the 
GP. The group also felt that patients often feel uncomfortable talking about their symptoms, 
with embarrassment about intimate symptoms quite common.  
The group felt that people often come to see the GP once health problems have been 
experienced for a while and it has got to a point where it can no longer be avoided. Long 
term health was perceived not to be a priority for many people in the local community.  
The group discussed how they think that people in local Communities First areas are aware 
of cancer, but tend to be less aware of the risk factors for cancer. There was a view that 
many people in the community do not have an accurate perception of personal risk and do 
not understand that engaging in risky behaviours (smoking, poor diet, lack of exercise etc) 
influences their risk of cancer. 
Negative beliefs and fears about cancer were thought to be widespread within the 
community, with cancer perceived as a non-treatable disease that is a death sentence. These 
beliefs were thought to be particularly prevalent in older people, who also fear being told 
what to do and having their independence taken away. 
Facilitators to going to the GP 
People living in Communities First areas were thought to be receptive to large scale cancer 
awareness campaigns, with discussions about increases in concerned patients following such 
campaigns. However, the group was concerned that such campaigns may result in increased 
visits by the ‘worried well’ rather than those who are most at risk. 
The group felt that social networks were very important for people in the local community. 
People in the community often discuss symptoms with family members and friends, with 
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advice from these people often taken on board. The group discussed how people often base 
their own health concerns on experiences of disease in family or friends. 
Health check content 
The Tenovus health check was considered to be easy to use and understand, with the traffic 
light system praised for making the results of the health check clear. The content of the 
‘green’ results was particularly praised for highlighting the good things that people are 
doing, and explaining why these are good things. 
The group agreed that the health check could be strengthened by making the questions 
more specific, especially the diet and family history related questions. The group thought 
that some answer options were too restrictive and do not allow people to accurately answer 
questions, with this leading to inaccurate results. The terminology in the health check was 
questioned, with words such as ‘history’ and ‘positive results’ examples of words that could 
be misunderstood. 
Questions were also raised by the group over the need to capture personal identifying 
information (e.g name and telephone number) at the start of the health check, and again 
before results are revealed. The group agreed that gender and age information was useful, 
but that the other information may put people off using the health check. 
Overall, the health check content was considered to be too broad, with the length of the 
health check too long for an intervention that is trying to get people who would not 
normally think about their health to do so. The group likened the health check to a full 
medical history, with this viewed as excessive and not necessary for such a health 
intervention. Whilst the content of the health check was viewed by the group as credible, it 
was perceived to be too long and containing questions that were irrelevant or non-
pertinent. Focusing the health check so that it contains fewer questions will help to get 
across the key messages. Streamlining was also deemed to be beneficial in terms of uptake, 
as the group felt more people would complete the health check if it was shorter.  
How to conduct the health check 
The group raised questions over how the health check was intended to work, and whether it 
was supposed to be completed by people opportunistically online, or whether it would be 
taken out in to communities. Both avenues were deemed acceptable, but it was felt that the 
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health check would need to be adapted and strengthened for either approach to be 
successful. 
For online completion, the group thought that the health check would need to be shorter 
and more visually appealing. Social media was discussed as a way to promote the online 
version of the health check. The group viewed the online version as a potential way to make 
people think about their health and then encourage them to do something about it. 
However, in order for this to be achieved, changes outlined above would need to be made. 
Whilst the internet was considered a way to engage some people, the group also discussed 
that this medium may not target the people who are most at need of such an intervention. 
Older people are an example of a group of people who would be less likely to engage with 
the health check in this format. 
Taking the health check out to the community and having a trained advisor to help people 
complete the health check was also discussed. The group discussed how, if done in the right 
settings, this could lead to people engaging with their health who would not usually do so. 
The support and signposting offered by an on hand advisor was viewed positively, especially 
for potential anxiety or concerns over results. However, the sustainability and the ability to 
demonstrate public health impact via this method was questioned, due to the large number 
of people who would need to complete the health check in order demonstrate impact. 
Places to conduct the health check 
The group felt that the health check would not be best placed in supermarkets or shopping 
centres, as people would not be willing to give up their time to complete a health check in 
such places. Places where people already spend a lot of time were viewed as better 
alternatives, such as the work place or community events. Drop in sessions in community 
venues were also discussed as a way of engaging people.   
Conducting the health check in places such as the pharmacy or GP waiting room were also 
discussed by the group, but it was felt that people do not want to extend their time in such 
places and would not be particularly willing to conduct the health check. 
Implementation and sustainability of the health check 
In order for the health check to be implemented successfully, the different dissemination 
pathways (internet and in person with an advisor) need to be given some more thought and 
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clear marketing strategies should be considered. The target audience (e.g age, ethnicity) also 
needs to be defined, as this will help guide decisions about content and marketing. 
Primarily, the content of the health check needs to be re-considered, as the group felt that it 
is too long and too broad in its current form. Streamlined content could lead to a more user 
friendly and approachable intervention.  
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Appendix 15: Focus group summary 3 
Community partner focus group Site 1 
Overall, the Tenovus health check was viewed positively as a useful tool for encouraging 
people living in community first areas in [place] to engage with their health. A number of 
barriers and facilitators to cancer awareness and early help-seeking were discussed. 
Barriers to going to the GP 
The group discussed the extent to which cancer is seen as a health priority for people in the 
local community. It was felt that people deal with their health when it becomes a crisis, 
rather than looking to prevention or seeking medical help early in the symptom experience.  
Concerns and priorities of the people in the community were also discussed, with concerns 
about bills, children and food the main priority and therefore potential barriers to 
prevention and early help-seeking. 
Difficulty getting an appointment to see the GP was discussed as a barrier to early 
presentation in the community. Sometimes people are required to ring GP practices at 
8.30am to get appointments, and for many this is not possible. 
Some people in the community are not registered with a GP. In these cases, it is hard to get 
people to register with a GP, and even harder to get them to make an appointment. 
Length of time in GP appointments was also mentioned as a barrier to discussion about 
health concerns. People feel they do not have enough time in appointments to explain their 
problems, and also feel that they can only go to the GP with one health concern, as opposed 
to multiple health problems. The ‘door handle’ diagnosis was also discussed, with this 
reflecting that many people wait until the end of the consultation to mention their real 
concern. 
There are also many negative beliefs about cancer that are held within the community, with 
cancer feared and considered a ‘death sentence’. These beliefs can lead people to think 
there is nothing they can do to prevent cancer, and may be particularly prominent in older 
members of the community, who would rather not know what is wrong with them.  
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Facilitators to going to the GP 
People in the community have often had experience of cancer in friends or family, which 
may help to raise levels of awareness. Cancer is now much more in the open, with cancer 
discussed in community places, such as clubs, as well in newspapers and on TV shows.  
Building relationships with community partners who they see regularly, such as tenancy 
support workers, can help people become more aware and engaged in their health by 
making it easier to disclose health issues, or for others to pick up on potential changes in the 
individual that are indicative of health problems. In these situations, people can get support 
and be encouraged to visit their GP. Sometimes it can be easier for people to talk to support 
workers than friends or family. 
Making GP practices more accessible with home visits and evening opening times was 
viewed as making easier for people to discuss their health concerns with a GP. Past 
experiences with sympathetic GPs can also help people re-engage with their health and help 
them feel confident and comfortable in presenting to the GP with concerns. 
Health check content 
The Tenovus health check was viewed favourably in comparison with other tools such as the 
Welsh Government’s ‘Add to your life’ online check, due to its brevity and efficiency.  
The group agreed that the health check could be strengthened by including information on 
recommended cancer screening. If people in the community were aware of and engaged 
with screening it may help problems to be picked up earlier, with early diagnosis a priority 
for better outcomes. It was felt that the screening information would be particularly 
relevant to the people who received ‘amber’ results, as this would emphasise that while 
there may not be an immediate risk of a health problem, it would good to signpost them to 
age/gender appropriate screening. 
Literacy levels were also discussed, with suggestions made to reduce the text and increase 
the number of pictures in the health check to make it more accessible and understandable. 
Questions were also asked about the use of the health check with people who are visually 
impaired or who speak other languages.  
The traffic light system was viewed positively as it was considered a clear way to show 
people their results. The use of tablets as a platform for the health check was viewed 
favourably and were seen as easy and intuitive to use.  
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The ability to print off the results of the health check was praised, and the printouts could be 
useful for people to take along with them to GP appointments.  
How to conduct the health check 
Overall, involving a trained advisor was considered preferable to people doing the health 
check alone because it would allow on hand support and advice to be provided, especially 
for people who receive ‘red flag’ traffic light results.  
It was thought that the opportunity to complete the health check alone should be available 
for those that want it, with the advisor available to answer questions and to discuss the 
results if needed.  
Places to conduct the health check 
 It was thought that the health check could be carried out in various places, such as rugby 
clubs, coffee mornings, church mornings and local events, such as healthy living days.  
Introducing the health check into ‘safe’ environments that people are familiar with may 
make them more likely to complete the health check. 
The length of the health check was viewed as lending itself to being conducted at the end of 
other sessions, such as housing discussions or other one-to-one meetings with community 
partners. 
Ways in which the health check could fit with current local initiatives was discussed, and 
could be maximised by training local community partners. This would remove the barrier of 
having to wait for a Tenovus health check Advisor to carry out the health checks, and could 
facilitate increased use and spread.  
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Appendix 16: Focus group summary 4 
Community partner focus group Site 2 
Overall, the Tenovus health check was viewed positively as a useful tool for encouraging 
people living in community first areas in [place] to engage with their health. A number of 
barriers and facilitators to cancer awareness and early help-seeking were discussed. 
Barriers to going to the GP 
The group discussed that people in community first areas are aware of cancer, but tend to 
think ‘it won’t happen to me’. People may turn to family members or elders about health 
concerns instead of going to visit their GP.  
The similarity of many cancer symptoms to symptoms for other illnesses was described as 
making it harder for people to attribute symptoms to cancer. This can sometimes lead to 
people minimising their symptoms and attributing the symptoms to something else. 
Difficulty getting an appointment to see the GP was discussed as a barrier to early 
presentation in the community. In many cases, unless it is an emergency, people have to 
wait around 2 weeks to get an appointment, with this discouraging people from going to see 
the doctor. Length of time in GP appointments was mentioned as a barrier to discussion 
about health concerns. The amount of time for appointments may not be long enough for 
the patient to explain themselves, with this leading to feelings of being rushed and 
pressured. 
The cultural diversity of the community was discussed, with some people not aware of the 
GP service as a place to discuss health concerns. If people have come from countries where 
they previously didn’t have a doctor, or had to pay lots of money to see a doctor, they often 
assume it is the same in this country. People therefore need to be made aware of the 
services that are available to them. There are also language barriers as a result of cultural 
diversity. 
There are also many negative beliefs and fears about cancer within the community. People 
are also concerned about bothering the doctor and wasting the doctor’s time. These feelings 
are particularly prominent in older members of the community. In some cases, people fear 
being taken seriously by the doctor. 
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Facilitators to going to the GP 
People in the community have often had experience of cancer in friends or family, which 
may help to raise levels of awareness. Experience of cancer in friends or family, and 
discussions with friends and family were thought to contribute to people’s knowledge about 
cancer. Cancer is now much more in the open, featuring more frequently in the media and 
on TV. This is especially the case for the more well publicised cancers, such as breast and 
testicular. It was felt that there is a lot to be gained through early diagnosis of cancer, and 
awareness of the different types of symptoms could help people make decisions to present 
to the doctor. 
Provision of clear information or guidelines on when to seek help would help people know 
when to go and see their doctor. For example, if people were told to seek help after 
coughing for X amount of weeks, or if a mole had grown X millimetres.  
Building relationships with community partners or other people in the community can help 
people become more aware and engaged in their health by making it easier to disclose 
health issues. People find it easier to discuss health with people that they trust, with this 
especially the case for the BME community.  People are often receptive to the advice and 
support given to them by the trusted person (e.g. friend, family or elder), and therefore if 
this person suggests going to see the doctor with the health problem, they may be more 
likely to go. It was discussed that sometimes people seek reassurance from others to help 
legitimise the decision to go the doctor and to avoid feelings of being a troublesome patient. 
If people were aware that they could take someone along to their medical appointment it 
may encourage them to visit the GP. Having a partner, family member or friend attend the 
appointment can increase confidence and help with questions and explanations.  
Health check content 
The Tenovus health check was viewed favourably in comparison with other tools such as the 
Welsh Government’s ‘Add to your life’ online check, due to its brevity and efficiency.  It was 
felt that the health check ‘delves a bit deeper’ than other health checks, and provides 
information on real symptoms of cancer. 
The group agreed that the health check could be strengthened by including questions on 
emotional wellbeing, as well as questions about ethnicity. These questions would enable 
tailored advice and support to be given to people.  Having a ‘live chat’ option is something 
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that features on many websites, and could be a useful way for someone to directly talk to an 
advisor about any concerns. 
It was also thought that including further response options would strengthen the health 
check, as the ‘yes’/‘no’ options do not allow people to accurately answer some questions. 
Some questions were also raised about the applicability of the questions to all people, for 
example, the bleeding/menopausal questions will not be relevant to all women.  
The results section was praised as providing people with positive reinforcement, as well as 
providing people with links to seek more help. The ability to print the results of the health 
check was thought to be a useful way of helping people to reflect on their results. 
How to conduct the health check 
Overall, involving a local trained advisor was considered preferable to people doing the 
health check alone because it would allow hands-on support, advice and signposting to 
relevant local services. Training trusted members of the local community may encourage 
people to complete the health check. Completing the health check with an advisor was 
considered to be more engaging than just reading information. 
Access to IT and privacy issues were raised as concerns about conducting the health check. 
However, it was thought that these issues could be resolved by taking the health check out 
to the community, and by trusted community members acting as the health check advisor.  
Places to conduct the health check 
It was thought that the health check could be carried out in a range of venues including 
community housing, job centres, mosques, and local events such as healthy living days. It 
was discussed how the health check would be most effective if taken to communities, 
thereby encouraging people to complete the health check who wouldn’t normally access it. 
Schools were also mentioned as a potential place to conduct the health check, as many older 
BME members of the community get their information from their children. 
The length of the health check was viewed as lending itself to being conducted in places 
where people already come for support, such as housing discussions or other one-to-one 
meetings with community partners or advisors. 
Social media was considered an important tool for the implementation and take up of the 
tool, as members of the community frequently interact with such media. Endorsement of 
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the health check at strategic organisational level was also considered an important 
motivator for staff providers implementing the health check. 
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Appendix 17: Focus group summary 5 
Member of the public focus group Site 1 
Overall, the group liked the Tenovus health check and thought it could be used with lots of 
different age groups. There were lots of ideas for places where people could do the health 
check. The group talked about the symptoms of cancer and the sorts of things that might put 
people off going to the doctor, as well as things that could make it easier to go to the doctor.   
 
Symptoms of cancer 
 
The group came up with a long list of symptoms that could be cancer and then put these in 
order of how long it would take to go and see the doctor.  
 
Some people in the group said they would go straight to the doctor, whereas others said 
they would ask someone for advice, look on the internet or try to block it out. If the group 
asked someone else for advice, they would pick someone who they think knows a lot about 
cancer. This might be a family member or friend who has some medical training (e.g. a 
nurse) or someone who has had cancer before.  
 
Things that make it harder to go and see the doctor 
 
The group talked about the sorts of things that would put them off going to see the doctor 
with a symptom of cancer. This could be things like embarrassment about the tests doctors 
use to diagnose cancer, fear of the unknown and fear of dying.  
 
Most of the group felt that some doctors don’t listen to what they have to say and try and 
rush appointments. Some of the group would be worried about wasting the doctor’s time. 
The group also talked about the receptionists in the doctor’s surgery. Some of the group felt 
that they were like gate keepers and will not give you an appointment quickly. The group 
thought this was because they did not know that some symptoms need to be seen quickly.  
 
Things that make it easier to go and see the doctor 
 
Some of the group could think of doctors that take lots of time and listen to what you have 
to say. Having a doctor like this makes it much easier to go with a symptom of cancer.  
 
 
419 
 
Health check likes 
 
The group thought that the health check was easy to understand with not too many 
questions. The group also liked how you could pick if you wanted to do it on your own or 
with someone else. The group liked the traffic light system. They thought this would help 
people to pick the most important things that they need to change. The group also thought 
doctors might take people more seriously if they had done the health check.  
 
Health check dislikes 
 
The group thought that there should be more information on how to look out for symptoms 
of cancer. They thought that there could be more information about asking for help from 
other health care professionals rather than just doctors.  
 
Places to do the health check  
 
The group came up with lots of ideas for places to do the health check. These were: drop in 
centres, a mobile van, community centres, GP surgeries and colleges. The group thought 
that the best people to give the health check would be people who have had cancer before. 
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Appendix 18: Focus group summary 6 
Member of the public focus group Site 2 
Overall, the group liked the health check. The group came up with lots of ideas for how the 
health check could be improved. The group talked about the symptoms of cancer and the 
sorts of things that might put people off going to the doctor, as well as things that could 
make it easier to go to the doctor. 
Symptoms of cancer 
The group came up with a long list of symptoms that could be cancer and then put these in 
order of how long it would take to go and see the doctor.  
The group said they would either go straight to the doctor or speak to a nurse if they had a 
symptom which could be cancer. Some of the group would not tell anyone else about their 
symptoms. Others would tell to someone close to them e.g. wife before going to see the 
doctor or nurse. 
Things that make it harder to go and see the doctor  
The group talked about the sorts of things that would put them off going to see the doctor 
with a symptom of cancer. They felt that some doctors don’t listen and that the 
appointments are sometimes rushed. Other things that put the group off going to see the 
doctor were seeing a different doctor every visit and having to wait a long time to get an 
appointment. The group also talked about fear of the unknown and anxiety about cancer.  
Things that make it easier to go and see the doctor  
Some of the group said that making a list of things they need to talk about before going to 
see the doctor helps. The group talked about how people seem to be less embarrassed and 
are more able to talk about cancer now compared to the past.  
Health check likes  
The group thought that the health check was a good idea. They thought the length was good 
and liked how anyone could be trained to do the health check with people. The group liked 
that there is a free helpline number in case people were worried when doing the health 
check. 
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Health Check dislikes  
The group thought that there was too much information at the end. They thought that some 
people might find it scary and that some people e.g. people with learning disabilities might 
not understand it. The group suggested that the information could be shorter with more 
pictures or videos. The group also thought that pictures and pop-up definitions in the 
question section of the health check could be used.   
The group thought that the health check should be available in more languages. The group 
felt that there should be some information to say that it is a secure site as they were worried 
about their personal details.  
Places to do the health check  
 
The group came up with lots of ideas for places to do the health check. These were: libraries, 
community centres, GP surgeries and schools. The group really liked how Tenovus would 
come to communities and do the health check with people.  
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Appendix 19: Topic guide for member of the public focus group 
Topic guide members of the public focus groups 
PUBLIC FOCUS GROUP TOPIC GUIDE 
 
BACKGROUND 
 Welcome and thanks; introduce the researchers. 
 Brief background on purpose of the focus group (setting the scene in terms of what is 
known about influences on cancer awareness and help-seeking, but that research is 
needed to understand the needs of deprived communities & develop targeted 
interventions such as the health check). 
 Explain what will happen in the focus group; etiquette (there are no right or wrong 
responses, everyone is entitled to their own opinion, respect for other people’s opinions 
/ try not to talk over). 
 Round of introductions from the participants (name, where you come from and what you 
do/ something about yourself). 
 
 
 
 
PART 1: INTERVENTION CONTENT 
 
 
 
A. INFLUENCES ON CANCER AWARENESS AND  
HELP-SEEKING IN THE COMMUNITY 
 
 
1.  Is health a priority for you? Is health a priority for people in your community? 
Is cancer a concern for you? Is cancer a concern for people who live in your community? 
How do you think cancer compares to other diseases e.g. diabetes or heart disease?  
What do you think about the treatments for cancer?  
Activity (write responses to the following question on individual cards): Can you think of 
any symptoms of cancer? Can you remember how you found out that these were symptoms 
of cancer?  
 
2. What would you do if you noticed a change in your body that you think might be 
cancer?      Would you tell anyone? Why would you tell this person? What do you think they 
would say?  
What would influence you in deciding what to do?  
Has anyone ever asked you for advice about a symptom? What advice did you give? Why do 
you think they came to you for advice? 
What do you think other people who live in your community would do if they noticed a 
symptom that they think might be cancer? 
Do you ever consciously look out for symptoms of cancer?  
 
3. Thinking about health care professionals e.g. doctors, nurses, pharmacists etc, who 
would you go to first if you thought you had a symptom of cancer?  
 
 
Rationale: to gain views on (a) factors 
influencing cancer awareness and help-
seeking in the local community, (b) ways 
in which the health check might facilitate. 
Aligned with Capability (knowledge, 
psychological skills, attention, behavioural 
regulation), Opportunity (environmental 
context/resources, social influences) & 
Motivation (emotions, beliefs about 
capabilities/consequences, intentions and 
goals). 
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4. Is there anything that would stop you going to see your doctor with a symptom of 
cancer?  
If you had a symptom that you think might be cancer, what would you say to your doctor? 
Would you go just for this symptom or for something else and then tell them about this 
symptom? 
What might encourage you to go?  
Probes can be barriers from BCW: knowledge, confidence, fear etc i.e. Do you think things 
like fear would stop you going to the doctor with a symptom of cancer? 
 
5. If you needed to go to the doctor, how easy would it be for you to go and see them?  
What is it like getting an appointment? How easy do you find it to talk to the doctor? Is 
distance/travel a problem? Do you feel confident talking about symptoms with your doctor?  
Are there other things that get in the way when going to see the doctor? Probe – attitudes, 
awareness, beliefs… i.e. What about your relationship with the doctor? 
Do your family members or friends influence your decision to go and see the doctor? Do you 
take anyone with you when you go to the doctors? Has experience of cancer in friends or 
family influenced your thoughts about cancer? 
What are the most important things influencing your decision to see the doctor? 
 
 
Activity: Look at the symptoms on the individual cards (previously generated from earlier 
activity). Ask participants to rank the symptoms in terms of how quickly they would make an 
appointment with their doctor.  
 
 
B. THE TENOVUS HEALTH CHECK  
 
  Now let’s talk about the Tenovus Health Check…….. Demonstration of the health check 
by the researcher (orientating to its cancer symptom awareness / early diagnosis 
functions). 
 
1. What do you like about the Health Check? What do you dislike? 
Pros and cons of content, format. 
What do you think about the information section at the end? 
 
2. What do you think are the benefits of using the Health Check? 
Do you think the health check will help you to know more about the symptoms of cancer? 
Do you think the Health Check will help you to know what to do if you had a symptom of 
cancer? 
If someone offered to do the Health Check with you, what would you do/say? What about 
other people in your community?  
What do you think about the questions in the health check about cancer symptoms? 
(Orientate and remind participants about which questions these are) 
Can you think of any problems with using the Health Check?  
 
 
3. Do you think anything else could be included in the Health Check to encourage people 
to go to their doctor quickly? 
For example, inclusion of additional cancer symptoms, links to age-appropriate screening 
recommendations, use of positive messaging to change beliefs, social 
encouragement/support, action planning (define). 
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Can you think of anything else that you would like to see included in the Health Check?  
 
 
4. Can you think of places where would it be good to have the health check?  
For example GP practice, Tenovus mobile unit, community centre, libraries, local pharmacy, 
sports clubs?  
Probe issues of confidentiality, embarrassment, stigma etc 
Can you think of ways we could advertise the health check?  
What do you think about having the health check online?  
What do you think about going through the Health check with a trained health check 
advisor? Who would you be most comfortable doing the health check with? 
 
 
5. Have you done anything like the Health Check before?  
How does it compare?  
 
 
NEXT STEPS 
We will now write up what we have talked about today, and we will email you a summary of 
what we have talked about- by post or email? 
Once we have completed a few more focus groups we will also be inviting people to take 
part in a follow-on workshop to gain feedback on ideas for modifying the health check and 
to test the evaluation study recruitment materials. It would be great if some of you would 
like to be involved with this, and we will send you an email to tell you more about this when 
the time comes.  
 
DEBRIEF 
Summary, address any questions or concerns, thanks. 
Hand out flyers for public focus groups. 
Housekeeping – travel expense & honorarium claim forms; ensure consent forms have been 
signed. 
 
NOTES: CAM symptoms: Lump or swelling, unexplained bleeding, unexplained pain, 
unexplained weight loss, change in a mole, change in bowel/ bladder habits, persistent 
cough, sore that does not heal, difficulty swallowing.  
Health check symptoms:, appetite change/weight loss , bowel change/blood in stool ,skin 
changes/moles , persistent cough, lumps and bumps , frequent urination , pain during 
sex/irregular bleeding (health check also covers: family history, BMI , Age, Exercise, Smoking 
, Alcohol, Diet, Sunburn) 
Welsh screening: Bowel: aged 60-74 every two years. Breast: aged 50-70 every 3 years.           
Cervical: aged 25-49 every 3 years. aged 50-64 every 5 years. 
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Appendix 20: Topic guide for local stakeholder focus groups 
LOCAL STAKEHOLDER FOCUS GROUP TOPIC GUIDE 
 
BACKGROUND 
 Welcome and thanks; introduce the researchers. 
 Brief background on purpose of the focus group (setting the scene in terms of what is known 
about influences on cancer awareness and help-seeking, but that research is needed to 
understand the needs of deprived communities & develop targeted interventions such as the 
health check). 
 Explain what will happen in the focus group; etiquette (there are no right or wrong 
responses, everyone is entitled to their own opinion, respect for other people’s opinions / try not 
to talk over). 
 Round of introductions from the participants (name, where you come from and what you do, 
what community initiatives you are involved in). 
 
 
 
 
PART 1: INTERVENTION CONTENT 
 
 
 
B. INFLUENCES ON CANCER AWARENESS AND  
HELP-SEEKING IN THE COMMUNITY 
 
1.  Is health a concern for people in your community?  
Is cancer a concern? How concerned are people in your community about cancer compared to other 
diseases?  
Do you think people in your community know much about cancer symptoms?  
How do people in your community find out about cancer symptoms?  
What do people in your community think about cancer / cancer treatment?  
 
2. What do you think people in your community would do if they had a potential cancer 
symptom?      Would they tell someone, go to the doctor, go somewhere else?  
What influences them about what to do? How much experience from others is there? Or personal? 
 
3. How easy is it for people in your community to go and see the doctor? 
How easy is it for people in your community to get an appointment / talk to the doctor? Is 
distance/travel a problem?  
Is going to the doctor with symptoms something that people in your community usually do?  
Are there other things that get in the way? Probe – attitudes, awareness, beliefs… 
To what extent do family members or friends influence decisions about going to see the doctor?  
What do you feel are the most important influences? 
 
4. Can you think of anything that could put people in your community off going to see their 
GP to discuss concerns about cancer symptoms?  
What could encourage them to go? 
Probes can be barriers from BCW: knowledge, confidence, fear etc 
 
 
 
 
Rationale: to gain views on (a) factors 
influencing cancer awareness and help-
seeking in the local community, (b) ways in 
which the health check might facilitate. 
Aligned with Capability (knowledge, 
psychological skills, attention, behavioural 
regulation), Opportunity (environmental 
context/resources, social influences) & 
Motivation (emotions, beliefs about 
capabilities/consequences, intentions and 
goals). 
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B. THE TENOVUS HEALTH CHECK  
 
  Now let’s talk about the Tenovus Health Check…….. Demonstration of the health check 
by the researcher (orientating to its cancer symptom awareness / early diagnosis functions). 
 
1. What do you like about the Health Check? What do you dislike? 
Pros and cons of content, format. 
 
2. What do you think the benefits of people using the Health Check are?  
Do you think the health check will help people know more about the symptoms of cancer and what to 
do? 
Is the health check something that you think could fit in with your community or not?  
Can you think of ways to support or promote the health check?  
Can you think of any problems with the health check being used by people in your community? 
 
3. Do you think anything else could be included in the Health Check to encourage people 
to go to their doctor quickly? 
For example, inclusion of additional cancer symptoms, links to age-appropriate screening 
recommendations, use of positive messaging to change beliefs, social encouragement/support, action 
planning (define). 
 
4. Where would it be good to have the health check?  
Can you think of places where it would be good to have the health check? For example GP practice, 
Tenovus mobile unit, community centre, libraries, local pharmacy, sports clubs? 
Probe issues of confidentiality, embarrassment, stigma etc 
 
5. Is using the Health Check alone something that you think could fit in with your 
community or not?  
How easy is it for people in your community to read and understand health information alone?  
To what extent will resources (internet access) hinder people in your community doing the health 
check alone?  
What do you think about the health check being done electronically rather than on paper? 
Do you think people in your community would want to do the health check with a health check 
advisor?  
Are there any groups of people within your community that you would be particularly concerned 
about using the Health Check? For example, older age groups?  
 
6. Are you aware of any other cancer awareness initiatives/tools? How do they compare 
to the Health Check? 
 
 
 
 
PART 2: INTERVENTION EVALUATION METHODS   
The next part of the research project will involve people 
completing the Health Check and then talking to us about 
their experience of using it. 
 
If we were trying to find people in your community to complete the Health Check, where 
would be best to find them? 
Can you think of any ideas to try and get people involved in the study? 
Are there incentives we could use to get people involved in the research project? (Reinforcement) 
Can you think of ways we could promote the health check so that people know about it? (Advice on 
recruitment materials.) 
Rationale: to gain views on suitable methods of 
engaging people in the study in terms of 
identifying, approaching, recruiting and 
keeping people in the study (and future trial). 
 
If time runs out, this section may be moved to 
the follow-on Advisory Workshop. 
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If we were to trial the health check, do you think people in your community would accept being 
randomised to a ‘no health check’ control group? (Explore whether delaying access to the health 
check, at the end of the study period, would be problematic.)  
 
NEXT STEPS 
We will now write up what we have talked about today, and we will email you a summary of 
what we have talked about. 
Once we have completed a few more focus groups we will also be inviting people to take 
part in a follow-on workshop to gain feedback on ideas for modifying the health check and 
to test the evaluation study recruitment materials. It would be great if some of you would 
like to be involved with this, and we will send you an email to tell you more about this when 
the time comes.  
 
DEBRIEF 
Summary, address any questions or concerns, thanks. 
Hand out flyers for public focus groups. 
Housekeeping – travel expense & honorarium claim forms; ensure consent forms have been 
signed. 
 
NOTES: CAM symptoms: Lump or swelling, unexplained bleeding, unexplained pain, 
unexplained weight loss, change in a mole, change in bowel/ bladder habits, persistent 
cough, sore that does not heal, difficulty swallowing.  
Health check symptoms:, appetite change/weight loss , bowel change/blood in stool ,skin 
changes/moles , persistent cough, lumps and bumps , frequent urination , pain during 
sex/irregular bleeding (health check also covers: family history, BMI , Age, Exercise, Smoking 
, Alcohol, Diet, Sunburn) 
Welsh screening: Bowel: aged 60-74 every two years. Breast: aged 50-70 every 3 years.           
Cervical: aged 25-49 every 3 years. aged 50-64 every 5 years. 
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Appendix 21: Coding framework 2 
Coding framework for focus groups onto COM-B (focus groups) 
Capability 
Both the physical and psychological capacity of a person to perform behaviour 
Physical (includes skills, strength, stamina) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
No codes  
1.Psychological (having the knowledge and the skills to perform the behaviour and the capacity 
to engage and direct behaviour) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
1.1Cancer 
symptom 
knowledge 
Identification of potential cancer symptoms. Also code 
here when HCPs and CPs speculate on symptom 
knowledge in the community.  
When they talk about how this knowledge was 
acquired, use the code ‘acquisition of knowledge’.  
‘Changes in digestive 
processes, anything 
dramatic, anything 
that’s sort of different’  
 
1.2Symptom  
attributions  
Any discussion around potential cancer symptom 
attributions. Code here when symptoms might be 
attributed to other benign causes, which acts as a 
barrier to symptom presentation (SP).  
‘It depends when I say 
headache....what sort 
of headache, a 
debilitating headache 
or, I’ve not had much 
sleep headache...’ 
1.3Knowledge of 
the causes of 
cancer  
Knowledge of what causes cancer or increases your risk 
for cancer (correct or incorrect). Also code here when 
HCPs and CPs speculate on community level knowledge 
of causes of cancer.  
‘They said my 
husband’s [cancer] was 
from because he was a 
steel worker’ 
1.4Communicati
on with Health 
care 
professionals  
When they mention anything about how public 
communicate with their GP or any other HCPs or vice 
versa. Also code here is communication is perceived as a 
barrier and any strategies used to aid communication 
such as the use of lists.  
‘I- Do you think there is 
anything that would be 
preventing them from 
actually going to the 
consultation or talking 
to the GP? 
P- confidence to be able 
to talk’ 
Opportunity  
All factors extrinsic to a person that either prompt the behaviour or allow enactment of the 
behaviour 
2.Physical opportunities (created by the environment e.g. time, financial resources, access and 
cues) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
2.1Practical/physi
cal barriers to 
medical help 
seeking  
Anything that acts as a practical or physical barrier to 
SP. E.g. being too busy, not being able to get to an 
appointment, disability 
 
‘I think mental health is 
an issue. Because I think 
people suffer from either 
depression of anxiety, 
seeing a GP [is difficult]’ 
 
2.2Practical/physi
cal facilitators to 
medical help 
seeking  
Any practical or physical facilitators to SP e.g.  
someone going with them to the doctors or the 
participant themselves took someone else to the 
doctors, home visits etc.  
[the CP says] ‘let me 
make an appointment for 
you, I’ll come with you, 
you know? And that has 
pushed it along’ 
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2.3Service barriers 
to medical help 
seeking  
Anything that acts as a barrier to SP that is to do 
with the health service. E.g. not being able to get an 
appointment, perceptions of not wanting to waste 
the docs time, ‘1 appointment 1 problem’ policies, 
time limited appointments, not liking a specific 
doctor.    
‘Sometimes when you go 
in about something there 
might be other things on 
your mind as well and 
you think I can’t mention 
too many things because 
they’ve only got 5 
minutes’  
 
 
2.4Service 
facilitators to 
medical help 
seeking  
Anything that acts as a facilitator to SP that is to do 
with the health service e.g. knowing they can ask for 
a different doctor, knowing that they can take the 
emergency appointments, piggy backing symptom, 
requesting an appointment earlier than the one 
given, liking their doctor.  
 
‘I’ve got a good GP’ 
 
2.5Current 
awareness 
campaigns  
When the participant mentions any cancer 
awareness campaigns or if they have not seen any 
campaigns. Also code here when the HCPs talk about 
campaign effects on presentation rates and reach.  
‘To be honest there’s 
some really good 
advertising campaigns for 
them. You know? Like 
more people survive 
cancer than die from it 
now.’ 
2.6Cancer in the 
media  
Any mention of cancer related articles or pieces in 
the media. E.g. news items, celebrities with cancer, 
newspaper articles on cancer risk etc. Also code here 
how such items in the media affect cancer 
awareness or presentation behaviour.   
‘When they did Eminem 
on the television, men 
shouldn’t be embarrassed 
to check their testicles 
and he had a t-shit to say 
he checked his, and I 
think that was good 
because the awareness is 
obviously raised.’ 
2.7Acquisition of 
cancer symptom 
knowledge 
Any mention of knowledge for how cancer symptom 
knowledge was acquired e.g. because they knew 
someone who had the symptoms, looked on the 
internet, campaigns etc. 
‘They know somebody 
who has similar 
symptoms. They think oh, 
I’ve got that aswell’ 
3.Social opportunities (created by cultural environment) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
3.1Health as a 
priority /concern  
Any comments about whether they think health is a 
priority in deprived communities or if health is a 
personal priority or concern.  
‘99% is fire fighting 
and 1% is 
prevention....short 
term health is a 
priority, long term is 
not’ 
 
 
3.2Lay system of 
health care 
When the participant is asked or says that they would 
tell anyone about a symptom or when HCPs/CPs talk 
about how symptoms are discussed with other 
members in the community. Code all aspects of the 
interaction: who, why and advice given.  
Also code here when they say they would not disclose a 
symptom. Also code when CPs say they notice 
symptoms in people in the community.  
 
 
 
‘I would tell my wife 
[about a symptom] 
because I would be 
seeking reassurance 
and possibly her 
saying to me don’t be 
silly or get yourself to 
the doctor’ 
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3.3Cultural 
barriers to 
medical help 
seeking 
When the participant talks about how culture acts as a 
barrier to SP e.g. cultural beliefs about not seeking 
medical help, only seeing the same gender doctor, 
stoicism etc.  
‘Culturally, where 
women are 
concerned, they will 
go to an elder and 
even if they were 
encouraged to go to a 
doctor at that point, 
they wouldn’t go to a 
male doctor. They 
would have to go to a 
female doctor’.    
3.4Experience of 
cancer (knowing 
someone with 
cancer) 
Any description of people they know with cancer. Code 
all details including symptom presentation behaviour, 
treatments etc.    
‘My brother is 
currently dying of 
cancer he had 
Barretts disease 
which is cancer of the 
oesophagus’  
3.5Social context/ 
environment  
Any description of the social environment in which 
people from deprived communities live in. Code here 
when the social opportunity affects health. Also code 
here for any comments about lack of trust associated 
with government.   
‘people’s 
expectations of their 
own health and the 
health of their family 
depending on where 
they live. So living in 
an area where there 
is low life expectancy, 
high premature 
mortality, everyone 
that you know has got 
a chronic condition, 
that’s what you 
expect yourself. So 
maybe there is a lack 
of motivation.’ 
3.6Talk about 
cancer within the 
community  
Any mention of how people within the community talk 
about cancer to one another, or if they don’t want to 
talk about cancer e.g. taboo around discussion of cancer 
 
‘Its just not talked 
about is it?’ 
 
 
3.7Gender 
differences  
Anything about gender differences relating to cancer or 
health e.g. presentation behaviour, self-examination 
behaviour, discussion of health issues.  
‘men tend to be 
too macho to go 
to the doctor’  
3.8Age differences  Anything about age differences relating to cancer or 
health e.g. presentation behaviour, self-examination 
behaviour, discussion of health issues.  
‘With younger 
people, to show the 
other side of the 
spectrum, is massive 
embarrassment. They 
don’t want to bear all 
to the doctor.’ 
Motivation 
The processes in the brain that energise and direct behaviour. This includes conscious decision 
making and habitual processes, emotional responses or processes involving analytical decision 
making.  
4.Reflective processes (involving evaluations and plans) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
4.1Beliefs about 
cancer  
(treatments, 
cures, early 
diagnosis)  
Any beliefs about cancer relating to early diagnosis of 
cancer, beliefs about treatments and beliefs about cures 
for cancer. E.g. They highlight the importance of 
diagnosing cancer early, comments about the side 
effects of treatments, beliefs about effectiveness of 
treatments, beliefs about curability (or not) of cancer. 
‘Years ago, if you had 
cancer, you more 
than likely died 
anyway. Now, you 
don’t. There’s lots of 
advances.’ 
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4.2 Cancer 
compared to 
other diseases  
Any comparisons made between cancer and other life 
threatening diseases such as heart disease.  
‘There is more anxiety 
about cancer then say 
about strokes or 
heart attacks’ 
4.3 Smoking 
behaviour 
Any detail about smoking behaviour (or lack of smoking 
behaviour) from the participant or members of the 
community. E.g. why they or people in the community 
smoke even if they know the risk associated with 
smoking, descriptions of how many people smoke, 
insight into why people take up smoking, stop smoking, 
general information about smoking behaviour.   
‘Young people 
smoking, they never 
think they are going 
to come to any harm 
by it’.  
 
5. Automatic processes (emotions and impulses that result from innate dispositions or 
associative learning) 
When the participant mentions any of the following for friends/ family/ other people in the 
community, double code under ‘community’ 
5.1 Fearful and 
fatalistic beliefs 
about cancer  
Any mention of fear associated with cancer or fatalistic 
beliefs about cancer.  For fatalistic beliefs associated 
with ‘no cure for cancer’, double code under ‘Beliefs 
about cancer (treatments, cures, early diagnosis).  
‘If you mention 
cancer, it’s almost like 
a death sentence’  
 
5.2 Emotional 
barriers to 
medical help 
seeking  
Anything that acts as a barrier to symptom presentation 
that is emotive. These might be quite similar to beliefs 
or cancer worry, but only code here when the 
participant explicitly states that these emotions will act 
as a barriers to their or others HSB. E.g. fear and worry 
of what they symptom might be, embarrassment. 
‘I think there is the 
fear of what they 
might be told...some 
people just wouldn’t 
go because they don’t 
want to hear it.’ 
 
5.3 Emotional 
facilitators to 
medical help 
seeking  
Things that make it easier for the person to seek 
medical help that is emotive. E.g. their fear motivates a 
visit to the doctor, anxiety, help seeking for reassurance 
 
‘you just cant take a 
chance, if you’ve got 
a concern, see the 
doctor’ 
5.4 Cancer 
concern/ worry/ 
denial 
How much the participant or people in their community 
worries about getting cancer. Also code here when they 
avoid cancer with denial.  
‘It’s [cancer] at the 
back of your mind all 
the time’ 
6. Behaviour 
Performance or intentions to perform a behaviour 
6.1 Symptom 
presentation  
Any discussion around actual SP behaviour of the public 
or when CPs/HCP talk about actual presentation 
behaviour in members of the community/ patients in 
their surgery.  
Also code here any discussion around timelines or time 
scales for presenting with symptoms in the public FGs 
using flash cards. 
  
 ‘if you had a lump, 
you’d go now 
wouldn’t you?...I’d be 
on my way, for me a 
lump is quit e 
important.’ 
6.2 Community 
health behaviours  
Anything discussion around changes in health 
behaviour. Also code here for reluctance to change 
health related behaviours.    
‘We are very active, I 
try to eat sensibly’ 
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7. Other codes that do not fit under COM-B 
7.1 Suggestion for 
an intervention  
When the participant generates any ideas for an 
intervention to encourage more timely symptom 
presentation. Or any suggestions for interventions 
that they don’t think would work.  
‘if there were 
guidelines, say, for 
example, if you’ve got 
a mole and you know 
you should go to the 
GP if it’s wider than X 
number of 
millimetres...that will 
make someone more 
likely to go’ 
7.2 Information 
about the 
participant  
Any demographic information about the participant. ‘I’m [name], I am the 
housing manager for 
[name]’ 
7.3 Talk not 
related to topic of 
interest 
 
Code anything here that is not related to what the 
focus groups are trying to capture. Also code the 
health check section here. 
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Appendix 22: Charting of data 2 (Focus groups) 
 Theme (Social Opportunity) 
 Focus group Health as a priority/ concern Lay system of health care 
Community 
Partner (site 
2) 
People in the community do not take their health seriously enough- they 
think cancer is never going to happen to them so people in the 
community don’t try to reduce the risk factors.  
In BME communities people speak to elders or family members about symptom because they do 
not trust doctors. They also get advice from elders about good/ bad experiences in health care- if 
they have had a bad review then they are put off going to the doctor. If people go to the 
community partner about symptom they suggest they go to the doctor about it.  
HCP (site 1) 
Health is 99% firefighting, 1% prevention- short term health is a priory, 
long term health is not.  
People in the community speak to family members/friends about symptom before going to see 
the HCP- they described times when people come in with family members with symptoms. They 
often have people phoning up to book someone else an appointment for them or people saying 
they are coming in because someone else made them go to the doctor.  
Public (site 
1)  
P’s felt that health was a priority for them, but for younger people in the 
community health is not a priority- the younger generation think they 
are invincible. They feel that it is all about avoidance- ignoring health so 
they don’t have to deal with problems and just put off getting checks 
etc.  
One participant recalled someone approaching to him with a lump symptom- he suggested that 
he should go to the doctor and the person was diagnosed with cancer. The individual was scared 
that his testicles would be removed, so he was asking the participant for advice on what to do. 
Another said she forced her husband to go to the doctors. Another participant would ask his 
partner for advice because she has had cancer.  
HCP (Site 2) 
Concern about health in the community is massively variable- for most 
health is not a concern until it becomes a problem. People struggle to 
take responsibility for their health. There was a perception that health in 
the community is not their problem, but the doctors problem. People 
don’t seem to want to maintain health, they just deal with problems 
when they become a  problem. People who come in with symptoms 
tend to be driven by anxiety.  
Patients tend to go to family members/friend/google to seek advice before going to see the 
doctor. Then they talk about bad experiences with tests/operations which can potentially put 
them off going. They worry that the loss of the traditional family structure is going to change the 
way in which advice is sought.  
Community 
Partner (site 
1)  
People in the community don’t see health as a concern- health is a the 
bottom of a pile of more important issues- e.g. paying the bills are more 
important. Health is dealt with at crisis point in a firefighting type role. 
Priorities are paying the bills- bad health behaviours e.g. smoking. is a 
way of dealing with daily life problems. Talking about health in the 
community is a taboo subject.  
People in the community ask support workers or family and friends for advice on symptoms. But 
talking about health in the community is a taboo. It tends to be that those who are diagnosed 
with early stage cancer, the support workers has noticed a symptom and suggested to go to the 
doctor/ accompanied them to an appointment.  
Public (site 
2) As people get older health becomes more of a concern 
People would tell family members/ friends about symptoms first to seek reassurance. Some 
would offer poor advice as they would not want to worry them.  
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 Theme (Social Opportunity) 
Focus 
group Cultural barriers to HSB 
Experience of cancer (knowing people in the 
community with cancer)  
Social environment/ context 
Community 
Partner (site 
2) 
BME community- medical help seeking is not the 
norm- it is perceived as a sign of weakness and 
taboo to seek medical help, so they tend not to 
seek help. Language barriers are also a problem. 
Self-examination behaviour is not a cultural norm.    
Lots of mistrust of the government and fear of authority in the 
community- they feel as though the government has an ulterior 
motive. They discussed the important of social networks and 
norms for health behaviours, therefore they suggest we study 
the social context of behaviours. They discussed lots of other 
problems with debt, housing- a cancer diagnosis is just too 
much for people in the community to deal with.  
HCP (site 1) 
The elderly population have seen lots of people 
dying from cancer. Therefore they are fearful of 
cancer. Fear is a big barrier. In addition, older 
generations tend to not want to bother the 
doctor.    
People go to the doctors to make sure they get signed off 
because there is high levels of unemployed (ESA)- this generally 
takes up the whole consultation timeslot- they will prioritise this 
and not discuss worrying symptoms.  
Public (site 1)    
Most participants know a few people with cancer- 
generally relatives or spouses, some of whom had died. 
Described instances when cancer had been detected by 
accident or cancer detected too late.  People in the community feel disempowered.   
HCP (Site 2) 
A cultural issue is that people don’t want to check 
their stools for blood- they come in with certain 
symptom and are asked if they have any blood in 
their stools but they say they don’t look at their 
stools so they are unsure. Social problems with 
housing and debt problems mean people in the 
community simply can’t cope with a cancer 
diagnosis- it would just another thing so they just 
don’t deal with it and ignore symptoms.  
People have certain expectations of what cancer is 
supposed to be like based on the people they know 
within the community with cancer. They form beliefs 
based on this and when they ask for advice on 
symptoms from family members/ friends they usually 
get told about all the negative things that happen 
during tests/treatment.  
 
Community 
Partner (site 1)    
People in the community know lots of people with 
cancer, usually with fatal circumstances.  
 
Public (site 2)   
Knew lots of people who have had cancer- mainly 
spouses who died from cancer or are currently 
diagnosed with terminal cancer. They are aware of lots 
of nasty treatment side effects because participants 
tend to nursed their spouses.  
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 Theme (Social Opportunity) 
Focus group Gender differences Talk about cancer in the community age differences  
Community 
Partner (site 
2) Women are more likely to go to the doctors than men     
Older members of the community tend to not want to 
bother the doctor.  
HCP (site 1)     
Younger patients tend to be the worried well- younger 
people in the community seem to be more aware of the 
red flag symptoms. The elderly see a lot of people dying 
of cancer and form negative beliefs about cancer.  
Public (site 1)  
Women more likely to do go to the doctors because 
they are more used to being in contact with health 
services and are less embarrassed to seek help. Men 
tend to put off going to the doctor.    
Younger people in the community think they are 
invincible  
HCP (Site 2)   
Unsure know how to react to people in the community who 
have cancer.  
Younger people in the community engage in harmful 
health behaviours such as smoking as they think they are 
invincible and will not become ill.   
Community 
Partner (site 1)  
Men are worse at seeking help, they usually present 
when in the advanced stages.  
They think doctors don’t even use the word ‘cancer’- they use 
different words to avoid using the word cancer to minimise 
distress 
The older generation are in more denial- have the 
attitude of they are going to die of something anyway so 
don’t need to be aware of symptoms/seek medical help.  
Public (site 2)  
 They think people are much more  open about cancer now 
and talk about it more than they used to 
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Appendix 23: All barriers and facilitators to behaviour   
Non-modifiable barriers/facilitators to 
prompt lung cancer symptom presentation  
Modifiable barriers/facilitators to prompt 
lung cancer symptom presentation 
Individual characteristics 
1.Age 
2.Gender  
3.Pre-existing co-morbidity 
4.Living alone  
5.Ethnicity  
6.Disability  
7.Previous health service utilisation 
8. Mental health  
Individual characteristics 
28.Smoking behaviour  
29.Stoicism 
Cancer knowledge 
N/A 
Cancer knowledge 
30.Knowledge of the symptoms of lung 
cancer 
31.Perceptions of symptom severity 
32.Lack of pain associated with lung cancer 
symptoms 
33.Belief lung cancer is symptomless 
34.Number of symptom(s) 
35.Worsening of symptom(s)/symptom(s) 
impacting on daily life 
36.Duration of symptoms(s) 
37.Symptom type (vague e.g. persistent 
tiredness vs specific e.g. haemoptysis) 
38.Attribute symptom(s) to smoking habit 
39.Attribute symptom(s) to co-morbidity 
40.Attribute symptom(s) to age 
41.Perceptions of the causes of symptoms 
42.Perceptions of individual risk of 
developing lung cancer 
Self-efficacy/skills 
9.Trait self efficacy  
 
Self-efficacy/skills 
43.State specific self-efficacy 
44.Confidence when communicating 
symptoms to the GP 
45.Listening skills during an appointment 
with the doctor 
46.Ability to articulate symptom concerns 
47.Knowledge of what to do when the 
individual experiences a symptom(s) 
48.Knowing how to book an appointment 
with the doctor 
49.Health information seeking 
Health service factors 
10.One appointment one problem policies  
11.Time limited appointments 
12.Not being able to get an appointment 
with the GP quickly 
13.Relationship with GP  
14.Interpersonal skills of GP 
Health service factors 
50.Worry about being told to stop smoking 
51.Concerns about wasting GP time 
52.Perception the GP cannot help/resolve 
the symptom(s) 
53.Worry about being perceived as a 
hypochondriac 
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15.Receptionist at the GP 
16.Lack of trust in the healthcare system 
17.Unable to get an appointment with 
preferred doctor 
18.Appointment booking policies 
 
Beliefs about lung cancer/treatments 
N/A 
Beliefs about lung cancer/treatments 
54.Beliefs about early diagnosis 
55.General fatalistic beliefs about cancer (no 
cure, death sentence, bad luck) 
56.The belief that lung cancer is a fatal 
disease 
57.The belief that there is no treatment for 
lung cancer 
58.Fear of the treatments for lung cancer 
Community factors/competing priorities 
19.Work commitments  
20.Family commitments  
21.Media influences  
22.Previous experience of cancer  
23.Lack of transportation 
24.Proximity of GP practice to house 
25.Financial commitments/worries 
Community factors/competing priorities 
59.Using a lay system of 
healthcare/symptom disclosure 
60.Cultural messages to reduce GP 
consultation behaviour 
Emotional barriers 
N/A 
Emotional barriers 
61.Fear of the unknown 
62.Shame 
63.Stigma associated with lung cancer 
64.Fear of a diagnosis of lung cancer 
65.Worry about what the doctor might find 
66.Fear of diagnostic tests 
67.Embarrassment around disclosure of 
symptoms 
Responses to symptoms/behavioural 
response 
26.Under frequent review for other health 
problems  
27.Previously presented with a symptom and 
told was not serious 
Responses to symptoms/behavioural 
response 
68.Use of traditional medicines 
69.Avoidance 
70.Denial  
71.Watchful waiting 
72.Self-management/self-medication  
73.Use of over the counter medicines 
74.Belief that the symptom will resolve on its 
own without medical intervention  
75.Appointment booked for another reason 
(piggybacking) 
76.Wait for another symptom/health 
complaint to appear  
77.Intention to act on symptom(s) (if 
symptom persists for three weeks) 
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Appendix 24: Intervention slides and corresponding script  
 
Welcome and introductions myself and observers. Group introductions.  
Structure of the morning. Right to withdraw etc. “Can everyone hear me and see the 
screen?” 
 
 
 
 
“There are lots of different types of lung diseases, for example asthma, emphysema, COPD, 
pneumonia and lung cancer. Today we are going to talk about lung cancer. By the end of the 
session, we will have talked about the signs and symptoms for lung cancer, and what to do 
if people in the community have these symptoms. We will talk about why it is important for 
people in the community to go to the doctor quickly with these symptoms. I will give you 
some advice on how prepare yourself for an appointment with the doctor, some tips on 
what people can take with them and how to tell the doctor about symptoms.”  
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“I’m not a doctor, so I can’t give you any specific advice on a symptom, but I can tell you 
where you can get help from. Also, this is not a smoking cession session. I will not talk about 
how to quit smoking, it is not the aim of this session. If you would like some advice on how 
to quit smoking, then I have some leaflets and phone numbers of services that can help you 
quit. Please let me know at the end of the session. Today is all about lung cancer only. If you 
would like some information leaflets from Cancer Research UK on other cancers, please let 
me know and I can send you some more information in the post.” 
 
 
 
“To start, I’m going to show you some of the things I often hear people say about lung 
cancer. I’d like to know if you think they are true or false, then I will tell you the answer.” 
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True or false: ‘There is no treatment for lung cancer’. Who thinks this is true? Who thinks 
this is false? Who is not sure? 
 
“False. There are lots of treatments available for lung cancer. If lung cancer is caught in the 
early stages, there are more treatments available and they are better and more effective. 
For example, when lung cancer is in the earliest stage, so if found quickly, patients can have 
an operation to take away the cancer. This is offered to about 20% of people with lung 
cancer. Scientists are constantly working to develop more treatments for lung cancer. So the 
treatments for lung cancer are getting better and more effective.” 
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True or false: ‘If you catch lung cancer in the early stages it can be cured’. Who thinks this is 
true? Who thinks this is false? Who is not sure? 
 
“True. Lung cancer can be treated and it can be cured if the cancer is found quickly. If lung 
cancer is found in the early stages, there are more treatments available and it is possible 
that lung cancer can be cured. Unfortunately today, lung cancer is often diagnosed in the 
later stages, where a cure is less likely. Currently, there is no screening service for lung 
cancer like there is for breast, bowel and cervical cancer. This means we need to get people 
to be aware of symptoms of lung cancer and go to the doctor quickly if they notice 
anything unusual. The quicker people to go to their doctor, the more likely lung cancer will 
be diagnosed in the early stages. We will talk later about what to look for and the types of 
advice you can give people on when to go to the doctor.” 
 
 
442 
 
 
True or false: ‘When air gets to cancer, it can make the cancer spread’. Who thinks this is 
true? Who thinks this is false? Who is not sure? 
 
“False. I hear this quite a lot, and it is probably one of the things that puts people off going 
to the doctor to get help or treatment for cancer. There is no scientific evidence that an 
operation or the air getting to cancer can cause cancer to spread.”  
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“So what is cancer? We have millions of cells in our body. Sometimes we can get abnormal 
cancer cells. If they multiply and grow, they can cause a tumour or cancer in any part of the 
body.  
   
Today we will be talking just about lung cancer. Your lungs are here [point to picture]. To 
diagnose lung cancer, the doctor sends the person to the hospital for an x-ray (a picture to 
look inside the lungs). It doesn’t take long and it doesn’t hurt. Once lung cancer is diagnosed 
the medical team will decide which is the best treatment for the person with lung cancer.” 
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“It is important to understand who is most at risk for lung cancer. This means the types of 
people where lung cancer is most common. This is because a lot of the signs and symptoms 
for lung cancer are similar to other things like a cold or asthma etc like a cough that won’t go 
away. We will talk more about these in the next section. Obviously the doctor cannot send 
everyone who has a cough for further tests, so the doctor will send those who are most at 
risk and also have signs and symptoms of lung cancer.   
  
People who are over the age of 40 and who currently smoke or used to smoke are more at 
risk for lung cancer. Some people who have given up smoking think their risk for getting lung 
cancer is zero. It is really good that they have given up smoking because their risk for 
getting lung cancer and other cancers is lower than if they were still smoking, but they are 
still at increased risk compared to people who have never smoked. So ex-smokers need to 
look out for some of the signs and symptoms of lung cancer too and go to the doctors if they 
have any of them and tell the doctor that they used to smoke.  
  
It is much more unlikely you will get lung cancer if you have never smoked, but it is 
possible. For example, people who breathe in other peoples smoke or used to work in mines 
or used to work with asbestos are at increased risk for lung cancer. So it is important that 
these people look for these symptoms and tell their doctor.” 
 
 
 
 
445 
 
 
“In this section I will tell you about some of the signs and symptoms of lung cancer. These 
are the sorts of things you should look out for in others and when they should go to the 
doctor. I have a hand-out to give you at the end of the session for you to keep. This has 
information on what to look for and when to go to the doctor. 
 
“A cough for 3 weeks or more or you a notice a change in someone’s normal cough. Cough’s 
often come and go. A cough can be a sign of lots of things, they might have always had a 
cough, especially if they smoke or it could be a sign of something like a cold. If someone has 
had a cough for 3 weeks or more, they should go and see their doctor. If someone else says 
that they have ‘always had a cough’, the important things to look out for are any changes in 
the cough or anything unusual. Also, if someone has a cough in combination with any of the 
other following symptoms they should go and see their doctor. A cough can be due to many 
things, but it is best to get it checked out.”   
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“Coloured or bloody phlegm. If someone is coughing up phlegm and it has blood in it or it 
has changed from it normal colour, especially if it is greeny in colour, they should go and 
see their doctor straight away. If they are unsure if their phlegm is coloured or bloody, just 
ask them to check the tissue next time to see if there is any blood in it or if it is green in 
colour. They should go to their doctor straight away. It could be nothing, but it’s best to get 
it checked out.” 
 
“Shortness of breath. If you know someone who feels like they just can’t catch their breath 
when doing normal tasks. If this has happened slowly they should go and see their doctor if 
it lasts for 3 weeks or more. If this happens suddenly and they feel very short of breath very 
quickly, they should go and see their doctor immediately. It could be nothing, but it’s best 
to get it checked out.” 
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“Chest pain. If someone you know has chest pain, they should go and see their doctor 
straight away. It could be nothing or something else, so it’s best to get it checked out.” 
 
 
“Weight loss. Weight tends to go up and down slightly. But if you notice that someone has 
been loosing weight without trying to especially over a short period of time or they can’t 
explain why they’ve been loosing weight, for example you have noticed their trousers are 
too big or they have gone down a notch on their belt, they should go and see their doctor. 
If they have not been dieting, they should go and see the doctor after 3 weeks. It could be 
nothing, and there is lots of different reasons for weight loss, but it’s best to get it checked 
out, especially if they’ve had some of the other symptoms.”   
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“Loss of appetite. Everyone has changes in their appetite at times. There are lots of different 
reasons why appetite can change. If there is a persistent change in appetite, so if you know 
someone who has been wanting to eat less for 3 weeks or longer and can’t explain why, 
they should go and see their doctor. There are lots of reasons for a loss of appetite, but it’s 
best to get it checked out especially if they’ve been losing weight.” 
 
“Feeling tired. If you know someone who been feeling tired or say they have no energy all 
the time for 3 weeks or more and can’t explain why. They should go and see the doctor 
after 3 weeks. There are lots of reasons for being tried, but it’s best to get it checked out 
especially if they’ve had other symptoms.” 
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“The problem with a lot of the signs and symptoms of lung cancer is that they can be other 
things like a cold or symptoms of other health problems we have. Here are some other 
things to consider or think about if you notice someone has one of the symptoms we have 
talked about. 
 
“Anything unusual. It is important to know what is ‘normal’ for someone. If you notice 
something which seems unusual or different for someone you know, you should tell them to 
go and get it checked out. The next time you see them you could ask them if they have been 
to the doctor about it or if they have made an appointment. This sometimes gets people to 
go to the doctor quicker” 
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“Any changes to current symptoms. Again it is important to know what is ‘normal’ for 
someone and notice any changes to what is ‘normal’. For example, someone you know may 
have had a cough for a long time. If you have noticed the cough has changed from the last 
time you saw them or you ask them and they think their cough has changed, they could 
suggest that they go to the doctor and get it checked out. 
 
“If you have noticed that someone has a new symptom that you’ve not previously noticed. 
For example, recently might have been saying they’ve had chest pain or you have noticed 
they get short of breath on tasks which they used to be fine with. You could suggest that 
they go to the doctor and get it checked out.” 
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“If you notice that someone has a couple or a few of the symptoms that we have talked 
about, then you should suggest that they go and get these checked out. For example, if they 
have had a cough for 3 weeks or longer and have been feeling tired all the time.” 
 
 
Or if they are having chest pain, shortness of breath and have noticed that they have lost 
their appetite. They should go and get these checked out.” 
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“If you know someone has had a chest infection for a while which won’t go away. Even if 
they have taken lots of medicines for it, they should go back to the doctor and get this 
checked out. They should tell the doctor that the medicine they or another doctor gave 
them is not working. You could suggest that they write down how long the chest infection 
has lasted, how many medicines they have taken and that they are not working. They could 
take this list along to the doctor.” 
 
“If it is you going to the doctor or you go along with someone, the doctor might ask what 
you think the symptom is, or say something like ‘what are you worried about?’ This is 
normal. They are trying to work out what is wrong and find out more about the problem so 
they can treat you better. You should be prepared to tell them about your concerns and 
expectations. Or you could be upfront from the start with your concerns- what you think 
your symptoms could be. They won’t think you are wasting their time or are a 
hypochondriac. You can take the piece of paper that I will give you are the end of this 
session to show the doctor to help.” 
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Comfort break and ask if anyone has any questions.  
 
 
 
“‘My friend or someone in my family told me to come to the doctor about this symptom’. I 
hear this a lot. In our research, we found that when people tell family members or friends to 
go to the doctor it makes people much more likely to go to the doctor and makes them go 
quicker. Remember earlier we talked about the importance of going to the doctor quickly 
with a symptom of lung cancer. This is because the treatments for lung cancer are better 
and someone is more likely to survive lung cancer the earlier the cancer is found. So after 
today, if someone tells you about a symptom or you notice that someone has a sign or 
symptom of lung cancer, it would be great if you could tell them to go to the doctor. 
Together we can try and get lung cancer diagnosed earlier in the community.” 
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“Activity. I’m going to read you some scenarios. They are also on the pieces of paper in front 
of you. I’d like to know what advice you would give each of these people.” 
 
 
Read the slide 
Advice:  
-Susan should go and talk to her doctor about her cough that has got worse and 
also about her tiredness. Because she is over 60 and is a smoker, she should go and 
talk to her doctor to find out what is wrong. It could turn out to be nothing, but it is 
best to get it checked out. The next time you see her, you could ask her if she has 
been to the doctor yet. If she hasn’t, you   could offer to go with her. Sometimes this 
helps people to know that someone else is there. 
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Read the slide. Advice:  
-As Aled is 25, it is unlikely that his cough is something more serious. Earlier we 
talked about the people that are most at risk being over 40, who are smokers or ex-
smokers. You could tell him to keep an eye on his cough and if it gets worse or 
changes to go to the doctors as it could be a chest infection. You could ask him if he 
has seen any blood in his cough and tell them to go to the doctors if he has blood. 
 
 
Read the slide. Advice:  
 -It sounds like the antibiotics are not working, so the doctors may need to do some 
more tests to find out what the problem is. You should encourage Ivor to go back to 
the doctor and tell the doctor that the antibiotics are not working. You should tell him 
that he needs to tell the doctors that he has had lots of antibiotics for the same 
problem but they are not working. You could offer to go with him to the doctor, 
sometimes this helps people to know that someone else is there. You or he could take 
the handout that I’ve got for you at the end of the session to show the doctor. 
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“I’m going to show you some of the most common things I hear people say which stops 
them going to their doctor with symptoms. If you are telling people to go to their doctor, 
then you might hear some similar things. I will give you some advice on possible solutions for 
these and the sorts of things you can say to someone if they say this.” 
 
 
 
 
 
 
 
 
 
457 
 
 
 
[read this] ‘The doctor will tell me that I can only talk about one problem’ 
 
“Does anybody have this problem?” 
 
Following discussion say: “Different doctors have different appointment policies. Some 
doctors will only allow you to talk about one problem during an appointment. For example, 
you won’t be able to talk about your both your cough and knee pain. Make sure you tell the 
doctors about the thing you are most worried about first and the thing that is most urgent. 
Or you can write a list before and ask the doctor to help you know which is the most 
important problem. Remember the earlier cancer is diagnosed the better, so make sure you 
tell the doctor about a symptom which are most worried about first. Make another 
appointment for the other, less urgent problem. In some doctors, you can make a double 
appointment, so if you have a few things you want to talk about ask the receptionist to 
make two appointments.  
  
Also, different doctor surgeries have different appointment booking systems, so it is worth 
checking with your surgery how they book their appointments. Some of them you need to 
ring early in the morning. Others you can ring anytime to make an appointment, but you 
might not be able to get an appointment for 2 or 3 weeks. Sometimes if you are really 
worried about something they can fit you in a little bit quicker. Tell the receptionist when 
you book your appointment.” 
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‘I get into an appointment and forget what to say’ 
“Does anybody have this problem?” 
Following discussion say: “This is very common and happens to lots of people. You could tell 
someone to write down what they want to talk about and the sorts of symptoms they have 
been having before the appointment and suggest they take this with them. You can also 
offer to go with someone to an appointment to help them tell the doctor about their 
symptoms.” 
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[read this]‘My doctor won’t take me seriously- they will just fob me off and tell me I have a 
cold’  
 
“Has anyone felt like this before?” 
 
Following discussion say: “A lot of people worry about their doctor thinking they are a 
hypochondriac or that the doctor won’t take them seriously. The doctor does want to see 
you and if someone has any of the symptoms which we have previously talked about and 
they go to the doctor in the times we talked about, then the doctor shouldn’t ‘fob them off’. 
They can take the hand out from this session with them to show the doctor, this will help. 
You should tell the person to be upfront with what you think is wrong. You could offer to 
go with them to help talk to the doctor.  
 
The doctor might prescribe some antibiotics or other medicines to see if these help before 
sending them for an xray. Symptoms can be because of lots of different things, so they might 
not get to the bottom of what is going on the first time around and you may need to go 
back after trying some other things like medicines. If they do this, make sure you tell the 
person to ask the doctor when they should make an another appointment to see the 
doctor if your symptoms don’t go away or get worse. The doctor hasn’t ‘fobbed them off’, 
the doctor is just wanting to make sure the symptoms are not something else.” 
 
 
 
460 
 
 
[read this] ‘I’m too scared to go to the doctor’  
“Has anybody felt like this before?” 
Following discussion say: “Anything to do with cancer is scary, but finding cancer early is 
really important. If cancer is diagnosed in the early stages, there are much better 
treatments available and your chances of surviving lung cancer are better. The symptoms 
could be something else, not necessarily lung cancer so it’s best to get them checked out. If 
someone is scared, you could offer to book them an appointment and go with them” 
 
 
‘My doctor will tell me to stop smoking’ 
“Has this happened to anyone before?” 
Following discussion say: “If they smoke, the doctor could tell them to stop smoking. You 
could suggest that they explain to the doctor that the reason you are here is to talk about 
symptoms and not smoking.”  
 
“Have I missed anything? Has anyone experienced anything else that might stop them going 
to the doctor?” 
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“We’ve already talked about a few of things you can take with you to help talk to the doctor. 
You can take a list of symptoms to help remember. You can take the hand out that I will give 
to you in a minute. And you can take someone else with you to help you talk about 
symptoms” 
 
“When you phone the doctors to make an appointment they might ask you if you need an 
appointment urgently. If you are worried then you can ask for a quicker appointment. You 
don’t need to tell the receptionist what you think is wrong. When you are in the 
appointment with the doctor, the doctor will ask about the sorts of symptoms you have 
been having. You can take a list with you to help you remember. They might listen to your 
chest or ask you to breathe into a small device called a spirometer. This is just to see how 
much air you breathe in and out. It doesn’t take long and it doesn’t hurt. They might then 
send you to the hospital for an X-ray which is a photograph of the inside of your lungs. It 
doesn’t take long and it won’t hurt. They might take some blood and some phlegm samples 
which they will send to the hospital for testing. If the tests do find lung cancer then the 
medical team will help the person to decide which treatment is best for them.” 
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“Today we have talked about some of the signs and symptoms of lung cancer. What to do if 
you or someone else has one of these symptoms and some tips on how to overcome some 
of the barriers to going to the doctor. Finally we have talked about how important it is to 
diagnose lung cancer early. The earlier lung cancer is found, the more likely it is to get cured 
because there are more effective treatments for lung cancer in the early stages. Here is a 
hand-out to go away with. It contains all the signs and symptoms to look for and when to go 
to the doctor with these symptoms. You can take it with you to a doctor’s appointment.” 
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Appendix 25: Intervention handout 
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Appendix 26: Ethical approval 3 
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Appendix 27: Information sheet (acceptability testing) 
What is the study all about? 
I am from Cardiff University, and I want to find out what people think about a lung health  
information session in the community. The results of the study will help to make the session 
better. This is a study funded by the charity Tenovus Cancer Care. 
Do I have to take part? 
No. It is up to you to decide to take part in this study or not. If you have any questions please 
ring me on 02920 687639.  
You can talk to your family and friends about the study. They might be able to help you 
decide if you want to take part or not.  
Before the interview starts, you will be asked to sign a consent form. I will go through this 
form with you. This is to say that you agree to take part in the study.  
If you do take part, you can stop the study at any time. You will not need to tell me why you 
would like to stop.   
What will happen to me if I take part and what do I have to do? 
If you would like to take part in the study, I will ring you to arrange a time for you to take 
part in the session. I will give you information about where the session will take place. We 
will pay for your travel to that place.  
You will take part in the lung health information session. This part will take about 1 hour. 
Before and after the information session, I will ask you to fill in a short questionnaire.  I will 
then ask you questions as a group about what you thought of the session. This is called a 
focus group, and this part will take about 1 hour. We will have a short break in between the 
information session and focus group.  
There are no right or wrong answers to my questions. I am just interested in what your 
thoughts are. All you need to do is tell me what you think of the session.   
If you do not want to answer any of my questions, just let me know and we can move onto 
the next one. If it is OK with you, the interview will be recorded.  
To thank you for your help, we would like to offer you £15 shopping voucher. 
What will happen after the interview? 
After the focus group, I will type up what you said. Your name or anything what could 
identify you will not be typed on any interviews. Some of what you say might be used in 
written research. No one outside of the research team will know you took part in the study.  
The final results will be used to see if the session is a good idea or not and to improve the 
session.  
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What happens to my personal details? 
This study is carried out by a team at Cardiff University. Your name and contact details will 
be stored on secure, password protected university computers. Your name and contact 
details will only ever be seen by members of the research team.  
Your details will not be used for anything other than contacting you as part of this study.  
Anything you say in the interview will be confidential. This means no one outside of the 
research team will know that you were in the study. Your name will not be linked to 
anything you have said in the interview. 
What are the potential risks or disadvantages in taking part in the study? 
This study involves talking about cancer. It is possible that talking about cancer may be 
upsetting. If you are upset during the interview please talk to the researcher about this. You 
can also stop the interview at any point without giving a reason. If you want to talk to 
someone else, you can contact Tenovus Cancer Care on the number at the end of this letter.  
Contact for further information
Grace McCutchan 
PhD researcher 
Institute of Primary Care and Public 
Health  
3rd floor, Neuadd Meirionydd 
University Hospital of Wales 
Cardiff  
CF14 4YS 
Phone: 02920 687197 
Email: mccutchangm@cardiff.ac.uk 
 
If there are any issues that I have not been 
able to resolve, please contact:  
Dr Kate Brain (supervisor) 
Institute of Primary Care and Public Health  
3rd floor, Neuadd Meirionydd 
University Hospital of Wales 
Cardiff  
CF14 4YS
 
The research is funded by the charity ‘Tenovus Cancer Care’ through Cardiff University 
 
Helpline 
 
Tenovus cancer care support line: 0808 808 1010 
 
The support line is open 8am-8pm, 7 days a week.  This is a free number from BT landlines. 
From mobiles, your network may charge.  
Website: www.tenovuscancercare.org.uk 
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Appendix 28: Recruitment flyer  
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Appendix 29: Pre intervention questionnaire 
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Appendix 30: Post intervention questionnaire 
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Appendix 31: Observation sheet  
Lung health intervention observation 
Name of observer:  
Date of observation:  
Purpose: To observe the group dynamic, note any questions participants ask, note any reactions participants had to the intervention   
Intervention 
section  
Topics/ questions Notes 
True/false activity  -Note the numbers of people who say 
true or false to each statement 
 
-Was anyone unsure? 
 
 
-Note any comments participants said 
about each statement 
 
 
Lung cancer treatment statement: True n=__ False n=__ 
 
 
 
 
 
Catch lung cancer early statement: True n=__ False n=__ 
 
 
 
 
 
 
Air getting to cancer statement: True n=__ False n=__ 
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Lung cancer and 
risk slides 
-Note any comments participants said 
during these slides 
 
 
-Did any one react to the smoking/risk 
slides? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptom slides -Did anyone disclose a symptom during 
these slides? 
 
-Did anyone say they know someone 
with any of these symptoms? 
 
-How did participants react to the 
symptom slides? 
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Questions/ break  What questions were asked at this 
point? 
 
Did anyone comment about the 
intervention during the break? What 
did they say? 
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Community 
responsibility 
aspect 
-How did the group interact with one 
another during this task?  
 
-Did anyone discuss what they think 
the symptoms might be? i.e. cancer, a 
cold etc.  
 
-How did the group come to a decision 
about what advice to give the 
individual e.g. 
      -Was their ‘relationship’ with the                      
individual important? i.e. If they were 
good friends would they be more likely 
to tell them to go to the doctor? 
    -Was the age and other risk factors 
such as smoking status important? 
    -Were the symptom(s) important? 
    -Any other aspects important? 
 
-Any other observations? 
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Barriers to 
symptom 
presentation 
section 
-Did participants say they had 
experienced any of the barriers? 
 
-How much discussion around each 
barrier was there i.e. was it 
manageable or was it difficult to bring 
it back to the slides if everyone wanted 
to share their story? 
 
-Did anyone come up with any other 
barriers? If so, what barriers did they 
mention? 
 
 
 
 
 
 
 
 
 
What will happen 
at the doctors? 
Any comments or questions from 
participants 
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Group 
management/ 
group dynamics 
-Was the group easy or difficult to 
manage? 
 
-Did they go off topic at any point? 
 
-Was there a few dominant people in 
the group or did everyone get a chance 
to speak? 
 
 
 
 
 
Hand out Did anyone comment on the hand out? 
If so what did they say? 
 
 
 
 
 
 
 
What questions 
were asked during 
the session? 
Please note any questions asked by 
participants during the session. Either 
in this box or in the corresponding box 
for the session.  
 
 
 
 
Any other notes/ comments/ observations 
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Appendix 32: Topic guide for intervention acceptability testing study 
Topic guide: 
Lung cancer awareness intervention user testing 
Aims: 
To present the pilot lung cancer awareness intervention to participants. A focus group 
following participation in the pilot intervention will provide the opportunity to see if the 
intervention is ‘fit for purpose’ and gain insight into the acceptability and feasibility of such 
an intervention.  
Interviewer note: 
The interviewer should stress that:  
 The focus group is not a test, we are seeing what participants’ opinions of the 
intervention are to see if it is something that could work in their community or not.  
 All comments including criticisms are welcomed. 
Prologue: 
‘Before we start, I need to give you some information about why we are doing this study and 
what you have to do.  
I would like to see what you think about a group session about lung health. At this stage, I 
am testing it to see what people think before it is finalised. So I am interested in what you 
think: both positive and negative.  
It is completely up to you whether you decide to take part or not. Taking part is voluntary. If 
you decide you don’t want to take part anymore, just let me know. You can stop the focus 
group at any point and you don’t need to give me a reason. If you don’t want to answer any 
of my questions, that is fine, just let me know and we can move onto the next one.  
If it is OK with you, I will record the group session and focus group. After the focus group we 
will type up what you said, but anything that could identify (your name etc.) you will be 
taken out. No one outside of the research team will know that you have taken part in the 
study.  
I have planned a few questions and things for us to talk about, but if you have anything else 
you want to say or add at any point, please feel free to do so.’  
[Verbally go through consent form with participants. Ask participants to sign consent form if 
they agree to take part. Give participants the baseline questionnaire. Set up audio-recorder] 
[Deliver pilot intervention to participants]  
[Give participants the post intervention questionnaire. Break for lunch] 
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[Before starting the focus group, remind participants about confidentiality and ask 
participants not to talk over each other. Go around the circle and ask participants to 
introduce themselves for the transcription] 
1. Usefulness of intervention: 
What do you think of the session? 
-What did you like? 
-What did you dislike? 
 
What part of the session would you find most useful? 
 
What part of the session would you find least useful? 
 -Was there anything that you thought was not relevant to you? 
 
What do you think of the hand out sheet with symptoms?  
 
2. Feasibility of intervention/ Reach:  
 
What do you think people in your community would think about the session? 
 -Why do you think they would feel this way?  
 
Do you think people in the community would come to the session? 
 -Who do you think would come to it? 
 -Why do you think people would not come to the session? 
 
3. Content/understanding: 
 
What did you think of the subjects covered in the session? 
-Do you think anything has been missed out? 
-Do you think there is anything in the session that should be taken out? 
 
What do you think the key messages from the session are? 
 -What was the one thing you took away from this session?  
 
What do you think about including stop smoking (smoking cessation) information in the 
session? 
 -How do you think smokers might react to including this information? 
 
What did you think about the whole session being about other people in the community? 
 
 
What do you think about noticing symptoms of lung cancer in other people in the 
community and asking them to go to the doctor? 
 -What would you say to them if they had a symptom? 
 -Would you feel comfortable doing this? 
 -How do you think they would take the advice? 
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4. Delivery of session: 
 
What do you think about the PowerPoint? Do you think the session should be delivered in 
a different way?  
 
Who do you think would be best to deliver the session? 
-What do you think about someone from Communities First delivering the session? 
 -Can you think of anyone else who could deliver the session? 
 -Is there anyone who should definitely not deliver the session? 
 
Where do you think would be best to have the session? 
 -Is there anywhere we should avoid doing the session? 
 
What do you think about the length of the session? 
 - Do you think it should be longer/shorter? 
-What could we take out of the session? 
 
What do you think of the hand out at the end of the session? 
 -Would you take it the doctor? 
 
5. Improvements:  
 
Can you think of anything else that could make the session better? 
 
Is there anything in particular that hasn’t been included, that you think should be? 
 
6. Recruitment 
 
How could we encourage people to come to the session? 
 -Can you think of any other ways we can encourage people to come to the session? 
 
How could we advertise the session in your community? 
 
 
 
Debrief 
‘Thank you for taking part in this study. We are interested in what people think of a lung 
cancer information session. The results will help us to make changes to the session to make 
it better. Anything you said will be treated as confidential. The voice-recoding will be stored 
securely. Any quotes used in published research will not have your name or anything that 
could identify you. Do you have any questions? [answer any questions] Here are my contact 
details if you have any further questions.’  
 
 
 
 
 
